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Paracocidioides brasiliensis (P. brasiliensis or Pb) IS the etiological agent of 
paracocidioidomycosis which is the most prevalent systemic mycosis m South 
America. About 60% of the clinical cases are found concentrated in Brazil and the 
disease is a major threat for the public health there. P. brasiliensis is a dimorphic 
fungus because it undergoes a morphological switching from a mycelium to yeast 
form after shifting the temperature from 26°C to 37°C. Similar morphological 
changes have been implicated to be important in the pathogenicity of other dimorphic 
fungi and they appear to be under the control of the cAMP signalling transduction 
pathway. 
In order to establish the relationship of cAMP signalling pathway and the 
morphological change in P. brasiliensis, a project was initiated to clone the key 
components of the cAMP signalling pathway and analyze their functions. To this end, 
a genomic DNA library and two eDNA libraries of Pb were constructed. Degenerate 
primers were synthesized based on the sequence of genes of several other important 
fungi in GenBa!lk. A__fter aplpliflcftti~ll:. §p~ecif~c P~R IJroducts were obtained ~Qd 
sequenced. The specific PCR products were used for labeling to screen libraries and 
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their sequences were used for designing specific primers to do genomic walking and 
RACE-PCR. Both eDNA and genomic DNA sequences have been determined for the 
key components of the cAMP signalling pathway including adenylate cyclase 
(PbCYRJ), three G protein a subunits (PbGPAJ, PbGPA2 and PbGPA3), a G protein P 
subunit (PbGPBJ), a G protein y subunit (PbGPGJ), a cAMP dependent protein 
kinase catalytic subunit (PbTPKJ), a cAMP depentdent protein kinase-like gene 
(PbTPKLJ) and a TUP gene (PbTUPA). 
The interactions of the proteins encoded by the genes in the cAMP signaling pathway 
were studied with Clontech's Matchmaker yeast-two-hybrid System III. This 
approach demonstrated that theN-terminal third of adenylate cyclase PbCyr1 1-678 can 
interact with PbGpal and PbGpbl. To further test ifPbGpa2, PbGpa3, PbRasl, and 
PbActin can interact with adenylate cyclase, random mutagenesis libraries were made 
for these genes and screened with PbCyr1 1•678, PbCyr1 600-1316, PbCyri 1302- 1876 and 
PbCyr1 1648-2100 . It was demonstrated that PbCyrl 1-678 , where the Ras association 
domain resides, can interact with truncated versions ofPbGpa2, PbGpa3, PbRasl, and 
PbActin, i.e., PbGpa2 1-102, PbGpa2 1-183 , PbGpa3 1- 160, PbGpa3 1-213 , PbRas1 1-83 , 
PbRas 126-238 , and PbActin 1-314• 
For the first time, the major components of Pb cAMP signaling pathway have been 
cloned and characterized; and we provide direct evidence that the G protein a subunits, 
G protein p subunit, RAS protein and actin interact directly with adenylate cyclase in 
fungal biology. This thesis funds the basis for the further study of the cAMP signaling 
pathway in P. brasiliensis. It may facilitate delineation of the mechanis!TI for the 
dimorphic switching and the development of potentially novel antifungal drugs. 
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Chapter I 
Introduction 
1.1 General Introduction: P. brasiliensis and Paracoccidioidomycosis 
Paracoccidioides brasiliensis (P. brasiliensis or Pb) is a fatal human pathogenic 
fungus that causes the disease paracoccidioidomycosis (PCM), which is 
geographically restricted to South and Central America (Borges-Walmsley et al, 
2002). The fungus is dimorphic growing in a mycelial form at temperatures below 
30°C (typically 26°C; Brummer et al, 1993), whilst in the human body, or on 
enriched media at 37°C, growing as a yeast form with a typical morphology 
described as "ship-pilot's wheel", a large globose cell surrounded with multiple 
daughter buds (Borges-Walmsley et al, 2002). The mycelia in the environment can 
produce conidia, which act as infectious propagules, causing infection by human 
inhalation. Conidia transform into the pathogenic yeast form after entry into the 
human body. Mammalian oestrogens inhibit the transition from conidia to yeast, 
giving rise to a much higher incidence of overt clinical manifestations in males (San-
Bias, 1993; Hogan et al, 1996). The disease is always initiated from a pulmonary 
infection, which is usually benign and transient in normal individuals but can be 
latent for 10 years or more. The later reactivation results in a chronic lung infection 
that can disseminate to the mucosa of mouth, the nose, skin, adrenals, lymph nodes, 
and other organs. Susceptible individuals supposedly have a genetic basis with a 
depressed cellular immune response after infection (Borges-Walmsley et al, 2002). 
Currently, ketoconazole and itraconazole are the drugs of choice and treatment 
usually lasts 0.5-2 years (Brummer et al, 1993; Borges-Walmsley et al, 2002). Early 
diagnosis is important for prompt treatment and a better prognosis; because mortality 
is high if the disease is not treated. Relapse is a common problem after treatment. 
Although the disease can be controlled by antifungal drugs, fibrotic sequelae in the 
lungs always constitute a major problem in the well-being of the patients for the rest 
oftheir life (Borges-Walmsley et al, 2002). 
1.2 Morphology, Structure and Physiology of P. brasiliensis 
P. brasiliensis is a dimorphic fungus. Dimorphism is a phenomenon in some fungi 
that can reversibly change between yeast and mycelial forms and it is frequently 
related to the virulence of these fungi. P. brasiliensis grows as a mycelial form at 
temperatures lower than 30°C (typically 26°C); and at 37°C, it grows as a yeast form 
in culture or in host tissue. A change of temperature is the only factor required for 
this dimorphic transformation (San-Bias, 1993). In cultures, the mold phase grows 
slowly, and it takes about 20-30 days for the mold colonies to become visible. Mold 
colonies are small, irregular and white to tan in color. The yeast phase grows slowly 
as well but faster than the mold form. Yeast colonies become apparent after 10-15 
days of incubation. Yeast colonies are soft, creased, and cream colored (Brummer et 
al, 1993). The full transition from mycelia to yeast usually takes 3 weeks after the 
temperature change (Borges-Walmsley et al, 2002). 
Microscopically, yeast cells are of different sizes from 4 to 30 f.!m (Brummer et al, 
1993). The shapes of yeast cells may be round, oval, or elongated. The most 
characteristic feature of the yeast cell is the ship-pilot's wheel appearance, i.e. a 
multiple budding mother cell surrounded by several peripheral daughter cells, on 
which cultural and histological diagnosis are made. The ultrastructure of yeast cells 
includes 2 sub layers of cell wall, 3 sub layers of plasma membrane, large numbers of 
mitochondria, a scanty endoplasmic reticulum, numerous vacuoles and multiple 
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nuclei. The hyphae of mold under the microscope are thin and septate. 
Chlamydospores and conidia can be seen in some laboratory media (Brummer et al, 
1993). 
Under adverse environmental conditions such as a lack of water and low levels of 
nutrient and oxygen, two forms of propagules, i.e. chlamydospores and conidia, can 
be produced from mycelia (San-Bias, 1986). Both forms ofpropagule can reproduce 
the mycelia or yeast parent structure under appropriate incubation. Chlamydospores 
are multinucleated, while conidia are uninucleated. The formation of conidia is 
considered to be a terminal event under environmental stress. It is supposed that 
conidia exist in the environment and are the form to cause infection through 
inhalation by human beings. Their small size (3.5-5.0 11m) is compatible with 
alveolar deposition (San-Bias, 1986). 
Cytochemical studies of both the yeast and mycelial cells focused on the cell wall 
components (Paris et al, 1986; Davilla et al, 1986). In vivo, a-1 ,3-glucan is the main 
polysaccharide in the yeast cell wall, and there are only traces of ~-1 ,3-glucan. In 
contrast, ~-1 ,3-glucan is the only form of glucan in the mycelial cell wall. The 
predominance of a-1 ,3-glucan in the yeast cell wall may have a role in protection 
against host defense because phagocytic cells do not digest a-1 ,3-glucan (Goldman et 
al, 2003 ), while ~-1 ,3-glucan can be digested and trigger the inflammatory response 
of the host lungs (Vassallo et al, 2000). In addition, Pb strains containing less a-1 ,3-
glucan and more ~-1 ,3-glucan are avirulent (Silva et al, 1994), supporting the role of 
a-1 ,3-glucan in avoiding the inflammatory response. 
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Notably, there is an increase in chitin content during mycelia to yeast transformation 
(Borges-Walmsley et al, 2002). Pb has been shown to have several chitin synthesis 
genes but no correlation has been found between transcription levels of these genes 
and the increase in chitin content during the transition (Nino-Vega et al, 2000). The 
morphological change of Pb is also accompanied by changes in the lipid composition 
of the cell membrane. The total lipid extracted from yeast is twice as much as from 
mycelia (Manocha, 1980). In addition, the percentage of individual lipid 
components changes during the phase transition, especially for glycosphingolipids 
(GSLs) (Toledo et al, 1995; Levery et al, 1998; Toledo, et al, 1999). The major 
neutral GSLs are two forms of ~-glucopyranosylceramides (GlcCer): unsaturated and 
saturated. The mycelia have both forms of GlcCer in a 1: 1 ratio; while in yeast the 
saturated GlcCer predominates (85%; Toledo et al, 1999). Two major acidic GSLs 
were extracted and structurally analyzed. They were found to be glycosylinositol 
phosphorylceramides (GIPCs) that differed in that one contained a ~­
galactofuranose. The mycelial membranes contain equivalent amounts of GIPCs. 
The yeast membranes predominantly comprise the ~-galactofuranose-containing 
GIPC which was reactive with sera from patients with PCM (Levery et al, 1998). 
The extract of GIPC without the ~-galactofuranose was not reactive with the 
patients' sera. The immunological reactivity of the ~-galactofuranose-containing 
GIPC was attributed mainly to the galactofuranosyl residue (Toledo et al, 1995). It 
was proposed that these changes in the composition of the cell membrane are used to 
regulate the synthases (e.g. glucan and chitin synthases) and hydro lases (e.g. 
glucnases and chitinases), which in tum modify the composition of the cell wall 
(Borges-Walmsley et al, 2002). 
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Another two chemical components correlated with pathogenicity are melanins and 
glycoprotein gp43 (Gomez et al, 2001; Vicentini et al, 1994; Hanna et al, 2000). 
Melanins play an important role in the virulence of the human pathogenic fungus 
Cryptococcus neoformans (Wang et al, 1995). It has been demonstrated that 
melanins protect the fungus from environmental insults, host defense and 
antimicrobial therapies. Melanins are found in Pb conidia and yeast cells and they 
are supposed to be a virulence factor for Pb as well (Gomez et al, 2001). The gp43 is 
a cell surface and exocellular glycoprotein with proteinase activity at acidic pH 
(Brummer et al, 1993). It is the major diagnostic antigen of Pb and this will be 
discussed later. In addition, it also acts as a virulence factor. It is a laminin receptor 
and responsible for the adhesion of Pb cells to the host cells: gp43 antiserum can 
abolish this binding activity (Hanna et al, 2000). The gp43 was also proposed to be 
responsible for invasion into host cells expressing laminin receptors. A hamster 
model indicated that Pb cells pre-coated with laminin enhance their virulence 
(Viceniti et al, 1994). 
A sufficient supply of oxygen is necessary for the growth of both the yeast and 
mycelial phase of Pb (Restrepo et al, 1981 ). However, under microaerophilic 
conditions, yeast cells can enter into a resting stage. Resting cells can regain activity 
when adequate oxygen is supplied. This capacity of yeast cells may well explain the 
prolonged latency of this mycosis. As for nutritional requirement, the mycelia form 
of the fungus is prototrophic. However, yeast cells were shown to require an 
accessory factor for growth, i.e. a sulfur-containing amino acid (Paris et al, 1985). 
The growth curve of the yeast phase has been studied: the doubling time of yeast 
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varied from 21 to 102 hours (Kashino et al, 1987). Many factors such as the strain of 
the fungus, culture media used and shaking speed can all affect the mean generation 
time. Growth curves do not correlate with the virulence of the fungus (Kashino et al, 
1987). A chemically defined medium, MMcM (modified McVeigh-Morton), was 
used for growth of Pb yeast cells (Restrepo and Jimenez, 1980). Yeast cells in this 
liquid medium reached stationary phase after 3 days if the inoculation was from 
MMcM agar after 6 passages. In this situation, the doubling time of Pb in the log 
phase is only 1-2 hours. 
1.3 Epidemiology 
Paracoccidioidomycosis (PCM) is restricted to Latin America, from Mexico (23 °N) 
to Argentina (34°S; Brummer et al, 1993). The disease is not evenly distributed in 
this scope of land. There are no reported cases in the Caribbean islands, the 
Guyanas, Surinan, Chili or Nicaragua. Brazil is the most affected country, 
accounting for 80% of reported cases, followed by Colombia and Venezuela. The 
so-called endemic areas are sub-tropical or tropical humid forest but not prairies, 
coastal regions, desert zones or equatorial jungles. The climatic features of the 
endemic areas is a mild temperature (17-24°C), abundant forest and water resources, 
short winters and rainy summers (Restrepo, 1985). 
A few cases of PCM have been reported outside of Latin America: in the United 
States, Canada, Europe, Asia and Middle East. With no exception, all the patients 
had visited one of the countries in the endemic areas. It is interesting that the latency 
period between the time when the patients departed from the endemic areas and the 
time when the mycosis became apparent was quite long (mean, 15.3 years). This 
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observation indicates that Pb remains dormant in the human body for years or even 
tens of years (Brummer et al, 1993 ). 
The ecology of Pb is poorly understood. The fungus seems to exist m the 
environment elusively because it was isolated from soils only occasionally 
(Brummer et al, 1993). However, it is generally accepted that the habitat of Pb is 
exogenous to humans and people get infected by inhalation of propagules or mycelial 
fragments from the environment. There have been no reports of outbreaks; nor of 
person-to-person communication. This might be due to the long latency of the 
disease which hinders the precise determination of the site of infection. The disease 
has usually been diagnosed in a place different from where it was acquired. This 
brings difficulty to precisely locate the source of infection as well as the ecological 
niche of the fungus. It has been postulated that Pb resides in aquatic animals like 
fish and amphibia in the endemic area (Brummer et al, 1993). Aquatic birds feeding 
on these reservoirs disseminate the fungus to the environment by excretion. Humans 
acquire the infection by inhalation of the spores during agricultural activity. 
However, this hypothesis has not been verified. There is growing evidence that 
armadillos act as a reservoir. Apart from human beings, armadillos (Dasypus 
horemcinctus) are the only confirmed animals to harbor the fungus. Pb strains have 
been repeatedly isolated from the spleens, livers, and lungs of healthy armadillos 
(Hebeler-Barbosa et al, 2003), supporting the presumption that the fungus exists in 
the environment. 
In endemic areas, skin tests with paracoccidioidin antigens suggested that substantial 
amounts of the population have been exposed to the fungus. It is estimated that 
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about 10 million people have been infected among the 90 million residents in the 
endemic areas (Brummer et al, 1993). However, only up to 2% of the infected 
develop overt diseases (McEwen et al, 1995). Even though, the total number of 
patients with overt disease is substantially large. Indeed, PCM is a major public 
health threat in Brazil as about 14.6% of hospitalized adults have been reported to 
have PCM in a local investigation (Ferreira-da-Cruz, 1987). PCM is a fatal disease if 
not treated. It will become more important in the future with the exploitation of 
indigenous forest and the development ofBrazil. 
Skin tests indicate that contact with Pb can be as early as in the first 2 decades of life. 
However, the incidence of the disease is usually low in children and young adults (3-
5% ). Most cases are found in adults between 30 to 60 years old, and most patients 
(70%) are connected with agricultural activity or field work (Brummer et al, 1993). 
The infection has no predilection toward any specific race but indigenous Indians 
seem to be rarely afflicted whilst immigrants to the endemic area tend to develop 
severe forms of the mycosis (Brummer et al, 1993). Histocompatibility antigens 
have been studied in searching the population with relatively high risk for developing 
PCM. The human leukocyte antigen HLA-B40 seemed to be more often found in 
patients in Brazil (Lacerda et al, 1988), while HLA-9 and HLA-Bl3 were thought 
important in Colombia (Retrepo et al, 1983 ). However, both investigations were 
inconclusive. 
The PCM has an obvious predilection toward males. The overall rate of the disease 
in males is 13 times higher than in females (Brummer et al, 1993). This imbalance 
on gender is not caused by the frequency of exposure because paracoccidioidin skin 
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tests in healthy individuals from the same area do not reveal any sex difference in 
subclinical infection. In addition, there is no sex difference in children with overt 
disease. The reason for the much more frequent progression to the disease in males 
is that the female hormone P-estradiol plays an important role in preventing females 
to get an overt infection. In vitro experiments confirmed that P-estradiol specifically 
inhibits the transformation of both mycelia and conidia into the yeast form (Restrepo 
et al, 1984; Salazar et al, 1988). Meanwhile, an estrogen-binding protein was 
discovered in the cytosols of Pb mycelial and yeast cells (Loose et al, 1983; Stover et 
al, 1986). The addition of P-estradiol into mycelial cultures before temperature 
change led to alterations in mycelial protein expression and blocked synthesis of 
proteins needed for transformation. All these data suggested that P-estradiol 
functions via specific binding to form a protein-ligand complex in Pb cells, thus 
influencing the fungal behavior and changing the pathogenic consequences. It was 
hypothesized that if the female host has sufficient levels of estradiols at the time 
when infectious propagules are inhaled into the body, the propagules will be 
inhibited from transforming into the yeast form in tissue, giving enough time for the 
host to mount a specific immune defense and destroy the infecting particles. 
1.4 Clinical Manifestations 
Paracoccidioidin skin tests in healthy residents in endemic areas revealed that sub-
clinical infection occurs quite frequently (Brummer et al, 1993). Pb cells have been 
found in residual, partially calcified lesions in the lungs of healthy people, indicating 
that fungal growth is halted in competent hosts. It is still unknown how the overt 
infections start in humans. When conidia get into the lungs, they immediately 
transform into yeast. These yeast cells could be destroyed by the host; otherwise, 
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they use their newly synthesized cell wall to avoid host immune surveillance in 
residual lesions and enter into a resting stage for months or years. There is some 
evidence that they exist in macrophages like M. tuberculosis. It was postulated that 
transient host-parasite imbalance trigger the progression of the disease (Brummer et 
al, 1993). The disease starts when the yeast cells change from the dormant to the 
active state. Yeast cells then use their virulence factors, such as the cell wall 
component a-glucan, gp43 and melanin, to overcome the host and give rise to the 
full-blown disease state (Borges-Walmsley et al, 2002). 
There are two forms of overt PCM: the acute/sub-acute juvenile form and the chronic 
adult form (Borges-Walmsley et al, 2002). The acute/sub-acute juvenile form 
accounts for only 3-5% of all cases (Brummer et al, 1993). It is characterized by a 
rapid (weeks to months) and severe course. The patients are children and young 
adults. The clinical manifestation is characterized by hypertrophy of 
reticuloendothelial system (spleen, liver, lymph nodes, and bone morrow). Lungs are 
usually not involved and there are no special radiologic manifestations. The 
hypertrophy of mesenteric lymph nodes can lead to bowel obstruction and an acute 
abdominal syndrome. The chronic adult form accounts for more than 90% of 
patients. Most of the patients are between 30 to 60 years old. Unlike the juvenile 
form, the disease progresses slowly and takes months and years to become fully 
established. The lung is the organ afflicted, and pulmonary manifestations are 
usually found in 90% of patients. Symptoms include fever, weight loss, cough, and 
shortness of breath. X-ray findings are often bilateral and preferentially located in 
the central and lower portions of the lungs. The lung manifestations resemble those 
of tuberculosis, with which the mycosis coexists in 10% of cases (Brummer et al, 
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1993 ). About 25% of cases are in unifocal form as the lung is the only organ 
afflicted. The majority of cases are in the multifocal form because extrapulmonary 
lesions are usually found. Extrapulmonary organs that are most frequently involved 
are the oral cavity, nasal mucosa, skin, lymph node and adrenal glands (Brummer et 
al, 1993). 
1.5 Immunology 
Depressed cell-mediated immunity is a characteristic of PCM patients (Borges-
Walmsley et al, 1993). In the acute/sub-acute juvenile form of PCM, cell-mediated 
immunity is severely depressed in patients, leading to bad prognosis and high 
mortality (Franco, 1987). In the chronic adult form of the disease, cell-mediated 
immunity is usually abnormal in the severe, multi-focal form of disease but relatively 
intact in the less severe uni-focal form. In general, depression of cell-mediated 
immunity is a common finding in PCM patients and this correlates with the severity 
of the disease (Mota et al, 1985). The depressed cell-mediated immunity does not 
seem to be an innate host deficiency but is likely caused by the infectious fungus. 
There is strong evidence in support of this argument, in that impaired cell immunity 
is often found to be reversed after successful therapy of the infection (Retrepo et al, 
1978). 
It was observed that compacted and localized granulomas were indicative of healing 
of the disease and associated with effective cellular immunity, while diffused 
granulomas were thought to be correlated with progressive disease and impaired 
cellular immunity (Borges-Walmsley et al, 2002). The depressed cell-immunity in 
patients with PCM was represented by reduced CD4/CD8 (helper T -cell/suppressor 
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T -cell) ratios (Mota et al, 1988), as well as low levels of cytokine production, 
especially interferon (Borges-Walmsley et al, 2002). DTH (delayed T -cell 
hypersensitivity) skin testing with paracoccidioidin was used to evaluate the immune 
status of patients. Depressed reactivity was observed in patients with severe disease 
of both acute and chronic forms. A reversion from non-reactive to reactive during 
the course of therapy indicates the restoration of cell-mediated immunity and signals 
a good prognosis (Brummer et al, 1993). A murine model demonstrated that 
immunosupression was caused by infection. DTH responses were observed after the 
first week of infection. However, DTH reactions decreased to insignificant levels by 
8 weeks, when antibody titers peaked and disease was severe (Castaneda et al, 1988). 
Pb cells can be ingested by monocytes and macrophages and replicate intracellularly 
(Brummer et al, 1989). However, macrophages activated by y-interferon have 
significant ability to kill intracellular Pb cells, indicating the important role of 
interferon in resistance to PCM (Brummer et al, 1988). 
In contrast to the depressed cellular immunity, patients with PCM are not deficient in 
specific antibody production. Almost all the patients with overt clinical 
manifestations have specific antibodies (Restrepo, 1988; Mendes-Giannini et al, 
1990). Levels of antibodies are directly paralleled with the severity of disease. 
Antibody titers are high in disseminated disease and decreasing antibody titer 
indicates clinical improvements. The protective role of antibodies in PCM patients 
has not been determined. Animal models of infection indicated that antibodies may 
constitute a mechanism of protection (Kamegasawa et al, 1988). However, these 
studies were inconclusive. 
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The opportunism of PCM has been studied. Although there is no observation of 
significant increase of PCM in immunocompromised patients, immunosuppression 
and immunodeficiency in transplant patients, patients receiving chemotherapy, 
patients with hemotologic malignancies and AIDS patients are predisposed for 
activation of latency. Particularly in AIDS patients, the severe acute/sub-acute 
juvenile form of PCM can develop in adult age, indicating the importance of cell-
immunity in control of this mycosis (Brummer et al, 1993). 
1.6 Laboratory Diagnosis 
The definitive diagnosis of PCM can only be achieved by laboratory procedures 
(Brummers et al, 1993). The best and fastest way to establish the diagnosis is direct 
examination of clinical specimens such as sputum or histopathological samples. 
Multiple budding yeasts like ship-pilot's wheels are the characteristic structure used 
for diagnosis. Direct examination can identify greater than 85% of PCM patients. 
Fungal culture is slow, taking at least 20-30 days. The recovery of the fungus from 
clinical samples is usually made at room temperature (25°C) in order to eliminate 
contaminating resident flora. Because the mycelial structure is not distinctive, the 
dimorphic switch must be made by subculture at 3 7°C to obtain yeast cells. Again, 
the observation of the pilot's wheel multiple budding yeasts is diagnostic. The 
isolation rate by fungal culture is greater than 86%. 
An agar gel immunodiffusion test was most commonly used in serological diagnosis 
because it is simple to perform and therefore suitable for small laboratories. About 
90% of patients were found to have specific antibodies with this method. It was 
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specific as well, producing no cross-reactivity with other fungal infections (Retrepo 
and Moncada, 1974). Research on immunodiagnosis has been emphasized on 
searching for no val antigen preparations to enhance sensitivity, specificity and 
reproducibility of tests. Historically, Pb antigens have been classified into 3 types: 
cell-wall antigens, cytoplasmic antigens and culture filtrate antigens. Cell-wall 
antigens proved to be galactomannans, the usefulness of which was limited because 
of their cross-reactivity with other fungal infections (Brummer et al, 1993). There 
were many preparations for cytoplasmic antigens. A typical cytoplasmic antigen is 
Favo-Netto's polysaccharide antigen, which was prepared from autoclaved yeast 
cells. This antigen has been widely used as paracoccidioidin in skin test studies 
(Brummer et al, 1993 ). Culture filtrate antigens have been frequently used in 
serodiagnosis of PCM. By using an immunodiffusion test, Restrepo and Moncada 
(1974) identified 3 precipitation lines, designated 1, 2 and 3. Later, Yarzabal et al 
( 1977) identified 2 antigens E 1 and E2 by immunoelectrophoresis. Puccia et al 
(1986) found a 43 kDa glycoprotein (gp43) as the major specific antigenic 
component in culture filtrate. The gp43 proved to be Restrepo and Moncada's line 1 
and Yarzabal's E2 antigen. It is continuously excreted into the culture medium by 
yeast cells during the exponential phase of growth (Stambuk et al, 1998). When used 
in Western blot, gp43 was recognized by 100% of patients' sera (Camargo et al, 
1989). The deglycosylated product of gp43 has a molecular weight of 38 kDa 
(Puccia and Travassos, 1991a). Peptide epitopes of gp43 were mapped and they 
were immunodominant in their reactions with patient and animal sera. Cross-
reactivities of gp43 with other fungal infections were attributed to carbohydrate 
epitopes but not the protein part (Puccia and Travassos, 1991 b). The gp43 is not 
only excreted into the culture medium but also released into the blood stream of 
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patients. Antigenemia of gp43 has been detected in 100% of patient sera (Mendes-
Giannini et al, 1989; Marques da Silver et al, 2003 and 2004). The gp43 has 
prognostic value as well because it was detected in patients without treatment but its 
concentration in patient sera decreased during the course of treatment. Concurrently, 
the decreased antigenemia was accompanied by a reduction in anti-gp43 antibodies 
in patient sera. Therefore, gp43, especially the recombinant protein portion, will be 
an excellent candidate antigen with high sensitivity, specificity and reproducibility in 
the application of diagnosis and monitoring the efficacy of treatment. 
1.7 Therapy 
Paracoccidioidomycosis used to be an incurable disease. It can be treated currently 
but the remission takes a long time (at least half a year; Brummer et al, 1993). 
Relapse is still a problem that needs to be solved by novel antifungal drugs. 
Sulfonamides and amphotericin Bused to be the drugs for treatment. However, they 
are not chosen in clinical use today because of shortcomings, such as the long term 
of treatment, severe side effects, difficulty in administration and high rate of relapse 
(up to 30%). The current drugs of choice are ketoconazole and itroconazole. When 
ketoconazole is administered at a dose of 200-400 mg/day for 12 months or less, 
about 95% of patients are responsive, and the relapse rate is about 11% at 3 years 
after therapy. Itraconazole seems superior to ketocanazole. The daily dose of 
itraconazole is lower ( 100 mg) and the period of therapy is shorter ( 6 months). The 
response rate is the same as ketoconazole but with a lower relapse rate (3-5%). 
Although the disease can be treated, recovery is often accompanied by fibrotic 
sequelae in the lungs, which are a cause of pain for the whole life of the patients 
(Brummer et al, 1993; Borges-Walmsley et al, 2002). 
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1.8 Initiation of P. brasiliensis Studies at the Gene Level 
As reviewed above, the basic pathobiology of P. brasiliensis, the disease 
paracoddidiodomycosis (PCM) and its immunology, have been characterized mainly 
by scientists in South America where the disease is endemic. However, further 
understanding of the biology of this fascinating fungus requires research at the gene 
level. At the beginning of our research project in 2000, only limited number of 
papers had been published concerning the molecular biology of this fungus ( da Silva 
et al, 1999). In deed, at that time the number of genes of Pb available in the 
GenBank was only a dozen. The progress of research was severely hindered by lack 
of gene information, molecular genetic tools, such as vectors for transformation and 
over-expression of individual genes, and gene knock-out techniques. Forward and 
reverse genetics could not be applied and therefore it was difficult to investigate the 
role of individual genes involved in the virulence and the progression ofthe disease. 
The most significant characteristic of Pb is its dimorphic switch, which correlates 
with its virulence since mutants unable to switch forms are less virulent (Borges-
Walmsley et al, 2002). Interestingly, temperature change is the only factor that is 
needed to cause this switch. However, there is little information in how the organism 
senses and responds to the temperature change ( da Silva et al, 1999). We chose to 
study the cell signaling pathways, especially the cAMP signaling pathway, as the 
entry point for the molecular biology of Pb. The reason is as follows: as early as in 
1985, it was demonstrated that exogenous cAMP (either added in the medium or 
induced by inhibitors of phosphodieaterase) inhibits the yeast to mycelial transition 
in Pb and elevated levels of cAMP were supposed to support the transition to the 
yeast form of Pb (Paris and Duran, 1985). This indicated that the dimorphic change 
16 
is under the control of the cAMP signaling pathway. For several other dimorphic 
pathogenic fungi, changes in cAMP levels have been found to correlate with 
morphological changes. The yeast Candida albicans can be induced to undergo 
germ tube or mycelia formation under a number of culture conditions and in host 
tissues. Changes in temperature seem to be critical; germ tube formation induced at 
40°C in a defined medium was accompanied by an increase of cAMP concentration 
in the cell; and exogenous cAMP, either added to the medium as dibytyryl cAMP or 
induced by cAMP phosphodiesterase inhibitors, induced germ tube formation at a 
lower temperature (32°C or 25°C; Niimi et al, 1980; Sabie and Gadd, 1992). 
Histoplasma capsulatum, a pathogenic dimorphic fungus causing the human disease 
histoplasmosis, grows as mycelia at 25°C in soil and as yeast at 37°C in tissues. 
During the temperature-induced transition from yeast to mycelia, there was a 5-fold 
increase in intracellular cAMP levels and more than 15-fold accumulation of cAMP 
in the culture medium (Medoff et al, 1981 ). Exogenous cAMP induced mycelium 
formation at the nonpermissive temperature of 37°C (Medoff et al, 1981). The 
dimorphic fungus Mucor racemoses was found to have an increased intracellular 
cAMP level during the morphologic change from an air-grown mycelium form to an 
anaerobic yeast form. The addition of dibutyryl cAMP to mycelia under aerobic 
conditions resulted in yeast like development (Paznokas and Sypherd, 1975). 
Interestingly, the model yeast S. cerevisiae has also been observed to have a 
morphological change from vegetative to pseudohyphal (or filamentous) growth 
when starved of nitrogen in the presence of a fermentable carbon source (Gimeno et 
al, 1992). This morphological change has been shown to be controlled by at least 
two cell signaling pathways, i.e. the MAP kinase pathway and the cAMP signaling 
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pathway (Lengeler et al, 2000). In fact, most of our knowledge of the cell signaling 
pathways controlling morphological switching in pathogenic fungi came from the 
research on pseudohyphal growth of S. cerevisiae (Borges-Walmsley and Walmsley, 
2000). Current research indicates that pathogenic fungi use similar components and 
mechanism in controlling the dimorphic switch between saprobic and pathogenic 
forms. Given that morphological changes in dimorphic fungal pathogens often 
underlie the development of pathogenicity (Lo et al, 1997; Wickes et al, 1996), 
studies of the genes, such as those in the cAMP signaling pathway that control the 
morphological change, will facilitate discovery of new targets for antifungal drugs. 
With this objective in mind, we initiated a study of the cAMP signaling pathway in 
P. brasilinesis by cloning the major components of the pathway and analyzing their 
structure-function relationship. In the following part of this chapter, I will review in 
detail the current understanding of the signaling pathways that control the 
pseudohyphal growth in S. cerevisiae with emphasis on the cAMP pathway. The 
pheromone mating pathway of the yeast S. cerevisiae is also reviewed as this will 
help in understanding G-protein regulation. In addition, signaling controls of 
dimorphic switching or virulence in some important pathogenic fungi are given as 
well. 
1.9 The G protein-cAMP-PKA Signalling Pathway of the YeastS. cerevisiae: 
Glucose Sensing and Pseudohyphal Growth 
1.9.1 Adenylate Cyclase CYRJ and Cyclase-Associated Protein CAP 
A central component of the cAMP signaling pathway is adenylate cyclase (Figure 
1.9; adapted from Borges-Walmsley and Walmsley, 2000), which catalyzes the 
synthesis of cAMP from ATP. The adenylate cyclase gene is essential as yeast cells 
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Figure 1.9. Summary of the cAMP-signaling pathway inS. cerevisiae 
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are non-viable when the gene is deleted (Borges-Walmsley and Walmsley, 2000). 
The interests in yeast adenylate cyclase started following the observation of a change 
in cAMP levels during the dimorphic switch in some pathogenic fungi. By isolating 
yeast mutants that require cAMP for growth, the adenylate cyclase gene of S. 
cerevisiae was first mapped at a chromosome locus, termed cyr 1 (cyclic AMP 
requirement), located near the centromere of chromosome X (Matsumoto et al, 
1982). The CYRJ gene was cloned by complementation of a cyrl strain deficient in 
adenylate cyclase activity with a yeast genomic DNA library (Kataoka et al, 1985). 
The DNA sequence of CYRJ encodes a protein of 2,026 amino acids. When 
analyzed by SMART (EMBL) today, the Cyrl protein contains at least four domains, 
i.e. a RA (Ras association; 676-756) domain, 11 LRR (23 amino acid Leucine-Rich 
Repeats; 885-1233) domains, a PP2Cc domain (1347-1622) and a catalytic domain 
CYCc (1611-1833). The isolated catalytic domain retains a Mn2+ -dependent 
catalytic activity, while the remaining portion of the protein was proposed to be 
essential for the GTP-dependent activation by RAS protein in the presence of Mg2+ 
(Kataoka et al, 1985). In yeast, adenylate cyclase activity was found in the insoluble 
fraction of cells extracted without detergent, indicating that the yeast adenylate 
cyclase is membrane-associated (Kataoka et al, 1985). However, the yeast adenylate 
cyclase is not an integral membrane protein because no membrane-spanning domains 
have been found. That adenylate cyclase is only peripherally associated with 
membrane is based on the following facts: adenylate cyclase activity was found in 
both membrane and cytoplasmic fractions; adenylate cyclase activity could be 
released from membrane, simply by the addition of 0.5 M NaCl; activity from both 
cytosolic fractions and NaCl extracts could be functionally reconstituted into 
membranes lacking adenylate cyclase activity (Mitts et al, 1990). The amphipathic 
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LRR domains were supposed to be responsible for the membrane localization 
because deletion of the LRR domains redirected the adynelate cyclase activity from 
the membrane portion to the cytosolic portion (Mitts et al, 1990). In another 
experiment, the adenylate cycalse activity located predominantly in the high speed 
pellet fraction when adenylate cyclase containing the LRR repeats was over-
expressed in E. coli, while the acenylate cyclase activity located predominantly in the 
high speed supernatant fraction when the LRR repeats were deleted (Kataoka et al 
1985). These results indicated that the adenylate cyclase may be anchored to the 
membrane by interacting with a membrane-associated protein. Interestingly, 
adenylyl cyclase activity in raslras2bycl cells was found in the soluble fraction, 
while it was found in the membrane fraction in the wild-type strain. Overexpression 
of the gene CDC25, encoding a guanine exchange factor for RAS proteins, in the 
raslras2bcyl strain relocalized adenylyl cyclase activity to the membrane fraction 
(Engelberg et al, 1990). In addition, deletion of !RAJ, the gene encoding a GTPase-
activating protein for RAS proteins, dislocated the adenylate cyclase activity from 
the membrane (Mitts et al, 1991). Both Cdc25 and Ira1 could complex with 
adenylate cyclase. These findings suggested that the membrane localization of 
adenylate cyclase is correlated with the RAS proteins, Cdc25 and Ira1 through the 
formation of a large complex. 
In fact, yeast adenylate cyclase exists as two enzyme complexes that associate with 
the membrane when fractionated in vitro (Wang et al, 1992). One complex, with a 
molecular weight of 890 kDa, at least consists of adenylate cyclase and another 70-
kDa protein component, termed CAP (cyclase-associated protein). The adenylate 
cyclase activity in this complex is Ras-dependent in the presence of Mg2+. Another 
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cyclase containing complex of 670 kDa was CAP free. Its adenylate cyclase activity 
is Mn2+ -dependent. Missense mutations in the leucine-rich repeats abolished the 
Ras-dependent acenylate cyclase activity and changed it into Mn2+-dependent (Wang 
et al, 1992). In another report, adenylate cyclase and CAP were co-purified, 
indicating that they are tightly associated (Field et al, 1988). The gene encoding 
CAP was cloned by screening a yeast eDNA expression library with antisera against 
the 70-kDa component. Adenylate cyclase in the yeast cell membrane lacking CAP 
was not stimulated by Ras2 in vitro, indicating that CAP is essential for Ras 
activation of adenylate cyclase (Field et al, 1990a). The CAP-binding site of 
adenylate cyclase was mapped to the last 148 residues at the C-terminal end. 
Overexpression of this small segment of adenylate cyclase sequestered the CAP 
protein and suppressed the heat shock sensitivity of yeast cells bearing the dominant 
active RASJ19v allele (Wang et al, 1993). CAP is necessary for the stimulatory effect 
of post-translationally modified Ras, but not for the unmodified Ras, and the region 
of CAP required for this effect was mapped to its N-terminal 168 residues (Shima et 
al, 1997). The N-terminus of CAP was proposed to bind to the C-terminus of 
adenylate cyclase through a coiled-coil interaction (Shima et al, 2000). 
CAP is a bifunctional protein. Its primary structure contains N-terminal and C-
terminal domains that are separated by a proline-rich region. Its N-terminal 36 
residues bind to a segment of adenylate cyclase (1898-20 16) near the C-terminal end 
of adenylate cyclase (demonstrated by yeast two-hybrid assay) in a coiled-coil 
interaction, and this binding mediates the activation of adenylate cyclase by RAS 
proteins (Nishida et al, 1988). The C-terminal domain of CAP is necessary for 
normal cellular morphology (cytoskeleton phenotype) and responses to nutrient 
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extremes (Vojtek et al, 1991). It has been demonstrated (by yeast two-hybrid assay 
and immunoprecipitation) that the C-terminal half of CAP binds both actin 
monomers and the actin polymer directly (Freeman et al, 1995; Zelicof et al, 1996). 
In addition, CAP forms a dimer via its last 27 amino acid residues (Zelicof et al, 
1996). The middle proline-rich region of CAP interacts with the SH3 (Src homology 
3) domian of Abp 1, a yeast actin-binding protein which in tum binds CAP to cortical 
actin (Freeman et al, 1996). These data suggest that CAP and adenylate cycalse are 
localized with actin. 
Although yeast adenylate cyclase appears to be central to the cAMP signaling 
pathway, it is difficult to demonstrate directly because the gene is essential for the 
cell viability and its deletion is lethal. However, a mutation near the end of the 
adenylate cyclase catalytic domain, Cyrl K1876M, was isolated and demonstrated to be 
able to maintain a basal cAMP level but failed to mount a transient increase in cAMP 
in response to glucose or intracellular acidification, confirming the key role of 
adenylate cyclase in transducing the cAMP signal (Vanhalewyn et al, 1999). 
1.9.2 Phenotypes of Pathway Activation 
The yeast S. cerevisiae cAMP signaling pathway was first demonstrated to be 
associated with glucose sensing, and later found to be correlated with pseudohyphal 
growth. There are two types of stimulation that trigger the activation of the cAMP 
signaling pathway (Mbonyi et al, 1988). First, addition of glucose or related 
fermentable carbon sources to the yeast cells grown on non-fermentable carbon 
sources (so-called derepressed cells) induces a transient peak in the cAMP signal. 
The activation of the pathway leads to the rapid depletion of the storage sugar 
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trehalose, inhibition of gluconeogenesis and stimulation of glycolysis. Cells grown 
on fermentable sugars have a higher basal cAMP level than cells grown on non-
fermentable carbon sources (e.g. ethanol, glycerol and acetate). Second, drastic 
lowering of the intracellular pH (e.g. by addition of dinitrophenol) in yeast cells 
strongly stimulates in vivo cAMP synthesis. The characteristics for activated cAMP 
signaling pathway are: an enhanced growth rate, depletion of storage carbohydrates 
such as glycogen, sensitivity to heat shock (growth defect at high temperature) and 
starvation, and defective in sporulation of diploid cells. On the other hand, reduced 
cAMP signaling causes increased accumulation of storage carbohydrate and 
sporulation even in rich medium and entry into stationary phase (Kataoka et al, 
1984). 
The glucose-induced and intracellular acidification-induced activation of the cAMP 
pathway are mediated by RAS proteins because the cAMP signal is absent in the 
RASJ-RAS2-bcyl double deletion strains (RAS deficiency is suppressed by the bcyl 
mutation; Mbonyi et al, 1988; Colombo et al, 1998). In addition, the dominant active 
RAS2G19v mutation failed to mediate glucose or intracellular acidification by 
mounting a transient peak of cAMP in a strain with repressed RASJ, although it can 
constitutively activate the adenylate cyclase to produce a higher cAMP level in vivo. 
In contrast, either RASJ or RAS2 alone can induce a prominent transient cAMP peak. 
Glucose induced Ras activation is dependent on glucose transportation and 
intracellular phosphorylation and the process of activation is probably through 
inhibition of the Ras-GAPs (Ras GTPase-activating protein) Iral/2 (Colombo et al, 
2004). 
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Glucose-induced but not intracellular acidification-induced cAMP signaling is also 
dependent on the G protein a subunit gene GPA2. Overexpression of GPA2 
enhanced glucose-induced cAMP levels and suppressed the growth defect of a 
temperature-sensitive ras2 mutant (Nakafuku et al, 1988). Constitutive GPA2R273A 
conferred heat shock sensitivity and a sporulation defect, indicative of activation of 
the cAMP pathway (Xue et al, 1998). In contrast, the glucose-induced increase in 
cAMP was absent in l:!..gpa2 strains (Colombo et al, 1998). Indeed, Gpa2 is coupled 
to Gpr1, the membrane receptor whose agonist is glucose (Lemaire et al, 2004). 
Glucose activation of Gprl does not need phosphorylation. 
The cAMP signaling pathway also regulates yeast pseudohyphal differentiation. In 
the diploid yeast, nitrogen starvation in the presence of carbon sources induces 
pseudohyphal or filamentous development (Gimeno et al, 1992). The pseudohyphal 
cells are elongated in shape and are attached to each other by their cell wall. The 
cells undergo a unipolar budding pattern in which daughter cells bud at the pole 
opposite the mother cells. The result is a filamentous, branched display of cells 
growing away from the centre of a colony and invading the agar medium (Borges-
Walmsley and Walmsley, 2000; Pan et al, 2000). Therefore, there are four 
phenotypes that are distinct and highly correlated in the process of filamentation: 
uni-polar budding, cell elongation, incomplete cell separation and invasive growth. 
The filamentous growth may allow this non-motile fungus to forage for nutrient in an 
adverse environment (Borges-Walmsley and Walmsley, 2000). Haploid cells have 
the axial budding pattern that precludes pseudohyphal growth when starved for 
nitrogen. However, haploid cells can invade the agar when grown in rich medium 
(Borges-Walmsley and Walmsley, 2000). The genes required for diploid 
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pseudohyphal growth are also necessary for haploid invasive growth (Lengeler et al, 
2000). Therefore, in this thesis, when pseudohyphal growth is mentioned, only the 
diploid situation is referred to unless otherwise stated. 
Because filamentous growth is induced by nitrogen starvation, nitrogen sources such 
as ammonium or amino acids may act as stimulants for pathway activation. The 
expression of the membrane receptor Gprl and the Tpk2 (catalytic subunit of PKA) 
are up-regulated upon nitrogen starvation (Xue et al, 1998; Pan and Heitman, 1999). 
A high affinity ammonium permease Mep2 was found to be required for 
pseudohyphal development upon ammonium limitation (Lorenz and Heitman, 
1998a). The pseudohyphal defect of !:!.mep2/!:!.mep2 can be suppressed by dominant 
active Ras2, Gpa2 and exogenous cAMP; but not by activated alleles of the MAPK 
pathway, indicating that Mep2 might be a component in the upstream cAMP 
pathway. Mep2 probably lost its original role as an ammonium transporter during 
evolution because !:!.mep2/ !:!.mep2 mutants have no obvious change in ammonium 
uptake. A possible role for Mep2 is as an ammonium starvation sensor, which 
regulates filamentation. In addition, another ammonium permease Mep 1, with low 
ammonium affinity, is an inhibitor of pseudohyphal growth and is correlated with the 
MAPK pathway (Lorenz and Heitman, 1998b ). 
Filamentous growth is partly regulated by the cAMP signaling pathway; but as 
discussed later, it is also regulated by MAPK pathway. The dominant active 
RAS2°19v gene stimulates filamentous growth, apparently by increasing the cAMP 
level in the cells (Gimeno et al, 1992). However, it also induces filamentous growth 
by activating the MAPK pathway (Mosch et al, 1996). Lowering cAMP level in 
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RAS2°19v cells by overexpression of the phophodiesterase Pde2 suppresses 
filamentous growth, indicative of a correlation of cAMP level and filamentous 
growth (Ward et al, 1995). In fact, exogenous cAMP in the media (10 mM) 
stimulates filamentous growth in wild-type strains even in the absence of nitrogen 
starvation (Lorenz and Heitman, 1997). The filamentous growth is highly correlated 
to glucose stimulation, firstly because morphogenesis occurs in the presence of 
glucose and absence of nitrogen; and, secondly, the Gpa2 coupled membrane 
receptor Gpr 1 is a glucose sensor (Lemaire et al, 2004 ). The details of the cAMP 
signalling pathway and its role in filamentous growth are discussed below. 
1.9.3 RAS Proteins 
The first regulator of adenylate cyclase was found to be RAS proteins (Toda et al, 
1985; Broek et al, 1985). In mammalian cells, RAS proteins are small guanine-
nucleotide-binding proteins that possess intrinsic GTPase activity. Ras cycles 
between an active GTP-bound form and an inactive GDP-bound form. The yeast has 
two RAS genes, RASJ and RAS2. Genetic analysis of RASJ and RAS2 indicated that 
neither RASJ nor RAS2 are essential individually but rasl-ras2- double deletion 
mutants are not viable. Yeast RAS proteins are structurally similar to their 
mammalian counterparts particularly in their N-terminal half. Yeast RAS proteins 
are membrane associated. At the C-terminus of the RAS proteins, there are 
conserved CAAX motifs (C, cysteine; A, aliphatic; and X, any amino acid) that were 
responsible for palmitoylation or famesylation of the cysteine residue (Kuroda et al, 
1993). Both yeast and mammalian RAS proteins undergo similar processing events 
and localize to membrane fractions. In yeast, palmitoylation is responsible for 
membrane localization, while famesylation is responsible for the activation of 
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adenylate cyclase. In one study, famesylated Ras2 had 100 times higher activity in 
stimulation of adenylate cyclase than the unprocessed form (Kuroda et al, 1993). In 
another study, although famesylation of Ras proteins had no significant effect on the 
cyclase binding, it was shown to increase Ras activity 5- to 10-fold and this effect 
was dependent on theN-terminus of the cyclase-associated protein CAP (Shima et al, 
1997). 
Twenty years ago, RAS proteins were proposed to be the direct activator of 
adynelate cyclase. The catalytic domain of adenylate cyclase alone can produce 
cAMP irrespective of the presence of RAS proteins. However, adenylate cyclase 
produces increased amounts of cAMP in the presence of RAS proteins (Uno et al, 
1987; Toda et al, 1985). It is generally accepted that the Ras proteins are in the GTP-
bound state when activated and turned off by GTP hydrolysis. A dominant active 
mutation RAS2G19v activates adenylate cyclase in a GTP-independent manner. The 
mutation point is the second Gly in the GXGXXG motif (where the X is any amino 
acid). RAS2G19v encodes a protein that has reduced GTPase activity and 
constitutively activates the CYRJ gene product. Diploid yeast cells containing this 
mutation are sensitive to heat shock and starvation, and are incapable of sporulating 
efficiently (Kataoka et al, 1984 ). The RAS2 protein can not activate adenylate 
cyclase when bound to GDP or a stable GDP analog GDP-~S. In a study, when 
purified from E. coli, the RAS2 protein did not have GTP bound, and therefore was 
not able to activate adenylate cyclase in vitro (Field et al, 1988). Membranes from a 
rasl-ras2-bcyl strain lack GTP-stimulated adenylate cyclase activity. Mixing 
membranes of a rasl-ras2- yeast strain with membranes from an adenylate cyclase 
deficient yeast strain reconstituted GTP-dependent adenylate cyclase activity (Toda 
28 
et al, 1985). In addition, a direct relationship between Ras2 and Cyr 1 was confirmed 
by reconstitution in an E. coli system both in vivo and in vitro (Uno et al, 1985). E. 
coli trans formant cells carrying both CYRJ and RAS2 (or the active dominant 
mutation RAS2°19v) produced GTP-dependent (GTP-independent for RAS2°19v) 
adenylate cyclase activity and cAMP, while E. coli cells carrying CYRI or RAS2 
alone had no measurable cAMP. Mixing the crude extract of E. coli carrying CYRI 
with the extract of E. coli carrying RAS2 reconstituted the GTP-dependent adenylate 
cyclase activity. 
RAS proteins can directly bind to adenylate cyclase in both a modified and 
unmodified form as indicated by immunoprecipitation of purified adenylate cyclase 
and RAS proteins, and this interaction is dependent on GTP but independent of CAP 
(Shima et al, 1997). Deletion and insertion mutations in the adenylate cyclase gene 
were used to map domains required for activation by RAS proteins. In one research, 
it was demonstrated that the 0.8 kb region adjacent to that encoding the catalytic 
domain (e.g. the PP2Cc domain) is associated with the regulatory function of RAS 
proteins (Uno et al, 1987). From other research, the N-terminal 605 amino acids 
were found to be dispensable for responsiveness to Ras, while the LRR domains 
(which were mapped to 674-1301) were found to be essential for Ras activation 
(Colicelli et al, 1990; Field et al, 1990; Suzuki et al, 1990). Interestingly, in 
Trypanosoma equiperdum, an open reading frame encoding a protein sequence 
similar to the leucine-rich repeats in S. serevesiae was found adjacent to its adenylate 
cyclase, suggesting that the two proteins may interact to regulate adenylate cyclase 
activity (Ross et al, 1991). Recently, an RA (Ras association) domain (676-756) was 
found in the previously so-called LRR domains (Kido et al, 2002). The purified RA 
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domain polypeptide directly binds to Ras in a GTP-dependent manner as 
demonstrated by immunoprecipitation. This domain competitively inhibits Ras-
dependent activation of adenylate cyclase both in vivo and in vitro. RA is the 
primary binding site for RAS proteins. 
Although famesylation of Ras and CAP are not essential for Ras interaction with 
adenylate cyclase, they are crucial for its activation (Shima et al, 2000). 
Immunoprecipitation experiments demonstrated that the complex of CAP and the C-
terminal-region of Cyrl (1764-2026) form a second Ras-binding site which binds 
modified Ras only. This is consistent with the fact that the last 66 C-terminal 
residues of adenylate cyclase are indispensable for Ras activation (Suzuki et al, 
1990). However, neither CAP nor Cyrl (1764-2026) alone can bind modified Ras. 
This second Ras-binding site is mainly used for adenylate cyclase activation because 
CAP mutants that increase or decrease Ras-binding at this site lead to deficiency in 
adenylate cyclase activation (Shima et al, 2000). 
Although both Ras1 and Ras2 activate the cAMP signaling pathway, Ras2 is a much 
more potent activator than Ras 1. The cAMP level in ras2- cells is lower than in 
rasl- cells (Toda et al, 1985), and Ras2 acitvates adenylate cyclase more efficiently 
than Ras 1 (Broek et al, 1985). The difference in efficiency of adenylate cyclase 
activation between Ras 1 and Ras2 resides in the highly conserved N-terminal domain 
rather than the variable C-terminal domain as indicated by chimeric constructions of 
RAS genes by swapping the sequences encoding the variable C-terminal domains 
(Hurwitz et al, 1995). 
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The function of yeast Ras is regulated by the GEFs (guanine exchange factors) 
Cdc25 and Sdc25, which catalyze GTP exchange, activating Ras; and by the GAPs 
(GTPase-activating proteins) Ira1 and Ira2, which accelerate the intrinsic GTPase 
activity of Ras and inactivate it (Borges- Walmsley and Walmsley, 2000). Defective 
mutations in ira] and ira2 leads to constitutive activation of the cAMP pathway, 
while disruption of CDC25 causes deficiency in glucose-induced increase in cAMP 
production (van Aelst et al, 1991 ). Cdc25 is a 180 kDa membrane bound protein that 
is essential for cAMP production (Garreau et al, 1990). It is under the direct positive 
control of Ssa1, which is a chaperone of the HSP70 superfamily (Geymonat et al, 
1998). Deletion of Ssa1 leads to reduced content of Cdc25 in the cell and reduced 
activity of the cAMP-dependent PKA pathway. 
As mentioned above, RAS proteins mediate glucose signaling. Another important 
function for RAS proteins is to regulate filamentous growth. The dominant active 
mutation RAS2c19v stimulates pseudohyhal differentiation through an increasing 
cAMP level (Gimeno et al, 1992; Ward, 1995). Deletion of RAS2 results in reduced 
filamentation, probably due to a decreased cAMP level in the cell, while the 
dominant active RAS2c19v allele enhances filamentous growth (Lorenz and Heitman, 
1997). In addition, Ras2 is also an activator of the MAPK pathway which will be 
reviewed in the later part of this chapter. 
1.9.4 GPA2, GPB1,2, and GPGJ 
Yeast GP A2 was cloned by low stringency hybridization with a rat G protein a 
subunit. GPA2 is homologous to mammalian G protein a subunits except for a 
stretch of 83 additional amino acid residues near the N terminus. Over-expression of 
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Gpa2 in yeast restored glucose-induced cAMP formation in a ras2 mutant, indicating 
that Gpa2 regulates the level of cAMP in addition to RAS proteins (Nakafuku et al, 
1988). The major function of Gpa2 is to positively regulate filamentous or 
pseudohyphal growth in yeast. A 11gpa2/ 11gpa2 mutant strain has a defect in 
pseudohyphal growth that can be rescued by exogenous cAMP in the media (a 
11ras2/11ras2 strain can still form filaments, indicating that Gpa2 is more potent than 
Ras2 in regulating filamentation; Kubler et al, 1997; Lorenz and Heitman, 1997). In 
addition, a dominant negative GPA2G299A allele (supposed to prevent a 
conformational change necessary for GTP binding) inhibits filamentation of wild-
type strains. In contrast, a dominant active allele GPA2G132v or GPA2QJOOL (with 
decreased GTPase activity) stimulate filamentation even on nitrogen-rich media 
(Lorenz and Heitman, 1997; Harashima and Heitman, 2002). 
GPA2 is upstream of adenylate cyclase in the pathway because exogenous cAMP 
suppresses the L1gpa2 pseudohyphal defect (Lorenz and Heitman, 1997). It is 
proposed that Gpa2 directly activates adenylate cyclase. To date, however, there is 
not direct evidence to prove this hypothesis. Unlike RAS proteins, Gpa2 does not 
regulate the MAPK pathway. Neither dominant active STEJJ-4 (Mosch et al, 1996) 
nor overexpression of STE12 suppresses the defect of filamentation conferred by a 
11gpa2111gpa2 mutation. None of the deletions of the MAPK pathway components 
ST£20, STEll, STE7 and STE12 blocks the dominant active GPA2G132v to simulate 
pseudohyphal growth. Overexpression of the dominant active GPA2G132v does not 
activate the MAPK pathway activation reporter FG(TyA)::lacZ (Lorenz and 
Heitman, 1997). 
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Gpa2 is negatively regulated by Rgs2, a member of regulators of heterotrimeric G 
protein signaling (Versele et al, 1999). Rgs2 can directly interact with Gpa2, but 
preferably with Gpa2 in the GTP-bound state, as demonstrated by yeast two-hybrid 
assays and immunoprecipitation. Rgs2 accelerates the hydrolysis of GTP on Gpa2. 
The dominant active GPA2°132v allele abolishes the effects of Rgs2 in terms of both 
the cAMP level and the phenotypes of cAMP pathway activation (Versele et al, 
1999). Gpa2 is coupled to the upstream membrane receptor Gpr1, whose major role 
is glucose sensing (Kraakman et al, 1999). 
Canonical G proteins exist as heterotrimers comprised of a, ~ and y subunits. 
Signaling through the conformational change in the G protein-coupled receptor 
promotes GDP-GTP exchange on the G protein a subunit, and releases the G~y 
complex. In mammalian cells, both Ga and G~y can induce downstream signaling 
events (Hoffman, 2005a). However, the yeast Ga protein Gpa2 lacks the traditional 
~y subunits (Lorenz and Heitman, 1997). The pheromone-responsive ~y complex 
(Ste4 and Ste 18) is not involved in pheudohyphal growth and thus has no 
relationship with Gpa2. There are another 8 candidate ~ genes and 3 candidate y 
genes in the yeast genome. However, none of these genes has a role in pseudohyphal 
differentiation (Lorenz and Heitman, 1997). The question is whether Gpa2 functions 
alone or in concert with other partners. Recently, it has been demonstrated that Gpa2 
binds to kelch repeat proteins Gpb2/Krh1 and Gpb1/Krh2, which serve as G~ subunit 
mimics, and Gpg 1 which serves as Gy mimic (Harashima and Heitman, 2002; BatHe 
et al, 2003; Harashima and Heitman, 2005). The G~y mimic negatively regulates 
Gpa2 and also negatively regulates its own effector that is unidentified, but could 
possibly be adenylate cyclase. 
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GPB2/KRHJ, GPBIIKRH2 and GPGJ were identified by yeast two-hybrid screening 
with GPA2 (Harashima and Heitman, 2002; Batlle et al, 2003). The Gpa2-Gpgl 
interaction is indirect and mediated by Gpb 1 or Gpb2 because the interaction is 
diminished in a strain with both gpb I and gpb2 deleted. Gpg 1 interacts with both 
Gpb 1 and Gpb2. Sequence analysis indicates that Gpb 1 and Gpb2 both contain 
seven kelch repeats and they are homologous to several kelch repeat proteins 
(Harashima and Heitman, 2002). The kelch repeat segment is about 50 amino-acid 
long and is characterized by a double glycine motif following four hydrophobic 
residues (Adams et al, 2000). Kelch repeats have been implicated in protein-protein 
interactions. The crystal structure of one kelch repeat protein indicates that these 
proteins are folded into a seven-bladed propeller structure that is strikingly similar to 
the structure of G protein ~ subunits (Ito et al, 1994). Gpgl is a small protein 
containing only 126 amino acid residues. It is similar in size to known Gy subunits 
and its secondary structure is predicted to be two linked a-helical domains, similar to 
known Gy subunits as well. However, Gpg 1 has no C-terminal motifs for 
posttranslational modifications such as farnesylation, myristoylation or 
palmitoylation. In general, Gpbl/2 and Gpgl form an atypical complex, which 
mimics the G~y subunits, and interacts with Gpa2. Gpbl/2 interacts with both the 
GDP and GTP-charged forms of Gpa2, but preferentially with the GDP-charged 
form: as demonstrated by both yeast two-hybrid assays and immunoprecipitation 
(Harashima and Heitman, 2002). However, another group reported that only the C-
terminus of Gpb2/Krh 1 interacts with Gpa2, and preferentially with the dominant 
active Gpa2R237A (Batlle et al, 2003). 
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Genetic analyses indicate that Gpb 1/2 negatively regulates the cAMP signalling 
pathway by both Gpa2-dependent and Gpa2-independent mechanisms (Harashima 
and Heitman, 2002). A !1gpbl !1gpb2 mutant exhibits phenotypes of the activated 
cAMP pathway, including hyperfilamentous growth, increased sensitivity to heat 
shock, reduced glycogen storage and reduced sporulation. These phenotypes were 
fully abolished by disruption of TPK2. Interestingly, introduction of !1gpa2 to the 
!1gpbl !1gpb2 mutant only partially reduces the hyperfilamentous growth. 
Furthermore, the expression of Flo 11 in !1gpa2 !1gpb 1 !1gpb2 cell is two- to three-fold 
lower than that in !1gpbl !1gpb2 cells, but higher than in !1gpa2 cells (Harashima and 
Heitman, 2002). These results indicate that Gpb 1 and Gpb2 must have another target 
in addition to Gpa2. This target is upstream of and might include Tpk2 itself (Lu and 
Hirsch, 2005). Adenylate cyclase is one of the candidates but to date there is no 
direct evidence to prove this (Ivey and Hoffman, 2002). Kelch repeat proteins can 
bind different proteins simultaneously on opposing surfaces of the p propeller 
structure (Adams et al, 2000). Therefore, the Gpy mimic Gpbl/2-Gpg1 could bind 
both Gpa2 and adenylate cyclase but using different domains. 
Gpa2 in both the GDP and GTP-binding state can interact with its upstream 
membrane receptor, Gpr1, but the interaction is stronger when it is in the GDP-
binding state (Harashima and Heitman, 2002). In addition, the Gpa2-Gprl 
interaction is independent of Gpb 1 and Gpb2, because Gpa2 is still functional in a 
!1gpbl !1gpb2 strain. However, the transient peak of cAMP production upon glucose 
stimulation exists in either single !1gpbl or single !1gpb2 mutants, but diminishes in a 
double !1gpb1!1gpb2 mutant strain, indicating that Gpbl/2 modulates Gpa2-Gprl 
coupling (Harashima and Heitman, 2002). It was demonstrated that Gpbl/2 inhibits 
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Gpa2-Gprl coupling (Harashima and Heitman, 2005). This is in contrast to 
canonical G~ subunits which promote interactions of the Ga-GPCR interaction. 
1.9.5 GPRJ and PLCJ 
The Gpa2 coupled receptor Gprl was cloned by yeast two-hybrid screening with 
Gpa2. The Gprl is a typical membrane receptor with 7 transmembrane domains. It 
interacts with Gpa2 with its C-terminal cytoplasmic tail (Yun et al, 1997; Xue et al, 
1998). Although the interaction is demonstrated to be direct in the yeast two-hybrid 
system, it does not necessarily reflect the situation in vivo. In another study, the 
interaction between Gpr1 and Gpa2 was reported to be mediated by Plcl, a 
phosphatidylinositol-specific phospolipase C, which hydrolyzes the membrane 
phospholipids phosphatidylinositol 4,5-biphosphate (PIP2) to produce the second 
messengers inositol 1 ,4,5-triphosphate and diacylglycerol (Ansari et al, 1999). Co-
immunoprecipitation experiments indicated that the interaction between Gprl and 
Gpa2 depends on the presence of Pic 1, while the interaction between Gpr 1 and Pic 1 
does not require Gpa2, and the interaction between Pic 1 and Gpa2 does not require 
Gprl. Deletion of GPRJ, PLCJ or GPA2 leads to defects of filamentation upon 
nitrogen starvation. These defects can be rescued by activating the cAMP pathway 
via overexpression of Tpk2 or by activating the MAPK pathway via an active 
STEJJ-4 allele. Interestingly, Plcl may crosstalk with the MAPK pathway. Deletion 
of Plcl leads to a 5-fold reduction of the expression of the filamentation MAPK 
reporter FG(TyA)::lacZ, while deletion of Ras2 (an upstream regulator of the 
filamentaition MAPK pathway) only caused a 2-fold decrease. Perhaps Plc1 is 
downstream of Ras2 because dominant active RAS2G19v does not rescue the defect 
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caused by 11plcl. Gprl has no effect on FG(TyA)::lacZ expression, indicating that it 
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is not in the filamentation MAPK pathway (Ansari et al, 1999). 
Gpr 1 is required for pseudohyphal differentiation because a gpr I Mgpr I/:). mutant 
strain exhibited a significant defect in filamentous growth (Lorenz et al, 2000). Gprl 
is upstream of Gpa2 as demonstrated by the suppression of this growth defect with a 
constitutive GPA2R237A allele (supposed to induce decreased intrinsic GTPase 
activity) in a double /:).gpr I /:).ras2 mutant (Xue et al, 1998). Expression of another 
dominant active GPA2°132v allele suppresses the filamentation defect of 
gpr I Mgpr I/:). mutant strains (Lorenz et al, 2000). Expression of Gprl is induced 
when cells are starved for nitrogen (Xue et al, 1998). However, neither nitrogen nor 
amino acids proved to be agonists for yeast Gprl, though methionine might serve as 
ligand for the G protein coupled-receptor Gprl and Gpr4 from C albicans and C. 
neoformans, respectively (Lorenz et al, 2000; Maidan et al, 2005b; Xue et al, 2006). 
Like Gpa2, Gpr1 is essential for the transient rise in cAMP levels in response to 
glucose and over-expression of Gpa2 can not suppress the defect caused by Gprl 
(either deletion or none-function allele). These findings indicate that Gprl is a 
glucose sensor (Yun et al, 1998; Kraakman et al, 1999). Later on, other structurally 
related fermentable sugars including fructose, mannose and the disaccharide sucrose 
were found to be agonists of the Gprl receptor (Lorenz et al, 2000). Recently, by 
cysteine scanning mutagenesis and SCAM (substituted cysteine accessibility 
method), Gprl was demonstrated to directly interact with glucose and sucrose 
(Lemaire et al, 2004). It is a low-affinity glucose sensor and high-affinity sucrose 
sensor. In addition, mannose is an antagonist for both glucose and sucrose. 
However, fructose does not act on Gprl (Lemaire et al, 2004). 
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1.9.6 PKA: BCYJ and TPKs; and Downstream of the cAMP Pathway 
The regulatory subunit of the cAMP-dependent protein kinase (PKA) BCYJ (bypass 
CYRJ) gene was identified by a gene mutation that suppressed the eyrl mutation and 
bypassed the need for cAMP for growth (Matsumoto et al, 1982). The bey 1 mutation 
caused a deficiency in the cAMP binding activity of a cAMP-dependent protein 
kinase and resulted in cAMP-independent activation (Matsumoto et al, 1982). 
Although yeast strains with eyrl- deletion and rasl- ras2- double deletion are not 
viable, strains eyr 1-bey 1 and ras J-ras2-bey 1 are viable (Toda et al, 1985). The 
BCYJ gene was cloned by complementation screening for strains sensitive to 
starvation and heat shock (Toda et al, 1987a). The Bcyl protein is homologous to 
regulatory subunits of the mammalian cAMP-dependent protein kinase. Strains of S. 
eerevisiae with disrupted BCYJ genes do not display a cAMP-dependent protein 
kinase activity in vitro, fail to grow on many carbon sources, and are exquisitely 
sensitive to heat shock and starvation (Toda et al, 1987a). All these phenotypes are 
the characteristics of the activated cAMP signalling pathway. BCYJ also regulates 
pseudohyphal growth, because its disruption in diploid cells induces pseudohyphal 
differentiation and expression of Flo 11, a cell surface flocculin which is a reporter 
for both the activated filamentation cAMP and MAPK pathways (Pan and Heitman 
et al, 1999; Rupp et al, 1999). The cAMP-dependent protein kinase is a tetrameric 
complex consisting of two regulatory subunits and two catalytic subunits. The 
regulatory subunits each contain two binding sites for cAMP. After binding to 
cAMP, the regulator subunits undergo conformational change that releases two 
active catalytic subunits with the regulatory subunits remaining as a dimer. 
Hydrolysis of cAMP by low affinity phosphodiesterases Pde1 and high affinity Pde2 
restores PKA to the holoenzyme state (Borges-Walmsley and Walmsley, 2000). 
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Pde1 appears to down-regulate agonist-induced cAMP levels, while the high affinity 
Pde2 specifically controls the basal cAMP level in the cell. Activated PKA can 
phosphorylate Pde 1 and render it much more efficient in cAMP hydrolysis, forming 
a feedback loop (Ma et al, 1999). 
There are three different catalytic subunit genes (TPKI, TPK2, and TPK3) of cAMP-
dependent protein kinase {PKA) from yeast {Toda et al, 1987b). The three Tpk 
proteins have conserved C-terminal residues and are homologous to mammalian 
catalytic subunits, but have heterogeneous N-terminal regions. Gene disruption 
experiments indicated that the three genes are redundant for viability but at least one 
TPK gene is required for normal cell growth (Toda et al, 1987b). Activated cAMP-
dependent protein kinases have negative feedback on cAMP synthesis because a 
yeast strain with TPKIITPK2 deleted and TPK3 partially inactivated showed high 
accumulation of cAMP on glucose-containing medium (Nikawa et al, 1987). The 3 
Tpk proteins are not functionally redundant in cellular metabolism as demonstrated 
by genome-wide transcriptional profiling (Roberson et al, 2000). They also have 
different roles in regulation of pseudohyphal growth. Overexpression of Tpk2 
stimulates pseudohyphal growth, while overexpression of Tpk1 and Tpk3 inhibit it 
(Pan and Heitman, 1999; Robertson and Fink, 1998). The IJ.tpk2/IJ.tpk2 mutants are 
completely defective for pseudohyphal growth and exhibit a 10-fold reduction in the 
expression ofFlo11. In contrast, deletion of TPKI and TPK3 enhance pseudohyphal 
growth and Flo 11 expression. The unique activating function of Tpk2 was mapped 
to the conserved catalytic region but not the unique N-terminal region (Pan and 
Heitman, 1999). By using yeast two-hybrid assays, two direct targets of Tpk2 are 
found to be the transcriptional activator Flo8 and transcriptional repressor Sfl1 (Pan 
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and Heitman, 1999; Robertson and Fink, 1998; Rupp et al, 1999; Pan and Heitman, 
2002). Deletion of FL08 in the 11bcy 1 strain abolishes pseudohyphal growth and 
Flo II expression, while deletion of SFLJ enhances pseudohyphal growth and Flo 11 
expression (Pan and Heitman, 1999; Robertson and Fink, 1998). Flo 11 is the direct 
target of both Flo8 and Sfll. The promoter of FLO 11 contains cis-element( s) in the -
1400 to -1150 bp region for both Flo8 and Sfll binding. Phosphorylation promotes 
Flo8 binding and activation of Flo 11, while phosphorylation inhibits Sfll binding 
and relieves the repression on Flo 11 by unphosphorylated Sf11 (Pan and Heitman, 
2002). 
An epistasis analysis indicated that PKA functions downstream of the Gpr 1 receptor, 
Gpa2 and Ras2 proteins (Pan and Heitman, 1999; Borges-Walmsley and Walmsley, 
2000). The PKA-activating bcyl mutation suppresses the filamentation defect 
caused by a !1gpa2/!1gpa2 or !1gprl/11gprl double deletion (Pan and Heitman, 1999). 
The Mpk21!1tpk2 completely suppresses filamentation caused by the dominant active 
allele GPA2°132v. On the other hand, the Mpk21!1tpk2 can only partially suppress 
filamentation caused by dominant active RAS2°19v, consistent with Ras2 signaling 
via both the cAMP and MAPK pathways (Pan and Heitman, 1999). 
PKA signaling is independent of MAPK pathway, because activation of the 
filamentous growth by PKA does not require components of the MAPK pathway, 
such as Ste 12 and Tee 1, nor does it stimulate the expression of filamentation MAPK 
pathway reporter FG(TyA):: lacZ, although it stimulates the expression of Flo 11 (Pan 
and Heitman, 1999). Flo 11 is a cell surface flocculin responsible for cell adhesion 
(or flocculation) and agar invasion (Lo and Dranginis, 1996 and 1998). Flo 11 is the 
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terminal target shared by both the cAMP pathway and filamentation MAPK pathway 
(Rupp et al, 1999). It is directly regulated by the transcription factors Flo8, Sfl1, 
Ste12 and Tecl. Ste12 and Tecl are downstream elements of the filamentation 
MAPK pathway, while Flo8 and Sfl1 are elements of the cAMP pathway. 
Exogenous cAMP can bypass the requirement for the transcription factor Ste12, but 
not the requirement for Flo8, in the activation of Flo 11 expression (Rupp et al, 1999). 
Adding cAMP to a flraslflras2flpde211ste12 strain can trigger Flo11 expression, but 
can not stimulate the expression of the filamentation MAPK pathway reporter 
FG{TyA)::lacZ, indicating that Flo11 is the terminal target in the cAMP pathway 
(Rupp et al, 1999). 
1.9.7 Summary of the cAMP-Signalling Pathway inS. cerevisiae 
The cAMP signalling pathway that controls filamentous growth in S. cerevisiae is 
summarized in Figure 1.9 (adapted from Borges-Walmsley and Walmsley, 2000). 
The central component of the cAMP signalling pathway is adenylate cyclase which 
catalyzes the formation of cAMP. Adenylate cyclase is tightly bound to cyclase-
associated protein CAP, which is essential for Ras activation and might play a role in 
subcellular localization of adenylate cyclase (Shima et al, 1997; Zelicof et al, 1996). 
Both guanine nucleotide-binding proteins Gpa2 and Ras activate adenylate cyclase, 
modulate cAMP levels, and regulate both vegetative and pseudohyphal growth 
(Borges-Walmsley and Walmsley, 2000). There are two RAS proteins in the yeast, 
Ras1 and Ras2. Ras2 is more potent than Ras1 in adenylate cyclase activation (Toda 
et al, 1985). The RAS proteins directly act on adenylate cyclase to maintain the 
basal cAMP level (Borges-Walmsley and Walmsley, 2000; Kido et al, 2002). The 
activation of adenylate cyclase by RAS proteins is dependent on GTP, famesylation 
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and the N-terminus of CAP. RAS proteins are regulated by GEFs (guanine 
nucleotide exchange factors Cdc25 and Sdc25) and GAPs (GTPase-activating 
proteins Iral and Ira2; Thevelein and de Winde, 1999). The upstream components of 
Ras have not been identified but Ras mediate glucose signalling (Colombo et al, 
2004). It is believed that Ga protein Gpa2 interacts directly with adenylate cyclase 
but there is no direct evidence for such an interaction. Gpa2 is coupled to the G 
protein-coupled receptor Gprl whose ligand is glucose or other fermentable sugars 
(Lamaire et al, 2004). The G protein complex in the cAMP pathway is not a 
canonical one. The kelch repeat protein Gpb2/Krhl (or Gpbl/Krh2) and the Gy 
mimic Gpgl form a Gpy mimic which interacts with Gpa2 and negatively regulates it. 
The Gpy mimic also negatively regulates its own effector that is still unidentified 
(Harashima and Heitman, 2002 and 2005), but possibly adenylate cyclase (Hoffman, 
2005a). 
Binding of cAMP to the regulatory subunit Bcy1 of protein kinase A (PKA) results 
in the release of active catalytic kinase subunits Tpkl, Tpk2 and Tpk3, among which 
Tpk2 is the most important in stimulating pseudohyphal growth (Borges-Walmsley 
and Walmsley, 2000; Pan and Heitman, 1999). Tpk2 phosphorylates the 
transcription activator Flo8 and the transcription repressor Sfll, both of which in tum 
trigger the expression of the cell wall flocculin Flo 11 (Pan and Heitman, 2002). 
Activated PKA can also phosphorylate Pde 1 and promote its efficiency in cAMP 
hydrolysis. Feedback regulation of the cAMP signalling pathway is controlled 
through PKA and Pde (Ma et al, 1999). 
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1.10 The G protein-MAP Kinase Signalling Pathway of S. cerevisiae: Mating 
and Pseudohyphal Growth 
Haploid yeast cells exhibit two mating phenotypes, designated MA Ta and MA Ta. 
When MATa and MATa cells are co-cultured, they conjugate and form a third cell 
type, the diploid MATa/MATa cell (Versele et al, 2001). When the diploid cells are 
starved for both nitrogen and carbon nutrition, they undergo meiosis (Lengeler et al, 
2000). The oligopeptide pheromone (a or a-factor) secreted by one mating type 
elicits three pheromone responses in the opposite mating type: division arrest at the 
01 phase of the cell cycle; induction of pheromone-induced gene expression (e.g. 
FUSJ transcription); and formation of an altered morphology termed shmooing or 
polarized morphogenesis (Versele et al, 2001; Dohlman and Thorner, 2001). These 
responses are mediated by the cell surface receptors encoded by STE2 or STE3 and 
the heterotrimeric 0 proteins encoded by GPAJ (a subunit), STE4 (~ subunit) and 
STEIB (y subunit), respectively (Whiteway et al, 1989; Hoffman, 2005a). 
The mating pheromone receptors Ste2 and Ste3 are similar to mammalian 0-protein 
coupled receptors in that they have seven transmembrane domains. Although Ste2 
and Ste3 lack significant sequence homology, they are all coupled to the Oa protein 
Opal and signal division arrest and other mating responses by similar mechanism 
(Burkholder and Hartwell 1985; Hagen et al, 1986). GPAJ was the first 0 protein 
cloned from yeast, using a cross-hybridization with a rat 0 protein (Nakafugu et al, 
1987). The primary structure of Opal is homologous to mammalian 0 protein a 
subunits but Opal has an extra 110 amino acid residues near theN-terminal region. 
Opal is localized to the membrane as it contains consensus signals for N-terminal 
myristoylation (Dohlman et al, 1993). Opal is specifically expressed in haploid cells 
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and is essential for mating-factor-mediated signal transduction (Dietzel and Kurjan, 
1987). 
In the S. cerevisiae pheromone MAPK pathway, the G proteins are canonical a~y 
heterotrimers. Genetic data indicated that oligopepeptide mating pheromones, a-
factor and a-factor, bind to Ste3 and Ste2 respectively, and activate the 
heterotrimeric G proteins. Both Opal and Ste4 (~) can interact with the C-terminal 
cytoplasmic domain of the pheromone receptor (Ongay-Larios et al, 2000). 
Functional coupling between receptors and G proteins is characterized by high-
affinity binding of pheromone to its receptor in purified membrane preparations 
(Jenness et al, 1983; Blumer and Thorner, 1990). The a subunit Opal is coupled 
with the receptor Ste2 or Ste3 in its GOP-binding state as indicated by high-affinity 
pheromone binding to its receptor. Opal dissociates from its receptor upon binding 
GTP and this is indicated by decreased pheromone binding. The coupling between 
Gpa 1 and its receptors requires the presence of both the ~ and y subunits because 
pheromone binding to its receptor decreased when either the STE4 or STEIB genes 
were altered (loss-of-function for Ste 18; loss-of-interaction with Opal for Ste4). It is 
supposed that the yeast G~y dimer contributes to the interaction between the Ga 
subunit and the receptor by directly interacting with Opal and causing a 
conformational change in this Ga subunit or by directly contacting the receptor itself 
(Blumer and Thorner, 1990). Indeed, the G~ Ste4 can directly interact with both the 
pheromone receptor and the Ga Opal in yeast two-hybrid analyses (Ongay-Larios et 
al, 2000). A G~ mutation (L 132F), which keeps the interaction with the pheromone 
receptor but abolishes the interaction with Opal, also disrupts the proper coupling of 
Opal with the pheromone receptor (Ongay-Larios et al, 2000). Interestingly, this 
44 
opLIJZF mutant (named ste4-IO) is constitutive in activating the mating pathway but 
fails to respond to mating pheromone, indicating that the Ga protein is upstream of 
Gpy in mediating the signal (Ongay-Larios et al, 2000). Although the receptor 
coupling of Gpa1 requires Gpy, the association of Gpa1 with the membrane is 
independent ofthe p andy subunits (Blumer and Thorner, 1990). 
Upon pheromone stimulation, the Ga Gpa1 becomes GTP charged, uncoupling it 
from the receptor, and concertedly, releases the Gpy dimer. In yeast, it is the Gpy 
dimer that modulates downstream effectors, while Gpa 1 negatively regulates the 
pheromone pathway. Loss of Gpa1 induces a pheromone response, while deletion of 
either Ste4 or Ste 18 leads to an inability to activate the pheromone response, even 
when GPAJ is absent (Whiteway et al, 1989). On the other hand, overexpression of 
STE4 alone or together with STEIB, generated a pheromone response in haploid 
cells, while cells with GPAI overexpression alone were more resistant to pheromone. 
Although overexpression of STEIB alone had no pheromone response, STEIB is 
essential for the pheromone response since overexpession of STE4 (p) in the absence 
of STEIB (y) did not produce the pheromone response (Cole et al, 1990; Whiteway et 
al, 1990). These results suggest that the Gpy dimer stimulates the pheromone 
signaling pathway, while the Ga Gpa1 plays a negative regulatory role. The function 
of Ste 18 is to aid proper folding of Gp Ste4 and localize it to the plasma membrane 
since it contains a conserved CAAX motif for palmitoylation or famesylation of the 
cysteine residue (Garcia-Higuera et al, 1996). 
The target of Gpy is the conserved mitogen-activated protein kinase (MAPK) 
cascade, which includes Stell, Ste7, and Fus3 (Lengeler et al, 2000). Free Gpy 
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(Ste4 and Stel8) dimer directly interacts with Ste5, a scaffold protein holding the 
components of MAPK cascade together (demonstrated by yeast two-hybrid assay; 
Whiteway et al, 1995), and Ste20, a p21-activated protein kinase P AK-related 
protein kinase (demonstrated by immunoprecipitation; Leeuw et al, 1998). The 
membrane associated free G~y recruits Ste5 to the membrane, bringing Ste5 in 
proximity to the cell surface-associated Ste20 (Pryciak and Huntress, 1998). The 
interaction between G~y and Ste5 is constitutive and does not depend on pheromone 
activation, while the interaction between G~y and Ste20 depends on pheromone 
stimulation. Therefore, G~y forms a complex with the MAPK cascade through Ste5, 
and upon pheromone stimulation, binds and activates Ste20. Concurrently, 
activation of Ste20 may also require Cdc42, a Rho family GTPase, and Cdc24, a 
guanine nucleotide exchange factor for Cdc42 because G~y can directly interact with 
Cdc24 (Zhao, et al, 1995; Nem and Arkowitz, 1998; Nem and Arkowitz, 1999). 
Activated Ste20 phosphorylates the MAPKKK Stell (van Drogen et al, 2000), 
which then phosphorylates the MAPKK Ste7. Ste7 then phosphorylates and 
activates the MAPK Fus3, which activates the transcriptional factor Stel2 by 
phosphorylating the Stel2 repressors Digl and Dig2, leading to expression of genes 
required for mating (Madhani et al, 1997; Tedfork et al, 1997). 
In yeast, the MAPK cascade is also required for pseudohyphal growth (Lengeler et 
al, 2000). In diploid cells, some of the same kinases and Ste 12 in the haploid 
pheromone MAPK pathway are utilized for filamentous growth, but the pheromone 
receptors and the heterotrimeric G proteins are not expressed in diploid cells and are 
not required in pseudohyphal differentiation (Liu et al, 1993). The scaffold protein 
Ste5 is not required either. Strains with mutations in STE7, STEll, STE12 and 
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STE20 have impaired pseudohyphal growth (Liu et al, 1993). There are two 
transcriptional reporters that have been used to discriminate between genes involved 
in the filamentous growth pathway and those in the pheromone mating pathway: they 
are FG(TyA)::lacZ and FUSJ::lacZ. The FG(TyA)::lacZ was derived from 
transposon Ty1 whose transcription depends on STE12 and TECJ (Laloux et al, 
1994). Expression of FG(TyA)::lacZ correlates extremely well with the activation 
of the MAPK cascade in filamentous growth but does not correlate with the 
pheromone induced activation of the MAPK cascade. In contrast, the FUSJ::lacZ 
reporter responds to pheromone stimulation but not the signals for activation of 
filamentous growth, such as nitrogen starvation (Trueheart et al, 1987; Hagen et al, 
1991; Mosch et al, 1996). 
Apart from stimulating the cAMP signaling pathway, Ras2 is also an upstream 
activator of the MAPK pathway for filamentous growth. The dominant active 
RAS2G19v gene simulates both filamentous growth and the expression of 
FG(TyA)::lacZ but not the mating pathway reporter FUSJ::lacZ (Mosch et al, 
1996). This activation is dependent on Cdc42, Ste20, the 14-3-3 proteins Bmh1 and 
Bmh2, a conserved MAPK pathway including Stell (MAPKKK), Ste7 (MAPKK), 
the MAPK Kss 1 and the transcription factors Ste 12/Tec 1, but is independent of the 
components of cAMP signaling pathway ((Mosch et al, 1996; Cook et al, 1996; 
Madhani et al, 1997; Roberts et al, 1997). Neither deletion of BCYJ nor 
overexpression of TPK genes enhances FG(TyA)::lacZ expression (Mosch et al, 
1996). 
The transcriptional factor Ste 12 binds to pheromone response elements (PREs) that 
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have the consensus sequence TGAAACA (Dolan et al, 1989). This consensus 
sequence is also found in the reporter FG(TyA)::lacZ. Interestingly, Ste12 is the 
terminal component in both the pheromone and filamentous growth pathways 
(Madhani and Fink, 1997). The question is how the yeast cell discriminates between 
the two signals with just one transcription factor. In fact, another transcription factor 
Tecl is also necessary for filamentous growth (Gavrias et al, 1996). Tecl binds to a 
consensus sequence (TCS) CATTCT, which is also found in the filamentous growth 
pathway reporter FG(TyA)::lacZ and is only 14 base pairs away from the Ste12 PRE. 
In yeast cells, PRE and TCS compose a filamentation and invasion response element 
(FRE), which is called Ty1 promoter in the reporter FG(TyA)::lacZ. Tecl binds the 
FRE in concert with Ste 12 to promote the transcription of genes specifically required 
for filamentous growth (Madhani and Fink, 1997). One of the direct targets of 
Ste12/Tec1 is Flo11, a cell wall flocculin which is responsible for cell adhesion and 
agar invasion (Lo and Dranginis, 1998). The promoter region of FLOJJ for Ste12 
and Tee 1 binding is very similar to that in the filamentation MAPK pathway reporter 
FG(TyA)::lacZ. Flo11 is the terminal target of both the cAMP pathway and the 
filamentation MAPK pathway (Rupp et al, 1999). Deletion of FLO 11 abolishes both 
pseudohyphae formation in diploid cells and agar invasion in haploid cells (Lo and 
Dranginis, 1998). 
The MAP kinase in the filamentaion MAPK pathway is Kss 1, while Fus3 has an 
analogous role in the pheromone MAPK pathway (Madhani et al, 1997). In the 
filamentation MAPK pathway, Kss1, together with repressors Dig1 and Dig2, bind to 
and inhibit the Ste 12/Tec I dimer (Cook et al, 1996). Phosphorylation of Kss 1 leads 
to the phosphorylation ofDig1 and Dig2. The phosphorylated Kss1, Dig1 and Dig2 
48 
dissociate from the Ste 12/Tec 1 and relieve repression, leading to activation of Flo 11 
transcription (Bardwell et al, 1998). 
1.11 Cross Talk between Distinct Signalling Pathways Regulates Filamentous 
Growth 
The cAMP pathway and MAPK pathway independently regulate filamentous growth. 
Exogenous cAMP restores filamentaton in ste20 and stel2 mutant strains but does 
not stimulate the expression of the MAPK reporter FG(TyA)::lacZ (Lorenz and 
Heitman, 1997). The cAMP pathway is responsible for unipolar budding and 
invasion, while the MAPK pathway is required for cell elongation and invasion (Pan 
and Heitman, 1999). The !J.tpk2/ !J.tpk2 mutant strains looses the unipolar budding 
pattern and agar invasion but retains the ability for cell elongation, while 
!J.stel2/J.stel2 mutants do not display cell elongation and agar invasion but still 
undergo unipolar budding (Pan and Heitman, 1999). 
There is cross talk between the cAMP pathway and the filamentation MAPK 
pathway. First, Ras2 has been implicated in both pathways. In addition to its well-
established role in regulating adenylate cyclase activity, Ras2° 19v stimulates the 
MAPK cascade and the reporter FG(TyA)::lacZ (Masch et al, 1996). Secondly, the 
two pathways converge on the cell wall flocculin Flo 11, which is responsible for cell 
adhesion and agar invasion under nitrogen starvation (Lo and Dranginis, 1996; Lo 
and Dranginis, 1998; Rupp et al, 1999). The direct regulators ofFlo11 are Flo8, Sfl1 
(both are in the cAMP pathway), Ste12 and Tecl (transcriptional activators in the 
filamentation MAPK pathway). Flo11 has a higher expression level in haploid cells 
than in diploid cells. This explains why haploid cells invade agar in rich media while 
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the diploid cells can not. The primary structure of Flo 11 is similar to a class of yeast 
serine/threonine-rich GPI (glycosyl-phosphatidyl-inositol)-anchored cell wall 
proteins. Overexpression of Flo 11 enables agar invasion in rich media, while 
deletion of Flo 11 abolishes pseudohyphal formation and agar invasion. Flo 11 is a 
good reporter for both the cAMP pathway and the filamentation MAPK pathway. 
Activation of either pathway increases Flo 11 expression, while mutations in either 
pathway blocks Flo 11 expression. The promoter of the FLO 11 gene contains cis-
elements for the binding of transcriptional factors Flo8, Sfl1, Ste 12 and Tee 1. 
Overexpression of Flo8 in a 11ste12 strain and overexpression of Ste 12 in a 11jlo8 
strain suppressed the pseudohyphal and invasion defects of the mutants. 
Interestingly, the morphologies of the filaments of these suppressed strains were not 
identical to that of the wild type. In the 11ste12 strain with Flo8 overexpression, the 
cells were shorter but had a denser network. In the 11jlo8 strain with Ste 12 
overexpression, the cells were longer than the filaments of the wild-type (Lo and 
Dranginis, 1996; Lo and Dranginis, 1998; Rupp et al, 1999). These observations are 
consistent with the conclusion that the cAMP pathway regulates unipolar budding 
and invasion, while the MAPK pathway is essential for cell elongation and invasion 
(Pan and Heitman, 1999). Meanwhile, these observations indicate that terminal 
structural components other than Flo 11 exist and are under the control of the cAMP 
pathway and the filamentation MAPK pathway, respectively. 
1.12 Other Genes Regulating Pseudohyphal Growth 
A number of other genes have been reported to regulate pseudohyphal growth. 
These include the protein kinases ELM1, ELM2, ELM3 (Blacketer et al, 1993), SCH9 
(Xue et al, 1998), and the transcription factors PHD1 (Gimeno and Fink, 1994), 
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ASHJ (Chandarlapaty and Errede, 1998), SWI5, SOK2 (Pan and Heitman, 2000), 
MSN2, MSN4 (Pan and Heiman, 1999) and MSSJJ (Gagiano et al, 2003). Elm1p is a 
serine-threonine protein kinase and its function is to repress filamentous growth 
(Koehler and Myers, 1997). However, Elm1 is not an element in either the 
cAMP/PKA pathway or the MAPK pathway. Overexpression or deletion of the 
ELM I gene can complement the abnormal phenotypes in dimorphism caused by 
mutations in the cAMP signaling pathway (Garret, 1997). Sch9 is a protein kinase 
under the control of Gpr 1 and Gpa2 but is parallel with Ras and the cAMP pathway 
(Xue et al, 1998; Lorenz et al, 2000). Phd1 is a transcription factor, overexpression 
of which induces invasive pseudohyphal growth on nutritionally rich medium. Phd1 
acts distinctly from the cAMP pathway, MAPK pathway and Ash1, which positively 
regulate filamentous growth (Chandarlapaty and Errede, 1998). Ash1 is proposed to 
be a transcription factor because it contains a zinc finger-like domain related to the 
GAT A family of transcription factors. Ash 1 appears to be under the control of Ras2 
and Cdc42 but is not a component of the MAPK pathway. Mutants with deletion of 
STEll, STE7 and STE12 can still form filaments if they express the activated alleles 
Ras2° 19v or Cdc42 12v. Further deletion of ASHI blocks filamentous growth. In 
addition, overexpression of Ash 1 can restore the defect of filamentous growth caused 
by ste7, steff, stel2 and ste20 deletion, but has no effect on the filamentation MAPK 
pathway reporter FG(TyA)::lacZ (Chandarlapaty and Errede, 1998). Swi5 is a zinc 
finger class transcriptional factor that can regulate Ash1 expression (Pan and 
Heitman, 2000). The transcription factor Sok2 negatively regulates pseudohyphal 
growth through a complex cascade of Phd 1, Swi5 and Ash 1. The sok2 mutation 
enhances expression of Phd 1, Ash 1, and Swi5 genes. Phd 1, Ash 1 and Swi5 all 
activate the FLOJJ gene independently of the cAMP and MAPK pathways (Pan and 
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Heitman, 2000). 
1.13 The cAMP Signalling Pathway of Schizosaccharomyces pombe 
In contrast to S. cerevisiae, mating in the fission yeast S. pombe is regulated by both 
the pheromone MAPK pathway and nutrient-sensing cAMP pathway (Lengeler, et al, 
2000). The pheromone MAPK pathway is similar to that of S. cerevisiae but there 
are still a number of differences (Hoffman, 2005a). Perhaps the most obvious is that 
the G protein in the MAPK pathway of S. pombe is not a typical heterotrimeric 
complex because Gpal appears to be monomeric. The Gpy dimer (Git5-Gitll) is not 
the cognate partner for Gpa 1 but they are coupled to Gpa2 to form a typical 
heterotrimeric G protein in the cAMP signaling pathway. In contrast to S. cerevisiae, 
it is Gpal inS. pombe that activates the pheromone MAPK pathway. In addition, 
Ras 1 activates the pheromone MAPK pathway but does not regulate the cAMP 
pathway. For details of the pheromone MAPK pathway of S. pombe, please refer to 
review by Hoffman (2005a). 
The cAMP signaling pathway in S. pombe is responsible for mating, glucose sensing 
and glucose repression on gluconeogenesis (Hoffman, 2005b ). Glucose detection 
results in elevated cAMP levels and activation ofthe cAMP signaling pathway. The 
transcription of the jbpl gene, which encodes fructose- I ,6-bisphosphatase, is 
repressed upon glucose stimulation, serving as a good reporter for activation of the 
cAMP pathway (Hoffman and Winston, 1990; Hoffman and Winston, 1991). 
Increased activity of the cAMP signaling pathway inhibits sexual development, while 
decreased activity leads to conjugation and sporulation (Lengeler et al, 2000). The 
major components of the cAMP signaling pathway include the seven-transmembrane 
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GPCR Git3, the heterotrimeric G-protein composed of the Gpa2 Ga (Git8) and G~y 
(Git5-Git11) dimer, the adenylate cyclase Cyrl (Git2) and Pka1 (Git6), the catalytic 
subunit of cAMP-dependent protein kinase A (PKA; Hoffman, 2005b ). The GPCR 
Git3 interacts with Gpa2 in two-hybrid assays. The interaction is facilitated by the 
G~ Git5 and abolished by a dominant active Gpa2 (Hoffman, 2005b). The Gy Git11 
was obtained from a two-hybrid screening with G~ Git5 (Landry and Hoffman, 
200 I). Gpa2 functions downstream of GPCR and G~y because the defect of jbpl 
transcriptional repression caused by llgit3, llgit5, or llgitll is suppressed by 
overexpression of the wild type gpa2 or an activated gpa2R176H allele. Deletion of 
G~y leads to the same phenotype as that of Gpa2 deletion (Welton and Hoffman, 
2000; Landry and Hoffman, 2001 ). This is in contrast to the S. cerevisiae pheromone 
signaling pathway in which deletion of Opal leads to the opposite phenotype of 
Ste4-Ste 18 G~y deletion. 
Gpa2 is the direct activator of adenylate cyclase (Ivy and Hoffman, 2005). The 
adenylate cyclase gene of S. pombe, spCYRJ, was cloned by cross-hybridization with 
S. cerevisiae CYRJ (Yamawaki-Kataoka et al, 1989; Young et al, 1989). The protein 
consists of 1,692 amino acids and a segment corresponding to the N-terminal 620 
residues of S. cerevisiae Cyr1 appears to have been lost. When analyzed by SMART 
EMBL, spCYRJ contains a RA domain (292-372), LRR domains (475-876), a PP2Cc 
domain (985-1273) and a catalytic CYCc domain (1261-1506). Unlike S. cerevisiae, 
there is no indication that the S. pombe adenylate cyclase is regulated by Ras 1 
although there is an obvious RA domain (Hoffman, 2005a). Interestingly, a recent 
discovery indicates that the RA domain of spCyr1 binds directly to GTP-charged Ga 
Gpa2 and plays an important role in adenylate cyclase activation (Ogihara et al, 
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2004). In another report, however, the interaction domain of adenylate cyclase with 
Gpa2 was mapped with a two-hybrid screen to residues 33-196, in which the Ll77, 
T178, P 180 and P 182 are crucial for the interaction (Ivey and Hoffamn, 2005). 
Overexpression of this domain leads to a defect in cAMP signaling, which can be 
restored by Gpa2 coexpression. These are the first evidence for direct activation of 
fungal adenylate cyclase by a G protein. 
1.14 The cAMP Signalling Pathway of Candida albicans 
C. albicans is the most important opportunistic fungal pathogen in human beings (Lo 
et al, 1997; Brown and Gow, 1999). It causes a wide range of diseases from 
superficial infections to life-threatening systemic infections in immuno-compromised 
patients. This fungus is dimorphic. Candida yeast cells can undergo two different 
types of switching, i.e. pseudohyphal and hyphal switching. A pseudohypha is a 
chain of distinct cells formed by budding but without the separation of daughter cell 
and mother cell in each cell division. A hypha is formed from a germ-tube which is 
a cylindrical outgrowth from a yeast cell. The ge.rm-tube extends to form a hypha, a 
long continuous tube with septa throughout the length, but no distinct indentation at 
the site of septum (Lo et al, 1997; Brown and Gow, 1999). Hyphal or pseudohyphal 
formation underlies pathogenesis because Candida variants defective in hyphal 
formation are less virulent (Sobel et al., 1984 ). Pseudohyphal and hyphal formation 
in Candida can be induced by many environmental factors. The most critical 
condition for pathogenicity may be the induction of hypha formation by biological 
conditions such as temperature change, serum and macrophages (Lo et al, 1997). 
At least two signal transduction pathways, the MAPK pathway and cAMP pathway, 
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are involved in the morphological switching (Borges-Walmsely and Walmsley, 
2000). The major components of the MAPK pathway include the kinases Cst20 
(Ste20 homologue), Stell, Hst7 (Ste7 homologue), Cek1(Kss1 homologue) and the 
transcription factor Cph1 (Brown and Gow, 1999); whereas the major components 
of the cAMP pathway include CaGprl (Miwa et al, 2004; Maidan et al, 2005a), 
CaRas1 (Feng et al, 1999; Leberer et al, 2001), CaGpa2 (Sanchez-Martinez and 
Perez-Martin, 2002), CaCdc35 (adenylate cyclase; Rocha et al, 2001), CaCap1 (Bahn 
and Sundstrom, 2001), CaTpk1, CaTpk2 (Bockmuhl et al, 2001; Cloutier et al, 
2003), CaBcy1 (Cassola et al, 2004) and the transcription factor Efgl (Lo et al, 
1997). Interestingly, the transcription factor Cph 1 is a homologue of Ste 12, and 
Efg1 is a homologue of Phd1 in S. cerevisiae (Lo et al, 1997). Similar to S. 
cerevisiae, both cphl/cphl and efgl/efgl single-mutant strains are partially defective 
in filamentous growth. The double mutant cphl/cphl, efgl!efgl strain is almost 
completely defective in pseudohyphal and hypha! formation under any conditions 
tested, including serum and macrophage stimulations (Lo et al., 1997). Most 
importantly, the non-filamentous cells show a drastic reduction in virulence when 
injected in mice (Lo et al., 1997). 
An increased cAMP level accompanies the yeast to filamentous transition (Sabie and 
Gadd, 1992). Adenylate cyclase CaCdc35 is essential for filamentous growth (Rocha 
et al, 2001) and cAMP levels are undetectable in a CaCDC35 deletion strain. In 
contrast to S. cerevisiae, cells with CaCDC35 deleted are viable but grow more 
slowly than wild type cells and are unable to switch to the hyphal form under all 
environmental conditions tested. Importantly, the homozygous Cacdc35L1 cells are 
avirulent for systemic infection in a mouse model (Rocha et al, 2001 ). The adenylate 
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cyclase CaCdc35 is regulated by Ras1 and Gpa2 (Leberer et al, 2001; Miwa et al, 
2004; Maidan et al, 2005a), the later of which is coupled to the cell surface receptor 
CaGprl as indicated by two-hybrid assays (Maidan et al, 2005a). Both CaGprl and 
CaGpa2 are involved in hyphal formation in solid media in a cAMP-dependent 
manner, but they are not required for hyphal formation in liquid serum media or 
systemic candidiasis (Miwa et al, 2004). There is still a dispute as whether CaGpr1-
CaGpa2 mediates glucose-induced signaling (Miwa et al, 2004; Maidan et al, 2005a). 
In contrast, CaCdc25-CaRas 1 mediates glucose, serum and macrophage-induced 
cAMP signaling (Feng et al, 1999; Leberer et al, 2001; Maidan et al, 2005). A 
Caras I L1 strain is viable but can not form hyphae in response to serum, whereas a 
dominant active CaRASIG19v allele enhances hyphal growth (Feng et al, 1999; 
Maidan et al, 2005a). The defect caused by the Carasii.l. can be restored by addition 
of cAMP in growth media or overexpressing components of the MAPK pathway, 
indicating that CaRas 1 regulates both the cAMP and MAPK pathways. In addition, 
the filamentation defect caused by Caras Ill. is associated with reduced virulence in 
the mouse model (Leberer et al, 2001 ). There are two cAMP-dependent protein 
kinase catalytic subunits in C. albicans, Tpk1 (named Tpk3 later) and Tpk2 
(Bockmuhl et al, 2001). Tpk1 controls the hyphal switch on solid inducing media, 
whereas Tpk2 controls agar invasion and the hyphal switch in liquid media. The 
conserved C-terminal catalytic portions mediate the Tpk specificities with regard to 
filamentation, while theN-terminal domain ofTpk2 mediates agar invasion. 
1.15 The cAMP Signalling Pathway of Ustilago maydis 
Ustilago maydis is the causative agent of com smut disease. The disease is 
characterized by large plant tumors that are filled with masses of black-pigmented 
56 
telispores (Durrenberger et al, 1998; Lengeler et al, 2000). The life cycle of this 
fungus can be mainly divided into two parts: the in vitro yeast-like haploid cells and 
in planta dikaryotic hyphae. The infectious dikaryotic hyphae are formed after 
mating of two haploid cells with different alleles at the unlinked mating type loci a 
and b. The a locus encodes pheromones and pheromone receptors and mediates cell 
recognition and fusion. The b locus is multiallelic and encodes two homeodomain 
proteins bE and bW, which form heterodimers only if they are derived from different 
b alleles. The bE-bW heterodimer controls invasion and filamentous growth after 
fusion of two haploid cells. The mating, filamentous growth and virulence of this 
fungus are inter-correlated. In addition, haploid cells can also adopt filamentous 
growth under certain conditions such as nutrient starvation, exposure to air, or 
growth at low pH. However, haploid cells are not pathogenic (Durrenberger et al, 
1998; Lengeler et al, 2000). 
The cAMP pathway of U. maydis is involved in mating, filamentous growth and 
pathogenicity (Gold et al, 1994). The major components of the cAMP pathway 
include the Ga protein Gpa3 (Regenfelder et al, 1997; Kruger et al, 1998), the G~ 
protein Bpp1 (Muller et al, 2004), adenylate cyclase Uacl (Gold et al, 1994; Kruger 
et al, 1998), the PKA regulatory subunit Ubc1 (Gold et al, 1994; Gold et al, 1997), 
the PKA catalytic subunits Adrl and Ukal (Durrenberger et al, 1998). In contrast to 
S. cerevisiae, it is a decreased level of cAMP or decreased activity of the cAMP 
pathway that leads to filamentous growth (Lengeler et al, 2000). Defects of uacl in 
haploid cells can lead to filamentous growth without the requirement for mating 
(Gold et al, 1994). However, co-infection of maize seedlings with two uacl-
deficient strains harboring compatible a and b mating-type alleles does not results in 
57 
disease, indicating that filamentation and virulence are divergently controlled 
(Mayorga and Gold, 1998). There are 4 Ga proteins in U. maydis (Gpa1-4). 
However, only deletion of gpa3 has a discernable phenotype (Regenfelder et al, 
1997). Gpa3 is essential for mating and pathogenicity. Deletion of gpa3 causes 
mating deficiency in haploid cells and loss of pathogenicity in diploid cells, and 
leads to a morphological change similar to that caused by deletion of uacl 
(Regenfelder et al, 1997). The sterility and morphology change caused by gpa311 
can be rescued by exogenous cAMP, indicating that gpa3 is upstream of uacl 
(Kruger et al, 1998). Recently, the G~ subunit bppl was identified (Muller et al, 
2004); and its deletion shown to cause filamentous growth and attenuated pheromone 
gene expression, the same phenotypes as the gpa311 strain. A dominant active allele 
of gpa3 suppresses the phenotypes of the bppl deletion strain, indicating that gpa3 
and bppl are subunits of the same heterotrimeric G protein. In contrast to the gpa3!1 
strain, the bppl/1 strain has no deficiency in inducing plant tumors, indicating that 
gpa3 acts independent of bppl in pathogenic development (Muller et al, 2004). Of 
the two PKA catalytic subunits, Adrl accounts for the majority of PKA activity, 
regulates filamentation and is essential for pathogenicity. In contrast, ukal plays 
little role in filamentation and pathogenicity (Durrenberger et al, 1998). Although 
Ras2 was identified in a screen for suppressor mutations of an adr 1 mutation, there is 
no indication that this Ras protein is involved in the cAMP signaling pathway. 
However, Ras2 promotes filamentous growth and pathogenicity through the MAPK 
pathway (Lee and Kronstad, 2002). 
1.16 The cAMP Signalling Pathway of Cryptococcus neoformans 
Cryptococcus neoformans is a significant human fungal pathogen that primarily 
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infects immunocompromised patients such as those with AIDS, malignancies, 
receiving chemotherapy or transplantation (Pukkila-Worley and Alspaugh, 2004). C. 
neoformans exists in the environment predominantly as haploid yeast with two 
mating types, MA Ta and MA Ta. They duplicate by budding and mate under the 
regulation of nutrient limitation and pheromones (Lengeler et al, 2000). Diploid 
cells are unstable and only occur transiently (Borges-Walmsley and Walmsley, 2000; 
Pukkila-Worley and Alspaugh, 2004 ). Diploid cells are filamentous and undergo 
meiosis and sporulation. MA Ta cells can also filament and sporulate in response to 
nitrogen starvation in the absence of MA Ta cells or in response to pheromone 
secreted by MATa cells (Lengeler et al, 2000). This perhaps makes MA Ta more 
prevalent in the environment and clinical isolates. In addition, MATa cells are more 
virulent than MATa cells (Lengeler et al, 2000). In C. neoformans, morphological 
switching is not critical to its pathogenicity; which depends mainly on three factors, 
production of antiphagocytic polysaccharide capsule and anti-oxidant melanin, and 
the ability to grow at 37°C (Pukkila-Worley and Alspaugh, 2004). The production of 
capsule and melanin is induced by signals encountered in the host during infection. 
For example, capsule formation can be induced by iron deprivation or physiological 
concentrations of C02/HC03- (Vartivarian et al, 1993). Melanin production can be 
induced by glucose deprivation and presence of diphenolic substrates such as 
catecholamines (Nurudeen and Ahearn, 1979). 
The mating, virulence and pathogenicity of C. neoforrnans are controlled by the 
cAMP signaling pathway (Pukkila-Worley and Alspaugh, 2004). The major 
components of the cAMP signaling pathway include the G protein-coupled receptor 
Gpr4 (Xue et al, 2006), Ga protein Gpal (Alspaugh et al, 1997), adenylate cyclase 
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Cacl (Alspaugh et al, 2002), the PKA regulatory subunit Pkr1 and catalytic subunit 
Pka 1 (D'Souza et al, 200 1 ). Gpr4 is the S. cerevisiae Gpr 1 homologue. It physically 
interacts with Gpa1 as indicated by the split-ubiquitin system. Deletion of GPR4 
leads to reduced capsule production and mating defects, similar to deletion of GPAI 
(Xue et al, 2006). t1gpal mutant strains are sterile and deficient in capsule and 
melanin production (Alspaugh et al, 1997). The adenylate cyclase gene CACJ is not 
essential for growth. Deletion of CACI has no effect on viability and vegetative 
growth. However, deletion of CACJleads to the same phenotypes as GPAI deletion 
(Alspaugh et al, 2002). Both gpal and cacl mutants are non-pathogenic in a mouse 
model (Alspaugh et al, 1997 and 2002). Deletion of the PKA catalytic subunit PKAI 
leads to similar phenotypes to deletion of GPAI and CACJ, while the PKA 
regulatory subunit pkr I mutation suppresses gpal capsule and melanin defects. The 
pkrl mutant strains are hypervirulent with more capsule produced than wild-type 
strains (D'Souza et al, 2001). The Gp subunit gene GPBI has also been identified 
(Wang et al, 2000). However, Gpbl regulates mating and haploid fruiting via the 
MAPK pathway. Gpb1 does not mediate virulence production and does not interact 
with Gpa 1. The partner of Gpa 1 has still not been determined. 
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Chapter II 
Materials and Methods 
2.1 Chemicals, Antibiotics and Solutions 
General chemicals, antibiotics and biological chemicals were mainly purchased from 
Sigma, Fluka, BDH, and Merck. Microbial growth media were acquired from 
Oxoid, Difco and Clontech. Enzymes used in molecular biology were supplied by 
Promega, Roche Biochemicals and Invitrogen. A list of frequently used antibiotics 
and solutions is presented in Table 2.1. Other solutions were prepared as previously 
described (Sambrook et al, 1989). 
Table 2.1 Antibiotics and solutions. 
Stock Storage Working 
Concentration Condition Concentration 
Ampicillin 100 mg/ml -20°C 100 J.tg/ml 
Carbenicillin 100 mg/ml -20°C 100 J.tg/ml 
Chloramphenicol 30 mg/ml in ethanol -20°C 30 J.tg/ml 
Kanamycin 10 mg/ml -20°C 20 J.tg/ml 
Tetracyclin 5 mg/ml in ethanol -20°C 10 J.tg/ml 
IPTG 200 mg/ml -20°C 4-12 Jll 
for surface spread 
on 90 mm plate 
X-Gal 50 mg/ml -20°C 35 Jll 
in dimethylformamide for surface spread 
on 90 mm _Qlate 
RNase A 10 mg/ml -20°C 
DNase I 500 units/ml -20°C 
Lyticase 10 units/ml in TE pH 7.5 -20°C 
Proteinase K 50 J.tg/ml -20°C 
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2.2 Strains, Media and Vectors 
PbOJ strain {ATCC 90659) was purchased from ATCC USA. It is a typical wild 
type Pb strain which undergoes a morphological switch in response to a change in 
temperature. Other bacterial and yeast strains used in this thesis are summarized in 
Table 2.2-1. Culture media used for growth of strains are listed in Table 2.2-2. 
Vectors used in this thesis are listed in Table 2.2-3. 
Table 2.2-1 Strains used in this thesis. 
Strains Source Am~lication 
PbOJ (P. brasiliensis) 90659 from ATCC DNA and RNA extraction 
E. coli NovaBlue Novagen Competent cell for 
blue/white selection 
E. coli XL1-Blue MRF' Stratagene Host of 'A ZAP phage 
E. coli XL 1 0-Gold Stratagene Ultra-competent cell 
E. coli SOLR Stratagene Phagemid excision 
E. coli DH5a Invitrogen Competent cell for cloning 
E. coli BL21 (DE3) Novagen Protein expression 
E. coli BL21 (DE3) pL YS Novagen Protein expression 
E. coli Rosetta 2 (DE3) Novagen Protein expression 
E. coli Rosetta 2 (DE3) pL YS Novagen Protein expression 
S. cerevisiae AD 1-8- From DNA extraction 
Prof A Goffean 
S. cerevisiae AH 109 Clontech Yeast two hybrid 
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Table 2.2-2 Culture media used in this thesis. 
Media ComQosition of media AQQlication 
LB 10 g/L NaCl, 5 g/L yeast extract, E. coli culture 
1 0 g/L bactotryptone 
YPD 20 g/L Difco peptone, 10 g/L Yeast culture 
yeast extract, 2% Glucose 
Modified-YPD 20 g/L neopeptone, 1 0 g/L yeast PbOJ culture 
extract, 2% Glucose 
Table 2.2-3 Vectors used in this thesis. 
Vectors Source AQQlication 
pGEM-T Easy Pro mega TA cloning 
pGEM-TE(Kpni) pGEM-T Easy Cloning of 
introduced with a Kpnl site full length PbCYRJ 
pBSK Invitrogen Cloning 
pYES6/CT Invitrogen Cloning and expression 
pDNR-LIB Clontech PbOJ eDNA library construction 
pGADT7 Clontech Yeast two hybrid 
pGBKT7 Clontech Yeast two hybrid 
pET-21a Novagen Protein expression 
2.3 Storage of Strains 
All the operations with PbOJ were carried out in two especially established Category 
3 labs (UK category for infectious agents) in the IBLS (Institute of Biological and 
Life Science), University of Glasgow, and in the CID (Centre for Infectious 
Diseases) at Durham University. Long term storage of PbOJ was achieved by 
maintaining the cells in 15_% gJyc~roJ at -70°~. PbO 1 )'_east form cells were_ grown 
into log phase (3-4 days) in 50 ml modified YPD medium with shaking at 120 rpm. 
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Replicate stocks were prepared by mixing 0.5 ml of cells and 0.5 ml of 30% sterile 
glycerol. The mixture was then placed in a -80°C freezer. Other bacterial and yeast 
cultures were stored in a similar manner. Usually, a 5 ml overnight liquid culture 
was propagated. Stocks were prepared by mixing 0.75 ml of the culture with 0.25 ml 
60% glycerol. The appropriate storage vials containing this mixture were then 
placed at -80°C. 
2.4 Centrifugation 
Routine centrifugation of 1.5-ml and 0.5-ml tubes was performed in a benchtop 
Eppendorf Centrifuge 5415D. Routine centrifugation of 20-ml universal tubes, 15-
ml and 50-ml Falcon tubes were carried out in Jouan CR3i benchtop centrifuge. For 
centrifugation of larger volume or with higher speed, Beckman's Avanti J-E 
centrifuge was employed, with either JA-20 or JA-1 0 rotors being used. 
2.5 DNA Agarose Gel Eletrophoresis 
As previously described (Sambrook et al, 1989), DNA agarose gel electrophoresis 
was routinely performed with 1 X TAE buffer (NBS Biologicals, UK). 
2.6 PCR Techniques 
PCR was a frequently used technique in this thesis for cloning genes and making 
plasmid constructions. Four major PCR systems were used in this thesis. They are 
Qiagen's HotStarTaq and ProofStart Taq, Promega's Taq in storage buffer B, 
ABgene's Extensor High-Fidelity PCR system, and Stratagene's Gene Morph II 
Random Mutagenesis PCR System. 
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2.6.1 Oligonucleotide Primers for PCR 
Oligonucleotide primers were synthesized by Invitrogen. Primers were reconstituted 
in distilled water to a concentration of 50 pmol/Jll. The primers used in this thesis 
are listed in Table 2.6.1. 
Table 2.6.1 Primers used in this study. 
Primers Sequences 
(5'-3'; restriction sites are underlined; A+C+G=V, 
T+C+G=B, A+T+G=D, A+T+C=H, A+T=W, C+G=S, 
T+G=K,A+C=M,C+T=Y,A+G=R,A+T+C+G=N) 
PbCYRJ 
PbAC-Fl GTBTTCACYGAYATYAAGAACWSBAC 
PbAC-F2 AGAACTGCACGTCGCTTTGG 
PbAC-F3 GGAAGCTGAAGGGGCTTGAG 
~ ~ ~ 
PbAC-F4 AGTTGCGGATGGTGGGCAAATC 
PbAC-F5 CCGTCCTCGAGGTGCAATGGAAACCCCATCCTCG 
PbAC-F6 TATGGCAGATAGCCTTGGGCGAAAC 
PbAC-F7 CAATCTGAAGAGTCTCGTTGATCTTGATATC 
PbAC-F8 GTGCCCTGAAAATTTCGGAGAGATTGGTCTTC 
PbAC-F9 GTCTGGCGCCGTTGGACTGTTGCTTTACGTTTGG 
PbAC-FlO GCCTCAACGCTCCACGGGCTGAGATTGAAGAGG 
PbAC-Fll CCGTTGCCTATGACTTGATGTC 
PbAC-Fl2 CCAGACACTCGTCGTCCTCAAAGAGTA 
PbAC-Fl4 GAGAATTCCGCAATCCCTTTGAACCCTCCAG 
PbAC-Fl5 CGTTTACGTTTGCGGGATCTCTGAAGCAAC 
PbAC-F16 GAATATCGGCCGGATGAATCACATCCACTC 
PbAC-Fl7 AGCGGCCAGAAACTTAGATTTGCGGCAGCA 
PbAC-Fl8 CAGCATGGCAAGGAGACAGCGGGAGAAAGA 
PbAC-Fl9 GAGATGCACCTGTGTATCCAGTTCCAGGAGA 
PbAC-F20 CCCCAACCCGGGATTTGAGCTACTCACAGAor 
TCCACGTCGCTTTGGGAGACGTATCC 
PbAC-F21 TTGGGATACCGTCTGCTCTTCCTCTCGCCA 
PbAC-F22 AGAGAGTCCCGTGCGCTGACACAGCCTTGA 
PbAC-F23 TTGTCACCGCGAGTTAAAGTCCGGAGTTGA 
PbAC-F24 CCACGTCGACTTGCACGGGCGCAGTCTCA 
~ -p!JAC=F25- ~ 
--oTCATA:TCTCGJ"\.GCTGCAACTGJ\.KACCCC:A ---- __ ._,_ -:-. --_- -~.--=-~ 
PbAC-F26(Kpni) GGTACCAAAATGTCTAGGAGACAGCGGGAGAAAGAT 
AGG 
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PbAC-F27 AGATTTCGGATCAGGATGACAGAAGGCTGA 
PbAC-F28 GATTTCGGATCAGGATGACAGACACTCGTC 
PbAC-F40 CCGCATTTCCGCAGTTGCGGATGGTGGGCAAATC 
PbAC-GSPl TGATGCTGTTGAATCGTGCGTCTATCTC 
PbAC-Rl TTVACCATRGGRCCSWRGATRTCCAT 
PbAC-R2 CAAGTAATCCATTCGACCAG 
PbAC-R3 CCGTCAACTCGTTATAGGACAAG 
PbAC-R4 NNNNCTCGAGTGGCGGCCGCTCTAGAACTA 
PbAC-R5 NNNNCTCGAGGTCTATAATATCTAATAGTGATG 
PbAC-R6 CAGGATTCTCAAGCCCCTTCAGCTTC 
PbAC-R7 AGTCACCCATAACCGTTCCAGTGTCGTAAGGCGTC 
PbAC-R8 TTCCAGTGTCGTAAGGCGTCCAATATCCGACAACTC 
PbAC-R9 ACTCACCTCCACCCGCGTAACCTGATGTTC 
PbAC-R9(2) GTTGAAGCTGATATCAAGATCAACGAGACTCTTC 
PbAC-RlO GTCCAGAGTTCTTGAAAGGTC 
PbAC-Rll CGCAGACTCCTTTTTGCGGTCAGACTCGACAC 
PbAC-Rl2 AGCTCGAATTCCGACCATATCTAGCAGGAGAC 
PbAC-Rl3 TCAAAAACCTAGATCCCTTCCCACCACCGTCG 
PbAC-Rl4 GATTGACTGCCAGATGACATAGG 
PbAC-Rl5 GTGGTGTCCATGATGGCGACCGCTTCC 
PbAC-Rl6 GTCATCCGATGCGCCAAGAATCGCAAG 
PbAC-Rl7 CCAAAGCTGGTTGTCGGTACGTCTGTTG 
PbAC-Rl8 CAGAGGAGAGAACTTGGCATTTCCGAACCA 
PbAC-Rl9 TATCTGAGCCAACTGTCGACGGAAGAGATC 
PbAC-R20 TCCAAAGCTGGTTGTCGGTACGTCTGTTGG 
PbAC-R21 TGGGGATACATCGGGGGAATGTGGCCTAC 
PbAC-R22 GAGTCACGCTCGCCATCTGTCATGGAACCA 
PbAC-R23 CTCTTTGAGGACGACGAGTGTATTTTGAAC 
PbAC-R24 AAGAAACCCCCAAGCAGCATGAAGCAGGCA 
PbAC-R25 ACCCATCCAAGCCCGAAAGAGCAACGTCCA 
PbAC-R26 GCCAAACAGCGAAACAACGCCGTTCCGGCA 
PbAC-R27 GGCGTTACGATTACTCTTTGAGGACGACGA 
PbAC-R28 GAATGTGGCCTACGGGGGGCGTTACGATTA 
PbAC-R29 CTGGTTGTCGGTACGTCTGTTGGGGATACA 
PbAC-R30 CCCTGCGGAATCTCCGTCAACTCGTTATAGGACAAG 
PbAC-R31 GACGGGGGGTTGAAGCTTTCGCCTCTCACA 
~ ~ 
PbAC-R32 AACAATATCGATCGTACCAAGCAAACAGACGCA 
PbAC-R33 CAAATCCACCCATATGAGCCAACTGTCGAC 
PbAC-R330 CATACTGTGGCCTGCAAGCAGGAGATTCCA 
PbAC-R34(Notl) GCGGCCGCGCCGTGCTCGAAGAACTAGAACCAC 
PbAC-R35 CTCCATAGTTTGATATATCCTTTGATTGAC 
PbAC-R36 CCATAGTTTGATATATCCTTCAGAAGACTTTCCG 
PbAC-R37 CATTCATAAAGCAGCTGTTCCTGTGGCAGG 
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PbAC-GADF 1 (Nco I) GGTACCACCATGGCAAGGAGACAGCGGGAGAAAG 
PbAC-GADF2(Ncoi) TCGTCCATGGAAGATGAGCTGAATAACTAC 
PbAC-GADR1(BamHI) TGATTTGGATCCCGTTGATTCCCAAGTCAGC 
PbAC-GADR2(BamHI) CCCCAGGATCCTAAGATGTTTCAAAGAGTTG 
PbAC-EF 1 (Ndel) GGGATTCATATGGTTAATAGCACAGATCTG 
PbAC-EF2(Ndel) AGTATCCATATGGGACTGTCTCCATTAACTG 
PbAC-ER1 (Xhol) CCATGGCTCGAGCGCCGTGCTCGAAGAACT 
PbAC-ER2(Xhol} CTCGCGCTCGAGATTGTGATTAAGATAGTC 
PbGPAJ 
PbGPA-DGF5 GCYGGWGARYSNGGNAARTCNAC 
PbGPA-DGR2 CARTGDATCCAYTTYTTNCK 
PbGPA-DGF5R2-3-4-F1 GAACAGCATGCCACTCATAGC 
PbGPA-DGF5R2-3-4-R 1 TCTAACGGCTCTGTCACTTGG 
PbGPA-DGF5R2-3-2-F1 GAGCTTTGCAAGGCTTAACTCG 
PbGPA-DGF5R2-3-2-R1 ATCGTGGCTCACGCATTTCGAG 
PbGPA1-ExGPAF1 CATATGGGTTGTGGAATGAGC 
PbGPA-F1 CGGGATCCGTCATATGGGTTGTGGAATGAGCACC 
PbGPA1-F1 TGTCCTTCGCTCCCGTGTTAAGACCACAGG 
PbGPA1-F2 TTGCGACTATATCCTCAACCGCTTCGTCTCGCTC 
PbGPA1-F3 GACTATATCCTCAACCGCTTCGTCTCGCTCAACC 
PbGPA1-F4 GATTGATCGGTTTAAGGAGAAACTGCCTGTTAGC 
PbGPA1-F5 CTCTGAGTACGACCAGCTCCTGTTCGAAGACG 
PbGPA1-F6 GACATGAAGCAGAACCTGTACATTCCGATATCGTC 
PbGPA1-F7 GTGTCATTCATCCATCTTGCTTTACGCC 
PbGPA1-F8 GGCTATGGAAGGACTAGATATCCCGTTGGA 
PbGPA1-F9 CTGCATGGTTTCCTTCTCAG 
PbGPA1-F10 GATCAAAATGCTCTTGCTTGGTGCTGGAGA 
PbGPA1-FII GAATGACTCTGCACGATACTATTTTGACTCCA 
PbGPA1-R1 CGGGATCCTCATATCAGTCCACAGAGGCGAAG 
PbGPA1-R2 TCCAACGGGATATCTAGTCCTTCCATAGCCor 
GCTTAGCCTAAACTCTCCATAGTCATCGTGTCC 
PbGPA1-R3 GAGCATTTTGATCTCGTTTCTCTGCAGC 
PbGPA1-R4 TCCTTGTCCTCGGTGCTCATTCCACACC 
PbGPA1-R5 CCTGTGGTCTTAACACGGGAGCGAAGGACA 
PbGPA1-R6 TGAAGACTGGCTGGGTTTTGCGGGAAAGGA 
PbGPA1-R7 CAATTACCCATGGCTTATTAGG 
PbGPA1-R8 CAGTGTATTCGGCACCCCCTTCGTAATCAG 
PbGPA1-R9 TGTCCTGGATGATTATATCGTTGACAGCCA 
PbGP A 1-p YER3 GCCTAGGTCATATCAGTCCACAGAGGCGAAG 
-EbGEAm-F 1- GG~~~~GCTTGGTGCTGTAGAGTCTGGCAAATGCAC 
PbGPAm-R1 GTGGATTTGCCAGACTCTACAGCACCAAGCAAAAGC 
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PbGPA2 
PbGPA2-Fl ACGAACGATACCAAAACCGCGCGGTCATCTACTC 
PbGPA2-F2 ACCGCGTCTTTACCCCTGGGTGGTTACCCA 
PbGPA2-F3 GGAGATCTACATCCACTACACAAATGCTAC 
PbGPA2-F4 TCAATGAGTGCAAACGGGATCTGCAAGGGAor 
CATGGGTTGCGCAAGTTCGAACGGTGAAGA 
PbGPA2-F5 CGCACTGGATGCCACTGGAAGGTGGCTTGA 
PbGPA2-F6 CATGGGTTGCGCAAGTTCTCAACCAGTGGA 
PbGPA2-F7(EcoRI) CTAGGAATTCATGGGTTGCGCAAGTTCTCA 
PbGPA2-F8 GGTGAAGATTCTTTTGCTTGGTGCTGGAGA 
PbGPA2-F9 TTGAGTTTGAAAAGACAAAGCCACTAGCCA 
PbGPA2-Fl O(BD-Ndel) ATGGCCATGGAGGCCGAACATATGGGTTGC 
PbGPA2-Rl TGAAGCATGTCTTGATTGTTGGGTAACCACC 
PbGPA2-R2 ATCGAGGAGAATCTTGAATGCAACAACCATG 
PbGPA2-R3 GCCGTCGACCACGCGTGCCCTATAGTGA 
PbGPA2-R4 CATACGGATCATCTTGTCGATCGCAGACCA 
PbGPA2-R5 TGGTGCAGAAACCGAGCGTGGCACAAGAGC 
PbGPA2-R6 CTGTTGGCACCTACAGAATCAGGTTGTTGA 
PbGPA2-R7 CAATTCCTATCAGAACTCAATCAGCATGCA 
PbGPA2-R8 AACGTAGCTCGAGTCCTTCCCCTCTGTTCA 
PbGPA2-R9 CTTCGCACTTTTCAAATGCCACGGGACATG 
PbGPA2-R10 GGCTTCATGCATTTGATTTGCATTTTGATCCor 
GAGCACAACTCTCAAGTGAGTGCAACACCA 
PbGPA3 
PbGPA3-Fl TCTTGGATTGCGCCAAGGACCTGATAGGAG 
PbGPA3-F2 CCTAATGAAGCCGATGTGTTGCGCGCTAGA 
PbGPA3-F3 TATCCTCAGTATGTATAGGAAAAGCACACC 
PbGPA3-F4 AACCGTGCCGCCAAGTACTTGCTCTGGAGA 
PbGPA3-F5 GTATCAGATACCTACCCACCCACAACGTor 
TGGTATCAGATAGGATGGGTGGGTGTTGCA 
PbGPA3-F6 GTGGGTGTTGCAGTTCTGCTTCTGGGGAGA 
PbGPA3-F7 CCACTTGGCCTTTTTTCCTTTTCCTTTTCC 
PbGPA3-F8 CAGCTCTGGTCCACTTGGCC 
PbGPA3-F8(EcoRI) ATCAGAATTCATGGGTGGGTGTTGCAGTTC 
PbGPA3-F9 ATGCAAGATCCTACTGCTTGGTTCGGGTGA 
PbGPA3-F10 TGGATTCAGCACCTTACTTCTTCGAGGAAGC 
PbGPA3-Fll(BD-Ndel) ATGGCCATGGAGGCCGAACATATGGGTGGG 
PbGPA3-Rl TTCACTCCGCTGCCCGCCAACATCGAAC 
PbGPA3-R2 ACGCACTGAATACTCAATTGGCCCATTGTG 
PbGPA3-R3 GCGTATTCGGGTCCGCGTCAATCTGGTATG 
PbGPA3-R4 CCTCTGCTCTGCATTCTCCCCAGAAGCAGA 
PbGPA3-R5 CCCTTTCACAAAATACCAGAATCTTTCAGG 
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PbGPA3-R6 AAAGCAGTGAGTGGCCTGGGGAGTTATACG 
PbGPA3-R7 GATTTGATAAGTAAGCGGCCCGATGCGGGA 
PbGPA3-R8 GTCGGTGGCTTGAGTAAGGTGAGGATAAAG 
PbGPBJ 
PbGPB-Fl GCNAARATHTAYGCNATGCAYTGG 
PbGPB-F2 TGGGTNATGACNTGYGCNTAYGC 
PbGPB-Rl GCRTANGCRCANGTCATNACCC 
PbGPB-R2 CCABWKCATRCANGTCATRTCNCC 
PbRASJ 
PbRAS-Fl(Ndel) CCGCGCTTCATATGCAGCTTTGTCTAAACC 
PbRAS-Rl(EcoRI) GTGATACTGTAGAATTCCACGAAACCCTC 
PbTPKJ 
PbTPK-Fl CATCCRTTYHTBATTMGAATGTGGGG 
PbTPK-F2 TGGGTACTGGHTCYTTTGGNMGNGT 
PbTPK-F3 CACGTTCCAGGATGTGAAGAATC 
PbTPK-F4 GTTTACTGAGGAAATCGCAGCGCTTC 
PbTPK-F5 TGCAAGCCAGTTTGATAGGTATC 
PbTPKI-F6 ATCCACCCCTCAACGATGAAGTGG 
PbTPKI-F7 GATGCGCCGTATATTCCTCCGGTGAAGGGA 
PbTPKI-F8 GACGGAGCCGTATGGGGGTAGTGGGGATGA 
PbTPKl-F9 AGACTAACAGCGGGGTCTGTGA 
PbTPKI-FIO CTGAGACGGGTCTATGTTCGATGG 
PbTPK-F40 GCTGTTTAGTTTACTGAGGAAATCGCAGCGCTTC 
PbTPK-Rl ACBTMTTTKGCRAABCCRAARTC 
PbTPK-R2 ATSARMAYMCCNARVSWCCACCARTC 
PbTPK-R3 CTTCAAATGTCCATATCGATC 
PbTPK-R4 CTAAAAGTAGATTCTCTGGCTTTAGGTCTCTG 
PbTPK-R5 GTGATGGTCATGTAGATATTCCAACGCCAACG 
PbTPK-R6 CTAAAAGTAGATTCTCTGGCTTTAGGTCTCGG 
PbTPKI-R7 TACCTGGAACGTGCCCCATAGCG 
PbTPKI-R8 TAGGAATGGATGTTTAACCCGCTGCAGC 
PbTPK-R9 TAATGTTCTTAATACTGGCGACATTTTGGGAGTG 
PbTPKI-RlO ATGTCGCGATTGAACCAGGTGTACTCGC 
- -- -- -
PbTPK-Rll CTCCGTCTAGATATTGGCATAGGC 
PbTPKI-Rl2 GGGTGAGGTAAACGCAGGGTGCTGGAGCA 
PbTPKI-Rl3 CTTCAGCAAATTGCCTAGACCCCGCATGGA 
PbTPKl-Rl4 GGGACTACGGCAAGGCCTGTGGGTGGATGA 
_f>bTJ>Kl,R15 - -
- - -ATGATGCTGAGGCCCGACGCCACTAGATAG- --
PbTPK-Rl6 GTAGAATGGAATTGAACCTGCAGACACTCA 
PbTPKI-Rl7 GTCCACGAAATAATCGCCATATGGATCATCC 
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PbTPK1-R18 CCCTAAGGGTATCAGGCGTGCCA 
PbTPK-R40 CGATCTAAAAGTAGATTCTCTGGCTTTAGGTCTCTG 
TPK-DFI GGNWSNTTYGGNMGNGTNCAYYT 
TPK-DF2 CARRTNGARCAYACNAAYGAYGA 
TPK-DRI RTTYTCNGGYTTNARRTCNCKRTA 
TPK-DR2 RAACCANGGRTGRTTYTTNAYRTC 
TPKL-DFI CCNTAYGTNGTNTGYDBNTTYGA 
TPKL-DF2 GARHTNGAYRTNWSNGTNTAYGA 
TPKL-DF3 GANGCNTTYYTNGGNCAYGTNMG 
TPKL-DRI SWCCARAARTCNACCATYTTNGT 
PbACTIN 
PbActin-F3 ATGCTCCTCGAGCTGTCTTCCCTTCGATCG 
PbActinGADFI CATATGGAGGAAGAAGTTGCTGCCCTCG 
PbActinGADF2 GTGATTCATATGGAGGAAGA 
PbActinGADRI TTAGAAGCACTTGCGATGGACAATAGAGG 
PbActin-R3 GGTACATGGTTGTGCCACCGGACATAACGA 
PbACTIN-R3(EcoR1) CGAGGGCGGTGAATTCCTATTGCATACGATC 
PbTUPA 
cPbTUPA-Fl ACTTCTTACCTTAGGCCAGCCTCGCCCTCA 
cPbTUPA-F2 ACACCCGATGGACGCTGGGTTATGAGTGGA 
cPbTUPA-F3 ATCGTGGCGTACAGTTCTGGGATCCAGCGA 
cPbTUPA-F4 CCCGTTCAACCCAGCCTACCAACTACCGCA 
cPbTUPA-Rl ATTATATGATGACGGCGGTGATAACGAGGA 
cPbTUPA-R2 ATAGCTGTAAATCCCATGTCGAGAGTTAGG 
cPbTUPA-R3 CCTTCCTCTGGCAAAGTTACGTGTTGCGCA 
cPbTUPA-R7 CTGATCATCTCCATCTCCTGGAGTTGGCCA 
PbTUPA-Fl MGSACYTTTGARGGNCAYAAR 
PbTUPA-Rl CCARATTCKNGCNCKCATRTC 
PbTUPA-R2 GTCGCTGGATCCCAGAACTGTACGCCACGA 
PbTUPA-R3 CACTCATAACCCAGCGTCCATCGGGTGTCA 
PbTUPA-R4 GGATATCCCAGACCTGTAGGTGGA 
PbTUPA-R5 GGCAACTTGTCAGGATCCAGGTC 
PbTUPA-R6 GAGTGCGGATTTCAGCCTCG 
ScGPRJ 
ScGPRI-Fl CGGGATCCGAAGTGTGACGAATAAAGC 
ScGPRI-F2 GCTGGGACATCAGACTTTCTCTTGCC 
ScGPR1-F3 CGGGATCCATATGATAACTGAGGGATTTCCCCCG 
-ScGP1H-F4 ------------ --- -GGGGATGGG4GA-MG1'AAMGAAT-T-AAAGGGC 
ScGPR1-F5 CCGGATCCAGGAAAAACCTTGGAACTATTCATG 
ScGPRl-Rl CGGGATCCATTTTCAAACATCGCGATAC 
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ScGPRI-R2 GTTACTAGTTATGTCGCTGTTATCG 
ScGPRI-R3 CCGGATCCTTAGATTCTTTTGAATTTGTGCC 
ScGPA2 
ScGPA2-Fl CCGGATCCTGGGTCTCTGCGCATCTTCA 
ScGPA2-F2 GGGTCTCTGCGCATCTTGAG 
ScGPA2-F3 CCGGATCCGTATGGGTCTCTGCGCATCTTCAG 
ScGPA2-F4 ATCATGGGTCTCTGCGCATC 
ScGPA2-Rl CCGGATCCGCTGTGCATTCATTGTAACAC 
ScGPA2-R2 AACGCGAGAAGAGGCATGCAG 
Universal primers 
3 'AD LD Screening AAGTGAACTTGCGGGGTTTTTCAGTATCTACGA 
5 'AD LD Screening CTATTCGATGATGAAGATACCCCACCAAACCCA 
3 'AD sequencing AGATGGTGCACGATGCACAG 
API GTAATACGACTCACTATAGGGC 
AP2 ACTATAGGGCACGCGTGGT 
APII GTAATACGACTCACTATAGGGCACGC 
AP21 TCACTATAGGGCACGCGTGGTCGAC 
AP3 TACGACTCACTATAGGGCACGCGTGGTCGA 
AP4 GTAATACGACTCACTATAGGGCACGCGTGG 
3'DNA-BD Screening TGGCTGCAAGCGCGCAAAAAACCCCTCAAGAC 
5'DNA-BD Screening TCATCGGAAGAGAGTAGTAACAAAGGTCAAAGA 
3'BD sequencing CGCAAAAAACCCCTCAAGAC 
CDS/3 'BamHI(2) ATTCTAGACGCGGATCCGCGGACATGTTTTTTTTTTTT 
TTTTTTTTTTTTTTTTTTVX 
CDS/3 'BamHI(3) GATTCTAGACCGGATCCGCGGACATGTTTTTTTTTTTT 
TTTTTTTTTTTTTTTTTTVN 
CDSJII/3 'Bam HI AACGCGGATCCGCGTTTTTTTTTTTTTTTTTTTTTTTTT 
TTTTT 
Creator-Fl CGACGGTACCGGACATATGCCCGGGAATTC 
Creator-Rl GCGCGCCAAACGAATGGTCTAGAAAGCTTC 
CYCI Reverse (pYES6) GGAGGGCGTGAATGTAAGCGTGAC 
GADFI GAAGAGAAAGGTCGAATTGGGTACCG 
GADRI CGCGGATCCGTATCGATGCCCACCCGGGTGGAATTC 
GADR2 CGCGGATCCGTGTATCGATGCCCACCCGGGTGGAATTC 
GALl Forward (pYES6) CCTCTATACTTTAACGTCAAGGAG 
5'LONG CTAATACGACTCACTATAGGGCAAGCAGTGGTATCA 
ACGCAGAGT 
3'LONG CTAATACGACTCACTATAGGGCATTCTAGAGGCCGA 
GGCGGCCG~ .. 
Ml3Fl ACCGCCTTACGCGTGTAAAACGACGGCCAG 
Ml3 forward GCGTGTAAAACGACGGCCAG 
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M13Rl CCAGGATCTCCTAGGGAAACAGCTATGACC 
M13 reverse GGGAAACAGCTATGACCATG 
3-2PB AAGCAGTGGTATCAACGCAGAGTACTTTTTTTTTTTT 
TTTTTTTTTTTTTTTTTTVN 
5-2PB AAGCAGTGGTATCAACGCAGAGTACGCGGG 
pGEMTE-SP6 AGGTGACACTATAGAATACTCAAG 
PolyT TTTTTTTTTTTTTTTTTTTTTTTTTVN 
pQE-Fl TGTGAGCGGATAACAATTTCACACAG 
pQE-Rl CAACCGAGCGTTCTGAACAAATCCAG 
5'RACE AAGCAGTGGTATCAACGCAGAGT 
3'RACE ATTCTAGAGGCCGAGGCGGCCGACAT 
SHORT CTAATACGACTCACTATAGGGC 
SIVl AAGAAGTGGTATCAACGCAGAGTGGCCATTACG 
SIV2 GTATCAACGCAGAGTGGCCATTACGGCCGG 
SIVBamHI AAGCAGTGGTATCAACGCAGAGTGGATCCGGG 
Smart IV AAGCAGTGGTATCAACGCAGAGTGGCCATTACGGCC 
GGG 
T3 AATTAACCCTCACTAAAGGG 
T7 TAATACGACTCACTATAGGG 
T7 Sequencing TAATACGACTCACTATAGGGC 
V5C ACCGAGGAGAGGGTTAGGGAT 
2.6.2 Routine PCR 
PCR was routinely carried out according to the manual of the product providers. A 
certain number of PCR reactions were performed with adjusted conditions; for 
example, increased primer concentration for PCR with degenerate primers. The 
annealing temperature and number of cycles could vary greatly according to the 
melting temperature of primers and the abundance of target gene in template 
samples. Here, a typical reaction composition is given below, when using 
HotStarTaq PCR system. 
Reaction composition 
lOX PCR Buffer 
dNTP (10 mM each) 
Primer A (50 f.LM) 
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Final concentration 
IX 
200 f.LM 
0.5-1 f.LM 
Primer B (50 ~M) 
HotStarTaq Polymerase (5 u/~1) 
Template DNA 
H20 
Cycling parameters are as below. 
1 cycle 95°C 
30 cycles 94°C 
50-65°C 
72°C 
I cycle 72°C 
0.5-I ~M 
2.5 u/reaction 
Up to 1 ~g/reaction 
To 50 ~1 
15 minutes 
30 seconds 
30 seconds 
1-5 minutes 
6 minutes 
PCR reactions were performed in an Eppendorf Gradient Thermocycler. The lid of 
the machine was set to I 05°C, removing the need for mineral oil overlay in PCR 
tubes. 
2.6.3 Single Specific Primer PCR (SSP-PCR) 
SSP-PCR was used to isolate gene fragments when the full-length gene sequence 
was unknown but limited sequence information was available. This technique has 
been used extensively in this thesis to clone genes of PbOJ from 2 eDNA libraries 
and a universal GenomeWalker library. For eDNA libraries, PbOJ cDNAs were 
cloned into A.-ZAPII phage vector and pDNR-LIB plasmid vector. For construction 
of the Genome Walker library, PbOJ genomic DNA was digested with blunt cutting 
restriction enzymes followed by universal adaptor ligation at both ends. SSP-PCR 
was done with a gene specific primer and a standard universal primer that annealed 
either at the boundary of the vector and the eDNA, or at the universal adaptor. In 
most situations, a two-step nested ·ss:P-PCR was applied when no obvious spe~ific 
band was observed with a single-step amplification. 
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2.6.4 RT-PCR and Nested 5' SMART RACE RT-PCR 
RT-PCR was performed in two steps, i.e. RT followed by PCR. RT was undertaken 
using Clontech's PowerScript Reverse Transcriptase according to its manual. 
Usually, 0.5-1 ~g PbOJ mRNA was used as template in a 20-~1 RT reaction. The RT 
product was directly used as the template for PCR with 1 ~1 RT product in each 50-~1 
volume of PCR reaction. In order to determine the transcriptional start site of a 
eDNA sequence, nested 5' SMART RACE RT-PCR was applied. The SMART 
(Switching Mechanism At 5' end of RNA Iranscript) technique is facilitated by 
paring the 3' end of the first strand eDNA with a 5' adaptor (Smart IV 
oligonucleotide from Clontech) which in tum serves as the second template for RT to 
switch to and extend first-strand synthesis to the end of the adaptor. The 
PowerScript Reverse Transcriptase possesses the activity of adding 3 to 5 extra 
cytosine nucleotides to the 3' end of the completed first eDNA strand. This poly-C 
motif allows the annealing of the 3' end GGG sequence of the Smart IV oligo. 
Primers derived from Smart IV oligo, coupled with a reverse gene specific oligo, 
allow 5' RACE (Rapid Amplification of ~DNA End). Usually, nested secondary 
PCR is necessary because it was hard to produce a sharp specific band after primary 
amplification. The typical reaction components and conditions are presented as 
below: 
PbOJ mRNA 
Reverse gene specific primer (2 ~M) 
Smart IV oligo ( 10 ~) 
H20 
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The mixture was heated to 70°C for 2 minutes and cooled on ice. Then the following 
components were added: 
5X First-Strand Buffer 
dNTP (10 mM each) 
DTT (lOOmM) 
PowerScript R T 
The mixture was incubated at 42°C for 1 hour. Reaction was terminated by heating 
at 70°C for 15 minutes. 
Primary PCR 
PCR was performed using the HotStarTaq PCR kit. 
RT Product 
lOX Buffer 
dNTP (10 mM) 
SIVl (50 ~M) 
Reverse gene specific primer (50 ~M) 
HotStarTaq 
H20 
Cycling parameters used are as below: 
1 cycle 
31 cycles 
1 cycle 
95°C 
94°C 
68°C 
72°C 
72°C 
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1 ~1 
5 ~1 
1 ~1 
1 ~1 
2 ~1 
0.5 ~1 
To 50 ~1 
15 minutes 
30 seconds 
30 seconds 
3 minutes 
10 minutes 
Secondary PCR 
A secondary PCR was performed using SIV2 and a nested gene specific primer. 
About 0.1 f . .tl of the primary PCR reaction was used as a template. The cycling 
parameters in the primary PCR were repeated, except that the annealing temperature 
was changed to 65°C. 
2.6.5 A-Tailing of PCR Products 
When hi-fidelity eDNA or gene fragments were amplified with ProofStart Taq 
polymerase, blunt ended PCR products were produced and an A-tailing procedure 
was required to facilitate cloning the PCR products into pOEM-T Easy vector. The 
procedure is outlined below: 
PCR fragment 
lOX Buffer (Promega) 
dATP (10 mM) 
Taq DNA Polymerase in Buffer B (Promega) 
H20 
5 fll 
1 fll 
0.2 fll 
1 fll 
To 10 fll 
The mixture was incubated at 70°C for 15-30 minutes. After cooling on ice, 2 fll of 
the mixture was used in a ligation reaction with pOEM-T Easy vector (Promega). 
2.7 Cloning Techniques 
Plasmid extraction was usually done with Qiagen' s Mini prep kit. When a large 
amount of plasmid was required for preparation of libraries, Qiagen' s plasmid Maxi 
kit was used. Restriction enzyme digestion of DNA was performed mainly using 
Promega's system. For cloning purpose, plasmid or DNA fragment elution from 
plasmid mmtprep, gel extraction, or PCR purification was directly subjected to 
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digestion. Digestions usually proceeded for 3-4 hours at 37°C and terminated by 
heating at 65°C for 15 minutes. Digested vectors and insert fragments were 
recovered using Qiagen 's Gel Extraction kit. PCR fragment purification was 
performed using Qiagen's Gel Extraction kit or PCR Purification Kit. Quantification 
of DNA was done by comparing the intensity of fluorescence from the target DNA 
band with those of Low Mass DNA Ladder (Invitrogen) bands after eletrophoresis. 
When single restriction digestion was applied in cloning, dephosphorylation of both 
ends of the digested vector was needed to reduce the frequency of self ligation. 
Shrimp AP (alkaline phosphatase, Roche Biochemicals) was used to this end. After 
dephosphorylation, the reaction was heated to inactivate the AP. The treated vector 
was directly used in ligation without further purification. Ligation reactions were 
carried out with Pormega's T4 DNA ligase, using a 1:3 molar ratio of vector to 
insert, and incubating the reaction mix at 4 °C for overnight. Transformation of 
plasmid into E. coli was carried out using commercial competent cells NovaBlue 
(Novagen) and DH5a (Invitrogen) and XL 1 0-Gold (Stratagene ). Competent cells 
were prepared according to the calcium chloride treatment protocol described 
previously (Sambrook et al, 1989). When transformation was performed, 50 ~-tl of 
competent cells mixed with 2 ~-tl of ligation mixture was incubated on ice for 5 
minutes, heat-shocked at 42°C for 30 seconds and snap cooled on ice for 2 minutes. 
Cells were then directly plated out if ampicillin or carbenicillin was used for 
selection. For selection with kanamycin resistance, cells were made more robust by 
shaking in SOC medium (Novagen) at 37°C for 1 hour before plating. For 
blue/white screening in TA cloning, IPTG/X-Gal were mixed with cells and spread 
on LB-ampicillin plates. Positive clones on selective plates were confirmed by 
restriction digestion of extracted plasmid. Sequencing was used to re-confirm the 
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accuracy of cloning if the constmctions were important enough for downstream 
work. Sequencing is another interesting aspect of this thesis in that at least 1 00 kb of 
DNA has been sequenced based on a conservative estimation. Sequencing reactions 
were performed by BaseClear (Netherlands) and University of Durham. The data 
were analyzed using VectorNTI software (Informax). 
2.8 DNA Extraction 
PbOJ DNA and S. cerevisiae AD1-8- DNA were extracted using Qiagen's DNeasy 
Plant Maxi kit. The purification was done by introducing a small modification into 
the kit manual. Materials provided from the kit appear underlined in the following 
procedures. 
1. PbOJ yeast form cells were grown in modified YPD for 3 days at 37°C. S. 
cerevisiae cells were obtained by overnight culture in YPD at 30°C. 
2. Fungal cells were precipitated by centrifugation at 4,200 rpm for 10 minutes. 
About 1 gram of wet cells was used for each Qiagen's Maxi column. Cells were 
ground into powder in liquid nitrogen in a mortar. The powder was then transferred 
to a 50-ml tube containing 5 ml of Buffer APt. 10 ~-tl RNase A was added in each 
tube and the mixture was incubated for 10 minutes at 65°C. 
3. 1.8 ml of Buffer AP2 was added to the lysate and the mixture was incubated for 10 
minutes on ice followed by centrifugation at 4,200 rpm for 5 minutes at room 
temperature. 
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4. The supernatant was decanted to the QIAshredder column. After spinning at 
4,200 rpm for 5 minutes, the flow-through was transferred to a new 50-ml tube and 
the volume was recorded. 
5. 1.5 volumes of Buffer AP3/E was added to the clear lysate and the mixture was 
applied to a DNeasy Maxi spin column. The column was centrifuged at 4,200 rpm 
for 5 minutes and washed with 12 ml Buffer AW. 
6. Genomic DNA was eluted with hot (65°C) 1.5 ml Buffer AE. DNA was 
quantified by measuring the optical density of a diluted sample at a wavelength of 
260 nm. About 1 Jlg of DNA was run in a 1% agarose gel for quality control. 
2.9 Total RNA and mRNA Extraction 
PbOJ total RNA and mRNA were obtained using Qiagen's RNeasy Midi kit and 
Oligotex mRNA Midi kit respectively. Materials provided from the kit are 
underlined. 
Total RNA extraction 
1. PbO 1 yeast cells were grown in 50 ml modified YPD with shaking at 110 rpm for 
4 days to obtain log phase cells. Cells were precipitated and re-suspended in 50 ml 
of fresh modified-YPD medium. The cells were shaken at 160 rpm for an additional 
6 hours at 37°C. Cells were again harvested and re-suspended in 10 volumes of 
RNAlater (Ambion) and stored at -80°C. 
2. On the day of RNA extraction, RNA later was discarded by centrifugation and cells 
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were broken in liquid nitrogen. About 1 gram of cell powder was transferred to a 50-
ml tube containing 10 ml Buffer RTL to make the cell lysate. 
3. The cell lysate was centrifuged for 10 minutes at 4,200 rpm. The supernatant was 
saved and mixed with 0.5 volume of 100% ethanol. 
4. The sample was passed through the RNeasy Midi column by centrifugation. The 
column was washed by Buffer RW1 once and Buffer RPE twice. 
5. For each column, 250 )ll RNase-free water was used to elute RNA. 
6. The total RNA was quantified by measuring the optical density of a diluted RNA 
solution at a wavelength of 260 nm as well as qualified by running 5 )ll of the total 
RNA on a 1% agarose gel followed by ethidium bromide staining. 
mRNA Extraction 
1. For each 250 )lg of PbOI total RNA, the volume of the sample was adjusted to 500 
)ll with RNase-free water, then 500 )ll Buffer OBB and 20 )ll Oligotex Suspension 
were added. 
2. The sample was heated at 70°C for 3 minutes to disrupt secondary structure. 
3. The sample was then placed at room temperature for 10 minutes to allow 
hybridization between the oligo-dT30 and the poly-A tail of the mRNA. 
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4. The Oligotex:mRNA complex was precipitated by centrifugation, re-suspended in 
400 Ill Buffer OW2 and applied onto a small spin column. This was washed by 
passing Buffer OW2 through the column twice with centrifugation. 
5. PbOl mRNA was eluted with 100 Ill hot (70°C) Buffer OEB. 
6. The mRNA was quantified by measuring the optical density of a diluted mRNA 
solution at a wavelength of 260 nm. The quality of the mRNA was tested by running 
1 jlg of mRNA on a 1% agarose gel and ethidium bromide staining. 
2.10 Construction of A.-ZAP-eDNA Library of PbOJ 
The A.-ZAP-eDNA expression library was constructed by usmg a ZAP-eDNA 
Synthesis Kit and a ZAP-eDNA Gigapack III Gold Cloning Kit (Stratagene) with 
modifications to the instruction manual. First strand synthesis of eDNA was primed 
with an oligo( dT) linker-primer which contained an Xhol site and was transcribed 
using MMLV-RT and 5-methyl dCTP, which protected the synthesized eDNA from 
Xhol digestion. Second strand synthesis was nick-translated using a nucleotide 
mixture supplemented with dCTP to ensure that the Xhol site in the linker-primer 
was digested. The uneven termini of the double-stranded eDNA were blunted with 
Pfu DNA polymerase and EcoRI adapters ligated to the blunt ends. Xhol digestion 
released Xhol and EcoRI cohesive ends to allow the eDNA to be inserted into the 
Uni-ZAP XR vector in a sense orientation (EcoRI-Xhoi) with respect to the lacZ 
promotor. The lambda library was packaged using Gigapack III Gold Packaging 
Extract and amplified by plating on E. coli cell line XLl-Blue MRF'. XLl-Blue 
MRF', an McrA-McrB- E. coli strain, was used as host for Uni-ZAP-hemimethylated 
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eDNA phage because hemimethylated DNA introduced into an Mer A +McrB+ strain 
would be subject to digestion by the mcrA and merE restriction systems. After 
passing through XL1-Blue MRF' cells, the eDNA library was no longer 
hemimethylated and could be grown in McrA+McrB+ strains such as XL1-B1ue. The 
procedure for eDNA synthesis, packaging and amplification of the A.-ZAP-eDNA is 
briefly summarized as follows. The materials provided in the kits or prepared 
according to the instruction are underlined. 
1. First-strand synthesis. The following components were added into an Eppendorf 
tube in order: 
4.5 ).!1 of 1 Ox first-strand buffer 
3.0 ).!1 of first-strand methyl nucleotide mixture 
2.0 J.!l of linker-primer ( 1.4 blg/bll) 
31 ).!1 ofmRNA (7 ).!g) 
1.0 ).!1 of RNase Blocking Ribonuclease Inhibitor ( 40U/).!l} 
3.5 J.!l ofMMLV-RT (20 U/ btl) 
First-strand reactions were incubated at 42°C for 1 hour. 
2. Second-strand synthesis. The 45 ).!1 of first-strand reaction mix was placed on ice 
and supplemented with the following reagents in order: 
20.0 ).!1 of lOxsecond-strand buffer 
6.0 ).!1 of second-strand nucleotide mixture 
116 J.!l of sterile distilled water 
2 ).!1 ofRNase H (1.5 U/b!l) 
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11 J.!l of DNA polymerase I (9 U/gl) 
The contents were mixed and incubated at 16°C for 2.5 hours. 
3. Blunt-ending the eDNA termini and ligation with EcoRI adapters. After the 
second-strand synthesis, the tube was placed on ice and then the following were 
added: 
23 J.!l of blunting dNTP mix 
2.0 J.ll of cloned P(u DNA polymerase 
The tube was incubated at 72°C for exactly 30 minutes, then was extracted with 
phenol-chloroform and precipitated with sodium acetate and ethanol. After 
overnight precipitation, the blunt-ended eDNA was pelleted and dried. The pellet 
was then resuspended in 9.0 J.ll of EcoRI adapters. The following components were 
added to the tube containing the blunt-ended eDNA and the EcoRI adapters: 
1.0 J.ll of 1 Ox ligase buffer 
1.0 J.!l of 10 mM rATP 
1.0 J.!l ofT4 DNA ligase (4 U/gl) 
The ligation was incubated at 4°C for 2 days. 
4. Phosphorylation of the EcoRI ends and Xhol digestion. The ligation mix was 
inactivated by heating the tube at 70°C for 30 minutes and cooling it down to room 
temperature. The adaptors were phosphorylated by adding the following and 
incubating at 3 7°C for 30 minutes. 
1.0 J.ll of lOxligation buffer 
2.0 J.!l of 10 mM rA TP 
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6.0 j..tl of sterile water 
1 j..tl ofT4 polynucleotide kinase (10 U/ul) 
The kinase was heat inactivated at 70°C for 30 minutes. Xhol digestion was done by 
adding the following components to the kinase tube and incubated for 1.5 hours at 
37°C: 
28.0 j..tl of Xhol buffer supplement 
3.0 j..tl of Xhol (40U/ul) 
5. Size fractionation. Fractionation of large size eDNA increases the quality of the 
eDNA library. 50-j..tl of a Xhol digest was mixed with 50 j..tl H20 and 2 j..tl 1% xylene 
cyanol. The mixture was run through Clontech's CHROMA SPIN-400 column 
according to the instruction from the manufacturer. The passage of the first 250 J..ll, 
corresponding to the eDNA with sizes larger than 500 bp, was collected and 
extracted with phenol-chloroform. The eDNA was then precipitated with sodium 
acetate and ethanol, and re-suspended in 5 J..ll of sterile water. The concentration of 
the eDNA was determined to be 40-50 ng/J..ll by an ethidium bromide plate assay. 
6. Ligating the eDNA into the Uni-ZAP XR vector arms. The ligation was set up as 
the following and incubated at l2°C overnight: 
2.5 J..ll of resuspended eDNA (about 100 ng) 
0.5 J..ll of 1 Ox ligase buffer 
0.5 J..ll of 10 mM rATP 
1.0 J..ll of the Uni-ZAP XR vector (1 ug/J.ll) 
0.5 J..ll ofT4 DNA ligase (4 U/ ul) 
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7. Packaging. 2.5 J ..d of ligated Uni-ZAP-cDNAs were added to 20 J..ll of packaging 
extract. The tube was incubated at room temperature for 2 hours. After adding 500 
J..ll of SM Buffer and 20 J..ll of chloroform, the tube was spun briefly and the 
supernatant was saved and stored at 4°C. 
8. Plating and titrating. 2 J..ll of the packaged ligation were serially diluted 10 fold. 1 
J..ll of each dilution was used in plating and titrating by the following mixing 
procedure: 
1 J..ll of a dilution 
200 J..ll ofXL1-Blue MRF' cells at OD6oo of0.5 
The mixtures were incubated at 37°C for 15 minutes to allow the phage to attach to 
the cells and the following components were added to each tube of cells: 
3 ml ofNZY top agar (48°C) 
15 J..ll of0.5 M IPTG 
50 J..ll ofX-gal (20 mg/ml) 
The mixtures were immediately plated onto NZY agar plates and incubated at 3 7°C 
overnight. The next morning, approximately 75% of plaques were observed to be 
white, and the whole packaging reaction contained 40,000 plaque forming units. 
9. Testing the average size of eDNA insertions. The average size of the eDNA 
library was determined by PCR amplification of individual plaques with T3 and T7 
primers. The PCR products were run on a 1% agarose gel and stained with ethidium 
bromide. 
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10. Amplification of the 1..-Uni-ZAP-cDNA library. Aliquots containing 10,000 
plaque forming unites (pfu) of the library were mixed with 600 ~1 ofXL1-Blue MRF' 
cells, which were grown in LB supplemented with 10 mM MgS04 and 0.2% maltose 
to an OD6oo of0.5. The mix was incubated at 37°C for 15 minutes, then mixed with 
6.5 ml ofNZY top agarose and spread evenly onto 150-mm plates ofNZY agar. The 
plates were then incubated at 37°C for 6-8 hours until the plaques grew to 1-2 mm. 
Then the plates were overlaid with 1 0 ml of SM buffer and gently shaken at 4 °C 
overnight. The next morning, the bacteriophage suspension was collected and mixed 
with a 1120 volume of chloroform. Cell debris and chloroform were removed by 
centrifugation. The supernatant was mixed with dimethylsulfoxide (DMSO) to a 
final concentration of 7%, then aliquoted and stored at -80°C. The P. brasiliensis 
eDNA library thus constructed, amplified and titrated similarly to the procedure 
mentioned above; indicating a titer of 3 x 108 pfulml. 
2.11 Creator SMART eDNA Library Construction of PbOJ 
Clontech's Creator SMART eDNA Library Construction Kit is the combination of 
the Creator technology and SMART technology. The cDNAs are cloned into pDNR-
LIB Creator vector which serves as donor vector. The Creator system allows the 
cloned cDNAs to be transferred directly into multiple acceptor expression vectors 
using Cre-loxP recombination without the need for sub-cloning. However, in this 
thesis, the Creator function has not been used. The SMART (.S.witching Mechanism 
At 5' end of RNA Iranscript) is used in eDNA synthesis to enrich full-length cDNAs 
and eliminate adaptor ligation. The mechanism of SMART has already been 
explained in section 2.6.4 of this chapter. In general, eDNA synthesized with the kit 
contains the complete 5' end of the mRNA, as well as the sequence complementary 
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to the SMART IV oligo, which then serves as a universal priming site (SMART 
anchor) in downstream applications. The construction procedure of pDNR-
PbOlcDNA Library is described below. The materials provided in the kit are 
underlined. 
1. First-strand eDNA synthesis. The following reagents were combined in a 0.5-ml 
RN ase-free tube. 
2 ~-tl ofmRNA sample (1~-tg mRNA) 
1 ~-tl of SMART IV oligonucleotide 
1 ~-t1 of CDSIII/3' PCR Primer 
Deionized H20 was added to make a total volume of 5 ~-tl. The tube was incubated at 
72°C for 2 minutes then cooled on ice for 2 minutes. The following were added: 
2 ~-tl of 5X First-Strand Buffer 
1 ~-tl of DTT (20mM) 
1 ~-tl of dNTP Mix (1 0 mM) 
1 ~-tl ofPowerScript Reverse Transcriptase 
The contents were mixed and the tube was incubated at 42°C for 1 hour in an air 
incubator. The reaction was terminated by adding 1 ~-tl of Sodium Hydroxide and 
incubating at 68°C for 30 minutes. 
2. Double-strand synthesis by primer extension. The following components were 
combined: 
11 ~-tl of First-strand eDNA 
71 ~-tl ofDeionized H20 
1 0 ~-tl of 1 OX Advantage 2 PCR Buffer 
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2 j.tl of SOX dNTP Mix 
2 j.tl of 5' PCR Primer 
2 j.tl of CDSIIV3' PCR Primer 
2 j.tl of SOX Advantage 2 Polymerase Mix 
The primer extension was performed using the following program: 
95°C for 1 minute 
72°C for 10 minutes 
3 cycles of 95°C for 20 seconds and 68°C for 8 minutes 
3. Proteinase K digestion. 2 j.tl of proteinase K was added to 50 j.tl of amplified 
double-strand eDNA. The tube was incubated at 45°C for 20 minutes. Proteinase K 
was then eliminated by phenol:chloroform extraction. DNA was precipitated with 
sodium acetate. The DNA pellet was re-suspended with 79 j.tl deionized H20. 
4. Sfi digestion. The amplified DNA was digested with the following components: 
79 j.tl of eDNA 
10 j.tl of 1 OX Sfi Buffer 
10 j.tl of Sfi Enzyme 
1 j.tl of 1 OOX BSA 
The digestion was incubated at 50°C for 2 hours. Then 2 j.tl of 1% xylene cyanol 
was added to the tube. 
5. eDNA size fractionation. The cDNAs were fractionated using a CHROMA SPIN-
400 column. Single-drop fractions were collected and the first 3 drops were the peak 
fractions collected. The fractionated eDNA was precipitated with sodium acetate 
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and re-suspended in 7 J.ll of deionized H20. 
6. Ligation of double-strand eDNA into the pDNR-LIB vector. Ligation was 
performed by mixing the following components. 
lJ.ll ofcDNA 
1 J.ll ofpDNR-LIB 
0.5 J.ll of 1 OX Ligation Buffer 
0.5 J.ll of 10 mM ATP 
0.5 J.ll ofT4 DNA Ligase 
1.5 J.ll of deionized H20 
The ligation was incubated at l6°C overnight. 
7. Transformation. The ligation mixture was transformed into XL 1 0-Gold Kanr 
Ultracompetent Cell (Stratagene) and plated out on LB-Chloramphenicol (30 J.lg/ml) 
plates. About IX 106 transformants were obtained. To test the average size of 
inserts for quality control, 30 colonies were selected and subjected to PCR with M13 
Forward and M13 Reverse primers. The library construction was finished by 
extracting library plasmids with Qiagen' s Plamid Maxi Kit. The concentration of 
library plasmids was determined by measuring their optical density at 260 nm. 
2.12 Screening the eDNA Library with a Non-radio-labelled DNA Probe 
To clone the Pb adenylate cyclase gene (PbCYRJ), the AZAPII-cDNA library was 
screened. Initially, a specific fragment (389-bp) of PbCYRJ was obtained by PCR 
with 2 degenerate primers, i.e. PbAC-Fl "and PbAC-Rl. This fragment was used for 
labelling and screening the A.ZAPII-cDNA library. The experiments were based on 
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Amersham's Gene Images Random Prime Labelling Kit and Gene Images CDP-Star 
Detection Kit, in combination with Stratagene's ZAP-eDNA Synthesis Kit and ZAP-
eDNA Gigapack III Gold Cloning Kit. The procedures for the experiments are 
detailed as below. Materials from the kits as well as prepared according to product 
manuals are underlined. 
Preparation of labelled probe 
About 50 ng of DNA fragment was used for one labelling reaction. The DNA 
sample was denatured for 5 minutes in boiling water and then snap cooled on ice. 
The following reaction mix was incubated at 3 7°C for 1 hour: 
9 !-!1 of H20 
25 !-!1 of denatured DNA 
10 !-!1 ofNuceotide Mix 
5 !-!1 of Random Primers 
1 !-!1 ofKlenow Enzyme Solution (5 U/ 1-!1) 
The reaction was terminated with EDT A and stored at -20°C before use. 
Plating, lifting and cross-linking 
The AZAPII-cDNA library phage was diluted with SM buffer. About 6,000 pfu were 
incubated with 0.6 ml of XL1-Blue MRF' cells (OD600=1) and plated out after 
mixing with NZY top agar. Plates were incubated at 3 7°C overnight to allow phage 
growth. A Hybond-N+ (Amersham) membrane was cut and marked with a ball point 
pen, and then overlaid on a pre-cooled phage plate. The orientation was assigned by 
pricking with a needle on the overlaying membrane and the agar underneath. The 
membrane was lifted after 5 minutes. Phage DNA attached to the membrane was 
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denatured with denature solution, neutralized with neutralization solution and rinsed 
with rinse buffer. DNA was cross-linked to the membrane with Stratalinker 1800 for 
1 minute. The membrane was stored at -20°e before hybridization. 
Hybridization 
The hybridization buffer was prepared according to the following formula. 
5X SSe (prepared from 20X SSe) 
0.1% SDS (prepared from 10% SDS) 
5% dextran sulphate 
20 fold diluted liquid block 
The hybridization buffer was preheated to 60°e prior to membrane emersion. Pre-
hybridization was carried out for 2 hours with agitation in an Amersham's 
Hybridization Oven. The labelled probe was denatured by boiling for 5 minutes and 
snap cooled on ice. The probe was then added into the pre-hybridization solution 
and hybridization was performed overnight at 60°e. Stringency washes were done at 
60°e with IX SSe plus 0.1% SDS once, then twice with 0.5X SSe plus 0.1% SDS. 
Frequently, the membrane was stored at 4oe before image detection. 
Image detection 
After hybridization, the membrane was blocked with liquid blocking (10 fold diluted 
in Buffer A) at room temperature for 1 hour. The membrane was incubated with 
anti-fluorescein-AP (5,000 fold dilution in 0.5% BSA plus Buffer A) for 1 hour 
followed by 3 washes with 0.3% Tween 20 in Buffer A. For image detection, the 
membrane was soaked in detection reagent for 2 minutes, wrapped in a plastic sheet 
and exposed to an X-ray film. 
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The second and third screening 
After image detection, phage plaques causing positive images on an X-ray film were 
cored and soaked in SM buffer. PCR was done to confirm that the phage solution 
contained the target gene. About 1,000 pfu were plated out for the secondary 
screening and 100 pfu for the third screening. Pure phage plaques containing the 
target gene were obtained after the third screening. 
Single-clone excision 
The principle of the in vivo excision of the pBluescript phagemid from the Uni-ZAP 
XR vector is described in the instruction manual of the ZAP-eDNA Synthesis Kit 
and ZAP-eDNA Gigapack III Gold Cloning Kit (Stratagene ). The purified plaques 
were converted into pBSK plasmid. The following components were combined in a 
50-ml tube and incubated at 37°C for 15 minutes: 
200 J.ll of freshly grown XL1-Blue MRF' cells at an OD6oo of 1.0 
250 J.ll of purified plaques (> 1 x 105 phage particles) 
1 J.ll of the ExAssist helper phage (> 1 x 106 pfu/J.ll) 
3 ml of LB broth were added to the incubation and again incubated at 3 7°C for 3 
hours. The tube was then heated at 70°C for 15 minutes and centrifuged at 4,000xg 
for 15 minutes. The supernatant containing filamentous phage particles of excised 
pBluescript phagemid was used to transfect fresh SOLR cells by the following 
combination and incubation at 37°C for 15 minutes: 
100 J.ll of the phagemid supernatant 
200 J.ll of SOLR cells at OD6oo of 1.0 
50 J.ll of the transfection reaction was plated on LB-ampicillin agar plates (50 J.lg/ml) 
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and incubated overnight at 3 7°C. Colonies appearing on the plates contained the 
pBSK plasmids with the target gene. The plasmids were purified with Qiagen's 
plasmid MiniPrep kit. 
2.13 Universal GenomeWalker SSP-PCR 
Genomic walking was used to obtain DNA sequence information on PbOJ genes. 
Clontech's GenomeWalker procedure is a simple method for walking upstream or 
downstream of a genomic DNA from a known sequence such as a eDNA or a DNA 
fragment obtained by PCR with degenerate primers. The Genome Walker Universal 
Kit was used to construct 4 PbOJ GenomeWalker libraries. High quality PbOJ DNA 
was digested with 4 blunt cutting restriction enzymes (Dral, EcoRV, Pvul and Stul). 
Each batch of digested genomic DNA was then ligated separately to the 
GenomeWalker Adaptor, which serves as an anchor in subsequent SSP-PCR 
amplifications. SSP-PCR was used to acquire new DNA sequence information with 
ABgene's Extensor Hi-Fidelity PCR Enzyme Mix. Usually, 2 PCR amplifications 
were necessary if no specific single band was observed with an one-step 
amplification. Specific bands obtained from different libraries were recovered by gel 
extraction and subjected to DNA sequencing. The detailed protocols for library 
constructions and SSP-PCR are given below. Materials from the kit are underlined. 
Digestion of genomic DNA 
The quality of PbOJ genomic DNA was checked on a 0.5% agarose gel. A single 
band was observed without obvious smearing. The DNA was subjected to 4 
restriction digestions as mentioned above. The following components were 
combined: 
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25 fll of genomic DNA (I 00 ng/fll) 
I 0 fll of I OX Restriction enzyme buffer 
I 0 fll of Restriction enzyme (1 0 U/fll) 
57 fll of Deionized H20 
The reactions were incubated at 3 7°C for 2 hours, then briefly vortexed and 
incubated at 37°C for a further I8 hours. After incubation, the efficiency of 
digestions was assessed by running 5 fll of each reaction on a 0.5% agarose gel. The 
remaining 95 fll of digested DNA was purified by phenol extraction and concentrated 
by precipitation with sodium acetate and ethanol. The pellet was dissolved in 20 fll 
ofTE buffer (pH7.5). 
Ligation ofGenomeWalker Adaptors 
For each library construction, the following components were added: 
4 fll of digested DNA 
1.9 fll ofGenomeWalker Adaptor 
1.6 fll of 1 OX Ligation buffer 
0.5 fll ofT4 DNA ligase (6 units/ul) 
The reaction was incubated at 16°C overnight followed by termination at 70°C for 5 
minutes. For each construction, 72 fll ofTE (pH7.5) was added before application in 
SSP-PCR. 
Genome walking by using SSP-PCR 
SSP-PCR was performed with ABgene's Extensor Hi-Fidelity PCR Enzyme Mix, 
which contains a combination of 2 DNA polymerases suitable for long distance PCR. 
Usually a two-step nested PCR was applied to achieve high specificity of 
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amplification. Therefore, 2 pmrs of primers were employed, with each patr 
composed of a gene specific primer and an anchor primer derived from the adaptor 
sequence. SSP-PCR was done as follows with materials from the kit underlined: 
Primary PCR 
To a thin-walled 0.5 ml PCR tube was added the following. 
1 f.!l ofGemoneWalker library DNA 
5 f.!l of 1 OX Extensor Buffer 
1 f.ll of dNTP (10 mM each) 
1 f.!l of gene specific primer (50 f.!M) 
1 f.!l of API or AP11 or AP3 (10 f.!M) 
0.5 f.!l of Extensor Hi-Fidelity PCR Enzyme Mix (5U/ f.!l) 
To 50 f.!l of Dionized H20 
Cycling parameters are given below: 
1 cycle 94°C 2 minutes 
5 cycles 94°C 10 seconds 
68°C 30 seconds 
68°C 3 minutes 
5 cycles 94°C 10 seconds 
65°C 30 seconds 
68°C 3 minutes 
25 cycles 94°C 10 seconds 
60°C 30 seconds 
68°C 3 minutes 
1 cycle 68°C 7 minutes 
For each primary PCR, 5 f.!l of the product was analyzed on an agarose gel. 
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Secondary PCR 
The primary PCR product was 1:50 diluted in H20 before serving as the template for 
the secondary PCR. PCR conditions were the same as those used in the primary 
PCR except that the final concentration of the anchor primer (AP2, AP21 or AP4) 
was increased to 1 J.!M. Also the 5 cycles with an annealing temperature of 68°C 
were deleted. 
2.14 Construction of Random Mutagenesis Libraries for Yeast Two-Hybrid 
Screening 
In order to find potential protein interactions, genes of the cAMP signaling pathway 
were randomly mutated, cloned into pGADT7 prey vector and subjected to yeast 
two-hybrid screening. The screening proved to be essential in some situations 
because mutations can lead to a change of protein activity or the interacting domain 
can only be exposed when one part of the protein is removed. Stratagene's 
GeneMorph II Random Mutagenesis Kit was used for random mutagenesis. A novel 
error prone PCR enzyme blend, Mutazyme II, is used in this kit to generate mutated 
PCR products. The advantage of Mutazyme II is the production of a less biased 
mutational spectrum with equivalent mutation rates for all the 4 nucleotides. 
Therefore, libraries created with Mutazyme II should exhibit greater mutant 
representation compared to libraries generated with other enzymes. In addition, the 
mutation frequency can be controlled by adjusting the initial target DNA amounts 
and the number of cycles. In this thesis, PCR parameters were selected to create a 
mutation frequency of 0-4.5 mutations/kb because 1 amino acid change per gene was 
desired. The procedure for library constructions is described as below with materials 
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from the kit underlined. 
Random mutagenesis PCR components 
5 !!1 of lOX Mutazyme II reaction buffer 
1 !!1 of 40 mM dNTP 
X !!1 of template ( 100 ng target gene, not the whole plasmid) 
0.5 fll of forward primer (50 f.lM) 
0.5 !!1 of reverse primer (50 flM) 
1 !!1 ofMutazyme II DNA polymerase (2.5 U/!!1) 
To 50 fll of HzO 
Cycling parameters 
1 cycle 95°C 
18, 20, 22, 24 cycles 95°C 
(four tubes) 60°C 
72°C 
1 cycle 72°C 
2 minutes 
30 seconds 
30 seconds 
1 minute 
10 minutes 
The 4 tubes ofreactants, which had undergone 18, 20, 22 and 24 cycles respectively, 
were mixed and the amplified band was purified by gel extraction. The mutated 
DNA was double digested with suitable enzymes and ligated into the pGADT7 prey 
vector. The ligation was transformed into XL 1 0-Gold Ultracompetent Cells to 
generate over 2 X 104 transformants. Randomly selected clones were subjected to 
sequencing to check the resultant mutations. Library plasmids were extracted with 
Qiagen's plasmid Maxi columns or MiniPrep columns. 
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2.15 Yeast Two-Hybrid 
Clontech's Matchmaker Yeast Two-Hybrid System 3 was used to analyze protein 
interactions with the PbOJ cAMP signaling pathway. It is a sensitive method for 
detecting relatively weak and transient protein interactions. Because the protein 
interaction is performed in vivo, the proteins are supposed to be in their native form, 
which leads to increased sensitivity and accuracy. The system is specific as well 
because a new GAL4-based two-hybrid system is featured to reduce false positives. 
In general, a bait gene is cloned into the vector pGBKT7 and expressed as a fusion 
with the GAL4 DNA-binding domain, while another prey is cloned into pGADT7 
and expressed as a fusion with the GAL4 activation domain. When bait and prey 
proteins interact, the GAL4 DNA-binding domain and the activation domain are 
brought together, activating transcription of 4 reporter genes (HIS3, AD£2, lacZ and 
MELJ) in a new yeast strain AH109. The ADE2 reporter alone can provide a strong 
nutritional selection. When it is combined with HIS3 selection, the incidence of false 
positives is greatly reduced. The following are the detailed protocols extracted from 
Clontech's Matchmaker GAL4 Two-Hybrid System 3 User Manual, Yeast Protocols 
Handbook and Yeastmaker Yeast Plasmid Isolation Kit User Manual. Materials 
prepared according to instructions of these manuals are underlined. 
Subcloning genes into pGBKT7 and pGADT7 
The genes of the major components of the PbO 1 cAMP signaling pathway have been 
cloned. They were then subcloned into bait vector pGBKT7 and prey vector 
pGADT7 for yeast two-hybrid analysis. ProofStart Taq polymerase was used for 
subcloning to secure the fidelity of gene sequences at the amino acid level. 
Sequencing was done to confirm that these genes were in frame with GAL4 DNA-
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binding or activation domain. For yeast two-hybrid screening, random mutagenesis 
libraries were constructed using prey vector pGADT7 as described in section 2.14. 
Sequencing was done as well to make sure that these genes were in frame with the 
GAL4 activation domain. 
Yeast transformation 
A single colony of S. cerecvisiae strain AH109 was used to inoculate 50 ml ofYPD 
or SD/-Trp (for sequential transformation). The culture was shaken at 250 rpm at 
30°C overnight. A fraction of the overnight culture was transferred to 300 ml of 
YPD or SD-Trp to produce an OD600=0.2. Cells were incubated at 30°C for several 
hours with shaking at 250 rpm until the OD6oo reached 0.5. Cells were centrifuged at 
1 ,OOOxg for 5 minutes at room temperature, and then washed with sterilized H20. 
Cells were precipitated again and re-suspended in 1.5 ml of freshly prepared IX 
TE/LiAc to make competent cells. The following mixture was made: 
Small scale simultaneous Large scale sequential transformation 
transformation for library screening 
0.1 Jlg of pGBKT7 construction 
0.1 Jlg of pGADT7 construction 20 Jlg ofpGADT7library 
0.1 mg ofHerring testes carrier DNA 2 mg of Herring testes carrier DNA 
0.1 ml of competent cell 1 ml of competent cell 
0.6 ml ofPEG/LiAc 6 ml of PEG/LiAc 
The mixture was incubated at 30°C for 30 minutes with shaking at 200 rpm. DMSO 
was then added to the mixture, using 70 111 for small scale transformation and 700 Jll 
for large scale transformation. The cells were heat shocked at 42°C for 15 minutes. 
The cells were chilled on ice for 2 minutes then precipitated and re-suspended in TE 
(pH7.5). Cells were plated out on SD/-Leu/-Trp/-His/-Ade plates for selections, and 
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positive clones were observed 5 days after transformation. For library screening, 
positive transformants were restreaked on SD/-Leu/-Trp/-His/-Ade plates 2 times to 
allow loss of non-interacting prey constructions. Plasmids were isolated from the 
positive clones for further analysis. 
Plasmid isolation from yeast strain AH 109 
Plasmids were isolated with Clontech's Yeastmaker Yeast Plasmid Isolation Kit 
according to the user manual. Positive clones were inoculated in 1 ml of SD-Leu/-
Trp/-His/-Ade liquid medium for overnight growth. Cells were precipitated and 
broken with lyticase and SDS. Plasmids were purified on a CHROMA-SPIN-1000 
column. This kind of plasmid, though not in high quality, was good enough for PCR 
amplification with a pair of gene specific primers to confirm that positives were truly 
brought by the gene tested. However, plasmids thus isolated contained both bait and 
prey constructions, and they were not good for sequencing. To segregate the 
plasmids, 5 111 of the plasmids isolated were used to transform NovaBlue E. coli 
competent cells, which were then subjected to either Ampr selection for pGADT7 
constructs or Kanr selection for pGBKT7 constructs. Plasmids recovered from E. 
coli were highly pure and in larger amounts, and therefore suitable for DNA 
sequencmg. 
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Chapter III 
Results 
3.1 Construction of Two eDNA Libraries of PbOJ 
PbOJ strain yeast cells were grown in modified-YPD medium at 37°C. Total RNA 
was isolated from the yeast cells using Qiagen's RNeasy Midi columns. About 1,700 
jlg total RNA was extracted from 3 grams of wet yeast cells. The quality of the total 
RNA was examined by eletrophoresis of 5 jlg of total RNA sample on a 1% EtBr-
agarose gel. Under the ultraviolet light, the total RNA lane was observed to cover 0-
8 kb with obvious 18s and 28s rRNA bands. Poly(A)+ RNA was obtained from the 
1,700 jlg total RNA by using Qiagen's Oligotex mRNA Midi Kit. About 50 jlg of 
mRNA was produced. The quality of mRNA was tested by running 4 jlg of mRNA 
on a 1% EtBr-agarose gel. The mRNA lane was found to be a smear covering 0-8 
kb, demonstrating its high quality without obvious degradation. The mRNA was 
then used to construct a A.-ZAP-eDNA library and a Creator pDNR-PbOlcDNA 
library using Stratagene's ZAP-eDNA library kit and Clontech's Creator SMART 
eDNA library construction kit, respectively. 
The quality of the A.-ZAP-eDNA library and Creator pDNR-PbOlcDNA library was 
tested. Two parameters are important in examining the quality of eDNA library: the 
average size of the eDNA insertions and the titer of the original library before 
amplification. The A.-ZAP-eDNA library contained 40,000 independent phage 
plaques, indicating that its quality requires to be improved and another library with 
high original titer may be needed if a gene with low expression level is going to be 
cloned. The average size of the A.-ZAP-eDNA library was determined by PCR 
amplification of the eDNA insertions from individual plaques. As demonstrated in 
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Figure 3.1-1. Average size of eDNA insertions of PbOJ /..-ZAP-eDNA library. 
Twenty randomly selected plaques were submitted to PCR with T3 and T7 primers. 
The marker on the right side lanes is the 1 Kb DNA Ladder from Invitrogen. 
~ lkb 
~ lkb 
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Figure 3.1-2. Average size of eDNA insertions of Creator pDNR-PbOJcDNA 
library. Thirty randomly selected independent clones were submitted to PCR with 
M13F and M13R primers. The marker in the middle of the gel is the 1 Kb DNA 
Ladder from Invitrogen. 
.---1 kb 
.---] kb 
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Figure 3.1-1, the average size of the eDNA insertions was more than 1 kb. The 
packaged A.-ZAP-eDNA library was amplified. The amplified A.-ZAP-eDNA library 
contained 3Xl08 plaque forming units/mi. It was stored at -80°C. 
The Creator pDNR-PbOlcDNA library contained 1,000,000 independent clones after 
transformation, indicating its high quality, which was confirmed later by cloning all 
the genes of PbOJ in this thesis from it. The average size of eDNA inserts was 
demonstrated to be more than 1 kb after checking PCR products of 30 randomly 
selected independent colonies (Figure 3.1-2). All the transformants were pooled and 
the Creator pDNR-PbOlcDNA library plasmids were extracted with a final 
concentration of 1 jlg/jll. The library plasmids were stored at -20°C. 
3.2 Cloning of Adenylate Cyclase Gene PbCYRJ from PbOJ 
The strategy for cloning the adenylate cyclase gene PbCYRJ included library 
screening and PCR amplifications walking on both genomic DNA and eDNA. 
Primers were designed on the basis of immediate sequencing results. The cloning 
procedure is described as following and illustrated in Figure 3.2-1. Initially, two 
degenerate primers, PbAC-Fl and PbAC-R1, were designed that corresponded to 
conserved amino acid residues VFTDIKNST and MDY(YCF)GPMVN, respectively 
(Binz et al, 1998). A single 389-bp fragment, gPbAC-FlR1, was amplified from 
PbOJ genomic DNA. This fragment was then labelled with fluorescein using Gene 
Images Random Prime Labelling Kit (Amersham) and used for screening the A-
ZAP-eDNA library. Approximately 6,000 plaques from the A -ZAP-eDNA library 
were plated out and screened. After the first screening, 2 positive clones were 
obtained. They were purified to homogeneity after the third screening (Figure 3.2-2). 
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The inserts of the 2 clones were excised using ExAssist helper phage in SOLR cells 
(Stratagene ), yielding pBSK plasmid containing insert. One of the 2 clones was 
named PbAC-2, having a 4.0 kb insert, and selected for sequencing. Sequence of 
PbAC-2 showed high homology to other fungal adenylate cyclases. However, it was 
a stretch of genomic DNA, indicating the existence of residual genomic DNA in the 
mRNA preparation before .A -ZAP-eDNA library construction. On the basis of 
PbAC-2 sequence, two specific primers, PbAC-F8 and PbAC-R30, were designed for 
downstream and upstream SSP-PCR. By using the 2 specific primers and 2 anchor 
primers (M13Rl and M13Fl), 2 fragments, named cPbAC-R30Ml3Fl and cPbAC-
F8Ml3Rl-B6, were amplified from the Creator pDNR-PbOlcDNA library plasmids. 
These 2 fragments turned out to be eDNA as indicated by the existence of an intron-
splicing and a poly(A) tail in the cPbAC-F8Ml3Rl-B6 eDNA fragment. Another 
eDNA fragment, cPbAC-Fl5Rl9, connecting cPbAC-R30M13Fl and cPbAC-
F8M13Rl-B6, was amplified subsequently. An upstream eDNA fragment, cPbAC-
R7SIVl, was amplified by SMART RACE PCR after RT reaction with PbAC-R7. 
Consecutively in the same way, two additional fragments from the 5' end of the 
eDNA were amplified, namely cPbAC-Rl2SIV1 and cPbAC-R21SIV2-12, and the 
start codon ATG was identified in the latter. Genomic DNA amplification was based 
on the sequence of the finished eDNA sequence. The genomic PbCYRJ sequence 
was finished by amplifying a sequence, gPbAC-Fl2R30, from genomic DNA and 
another fragment gPbAC-Rl6AP21 from a GenomeWalker library by SSP-PCR. 
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Figure 3.2-2. The first (upper panel) and the third screening (lower panel) of A.-
ZAP-eDNA library with a fluorescin labelled gPbAC-FlRl DNA fragment. 
Clone PbAC-2 was purified to homogeneity after the third screening. 
Two positive clones obtained after the first screening 
• 
Positive plaques purified to homogeneity after the third screening 
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3.3 Nucleotide Sequence and the Deduced Amino Acid Sequence of Adenylate 
Cyclase PbCYRJ 
Following the successful amplification of fragments of eDNA and genomic DNA, 
the genomic DNA sequence, eDNA sequence and the deduced amino acid sequence 
of PbCYRI were determined and are illustrated in Figure 3.3-1. The PbCYRJ gene 
can now be retrieved from GenBank with accession number of A Y444997. This 
gene is very large, spanning more than 8 kb with 6,300 bp coding sequence 
interrupted by 3 introns. The first intron is 150 bp in length and located at nucleotide 
position 171-320; the second intron is 459 bp long and located at position 874-1,359; 
and the third is 74 bp long with position from 6,640 to 6,713 (Figure 3.3-1). The 
start codon A TG was determined by finding a Kozak consensus sequence 
(ANNATGG) at an ATG site and stop codons in the eDNA sequence upstream of it 
(Kozak, 1987; and Kozak, 1991). The gene encodes a protein of 2,100 amino acid 
residues with molecular weight of234 kDa and predicted pi of7.38. 
In order to determine the initiation of transcription, R T-PCR was carried out on PbO I 
mRNA using a reverse primer PbAC-R22 (positions after the 2"d intron) in 
combination with different forward primers, which were designed on the basis of the 
5'-noncoding genomic sequence, i.e. PbAC-F16, PbAC-F20, PbAC-F21, PbAC-F22 
and PbAC-F23. Obvious bands were obtained when using primers PbAC-F16, 
PbAC-F20, PbAC-F21 and PbAC-F22. No amplification was observed when using 
primer pair F23 and R22, indicating that the initiation of transcription was located in 
the region between PbAC-F23 and PbAC-F22 (Figure 3.3-1 and 3.3-2). Potential 
promoter TAT A boxes were found in that region. However, no CAA T boxes were 
found. A polyadenylation site was determined by observing a poly(A) tail in the 
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eDNA amplification (Figure 3.2-1 and Figure 3.3-1). 
Fungal adenylate cyclase proteins are highly homologous. Figure 3.3-3 illustrates 
some important fungal adenylate cyclase proteins and their identity to PbCyrl. 
PbCyrl is 53% identical to the adenylate cyclase AcyA of A. fumigatus, 50% 
identical to AnCyr1 of A. nidulans, 24% identical to Cyrl of S. cerevisiae and 21% 
identical to SpCyr1 of S. pombe. A comparative alignment of adenylate cyclase 
catalytic domains of these fungi is illustrated in Figure 3.3-4. 
PbCyr1, like other fungal adenylate cyclases, belongs to Class III adenylate cyclases. 
When a phylogenetic tree is created with catalytic domains of adenylate cyclases 
from different organisms, it is obvious that fungal adenylate cyclases and 
mammalian adenylate cyclases fall into 2 different groups and are very distantly 
related at the 2 ends of the tree (Figure 3 .3-5). However, catalytic domains of fungal 
adenylate cyclases are relatively closely related to that of Trypanosoma brucei, the 
structure of which has been determined (Bieger and Essen, 2001). 
The P. brasiliensis adenylate cyclase, when analyzed with SMART (EMBL), 
contains 4 domains, i.e. a Ras association domain (RA), 14 domains containing 
leucine-rich repeats (LRR_TYR domains), a serine/threonine phosphatase family 2C 
catalytic domain (PP2Cc domain) and an adenylyl/guanylyl cyclase catalytic domain 
(CYCc domain). A schematic illustration of the domains and their positions is given 
in Figure 3.3-6. 
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Figure 3.3-1. The nucleotide sequence and deduced amino acid sequence of Pb 
adenylate cyclase. Nucleotide positions are written in red numerals, amino acids in 
blue. Introns are denoted by lowercase letters with red colour. Potential promoter 
T ATA boxes and polyadenylation site are underlined. 
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TATGTGTGTATGATTCTTTCGAACCCCCCTTTCTTGGTGATGAGCATGGC 
AGTGCTACAGCTAGAGGGGGACCTGTAGCATTCGATCCCTACCCCCGATA 
TACGGCCAAGTACACCTAGGCTTCGGCAGGAACATTGTCACCGCGAGTTA 
AAGTCCGGAGTTGACGGTCGGCATCTCCTCTCTCGGGTTTGACATTAATA 
primer PbAC-F23 
AGTGGGGAATTGAGGTTGCGGTCACGCTACTGTTAGTTAGTCGAACTGGC 
AGGGGAACTCTAGCTCATGGTCCCAGCGTTAACATCCCAGACAACTCCTG 
GCGCGAATGCAACGGTTGGAGTCGGAGAGGTGTCTGTGGCTCTGTCTGTG 
GCTCTGTCTGAGATTGTATACTTGATTGCTGGGTTGCGATTCAGGCTGAA 
CATCTACTTGGCCCCCTCCTGTGATTCATATAGTGATCATATACTCCAGA 
ATTATACTCCAGAATTAGGGAGTTAAATTATGTTGACGTGAGAGAGAGTC 
CCGTGCGCTGACACAGCCTTGAGTAAGCGGACACGTGGGTCTAGCGCTTG 
primer PbAC-F22 
CTTCGGGACAGGCCGAACCGGCCCCCATCGTTAGTCAGCAGCTGCCGGAA 
CGGCGTTGTTTCGCTGTTTGGCGGCTTGGACGTTGCTCTTTCGGGCTTGG 
ATGGGTCATTTCATTCTATCCCGATGTTATCATAAGTCAAACCATCATCA 
GTCTTCGAACATTATGCTTTAAACACCACCTCCCCATTCCCCAACATACC 
TGCCTGCTTCATGCTGCTTGGGGGTTTCTTCCGTCGTATGAACGGATGAA 
GCATAGCTCCTTATTTTAGCCTCTTTGTCCGCCTCACCCCCGTCCCCTCG 
CCTAGCTCTTACCCCGTTGTCCTTCCTTTGTCCCCGTATGTCCGGATATA 
TATGCACACACTGCAGGTTCTGAAATGGTTTAGCTTTGGGATACCGTCTG 
CTCTTCCTCTCGCCATCTCTGTCTCGTCGCTGTGTATCCCGTGGCCAACG 
primer PbAC-F21 
GATTACGTTTGGAGCCAATGAGCCAGTTGGTTTCACCTTCGTAGCCTTTC 
CTAGATTTTCGTATCCACGTATCCCCAACCCGGGATTTGAGCTACTCACA 
GAGTTCATATTCGACCCCGAGCTTCGTGGCACTTCAAATCATATCTCCCC 
TACATCCCCCATCCAAGTCCCTTCCACGTCTCAATTCCACCCGCCACCCG 
CCTTGTCCAACCCAACATCTATCTACGCTGAATATCGGCCGGATGAATCA 
CATCCACTCGCGTCGTCTGAGAGTGTGAGAGGCGAAAGCTTCAACCCCCC 
-100 GTCCAGCTCTCCATTCCCCCCCCATCCCTTTCCCCCCCCCCCCCTTCCAA 
110 
-50 CGGGGCTTTTGATCTCCTTGGAGCGGCCAGAAACTTAGATTTGCGGCAGC 
primer PbAC- F17 
1 ATGGCAAGGAGACAGCGGGAGAAAGATAGGAACCTAAGGCGTGGTTCGGA 
1 M A R R Q R E K D R N L R R G S 
51 AATGCCAAGTTCTCTCCTCTGGCGGTCCCCTGATGCGTTGCTGATATCGC 
17 E M P S S L L W R S P D A L L I S 
101 AGGGTCTTGGCTTGGAAAGGGAACCCCGTCGCCCCAGTAGAGCTAGGGAG 
34 Q G L G L E R E P R R P S R - A R E 
151 ATTTCGGATCAGGATGACAGgtatgtttgatttcgtttttgaagaagcag 
51 I S D Q D D 
201 ttttgcttcgtgatgaattgttaggtcctgtttgggcacatcggaggcct 
251 tcattctgttcaaaatgtggggaaacgctgttacgcaaacgttttatact 
301 taatttttttttctttccagAAGGCTGAACTCGACATCCAGACACTCGTC 
57 R R L N S T S R H S 
351 GTCCTCAAAGAGTAATCGTAACGCCCCCCGTAGGCCACATTCCCCCGATG 
66 S S S K S N R N A P R R P H S P D 
401 TATCCCCAACAGACGTACCGACAACCAGCTTTGGAAACCATAAGAAAGCC 
84 V S P T D V P T T S F G N H K K A 
451 CTTGCGATTCTTGGCGCATCGGATGACCCATCAGTCTCGCAAATGTTTCT 
101 L A I L G A S D D P S V S Q M F 
501 ACAATACTCAAGCACAAATGCTCGGAAGCGGTCGCCATCATGGACACCAC 
117 L Q Y S S T N A R K R S P S W T P 
551 CCGCATCGTTAAAAACGACGGCTACTCGGGGAACCTTCTTTAACGATGGT 
134 P A S L K T T A T R G T F F N D G 
601 TCTGATGCGGAGGAAACCTCCCCTCAATTTCAGCTGGAGGCTGCCCTAAC 
151 S D A E E T S P Q F Q L E A A L 
651 CGATCCCAGTAATTCCCCAGAACCCGTCCATGACGAACATCGCAGACCGT 
167 T D P S N S P E P V H D E H R R P 
701 CCGTTGCTAGCGCCACTACTGTTAGCAGTCAAGGATCGAAAGGCAGCGGT 
184 S V A S A T T V S S Q G S K G S G 
751 GGTCGTTTCCACAAACGCCTGCGCGGTCTCTTTGGGGATGAGCATGGCAG 
201 G R F H K R L R G L F G D E H G 
801 CGCGTCAGATTCGGCTCTCCCGGAGCGGAGTCTGTCAAACCGAATTCCTA 
217 S A S D S A L P E R S L S N R I P 
851 TGTCATCTGGCAGTCAATCAAAGgtccgtgaaagaaataattcgacccca 
234 M S S G S Q S K 
901 tctttgcaccccccagagcgttcttcaccccttggtcgtggcttccgacc 
951 atgcactcctctaccttccagtgatgttaccccttgaatgtatcaaaagc 
1001 tcaatctaagatggcacgaaaagttccttcgttaatcggaatttacttca 
1051 agggaagcctatatggtttcctgtcgttacatgttcccaactgcttcctt 
1101 cggaaagtcttctgaaggtatctggataaaactgcacgacttgttgaaac 
1151 tgcatattattcatcactagctctataaaccctttctcccttcattattt 
1201 ggtttgcccatccctttctctaccattcctggctctctatttctaattag 
1251 cacccctcagggacattttcattatattctcgccatttcattctgaatta 
1301 tactcgaactttaagctaatgtgggattgtagGATATATCAAACTATGGA 
242 D I S N Y G 
1351 GATGCACCTGTGTATCCAGTTCCAGGAGACCCGGATGTTGAACGCTTTGG 
248 D A P V Y P V P G D P D V E R F 
111 
1401 
264 
1451 
281 
1501 
298 
1551 
314 
1601 
331 
1651 
348 
1701 
364 
1751 
381 
1801 
398 
1851 
414 
1901 
431 
1951 
448 
2001 
464 
2051 
481 
2101 
498 
2151 
514 
2201 
531 
2251 
548 
2301 
564 
2351 
581 
2401 
598 
2451 
614 
2501 
631 
2551 
648 
2601 
664 
2651 
681 
2701 
698 
2751 
714 
2801 
731 
285~ 
748 
TTCCATGACAGATGGCGAGCGTGACTCAAAGAAAGATTCTCGTCTTCCTT 
G S M T D G E R D S K K D S R L P 
TCCACAGACATCGGCATGCTCGGAGTAAAGAAGAGAAGTTATCAGACCAA 
F H R H R H A R S K E E K L S D Q 
GGGTCTAACTTGCAACACATTTTCAGATCTTCAGACCATGACAACCACAA 
G S N L Q H I F R S S D H D N H 
ACAAGTGTATAGTAAAGTAAAAGAGGGCACCCTCTCTCCAACTATCCCCA 
K Q V Y S K V K E G T L S P T I P 
CCGCTCTAGGAGCCCGCTCGATCAGTCCTTCGCCTAGTTTGCAGGGCGGC 
T A L G A R S I S P S P S L Q G G 
AGTGGGCAAGACTCTCAAGGGACAAGGTCGCCTGGAGGTTCATCCAACAA 
S G Q D S Q G T R S P G G S S N 
GCGATCATTTTTTACGAAGATTCGACGCCATCCAAAACCTCCAATCGGGA 
K R S F F T K I R R H P K P P I G 
GTAGTCTTCGGGGTATGCCATCTTCGAAATCTGCCTACGACGGTGGTGGG 
S S L R G M P S S K S A Y D G G G 
AAGGGATCTAGGTTTTTGAAACGAGATATGTCTCCTGCTAGATATGGTCG 
K G S R F L K R D M S P A R Y G 
GAATTCGAGCTTTGATAGTGTCACCAATACAAAGCCGTGGGAAAGTGTCG 
R N S S F D S V T N T K P W E S V 
AGTCTGACCGCAAAAAGGAGTCTGCGAAGGGGGTATCCAAGTTCCGCCAT 
E S D R K K E S A K G V S K F R H 
CCGCGTTTTCCGTTTGGTCATGATACTGGAAATAAGGATGACAAAACACA 
P R F P F G H D T G N K D D K T 
CCAAGATAATTTTGAACAAGATCGGATCTGGAAGTTAGATACCGATCTGA 
H Q D N F E Q D R I W K L D T D L 
CAAATCTCTCTGGTATCGTCGCACAACCTCAACCTTTATCCCCTACCGAT 
T N L S G I V A Q P Q P L S P T D 
TGTGGTGGTATATATACTGGAACTCCACTTCCTGAGCATAAGGAAAGAGA 
C G G I Y T G T P L P E H K E R 
ATTCCGCAATCCCTTTGAACCCTCCAGCACTGGTGACTGGCATGCTCCAG 
E F R N P F E P S S T G D W H A P 
AGAGCTGGGCTGTGAGGAAAGTTGGGGATGACATTTTGTCCCGGCTTCCT 
E S W A V R K V G D D I L S R L P 
GAGCTCACTGATGATGGCGGGGCGATGGTAGACGACGAAGGGCGACCGTA 
E L T D D G G A M V D D E G R P 
CTGTGTCCGCATCTTTCGCATCGACTCTACATTTACAACTCTTTCCTCTA 
Y C V R I F R I D S T F T T L S S 
ATCTGAACACTACCGTGACCGAAATACTGGAAATGCTTGGCCGCAAGTCG 
N L N T T V T E I L E M L G R K S 
TTCTTGCAAGATGAGCTGAATAACTACGATATAGTCGTACGGAAGAATGA 
F L Q D E L N N Y D I V V R K N 
CCTTTCAAGAACTCTGGACTACGGGGAGAGGCCGATTCTCATGCAAAAGA 
D L S R T L D Y G E R P I L M Q K 
AATTGCTCGAGCAGGCTGGATATCAACCATCAGACCGTATAGCGGATATT 
K L L E Q A G Y Q P S D R I A D I 
GGTCGAGAGGATAATAGCTACCTCTGCTGTTTCACATTCCTTCCCACGAA 
G R E D N S Y L C C F T F L P T 
ACTTTCGGGCTATTCGAGTCTGGATGCTGACTTGGGAATCAACGAGAACC 
K L S G Y S S L D A D L G I N E N 
AAAAGTTTAGCCACGTCGACTTGCACGGGCGCAGTCTCATCACCCTGCCC 
Q K F S H V D L H G R S L I T L P 
ATCACACTCTATAAAAGGGCGAGTGAGATCATATCCTTGAATCTTTCGAG 
I T L Y K R A S E I I S L N L S 
AAATTTAGCCTTGGATATTCCGAAGGATTTTATTCAAAGCTGCATCAACC 
R N L A L D I P K D F I Q S C I N 
TCCGTGAATTAAAATATATCGGAAACGAGGCATGGCGTCTTCCGGCAAGC 
L R E L K Y I G N E A W R L P A S 
TTAAGCTTGGCGACGCGGCTTACATATCTAGACATATCCKACAATAGGCT 
L S L A T R L T Y L D I S N N R 
112 
2901 
764 
2951 
781 
3001 
798 
3051 
814 
3101 
831 
3151 
848 
3201 
864 
3251 
881 
3301 
898 
3351 
914 
3401 
931 
3451 
948 
3501 
964 
3551 
981 
3601 
998 
3651 
1014 
3701 
1031 
3751 
1048 
3801 
1064 
3851 
1081 
3901 
1098 
3951 
1114 
4001 
1131 
4051 
1148 
4101 
1164 
4151 
1181 
4201 
1198 
4251 
1241 
4301 
1231 
4351 
1248 
TGAACAGCTGGATAATGCAGAATTACACAATTTGCATGGACTTGTCAGCT 
L E Q L D N A E L H N L H G L V S 
TGAAAATGTCGAATAATAACCTCTCGACGCTGCCTGCTTATTTTGGAGAC 
L K M S N N N L S T L P A Y F G D 
TTCCCTGCATTACGAAGCCTGAATATTTCTTCCAATAGTTACCGCACTTT 
F P A L R S L N I S S N S Y R T 
TCCCGAGTGTTTATACAATCTGAAGAGTCTCGTTGATCTTGATATCAGCT 
F P E C L Y N L K S L V D L D I S 
TCAACAAAATCTCCGAGTTGTCGGATATTGGACGCCTTACGACACTGGAA 
F N K I S E L S D I G R L T T L E 
CGGTTATGGGTGACTAACAATGGCTTGCATGGCCCGCTGGGTGAGACTTT 
R L W V T N N G L H G P L G E T 
TAGAGATCTTGTCAATCTCAAAGAGATAGACGCACGATTCAACAGCATCA 
F R D L V N L K E I D A R F N S I 
CTAGTATAGATAACATCACTCACCTTCCACGACTAGAGCGGTTGTTGATT 
T S I D N I T H L P R L E R L L I 
GGCCATAACAGCGTGTCCACATTTTCAGGCTCTTTCATGAAGCTGCGCAC 
G H N S V S T F S G S F M K L R 
TCTTGCCCTGGACCATTGCCCAGTCACCGAGTTTGATCTCACTAGCCCCC 
T L A L D H C P V T E F D L T S P 
TTCCGACTCTCACCTCTCTCAACATCGCGTCAGCCAAACTTGTTCAATTC 
L P T L T S L N I A S A K L V Q F 
AAGGATACCCTTTTTACCAATATCCCACACCTGACCAAACTTATTCTTAA 
K D T L F T N I P H L T K L I L 
TAAGAATCATTTCGTTACTCTCTCCTCCTATATCGGAACCCTCCGAAAAC 
N K N H F V T L S S Y I G T L R K 
TTGAGCACTTCAGCATTTCGAAAAATCCCCTGTCAACTCTTCCACCGACG 
L E H F S I S K N P L S T L P P T 
ATAGGATGTCTAACAGAATTGAAGTGCCTCAACCTACGCGAATGTAATCT 
I G C L T E L K C L N L R E C N 
CAACAAACTCCCTTCTGAGCTGTGGTACTGTTCTAAACTGGAGACCCTGA 
L N K L P S E L W Y C S K L E T L 
ATGTGTCGTCTAATGTCCTTGACGCCTTTCCAAAGATCGCTGGCTCACCT 
N V S S N V L D A F P K I A G S P 
CCTATTCCTCCAAACGAATATCATGGAAATGGTACTCCCGCAACCACTCC 
P I P P N E Y H G N G T P A T T 
TGGTCTGGCTTCGCCAAGTCACGAAGAACTTGGAAAGCTGGAGGATTTCG 
P G L A S P S H E E L G K L E D F 
AAGCCAGACGACCAAGTCATTCCTCCAGTGGTCTTCTGAGCGTGGCAAGT 
E A R R P S H S S S G L L S V A S 
TCCTCCGCTAATTCATCAAATAGAAAAGGCTCAATTGTCTCGATGCCTCA 
S S A N S S N R K G S I V S M P 
TAACCCGACTGTAAAGAAGTCTTCTGTCATATCTCGAGCTGCAACTGAAA 
H N P T V K K S S V I S R A A T E 
CCCCATCCTCGCGCAAGGATTCAACCTTCTCGCAAAGAATATCGTTTACG 
T P S S R K D S T F S Q R I S F T 
TTTGCGGGATCTCTGAAGCAACTTTATCTTGCAGACAATCGTCTTGAAGA 
F A G S L K Q L Y L A D N R L E 
CGATGTATTTCAACAGTTGGCCTTTTTGGTGGAAATCCGCATCTTGAACT 
D D V F Q Q L A F L V E I R I L N 
TGTCCTATAACGAGTTGACGGAGATTCCGCAGGGTCTCCTTAGACGGTGG 
L S Y N E L T E I P Q G L L R R W 
CAGTATTTGGTGGAGCTGCATGTCTCAGGAAATCAACTGAGCGCGCTTCC 
Q Y L V E L H V S G N Q L S A L 
CTCGGACGACCTTGAAGAATCAAGTAGTCTAAAGGTATTGCACATAAACG 
P S D D L E E S S S L K V L H I N 
GCAATAAATTCCAGGTACTTCCTGCGGAGCTCTGTAAGGTGAATCGCCTT 
G N K F Q V L P A E L C ~ V N R L 
GCGATTTTAGATGTGGGGAGTAATTCTCTAAAATACAATGTTTCCAACTG 
A I L D V G S N S L K Y N V S N 
113 
4401 GCCGTACGATTGGAATTGGAATTGGAATCGCAATTTAAAATACCTGAATT 
1264 W P Y D W N W N W N R N L K Y L N 
4451 TCTCGGGCAACAAGCGATTTGAGATCAAACCCAATACCTCTTATACTTCT 
1281 F S G N K R F E I K P N T S Y T S 
4501 GGGATTCCTGCCGTTAATAGCACAGATCTGACCAACTTCAACTCTTTGAA 
1298 G I P A V N S T D L T N F N S L 
4551 ACATCTTAGAGTCCTGGGGTTGATGGATGTTACTCTTACTATCCCTACCA 
1314 K H L R V L G L M D V T L T I P T 
4601 TCCCTGACCAGACTGAGGATAGGAGAGTGCGGACGTCATCATCCTTGTCT 
1331 I P D Q T E D R R V R T S S S L S 
4651 GGCTCTCTTGCGTATGGTATGGCAGATAGCCTTGGGCGAAACGAACATCT 
1348 G S L A Y G M A D S L G R N E H 
4701 ATCAATAGTTGATATGCTTGTTACTCGGTTCCGAGGCAACCAGACGGAGA 
1364 L S I V D M L V T R F R G N Q T E 
4751 CGGTTCTCGGTTTATTTGACGGCCAGTCCTCTTCTAGCAGCGGATCAAGG 
1381 T V L G L F D G Q S S S S S G S R 
4801 ATAGCGAAATACCTTCAAGAGCACTTCACTACATCGTTTACAGAAGAGTT 
1398 I A K Y L Q E H F T T S F T E E 
4851 GAAAAAGCTTCGTCCATCAGGAGAAACCCCGCTCGATGCACTGCGGAGGA 
1414 L K K L R P S G E T P L D A L R R 
4901 CCTTTTTGGGACTCAACAAGGATATAGCTACGGCTGCTCAACGGTCTTCC 
1431 T F L G L N K D I A T A A Q R S S 
4951 ATGGATGATCGTGAGCTCCATCATTTTGAACGTGGGACAACAACATCTAG 
1448 M D D R E L H H F E R G T T T S 
5001 CAAGCTGCTCACGAAGGATGACTATAATCTAGGAGGCGTAGCGACTGTCC 
1464 S K L L T K D D Y N L G G V A T V 
5051 TGTATCTGCAAAATATGGAGTTGTTTGTTGCAAATGTTGGGGATGCTCAA 
1481 L Y L Q N M E L F V A N V G D A Q 
5101 GCGGTTCTTGTGCATTCGAATGGGGATTTCAAGTTTTTGACTTGTAACCA 
1498 A V L V H S N G D F K F L T C N 
5151 CGATCCTGCTGAGGCTTCGGAACGGGAACGTATCCGGGCAGCTGGCGGGT 
1514 H D P A E A S E R E R I R A A G G 
5201 TTGTTTCCCGCAATGGAAAATTGAATGATAAGCTATCTGTGTCTCGGGCC 
1531 F V S R N G K L N D K L S V S R A 
5251 TTTGGATATTACACAATGATGCCTGCGGTTATTGCGGCTCCTAGCACCCG 
1548 F G Y Y T M M P A V I A A P S T 
5301 GAAAGTTACTTTGACCGCCCAGGACGAAATGATAATTCTTGCGTCAGGCG 
1564 R K V T L T A Q D E M I I L A S G 
5351 AGTTGTGGGATTATGTTACACCGGACGTTGTTGTTGATGTTGCAAGATCT 
1581 E L W D Y V T P D V V V D V A R S 
5401 GAACACGGAGACTTGATGATTGCCTCTCAGAAGCTTCGTGACTTGGCCAT 
1598 E H G D L M I A S Q K L R D L A 
5451 TGCCTATGGTGCTACCAACAAAATCATGGTGATGATTGCTGGTGTCAGTG 
1641 I A Y G A T N K I M V M I A G V S 
5501 ATCTTAAACGACGGGGTGAACGTCCCAAGCTCAGAAGTCACAGTATCTCC 
1631 D L K R R G E R P K L R S H S I S 
5551 ATGGGACTGTCTCCATTAACTGACGAACATCTCTTCACCACACCAAGTAA 
1648 M G L S P L T D E H L F T T P S 
5601 GATCAAGAAACGTGGCAGACCAGGCGACTCCAGGTTAGCACGTTTGGATC 
1664 K I K K R G R P G D S R L A R L D 
5651 GCGTGGAAGCCCCTACTGGCGAATTGGCGATCATTTTCACTGATATTAAG 
1681 R V E A P T G E L A I I F T D I K 
5701 AAATCCACGTCGCTTTGGGAGACGTATCCCGTTGCCATGCGCTCTGCAAT 
1698 K S T S L W E T Y P V A M R S A 
5751 TCAAATTCATAATGATCTCTTCCGTCGACAGTTGGCTCAGATAGGTGGAT 
1714 I Q I H N D L F R R Q L A Q I G G 
5801 TTGAAGTGAAAACAGAAGGTGACGCTTTCATGGTCTCCTTCTCCACGGCC 
1731 F E V K T E G D A F M V S F S T A 
5851 ACCGCAGCGTTACTCTGGTGCTTCACCTGCCAAAGCCAACTTCTTGAAGC 
1748 T A A L L W C F T C Q S Q L L E 
114 
5901 GGAATGGCCGACGGAGATCATGGAATCTCCTGCTTGCAGGCCACAGTATG 
1764 A E W P T E I M E S P A C R P Q Y 
5951 ACTCGGATGACAACATCATATACCGCGGGCTGTCTGTGCGAATGGGAGTA 
1781 D S D D N I I Y R G L S V R M G V 
6001 CACTGGGGAACGCCTGTCTGTGAACAAGATCCTGTTACTGGTCGAATGGA 
1798 H W G T P V C E Q D P V T G R M 
6051 TTACTTTGGCCCCATGGTAAACCGTGCCTCCCGCATTTCCGCAGTTGCGG 
1814 D Y F G P M V N R A S R I S A V A 
6101 ATGGTGGGCAAATCTTCGTTTCAGCCGACTTCGTTGCTGAAATTCAACGG 
1831 D G G Q I F V S A D F V A E I Q R 
6151 AATCTTGAAACATTCGCGGATTATGATCGGATCGGCTCTATGGATTCTTC 
1848 N L E T F A D Y D R I G S M D S 
6201 TGAGGATAATTACATTGACGACTATCTTAATCACAATATCCGTCGCGAGC 
1864 S E D N Y I D D Y L N H N I R R E 
6251 TTTATCAACTAAGCACCCAGGGCTTTGAGGTAAAGGATATGGGTGAGCGG 
1881 L Y Q L S T Q G F E V K D M G E R 
6301 AAACTGAAGGGGCTTGAGAATCCTGAATTCGTTTACTTGATGTATCCACA 
1898 K L K G L E N P E F V Y L M Y P 
6351 CTCTCTTGCTGGACGCCTCAACGCTCCACGGGCTGAGATTGAAGAGGCAG 
1914 H S L A G R L N A P R A E I E E A 
6401 ACACACTTCCCATTCCCTTGGGTCAAGACAAGCATCTCAGTATTGAAGCG 
1931 D T L P I P L G Q D K H L S I E A 
6451 GATCTAGTCTGGCGCCTGTGGACTGTTGCTTTACGTTTGGAGGCATTTTG 
1948 D L V W R L W T V A L R L E A F 
6501 CAGTGCCCTGGAAAATTTCGGAGAGATTGGTCTTCGGCAGCCGGAGATGG 
1964 C S A L E N F G E I G L R Q P E M 
6551 GCCTGATTGATGCAGTCAAGCAGCGCCCTGGGGAACTTTCGGATGCGGTA 
1981 G L I D A V K Q R P G E L S D A V 
6601 GTGTTGAGTCTAATTGAACATCAGGTTACGCGGGTGGAGgtgagttactc 
1998 V L S L I E H Q V T R V E 
6651 ttccccacttacactactattctatattgtagactaaactaacgcaacgg 
6701 aaacccgttatagACATGTGCAAATACCCTCACAATCCGGCACATGATGA 
2011 T C A N T L T I R H M M 
6751 GGCCTTTCAAACGCGGAAACTCTCTCAAAGATATCGCCGTTCCCATGTCG 
2023 R P F K R G N S L K D I A V P M S 
6801 GATATTCTCAATCAGTTGAAGGTGCAGTTGAGCGAATTTAGAGCTCTAAA 
2040 D I L N Q L K V Q L S E F R A L 
6851 GGAGTCAATAAGTCCCATCGCCGACTCTCAGGATCCCCAACAAAGCCTTG 
2056 K E S I S P I A D S Q D P Q Q S L 
6901 CGGTGTTGAAGAGCCCCATACAGAGCTCGTCAGCCTTATCTGATATTATG 
2073 A V L K S P I Q S S S A L S D I M 
6951 GCCGTTGGTGGTTCTAGTTCTTCGAGCACGGCGTAAAGCTTTATAAAACC 
2090 A V G G S S S S S T A * 
7001 TGCCACAGGAACAGCTGCTTTATGAATGGAATCGAAGTCCTTGACATCAA 
7051 TTCTTTTATGCTCTTACTCAACTAGCGCCGATCGGATTGCAAGTCGTCCG 
7101 GAGTTATTCTCTGTTCCACCCTTTTTTTTTTCGCTTCCCCTTTTTCTCTT 
7151 TCGTCCGCTTTTGTTCTCTTTATCCCGGCCGTTGCCTATGACTTGATGTC 
7201 CGTTTGATTTAATTCGTGGGGAAAAGCAGCGTATTTGGAATTTAATTACC 
7251 ACCTTGCCGTATTACTTTCTGCCATATTTTGGTTTATTTTTTTCATTTAC 
7301 TTTATTTACTTAATTTTGGGTGTGGGGGGTTTGCGTCTGTTTGCTTGGTA 
primer PbAC-R32 
7351 CGATCGATATTGTTTCCATAAAGTGCTTCTTTCTCTCTGGCCGGTTCCAT 
7401 CGTTCATTTCTGGGATTACACCATTTTATTTTTGCTAAGATCGGCGTATG 
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7451 TGGCTGCTGGAAATGAGGAGTATATTATCTTATCCCCATTTATCTATCAT 
7501 TATAATTTGGTGAGCCTTTGGTATATTTACAGGTAATTTTGGTGCCAATG 
7551 AAGGAATTTTTTTGCTCTCTTCGTTTTCGTGCAAAAAGGGATCCGTGGCT 
poly(A) adding position 
7601 GGTGCAGGATGACGTAAAGTCACATGACATACCTGACCTGTGGAGTTAAT 
7651 ATGTGGCGCGGCGCCGCGCATCGCATCTTGTTTTTTGTTGCTTTCTTGTT 
7701 GTCGCCGCCATCCAAATTGCATCAAAGCTACATCTCTCCACTCCATCATT 
7751 CCATCCAGGGTCTTTTCAACTTGGCCTCCGGATTCGTCTTCTTAAAATAC 
7801 ACTCTCTTATCTGCAGCTTTTGGTGCACGTGAATTTGTATTGATGCCGTA 
7851 GTTGCAGCGTGGATTTTTCCTGCTGTTGCCCTGGATACGGAACGCTTCAC 
7901 ACGCACTTAATTTATTGGCTCAACCTTCTTGAGTAAAGCGAAACAATTTT 
7951 TTTTTTTTTTTCCTGAGAGATACACCG 
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Figure 3.3-2. Determination of transcription initiation site of PbCYRJ. 
A: RT-PCR products after amplification with different pairs of primers. Bands can 
be observed when using primer pairs "PbAC-F16 and PbAC-R22", "PbAC-F20 and 
PbAC-R22", "PbAC-F21 and PbAC-R22", and "PbAC-F22 and PbAC-R22". No 
band was amplified when using "PbAC-F23 and PbAC-R22". 
B: A schematic diagram illustrating the PCR reactions in A. The predicted 
transcriptional initiation site was located at -1238 to -908 (referred to figure 3.3-1). 
A: RT-PCR products on agarose gel 
1.5 kb 
1 kb 
1 2 
B: Schematic illustration of A 
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the following pairs of primers. 
I: PbAC-FI6 and PbAC-R22 
2: PbAC-F20 and PbAC-R22 
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···~·····~················································· I I 
I 
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I~ Potential transcription initiation site from -1238 to -908 
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Figure 3.3-3. Homology of fungal adenylate cyclase proteins. 
GenBank Accession Number Protein: Organism % identity to PbCyrl 
AAS01025 PbCyr 1: P. brasilliensis 
CAC81748 Acy A: A. fumigatus 53% 
EAA59222 AnCyrl: A. nidulans 50% 
AAC34139 Mac 1: M. grise a 39% 
XP 329423 NcCyrl: N. crassa 34% 
BAA93553 CaCyr1: C. albicans 27% 
P49606 Uacl: U maydis 24% 
CAA89295 Cyr 1: S. cerevisiae 24% 
EAL19815 CnCyr 1: C. neoformans 24% 
CAA19571 SpCyr 1 : S. pombe 21% 
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Figure 3.3-4. Comparative alignment of adenylate cyclase catalytic domains. A 
multiple amino acid sequence alignment was performed using VectorNTI 6.0 
(Informax). GenBank accession numbers of proteins are given following the names 
of the proteins. The abbreviations are: Pb, P. brasilliensis; Af, A. fumigatus; An, A. 
nidulans; Sc, S. cerevisiae; Sp, S. pombe. 
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1. 
L 
Figure ~.3-5. Phylogenetic relationship of Class III adenylate cyclases. The tree was constructed by using Vector NTI 6.0 (lnformax). Only 
catalytic1 domains were used in the phylogenetic analysis (for mammalian adenylate cyclases, it is the 2nd catalytic domain that was used). The 
·I 
protein ~enBank accession numbers and the amino acid positions are bracketed. The abbreviations are as below: 
]1 
HumanAdcy1-C2, Homo sapiens adenylate cyclase 1 second catalytic domain; Rat, Rattus norvegicus; Mouse, Mus musculus; Mytu, 
Mycobabterium turberculosis; Anabaena, Anabaena sp. PCC7120; Plasmodium, Plasmodium falciparum; Dicttyostelium, Dictyostelium 
discoide~m; Treponema, Treponema pallidum; Streptomyces, Streptomyces coelicolor; Trypnosoma, Trypnosoma brucei; Leishmania, 
Leishmdnia donovani; Sc, S.cerevisiae; An, A. nidulans; Pb, P. brasiliensis; Sp, S. pombe. 
:1r 
I 
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HUn 
Rat 
Mo 
MytuCya-C(O: 
HurranAdcy1-C2(NP _066939:828-1039) 
nAdcy2-C2(NP_065433:842-1056) 
cyii-C2(AAA40682:846-1 060) 
seAdcyVI-C2(AAA37182:931-1139) 
820:214-412) 
AnabaenaCyaE -C2(NP _ 484705:846-1060) 
PlasmodiumAc1-C(CAC81938:479-735) 
DictyosteliumA.crA-C(AAD50121 : 1 051-17 43) 
nerra-C(NP _218926:357-557) Tre1 
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SeC 
Ar 
F 
~ 
mycesCya-C(P40135:75-331) 
osorra-C(S14210:873-1088) 
eishrraniaRacA-C(Q27675:850-1115) 
r1-C(CAA89295: 1611-1833) 
Cyr1-C(EAA59222: 1617 -1897) 
Cyr1-C(AAS01025: 1574-1856) 
pCyr1-C(CAA19571 :1261-1506) 
Figure 3.3-6. Domains of Pb adenylate cyclase PbCyrl protein 
Domain Name Positions 
Low complexity 39-50 
Low complexity 57-78 
Low complexity 337-354 
RA 562-643 
LRR TYP 752-774 
LRR TYP 775-797 
LRR 798-817 
LRR TYP 821-843 
LRR TYP 867-888 
LRR TYP 889-911 
LRR TYP 931-954 
LRR TYP 955-976 
LRR TYP 978-1000 
LRR TYP 1001-1024 
LRR TYP 1025-1047 
Low complxity 1086-1108 
LRR TYP 1173-1196 
LRR TYP 1200-1220 
LRR TYP 1222-1244 
PP2Cc 1341-1627 
CYCc 1574-1856 
Low complexity RA LRR TYP CYCc 
PP2Cc 
II I I 1111 II IIIII I Ill <.___~>;;>-----
Note: This figure is adapted from EMBL's SMART output when PbCyr1 was 
analysed. Due to the overlap in domains, there are 2 representations of the protein. 
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3.4 Differential Splicing at the First Intron of PbCYRJ 
Interestingly, when the eDNA fragment cPbAC-R21SIVII-12 (Figure 3.2-1) was 
amplified during the cloning of PbCYRJ eDNA using SSP-PCR, 2 additional types 
of eDNA clones were obtained and named cPbAC-R20SIVI-8 and cPbAC-R21 SIVI-
2. The differences in eDNA sequence were found to be caused by differential types 
of splicing at the first intron after the genomic DNA sequencing was finished. 
Therefore, 3 versions of eDNA were supposed to exist due to differential splicing 
and they were accordingly named PbCYRJ-cDNA-R21SIVII-12, PbCYRJ-cDNA-
R20SIVI-8 andPbCYRJ-cDNA-R21SIVI-2 (Figure 3.4-1). 
In order to check if there are further types of differential splicing and if there are 
additional introns, full-length eDNA cPbAC-F17R32 was amplified in a single RT-
PCR using ABgene's Extensor Hi-Fedelity PCR kit with primer PbAC-F17 
(positions -29-1) and PbAC-R32 (positions 7332-7364). The RT-PCR amplification 
of cPbAC-F17R32 was very successful because a single 6.6 kb band was obtained 
(Figure 3.4-2). Sequencing of cPbAC-F17R32 indicated that the eDNA was 
homogeneous except in the regions of the 1st and the 2"d intron, suggesting 
differential splicing in those regions. To delineate the 1st and the 2"d intron, cPbAC-
F17R32 was cloned into pGEM-T Easy vector and 8 individual clones were 
submitted to sequencing analysis. Two new types of splicing were found. However, 
they were proved to be odd mis-splicing as indicated by the appearance of premature 
stop codons immediately following the spliced sites (Figure 3.4-3). The result is 
illustrated as below: 
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Clones Description 
4 clones of cPbAC-Fl7R32 The same as the sequence of PbCYRl-cDNA-
R21SIVII-12 (Figure 3.4-1) 
1 clone of cPbAC-Fl7R32 The same as the sequence of PbCYRl-cDNA-
R21SIVI-2 (Figure 3.4-1) 
PbCYR 1-cDNA-F 17R32-12 Mis-splicing (see Figure 3.4-3) 
PbCYRl-cDNA-Fl7R32-16 Mis-splicing (see Figure 3.4-3) 
PbCYRl-cDNA-Fl7R32-ll Deletion caused by secondary structure of mRNA 
during RT 
In general, apart from the 2 types of mis-splicing, there are 3 types of sensible 
splicing in PbCYRI (Figure 3.4-1) at the 151 intron. They were named PbCYRI (full 
length eDNA version), PbCYRI (-3 bp eDNA version) and PbCYRI (-21 bp eDNA 
version), which in tum give rise to 3 types of proteins translated, i.e. full-length 
PbCyr 1, truncated protein PbCyr 1 t-. 58 and PbCyr 1 t-.58-64 . 
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Figure 3.4-1 Three types of differential splicing at the first intron of PbCYRJ. 
Nucleotide sequence and amino acid sequence alignment was done with Vector NTI 
6.0 (Informax). 
A: Three different types of splicing at first intron. They are PbCYRI full length 
eDNA version represented by clone PbCYR1-cDNA-R21SIVII-12 (171-320 spliced); 
PbCYRI -3 bp eDNA version represented by clone PbCYR1-cDNA-R20SIVI-8 
(171 -323 spliced); and PbCYRI -21 bp eDNA version represented by clone 
PbCYR1-cDNA-R21SIVI-2 (171-341 spliced). 
(160) 160 180 190 200 210 221 
Fb0t'R1-geraric DNA (160) ·,. ;; •1\'ll ;,, ·, GTATGTTTGATTTCGTTTTTGAAGAAGCAGTTTTGCTTCGTGATGAATTGT 
FbOt'R1-cQNA.R21SIV11-12 (160) 
FbOt'R1-cDNA-R20SIV1-8 (160) '·\ ; ;, 'I C,'.• ',\ ---------------------------------------------------
FbOt'R1-cQNA.R21SIV1-2 (160) ·: ... ;. ; .. :.'!', :;,. • \ ---------------------------------------------------
Glnsensus (160) CAGGATGACAG 
(222) 222 230 240 250 260 270 283 
FbOt'R1-geraricDNA (222)TAGGTCCTGTTTGGGCACATCGGAGGCCTTCATTCTGTTCAAAATGTGGGGAAACGCTGTTA 
FbOt'R1-cQNA.R21SIV11-12 (171) --------------------------------------------------------------
FbOt'R1-cDNA-R20SIV1-8 (171) --------------------------------------------------------------
FbOt'R1-cQNA.R21SIV1-2 (171) ------ - - - - ----------------------------------------------------
Glnsensus (222) 
(284) 284 290 300 310 320 330 345 
Fb0t'R1-geraric DNA (284) CGCAAACGTTTTATACTTAATTTTTTTTTCTTTCCAGAAGGCTGAACTCGACATCCA , 
FbOt'R1-cQNA.R21SIV11-12 (171) ------------------------------------- GGCTGAACTCGACATCCA ; ' 
FbOt'R1-cDNAR20SIV1-8 (171) ---------------------------------------- CTGAACTCGACATCCA I' ' 
FbOt'R1-cQNA.R21SIV1-2 (171) -------------------------------------- --------------------
Glnsensus (284) AAGGCTGAACTCGACATCCAGACAC 
B: Differential splicing leads to the 2 types of truncations for PbCyrl protein, i.e. 
PbCyr 1 ~58 and PbCyr 1658-64• 
(30) 30 40 50 60 70 84 
RJC¥1 (R21SIVII-12p) (30) .QG , ~P~ ~ < ;.· c. 'l." Jl JAPRfl !:' , 2 
RJC¥1 (R20SIVI-8p) (30) SQ\.; ,1 IF'<·: 'l.l<P~RA ~"'I~ Ill.. ~ -!LNSTSR i~ ;c;c; ~ I\J~·,p,pf PPl:SPill 
RJC¥1 (R21SIVI-2p) (30) ------- , c 
Cb~ (30) LLISQGLGLEREPRRPSRAREISDQDDR LNSTSRHSSSSKSNRNAPRRPHSPDV 
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Figure 3.4-2 Full-length PbCYRJ eDNA amplification by RT-PCR. RT-PCR was 
done by using primer PbAC-F17 (positions -29-1) and PbAC-R32 (positions 7332-
7364). A single band of 6.6 kb eDNA was obtained. Further analysis of the band 
indicated differential splicings at the 1st and 2nd introns. 
6.6 kb .. 
..- cPbAC-F17R32 
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Figure 3.4-3 Illustration of 2 types of mis-splicing of PbCYRJ. Nucleotide 
sequence alignment was done by using VectorNTI 6.0 (Informax). Two types of 
mis-splicing were observed when individual clones of RT-PCR products obtained 
with primer PbAC-F17 and PbAC-R32 were sequenced. Clones were considered to 
be mis-spliced because premature stop codons were found immediately after the mis-
spliced site. 
For clone PbCYR1-cDNA-F17R32-12, the mis-splicing (positons 45-102) happened 
before the first intron (positions 171-320). 
For clone PbCYR1 -cDNA-F17R32-16, the 2nd intron (positions 874-1333) was 
turned into 2 sub-introns (874-1023 and 1119 to 1333), leading to premature stop 
codons in the new exon (1024-1018) such caused. 
PbCY'R1-geraric DNA 
PbCY'R1-cDNA-F17R32-12 
PbCY'R1-cDNA-F17R32-16 
Cbnser19Js 
20 30 
Mis-splicing 
50 
(64) 64 70 80 90 100 110 
PbCY'R1-geraric DNA (64) !::Tee CCTGATGCGTTGCTGATATCGCA • n ·, , 
PbCY'R1-cDNA-F17R32-12 (44) ---------------------------------------
PbCY'R1-cDNA-F17R32-16 (64) CTCTGGCGGTCC TGATGCGTTGCTGATATCGCA 
63 
Cbnser19Js (64) CTCCTCTGGCGGTCCCCTGATGCGTTGCTGATATCGCAGGGTCTTGGCTTGGAAAGGGAACCC 
The start of the 1st intron 
(127) ,:::12=7=---==-...:1:..:4.:..0 --:-__,;1:..:5.:..0_-=-__.1=..:6:..:0 __ ----'S:-17:...:0 ______ .:..18:..:.9 
PbCY'R1-geraric DNA (127) 
PbCY'R1-cDNA-F17R32-12 (68) 
PbCY'R1-cDNA-F17R32-16 (127) 
TATGTTTGATTTCGTTTT 
,, 
~~s (127) CGTCGCCCCAGTAGAGCTAGGGAGATTTCGGATCAGGATGACAG 
(100) 190 200 210 220 230 240 252 
PbCY'R1-geraricDNA (100) TGAAGAAGCAGTTTTGCTTCGTGATGAATTGTTAGGTCCTGTTTGGGCACATCGGAGGCCTTC 
PbCY'R1-cDNA-F17R32-12 (112) ---------------------------------------------- -----------------
PbCY'R1-cDNA-F17R32-16 (171) ---------------------------------------------------------------
Cbnser19Js (100) 
(253) 253 260 270 280 290 300 315 
PbCY'R1-geraric DNA (253) ATTCTGTTCAAAATGTGGGGAAACGCTGTTACGCAAACGTTTTATACTTAATTTTTTTTTCTT 
PbCY'R1-cDNA-F17R32-12 (112) ---------------------------------------------------------------
PbC't'R1-cDNA-F17R32-16 (171) ---------------------------------------------------------------
Cbnser19Js (253) 
The end of the 1st intron 
PbC't'R1<DNA-F17R32-12 (112) ---- ;.. ~; ;c·rr ~,;,;,-·T~-\-;;, ,_,A': · _·M ;.;t_'.Z'-\l_"rr ·~-~·~ · ~;'_:'C,~"'I 1 _·:\;.,_;....~ ;;... -;T \.: ·. { · ;·r.z"~ i\( .. 1; • "--r:~ 
PbC't'R1-cDNA-F17R32-16 (171) ---- ,;, ;,~, 'T -,;,_:._r·T· :'~-~·~-". _., ·., ,,,, ·;,c ·T ·r ;· ... ; Icc! ,_ .. \.~_,;._;_;:.;T,,;,·r • · ;T ;,;,c• ;r: ·: --:r:-
Cbnser19Js ~17) AAGGCTGAACTCGACATCCAGACACTCGTCGTCCTCAAAGAGTAATCGTAACGCCCCCC 
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The start of the 2"d intron 
(~)_83_0 __ -=--~84_0 __ -= __ ~8_5_0 __ ~--~8_6_0 __ ~--~8_7_0 ______ ~8_80 ________ 8__ 92
A:lCYR1-gerroic DNA (~) 
A:lCYR1-cDNA-F17R32-12 (621) ~ 
A:lCYR1-cDNA-F17R32-16 (680) ,.. 
>GTCCGTGAAAGAAATAATT 
~(~) GTCTGTCAAACCGAATTCCTATGTCATCTGGCAGTCAATCAAAG 
(893) 893 ,900 ,910 ,920 ,930 ,940 955 
A:lCYR1-gerroicDNA (893) CGACCCCATCTTTGCACCCCCCAGAGCGTTCTTCACCCCTTGGTCGTGGCTTCCGACCATGCA 
A:lCYR1-cDNA-F17R32-12 (665) ---------------------------------------------------------------
A:lCYR1-cDNA-F17R32-16 (724) -------------------------------------------------------------- -
Cbnsen&JS (893) 
(956) 956 970 980 990 1000 1018 
A:lCYR1-gerroicDNA (956) CTCCTCTACCTTCCAGTGATGTTACCCCTTGAATGTATCAAAAGCTCAATCTAAGATGGCACG 
A:lCYR1-cDNA-F17R32-12 (665) ---------------------------------------------------------------
A:lCYR1-cDNA-F17R32-16 (724) ------ - ------------ - - - - - - - -------- - - ---- - ------------------ - - --
Cbnsen&JS (956) 
New exon caused by mis-splicing 
(1019) 1019 1030 1040 1050 1060 1070 1081 
AJCYR1-gerroic0NA(1019) AAAAG~ ':·.'· ,. -,; ~ ~<o ':'!-_:,;,·~~;c:;"-,_,;,· 1!,.· ; 
A:lCYR1-cDNA-F17R32-12 (665) ----- -; ~-'·.!\'~T~A~'il·~.:,_:,,;G;;_,:,c;: .--~x:xr;~; !i•' ·• ;; · ;'!'1.'1<.'. 
A:lCYR1-cONA-F17R32-16 (724) ----- ! · ·- -,·::·.:,; •. •;.;c_,,,-,:;::: . . I: ·r.:•,·: : 
Cbnsen&Js(1019) TTCCTTCGTTAATCGGAATTTACTTCAAGGGAAGCCTATATGGTTTCCTGTCGTTACA 
(1082) 1082 1090 1100 1110 
A:lCYR1-gerroic DNA(1082) "GTT<'.'<J",.J;C'lU TT< ': 
A:lCYR1-cDNA-F17R32-12 (723) 'I'-:.;T'n~C<~.:,;,~ I'c:• .. ". :· ~ .''l 'I'• X·;";,,;,_:;; C'l 'l'L'i Gi;;,.:.; 
A:lCYR1-cONA-F17R32-16 (782) '< :'[''['< ·, · :·,:, .,., :r"; T . • , 'TT• ., ;, :;, :,;, :": "' '' <"!'< ·:,;; c 
Cbnsen&Js(1082) TGTTCCCAACTGCTTCCTTCGGAAAGTCTTCTGAAGG 
1120 1130 1144 
TATCTGGATAAAACTGCACGACTTGT 
(1145) 1145 1150 1160 1170 1180 1190 1207 
A:lCYR1-gerroic DNA(1145) TGAAACTGCATATTATTCATCACTAGCTCTATAAACCCTTTCTCCCTTCATTATTTGGTTTGC 
PbCYR1-cDNA-F17R32-12 (760) ---------------------------------------------------------------
PbCYR1-cDNA-F17R32-16 (819) ---------------------------------- - --- - ------------------------
Cbnsen&Js(1145) 
(1208) 1208 1220 1230 1240 1250 1260 1270 
A:lCYR1-gerroic DNA(1208) CCATCCCTTTCTCTACCATTCCTGGCTCTCTATTTCTAATTAGCACCCCTCAGGGACATTTTC 
PbCYR1-cDNA-F17R32-12 (760) ---------------------------------------------------------------
PbCYR1-cDNA-F17R32-16 (819) ---------------------------------------------------------------
Cbnsen&Js(1208) 
The end of the 2"d intron 
(1271) 1271 1280 1290 1300 1310 1320 1333 
A:lCYR1-gerroic DNA(1271) ATTATATTCTCGCCATTTCATTCTGAATTATACTCGAACTTTAAGCTAATGTGGGATTGTAGG 
PbCYR1-cDNA-F17R32-12 (760) ---------------------------------------------------------------
PbCYR1-cDNA-F17R32-16 (819) ---------------------------------------------------------------
Cbnsen&Js(1271) 
(1334) 1334 1340 1350 1380 1396 
A:lCYR1-gerroic DNA(1334) . T.;T.::m 'A.A.,·, ~-'· :• ;. ;_;, .:,•Jc; 
PbCYR1-cDNA-F17R32-12 {760) .T.~T.---.Tc_·_;.. __ :->:A(_ ··:-rl';: :i'-:;:-\,:_;,.-\'1 ,_; _ . ; .L·-31-t-.'l\_·,_·.~. :~T~C\_-_·A ·; ·;hc;_.;(·(_'t .,-~ :-;A--~.G', -~--~ • .-".M(\_~i-· 
PbCYR1-cDNA-F17R32-16 (819) ·.c:.:.:t.-.'1, ,· ... ::,.., ": :.", ;. ;;,: ·_:.·t, _:, · · ·• :. :·: _:,-r. _·,_·_:._,_;-r ·:· ~-:~·:. ~.:; ... :.:.-.' · .-: ; · .• ;·: ·:·.;;..:,, · _: _ .. 
Cbnsen&Js(1334) ATATATCAAACTATGGAGATGCACCTGTGTATCCAGTTCCAGGAGACCCGGATGTTGAACGCT 
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3.5 Construction of a High Fidelity PbCYRJ eDNA 
In order to obtain a 6.3 kb high fidelity eDNA for PbCYRJ, small segments of the 
PbCYRJ eDNA were cloned and sequenced to confirm their fidelity at the amino 
acid level. These segments of eDNA were then recombined into a full-length eDNA. 
The procedures for this construction are illustrated in Figure 3.5-1 and Figure 3.5-2. 
In general, 3 important constructions were obtained, namely p YES6-cPbAC-
F26R34-1-14, pBSK-cPbAC-F26R34-1 and pGEMTE-cPbAC-F26R34-1. pYES6-
cPbAC-F26R34-1-14 was constructed in pYES6/CT (Invitrogen) using the -21 bp 
eDNA version of PbCYRJ, with a point mutation that introduced a single amino acid 
change in the protein derivative (Q600R; nucleotide A at position 2,408 in Figure 
3.3-1 replaced by G in addition to A2S introduced by primer PbAC-F26). The 
pBSK-cPbAC-F26R34-1 and pGEMTE-cPbAC-F26R34-1 constructions were made 
with full-length PbCYRJ eDNA, into which no point mutation at the amino acid level 
had been introduced (except for A2S introduced by primer PbAC-F26), cloned into 
pBSK (Stratagene) and pGEM T Easy (Promega) vectors respectively (pGEM T 
Easy vector was artificially introduced with a Kpni site). These constructs were used 
as templates in sub-cloning of genes for yeast two-hybrid analyses or other 
downstream work. 
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Primers 
::0 
CTl 
8 
3 
0"' 
:r 
Ill 
....... 
6" 
:::J 
"0 
a 
£ 
a. 
c: 
m 
(J) 
PbCYR1 eDNA: 6.3 kb 
..... ..... ..... ..... 
rbAG-F26 PbAe-F19 PbAe-F24 PbAC-F20 
PbAC-R13 GSP1 PbAC-R33 PbAC-34 
.... .... 
.... .... 
Kpnl F26R13 Bg/11 
Sa/1 F19GSP1 Sa/1 
F24R33 Notl 
I I 
F20R34 
~ 
Kpnl F26GSP1 Sa/1 
Kpnl Sa/1 Notl 
pYES6-ePbAC-F26GSP1 F20R34-1 (-21 bp eDNA version) 
Kpnl Sa/1 ~ Sa/1 Notl 
pYES6-ePbAC-F26R34-1-14 (-21 bp eDNA version of PbCYR1 with a point mutation Q600R) 
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Figure 3.5-1 
Construction 
of fidelity 
PbCYRJ 
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3.6 Cloning of 3 Iso-forms of G Protein a Subunit Genes PbGPAJ, 2 and 3 from 
PbOJ 
The strategy for cloning of PbGPAJ-3 was PCR amplifications, with walking on 
both genomic DNA and eDNA. The cloning procedures are illustrated in Figure 3.6-
2, Figure 3.6-3 and Figure 3.6-4. Primers were designed on the basis of immediate 
sequencing results. At the beginning, two degenerate primers, PbGPA-DGF5 and 
PbGPA-DGR2, were designed corresponding to conserved amino acid residues 
(AS)GESGKST and RKKWIHC, respectively. Three fragments of 578 bp, 680 bp 
and 644 bp were amplified from genomic DNA, and designated PbGPAJ, PbGPA2 
and PbGPA3 accordingly (Figure 3.6-1). The fragments were sequenced and 
specific primers were designed, with which, fragments upstream and downstream of 
the genes were amplified from both our genomic walker library and pDNR-
PbOlcDNA library. 
On the basis of the gPbGPA-DGF5R2 (578 bp, PbGPAJ) sequence, two specific 
primers, PbGPAl-Fl and PbGPA1-R2, were designed for upstream and downstream 
SSP-PCR. By using these 2 specific primers and 2 anchor primers (M13Rl and 
M13Fl), 2 eDNA fragments, namely cPbGPA1-FIM13Rl and cPbGPA1-R2Ml3Fl, 
were amplified from the pDNR-PbOJcDNA library plasmids. An upstream genomic 
DNA fragment, gPbGPA1-R4AP21-3, was amplified by SSP-PCR using our 
GenomeWalker library. A downstream genomic DNA fragment, gPbGPA1-F2AP3-
2, was amplified as well. The genomic DNA sequence was finished by amplifying a 
fragment, named gPbGPA1-F7Rl, bridging gPbGPAl-R4AP21-3 and gPbGPA1-
F2AP3-2. The full-length PbGPAJ eDNA sequence was amplified with 2 specific 
primers, PbGPAl-ExGPAFl and PbGPA1-pYER3, which include the ATG start 
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codon and TGA stop codon respectively. The cloning procedure for PbGPAJ is 
illustrated in Figure 3.6-2. 
On the basis of the gPbGPA-DGF5R2 (680 bp, PbGPA2) sequence, 4 specific 
primers, PbGPA2-Fl, PbGPA2-F2, PbGPA2-Rl and PbGPA2-R2, were designed for 
cloning of PbGPA2 by SSP-PCR. By using specific primers PbGPA2-Fl and 
PbGPA2-Rl, and an anchor primer AP3, 2 genomic DNA fragments, namely 
gPbGPA2-FlAP3 and gPbGPA2-RlAP3, were amplified from our GemomeWalker 
library. Another 2 eDNA fragments were amplified, namely cPbGPA2-R2M13Fl 
and cPbGPA2-F2M13Rl, from our pDNR-PbOlcDNA library. Then a genomic 
DNA fragment was amplified using specific primers PbGPA2-R2 and PbGPA2-F4 
(designed from sequence ofcPbGPA2-R2M13Fl) and PbOJ genomic DNA as target. 
A further upstream genomic DNA sequence, gPbGPA2-R8AP4-4, was amplified 
from our GenomeWalker library. The full-length eDNA of PbGPA2, namely 
cPbGPA2-F6R6, was amplified from PbOJ mRNA with PbGPA2-F6 and PbGPA2-
R6, which included the start and stop codons respectively. The cloning procedure for 
PbGPA2 is also illustrated in Figure 3.6-3. 
On the basis of the gPbGPA-DGF5R2 (644 bp, PbGPA3) sequence, two specific 
primers PbGPA3-Fl and PbGPA3-Rl were designed for cloning PbGPA3 by SSP-
PCR. By using the 2 specific primers and the anchor primer AP3, 2 genomic DNA 
fragments, gPbGPA3-FlAP3-2 and gPbGPA3-RlAP3-2, were amplified from our 
GenomeWalker library. A new primer PbGPA3-R4 was designed and used to 
amplify a further upstream genomic fragment, gPbGPA3-R4AP3-3. The full-length 
eDNA was deduced from the genomic DNA sequence. Two primers, PbGPA3-F5 
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Figure 3.6-1. Three iso-forms of G protein alpha subunit amplified by using 
degenerate PCR. With a pair of degenerate primer PbGPA-DGF5 and PbGPA-
DGR2, 3 iso-forms of PbGPA were amplified from PbOJ genomic DNA. 
I kb + / 680 bp PbGPA2 
500 bp .. 
644 bp PbGPA3 
578 bp PbGPAJ 
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and PbGPA3-R5, including start and stop codons respectively, were designed and 
used to clone the full-length eDNA cPbGPA3-F5R5 from pDNR-PbOlcDNA library 
plasmids. The cloning procedure for PbGPA3 is also illustrated in Figure 3.6-4. 
3.7 The Nucleotide Sequence and the Deduced Amino Acid Sequence of G 
Protein a Subunit Genes PhGPAJ, 2 and 3 
Following the successful amplification of genomic DNA and eDNA fragments, the 
genomic DNA sequence, eDNA sequence and the deduced amino acid sequence of 
PbGPAI, 2 and 3 were determined; and these are illustrated in Figure 3.7-1, Figure 
3.7-2 and Figure 3.7-3. The PbGPAJ, 2 and 3 genes can now be retrieved from 
GenBank with accession numbers of A Y550246, A Y550248, and AY550247 
respectively. The PbGPAI gene is interrupted by 4 introns. The coding sequence of 
PbGPAI gene is 1,059 bp long and encodes a protein of 353 amino acids with a 
molecular weight of 41 kDa and predicted pi of 5.0 (Figure 3.7-1). The PbGPA2 
gene is interrupted by 4 introns. Interestingly, the eDNA of PbGPA2 is quite long 
with an additional 5 introns spliced before the start codon ATG (Figure 3.7-2 and 
3.6-3). The function ofthis long stretch ofun-translated eDNA (about 1.5 kb) needs 
to be investigated further. The coding sequence of PbGPA2 is 1,077 bp long and 
encodes a protein of 359 amino acids with a molecular weight of 41 kDa and 
predicted pi of 6.2 (Figure 3.7-2). The PbGPA3 gene is interrupted by 5 introns. 
The coding sequence of PbGPA3 is 1,068 bp long and encodes a protein of 356 
amino acids with molecular weight of 41 kDa and predicted pi of 6.3 (Figure 3.7-3). 
The PbGpal, 2 and 3 proteins are conserved within themselves; with PbGpal and 
PbGpa2 displaying 43% identity; PbGpa2 and PbGpa3 41% identity; and PbGpa1 
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and PbGpa3 47% identity. Interestingly, the 3 genes share some intron-splicing sites 
exactly at the same positions in amino acid sequence, indicating that they were 
created by duplication during evolution (Figure 3.7-4). 
The currently known fungal G protein a subunits can be grouped into 3 distinct 
subfamilies (Figure 3.7-5). The close relatives ofPbGpal are as the follows: 
Protein: organism % identity to PbGpal 
PmGasA: P. marneffei 93% 
AnFadA: A. nidulans 92% 
NcGnal: Neurospora crassa 91% 
MgMagB: Magnaporthe grisea 91% 
CpCpg 1 : Cryphonectria parasitica 92% 
UmGpal: Ustilago maydis 75% 
CnGpaB: Cryptococcus neoformans 62% 
ScGpal: S. cerevisiae 37% 
The close relatives ofPbGpa2 are as below: 
Protein: organism % identity to PbGpa2 
AnGanA: A. nidulans 78% 
PmGasB: P. marneffei 78% 
MgMagC: Magnaporthe grisea 52% 
CpCpg3: Cryphonectria parasitica 51% 
NcGna2: Neurospora crassa 52% 
UmGpa2: Ustilago maydis 47% 
SpGpa 1: S. pombe 39% 
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The close relatives of PbGpa3 are as below: 
Protein: organism % identity to PbGpa3 
PmGasC: P. marneffei 86% 
AnGanB: A. nidulans 85% 
NcGna3: Neurospora crassa 78% 
MgMagA: Magnaporthe grisea 77% 
CpCpg2: Cryphonectria parasitica 76% 
UmGpa3: Ustilago maydis 68% 
CnGpa 1: Cryptococcus neo.formans 66% 
ScGpa2: S. cerevisiae 50% 
SpGpa2: S. pombe 45% 
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Figure 3.7-1 The nucleotide sequence and the deduced amino acid sequence of 
PbGPAJ 
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TTTAAGCTATACAGGGTTCAAGTTTCCTTCCAAGCCTTCTAGAAGCATCA 
CGATTGCACTGGGCTCCACAAGTGAAGAGGGGGTGGAAACGAAAGGCTGG 
TAAATTTGGGATTTTTGTAGGGAATGGCTTGGAGGAGTTTAACCCTAGGC 
GAACGGAACAATTATTTTTGGAAGGGAATGGCTTGTCTATGACTCGTGGG 
TTTTCGCCTCTTGTTCTGGGCTGTTGAACTGGGATGATGAGGATGACATG 
CAAGGTAGACTTGTTCTCTAATATCTCCTCCTGTGGAGATATAAATTTCT 
GATTAAATTCTCCCAATTTCTCCCAATTTCTTCCGTTTTTCGTTTTCCCC 
TCTGGCGGGATTGGGTTCCACTCTGCAGTCAAGCTGCCGATTCGTCAGCG 
GGATAAACATGGGTGCAAGAACCATTTCAACCTTTTTTCCGTTTATCTCT 
AAAGCCCGACTTTGGGAAGTTTCTTCTATTTTCGGGACACTGCGTCCTCT 
ATTTATCGATGTTGATACGCTGGGAACAATGGATGCCACGTTTGCCTGAG 
CTTACCTAGGCAGAAAGGTATCCAACGGGCAAATTCTTCTATCTTTCTCG 
AGAAATTTCGGGACGTATTTCTAAAGGGGCACACAAACGCAGGCAGACTG 
CAGTGCAGTATTATCTCCAAGGCTGGGAGTGGATTAATAATTTGATACCC 
AAGAAACTAATAATGTCATCCTAATAAGCCATGGGTAATTGCGCCCGTTA 
TAGTTACCTCTCCTCCCCCTTTATTTTATTTCTTACACGAGATGGGGGAC 
TTGTAAGGAAGAGACCAATTCTCTGGGCGGTCGGTGGGTGGGTATTCGGG 
GTGTTCTGTTGTTACGAAGCAGGTCACCAGCGGACTCATTCCAACCAACT 
CGGCCATGGATGGAGGAGAAACCTGCCCCTTGTACTGCACATACTAGTGT 
ATTTAGCACTTGACACCTCGTTTGGCGCTGGACCTTGGCGTGTGTTGCAA 
GGCGGTTGAATATTGTATGTATCATAACTTATTGAACTGTAACATAACAG 
CCGTAAAGGCCGTGACCATACCGTACAACGCTTCCTCTTCCTTCGTCCCA 
CCTTCCCCTTCTCAGCCGGCATACCCTTGTTGTGTTCTTTCCTGCTTCTT 
CCTCCTCCATTGTTCTTTGCCCAGGCCAACCTCCAAACCTCCAAACCTCC 
AACCTCCAACCTCCTCCTTCGCTATCTTCATCTCCATCTTCACCTTCAAT 
CCTCTAATCTCCCGCCCTGCCGTGTTGTTGGACTGTTGGCCTGAACCTGT 
AGGATTCCATTCCAGTCCTTTCCCGCAAAACCCAGCCAGTCTTCAGCAAA 
TTGAATCGCTCTTTTCCCAGCGTGCGATTTGGTCCGCTCTCCCCTAAGTT 
CTCTTTGACTCCCTGCAGACCACCACTACCTGACCTCTTCTGCTCTGCCC 
ACCAACCCTCTCTCTTTGGAATACGGTATTATCGGTATCTCCAAAGCAAT 
ACTGAATTGAGTTGATTGGTCTTGGTTTAATTGTTTCTTTCCCCCATTGG 
AGTATATTGTGAGTGTAGAATGTCTTGACTTTATGGCTTGCCTCTTGGGC 
TCTTGTTGCCGCATTGTCGGGACGACGGCATTGGGGGAATGTGACCGGCT 
GCAACCCTTTTGCTGGCCAGCAGCACCAATCATCTTCTACCAATCGATTC 
ACTCTCTCTTTACCGCCCTACCTGCTTTTTTTTACCTTGTCGAGCTCTGG 
GATGTGTAGTTGATCCATTTCCCACTGACATGAAGCAGAACCTGTACATT 
CCGATATCGTCCAGAGCATTTTGTGTCATTCATCCATCTTGCTTTACGCC 
CTGAAAAATAAACTCACCCCAGTCTTTACACATTCTGTAACTTGACAACA 
ATGGGGTGTGGAATGAGCACCGAGGACAAGGAAGGAAAGGCTAGAAATGA 
M G C G M S T E D K E G K A R N 
AGAGATTGAGAATCAACTGAAGAGGGATAAGATGCTGCAGAGAAACGAGA 
E E I E N Q L K R D K M L Q R N E 
TCAAAATGCTCTTGCTTGgtaagatgattctttttccttttgtttaatcc 
I K M L L L 
ggctgtatgacttacttggtctgaaccacccagGTGCTGGAGAGTCTGGC 
G A G E S G 
AAATCCACAATTTTGAAACAGATGAAACTCATTCACGAGGGTTCATATTC 
K S T I L K Q M K L I H E G S Y 
GCGAGATGAGAGAGAATCCTTCAAGGAAATCATTTTCAGCAACACCGTCC 
S R D E R E S F K E I I F S N T V 
AGTCGATGCGCGTTATTCTCGAGGCTATGGAAGGACTAGATATCCCGTTG 
Q S M R V I L E A M E G L D I P L 
GATGACCAGCGTGCCGAATACCATGTTCAGACTATCTTCATGCAACCAGC 
D D Q R A E Y H V Q T I F M Q P 
ACAGATTGAAGGCGATTGCTTACCCCCCGATGTTGGCAGTGCAATCGACG 
A Q I E G D C L P P D V G S A I D 
CCCTTTGGAACGATGCTGGTGTACAAGAATGTTTCCGGAGATCTCGCGAG 
A L W N D A G V Q E C F R R S R E 
140 
501 TATCAGCTGAATGACTCTGCACGATAgtaagcttcattgctgccacaaac 
146 Y Q L N D S A R 
551 acaatatatttgattaataaccaagatatatagCTATTTTGACTCCATCA 
154 Y Y F D S I 
601 AGCGTATCGCCGCATCCGATTATTTACCTAGCGACCAGGATGTCCTTCGC 
160 K R I A A S D Y L P S D Q D V L R 
651 TCCCGTGTTAAGACCACAGGTATCACGGAGACAACGTTTATCATTGGCGA 
177 S R V K T T G I T E T T F I I G 
701 TCTCACGTACCGTATGTTCGACGTAGGTGGTCAGCGTTCTGAGCGCAAGA 
193 D L T Y R M F D V G G Q R S E R K 
751 AGTGGATCCATTGCTTTGAAAACGTCACAACCATTCTTTTCCTCGTTGCT 
210 K W I H C F E N V T T I L F L V A 
801 ATCTCTGAGTACGACCAGCTCCTGTTCGAAGACGAAACCGTCAACCGTAT 
227 I S E Y D Q L L F E D E T V N R 
851 GCAGGAAGCTCTCACACTTTTCGATTCCATTTGCAATTCGAGATGGTTTA 
243 M Q E A L T L F D S I C N S R W F 
901 CCAAGACTTCTATCATCCTCTTTCTCAACAAGATTGATCGGTTTAAGGAG 
260 T K T S I I L F L N K I D R F K E 
951 AAACTGCCTGTTAGCCCAATGAAAAACTACTTCCCTGATTACGAAGgttt 
277 K L P V S P M K N Y F P D Y E 
1001 gttttcgcccaactcctttatttttctcttattcatgataaacgttgctg 
1051 atattgtgtaccagGGGGTGCCGAATACACTGCTGCTTGCGACTATATCC 
292 G G A E Y T A A C D Y I 
1101 TCAACCGCTTCGTCTCGCTCAACCAGGCTGAGCAGAAGCAAATTTATACA 
304 L N R F V S L N Q A E Q K Q I Y T 
1151 CACTTCACCTGTGCTACTGATACCTCTCAAATCCGATTCGTCATGATGGC 
321 H F T C A T D T S Q I R F V M M 
1201 TGTCAACGgtatgtggcttgttcattttttatgtacaaattaatactaga 
337 A V N 
1251 atcatacatgtcatgctaactctagagtccagATATAATCATCCAGGACA 
340 D I I I Q D 
1301 ACCTTCGCCTCTGTGGACTGATATGACGAAGTCTTTTGAATACGTTTGAT 
346 N L R L C G L I * 
1351 TCTTTTTAGTTACTTTTGATTTTTTTCGCTAATTAGATAATTTTCCTTTT 
1401 CACGCCATGTGTATTTGATATTACCTTCAGCTTTTTCTTTGTACCTTGTC 
1451 TTCCTCTTGGTTAAGGTTTATCTCCGGCCCGCTCCTCCTCCCTGACCTGT 
1501 CAGCATCTGTCATTCAGAATTTCCTTTTCTATTAAGACATCTATACTTTT 
1551 GCCCATATTATGGAGGATTTGACCAGTGGTTGAAAAGCCCTTTTTCCTAC 
1601 ATCCCAAAAACATGGAGTAATGCAGCCTCGTCAGCACAACCGGCACCACA 
1651 TGAACGGGACATACGATTTCTTTCCCTGACCACCCTTTCCTTATGTGTCT 
1701 CTTTTTTCTTCAGATCCATCTTGCCTGATCTTGTTACTTTTGTTTTTTTC 
1751 AATTACCCTGCATGGTTTCCTTCTCAGTTTGATTTGAGATTATTTCTCTT 
1801 TTTTCACCCTTTTTTATATCCTCTTGATGTATCTGTTGTGCGTATGAGGT 
1851 ATGTTTTTTTTTCCATACCTTATTTTTATTCTTTTTGTTAGGGATTCTTT 
Polyadenylation site 
1901 TCTCTTTTCTTTTTCATTTG 
Notes: 
Nucleotide positions are written in red numerals, amino acids in blue. 
Introns are denoted by lowercase letters with red color. 
Polyadenylation site is underlined. 
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Figure 3.7-2 The nucleotide sequence and the deduced amino acid sequence of 
PhGPA2 
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TTGAGAAATATAATTGCTAAGTATAAGNTTTTATTAAAAGATATATACAA 
CTTTGATAAAATTGAACNTGCTATGAAAGTTTATATCATTGCTAAAAATA 
TTACTAGTAGTGAGTGCTACNGTAGAGCAAAAGCTTTGATCAAATTATTA 
AAATTTGTGAATATAAAAATGATCAGTATTATTATTTATGAAAAAGTAAT 
ATCNGAATATATTCNATATAAATAAAATAAAAAAGTAAAAATGCNAGAGA 
TCTAAATATCAAATTTAACNAAAAATAGAAGATTTAACTAGTAAAGAAGT 
TCAAATTCTTCTAGCTTTATCTGCATCATTTGCATCATTTGCAGCATTTG 
TTGAACAGTCAATTATTCAATTTTATCAAGTTCTTATTACTTGCATTTGC 
TTCATGCTGATGAGCTCTACAACAATGCAGCAATTGTAATATTNTTAGGC 
ATACAAGATTAAGATGTTCTCAACTGTGTGTAATTTAATTTAATTTAATT 
TAATTGAGTGTTGTAGCATTGAGATAATTTGAATTAAAATCTAATAAGCT 
GAGCTCTGGTGATTTTGGTGTTGCACTCACTTGAGAGTTGTGCTCACTTG 
GGAAATACATTAACTAACTAGTTATAGTTAGTTAACTAATAATTAACTAA 
CTTTGGTCATTGTGTTCCGGATATTTCTTCTTGTGACCATTTAAAGAACA 
AAGTCAATGAGTGCAAACGGGATCTGCAAGGGAGCGTTTAGTTCAAAAGC 
AAAGGTCCACGGGCAATAAAATTATTACCAGCGCATGTCCCGTGGCATTT 
GAAAAGTGCGAAGAAAACAACGAGACCCATAACTATATTAAATGCCATTA 
TGCTTTGCAATGAATTCAGgcaagaaaattccatgcatatctatagacaa 
ttcttcatcggacaacacactgaacagaggggaagGACTCGAGCTACGTT 
GCAACGGAACAATTCCCATGTCCCTTCTCTTCTCCTGCAGGCCACACACA 
GAATCTCCCGCTATCGATATCTCATCAACATGCCTGGCACTGTGTGAAAC 
GCATAATATCGGGGCTGGATCTTAAAGATAACCACATGGCAACCAAAAGC 
AAGCCGgtcagcattcttctagcaacatggtcgtatcatcgggtaattca 
agcgtcatacctgtgactggttggtgggtgcttatttatttcttggaagT 
AATTTCGTCGCCCGGCATCCCAGTCGATCACTCGCTAGTCTTGCAACAGT 
TTTCTGGACGAATTCCAGGGCTGGTTTAGCGGGCCGTGAAGCTAATGCAG 
CTAATCCGTTTAACCAATTGTTCCCCGAACTGGCGGTGTTGACGCACTGG 
ATGCCACTGGAAGGTGGCTTGATGGCGAACTTTAACCGTCTGCCATCGAA 
TTATTAACACACAAGgttcggtaattaccatactacataccatgggagca 
ttagttaacactgtttcgcatgattctggtcagCAACCACTTCCTTCACA 
GGGATTTGAAAGATCGAGTCCGAATGTCGGGATGTCGGCGTTCTATAGAG 
AAGATACAGCAGTCGGCGTAGAGAATCATGAGCGAGACAAGAACGTATGC 
GTGGAGGAATGGATATAGGAAAACCGAGATCGATCCTGCAGCAGCACCAC 
AGCCGTAGGTAATAATATGCTCTGATATTGCTCTCTCCTTAGTCTCCGGT 
AGGGGAACATGTCAATTTTCCGTCAGCGGGCCAGCTTCAAGAGTCTAGCT 
GCAACTAAAACATAGCGGAGTCCACTACAGGATTCCTGCGCACTCCATCC 
AACTGGCTTTGACGCTATTGAGGAAAAATAAGTAAATCACTAACAACGAC 
CAGCTCACGCCTTTGCCGGCTGTCATGCTGTACTCATCTTTCCAACAGCA 
GCAGCAGCAGAAGCAACAACAACAACAACACTGTTCCAATTCACTCCTTT 
GTATGCCTTGTTACCTGACTGGGTGTCTGCTCCTCGTTCGCAGGACTCAG 
CCAGATAAGCCAGCCATATGTTTTCCGTTCTCTAAAAAGTTGCTTCAGAT 
GCCTCCTTGACCTCACGCAAACCTCCCTAGCAACCGCATATCCCAATGAT 
TCAGCGGAAAAATAAACTCGTTGATACAAACCGTTAACCGGTCCTAATCG 
ACAGTAGAACTTACATACCTAAATCCAAAAACTCCTCTCACTAATATTTT 
GAACACACCAAAGGCTTCAAACCTTTCTCTCTTCACAACGAGCTCTGATT 
TCCGGTGCCCACTTCGCGCAGAAATACAACAGCACAGAGCAGATTCTAGC 
CCAAACTCTGAGGCATTTAAGAGTTCTCCTTATCTCGGGGTGCTCCGAGC 
CATTTCACCCTCTCGTGTGGTGTTTTTTTATTTTATTTTATATTTTGTTT 
AGAATTTTTTGAGAGTGTCTGAAGCTGTGGGAGGAAGCCTGTTACTGTCG 
CACCGACGGCACAACCGCCAACATAAGAAGCCGTAGCTCTTGTGCCACGC 
TCGGTTTCTGCACCATTGTCGTCCCCGATATCTTCACGCAACCTTATTTG 
CTGTTCCGGTCCGgtatgtggagccatttgtcgacttccccgcttaacta 
tgaggcaaaagttcagaatgatggtctcatctccatgctcatgcgctggt 
tcatgtttaacttgcatgctgattgagttctgatagGAATTGATTGTGCA 
TTTTAGCAGATTCGATTAATTGgtatgtatgctctatgcaagactatatt 
caagttgtcaaatgtttttaacccttcccctttacgtctcatcccctata 
attttgggttctacggcaaccatggaggtctacaatctcatagcgcgggg 
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-150 catggtacaaatttgatatcacttcaaaaccacttttctctcaagccatt 
-100 ctctgggtgatctcggattaagcctgattcttattcattttatcatctca 
-50 actaatgattcattctcacgacaaaaagGTTCCAATTTCATTTCTTAATC 
1 ATGGGTTGCGCAAGTTCTCAACCAGTGGATCCGACGGATAAGATTGCAGC 
M G C A S S Q P V D P T D K I A 
51 TAGACACACAGCTGCGATCGACAAGATGATCCGTATGGACAAGAAGGTTC 
A R H T A A I D K M I R M D K K V 
101 AGGATCGAACGGTGAAGATTCTTTTGCTTGgtacgtcactaaatctaaat 
Q D R T V K I L L L 
151 ctgcaactcgggtaatgatcatcactggaatttacttgttttaatattta 
201 ttcttagGTGCTGGAGAGTCTGGAAAATCAACAATAATTAAACAAATGCG 
G A G E S G K S T I I K Q M 
251 AATTATCCATGCGGGTGGCTTCCCCGAAGACGAACGATACCAAAACCGCG 
R I I H A G G F P E D E R Y Q N R 
301 CGGTCATCTACTCCAACATGGTTGTTGCATTCAAGATTCTCCTCGATATT 
A V I Y S N M V V A F K I L L D I 
351 ATGCAGACGGAAAATATTGAATTTGAGTTTGAAAAGACAAAGgtacgaaa 
M Q T E N I E F E F E K T K 
401 tttcgaccttgattcctgctgctaaataccgacgactctggaggttttgc 
451 ttatataaatgccgtaaagCCACTAGCCAAGCTATTAGACCAGACAGAGC 
P L A K L L D Q T E 
501 CGGACGTGGACACAAACGAAGCTTTTAGTGATCTCGCCGTCAAAGATGCA 
P D V D T N E A F S D L A V K D A 
551 ATGAGTGGAATGTGGCTAGATAGGGGCGTACAGAAAGCTGTTTTACGAGG 
M S G M W L D R G V Q K A V L R 
601 ACACGAATTTGCACTTCATGATAATCTTCAGTAgtacggatttccttttt 
G H E F A L H D N L Q 
651 tttttttttttgatatcatggatatttcgggagatatatcaattgacata 
701 caacacagCTATTTCAAATCTCTCAACCGCGTCTTTACCCCTGGGTGGTT 
Y Y F K S L N R V F T P G W 
751 ACCCAACAATCAAGACATGCTTCATTCCCGACTTCGTACCACAGGCATCA 
L P N N Q D M L H S R L R T T G I 
801 CAGAAACCTTATTTGAATTGGGACAAATAAATTTCCGAATGATGGACGTT 
T E T L F E L G Q I N F R M M D V 
851 GGCGGGCAACGATCGGAGCGTAAGAAGTGGATTCATTGTTTCGAGGGGGT 
G G Q R S E R K K W I H C F E G 
901 GCAGTGTCTTCTATTTATGGTTGCTCTGTCAGGTTATGATCAATGCCTTG 
V Q C L L F M V A L S G Y D Q C L 
951 TTGAGGATCAAAATGCAgtaagttcgaaattcccccccttttaacaaaat 
V E D Q N A 
1001 gtataaataaatggaaaaccttagcatggcttacatataattatgttgtt 
1051 gacagAATCAAATGCATGAAGCCATGATGCTATTCGAATCTCTGGTAAAC 
N Q M H E A M M L F E S L V N 
1101 GGGGAGTGGTTCAAACGGAAACCGGTGATTCTATTTCTCAATAAAATCGA 
G E W F K R K P V I L F L N K I 
1151 CCTCTTCAAGGATAAGGTTTCTATATCCCCAGTGTCTAAATTCTTCCCGG 
D L F K D K V S I S P V S K F F P 
1201 ATTACCATGGCGCAGACGGCGATTATGATGCGGCTGCTAAGTATTTCTCT 
D Y H G A D G D Y D A A A K Y F S 
1251 GACCGATTTCGCGGCATCACCCGCGTCCCTGAACGGGAGATCTACATCCA 
D R F R G I T R V P E R E I Y I 
1301 CTACACAAATGCTACTGATACCACCCTATTAAAGGCCACGATGGATTCAG 
H Y T N A T D T T L L K A T M D S 
1351 TGCAGGACATGATTATCCAGAAGAACCTCAACAACCTGATTCTGTAGGTG 
V Q D M I I Q K N L N N L I L * 
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1401 CCAACAGTGCTAGAAATGAAACTGCAACGGAGCTCCTAGTAGGAGACAAT 
1451 TTATTTTGCCGTGATACCGAATAGAGTCTGCTATTATCACATTAAGTCTG 
Polyadenylation site 
1501 ACACCCCCCTCCACCGCTCCCGGGATTTCTCCACGCACCCTGTCTCATCT 
1551 CCTTTTCGTTTCCTTTTGATGGCTAAGATTTTTTTTCTTTTTTCTTTTTT 
1601 CTCTCTTTTTTTTTTCTATTCTTTTTTTTAATGGCC 
Notes: 
Nucleotide positions are written in red numerals, amino acids in blue. 
Introns are denoted by lowercase letters with red color. 
Polyadenylation site is underlined. 
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Figure 3.7-3 The nucleotide sequence and the deduced amino acid sequence of 
PbGPA3 
-700 TCTCTCTCTCTCTCTCTCTCTCTGTGGCGCTGAACGCTTCCCAATATCCT 
-650 CTACCTTCTCCATCCTCGCCTTCCATTCAGCCTCTTCAACCCACCCTACC 
-600 ATAACCCTGTCCAACTCCACGAACTTCTCCCTCCTGCATTCATCGAAGAA 
-550 TTATCCCGCATCGGGCCGCTTACTTATCAAATCGACAATACCTTATTGCA 
-500 ACCTACTTATTCCCAGGCCAAACTATGTGAGCCACCGTATAACTCCCCAG 
-450 GCCACTCACTGCTTTCTTTGCCGATCTCGGCTTTGTGGTTCATTGTTCCA 
-400 GATATCTCACGATCAACCGTCTATCCATCTGACAATCTAGCCTCCTTGGC 
-350 TTCTCCATATTCCCAGAATCTATCAGAATCTACAAACTACCGTATAATAC 
-300 CTTCTTCGCCTCAGTCGGTCTCCGTTCCGTGGCTTCAGGCCCAGGACGGC 
-250 TGGCTGCCTCGATCTCAAATAATACACACAGTGTCCCTCCCGGTCCCATC 
-200 TCGATTTGATCGCGCCTTTCCATCTATCTGCCCTTGCTACCCGAGATTTT 
-150 GTTTCGAGGTTATAATCAGGCGTGTAGTGCATTCCTAATATCGTCTCCAT 
-100 ACATCCATAGAGGCGCCTTACATCTCTCTCCTGTTGTGTGGTTGGTGTAT 
-50 TAAGGTCATATTGTTCGCCCTGTTAGTAGAAGCATTCGATATCAGATAGG 
1 ATGGGTGGGTGTTGCAGTTCTGCTTCTGGGGAGAATGCAGAGCAGAGGAA 
M G G C C S S A S G E N A E Q R 
51 GAGAAGCCAGATGATTGACAAGGGGCTCGAGGATGATTCAAAACGATTAC 
K R S Q M I D K G L E D D S K R L 
101 GGAGAGAATGCAAGATCCTACTGCTTGgtctgtcattaccgtccttttct 
R R E C K I L L L 
151 tcttcacccccagtcacgggtgcattggccttgccaacttaccaactttg 
201 cactctgttgagtgtctgtgtgtctgttagatgtgtaaacagtggatatg 
251 ttctgacggtcattacagGTTCGGGTGAGAGCGGAAAATCGACGATCGTA 
G S G E S G K S T I V 
301 AAGCAGATGAAAATTATCCATCAGAACGGATATTCTGTCGAAGAACTTAC 
K Q M K I I H Q N G Y S V E E L 
351 CTTGTGCCGTTCAACAGTCTACAAAAATCTCTTGGATTGCGCCAAGGACC 
T L C R S T V Y K N L L D C A K D 
401 TGATAGGAGCTTTACATCATTTCGACTTACAGCCATCCAGTCCCAAAGTT 
L I G A L H H F D L Q P S S P K V 
451 CAAGATTATATAGAGTATCTTAGTTCATACCAGATTGACGCGGACCCGAA 
Q D Y I E Y L S S Y Q I D A D P 
501 TACGCCAATAGATCCGAAAGTGGGTGATGCCGTGACATATCTCTGGAATG 
N T P I D P K V G D A V T Y L W N 
551 ATCCTATCATGCCATCCGTGCTCGAACATCAGAACGAGTTCTACCTCATG 
D P I M P S V L E H Q N E F Y L M 
601 GATTCAGCACCTTAgtatgccctcccccttttcactggagtctttgcttt 
D S A P 
651 gcgatgttctaatcattctcagCTTCTTCGAGGAAGCCAAACGTATTACC 
Y F F E E A K R I T 
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701 GCACCCGACTACATACCTAATGAAGCCGATGTGTTGCGCGCTAGAACAAA 
A P D Y I P N E A D V L R A R T 
751 GACAACTGGTATATATGAAACGAGATTCACAATGGGCCAATTGAGTATTC 
K T T G I Y E T R F T M G Q L S I 
801 Agtgcgtttaaatatatcacccctactttgccggaacatgaccctaatat 
851 gtatatcttttagCATGTTCGATGTTGGCGGGCAGCGGAGTGAACGGAAA 
H M F D V G G Q R S E R K 
901 AAGTGGATTCACTGCTTTGAAAACGTAACCTCCATAATATTCTGCGTCGC 
K W I H C F E N V T S I I F C V 
951 ATTGAGCGAGTATGATCAAATGTTACTAGAAGAAAGTAATCAAgtatgcg 
A L S E Y D Q M L L E E S N Q 
1001 atgaccctcatttcctcgcgttacctctattgcgttgtttactgggtcta 
1051 accttgacgaaagAACCGCATGATGGAGAGTTTAGTGCTGTTTGATTCCG 
N R M M E S L V L F D S 
1101 TTGTCAATTCCCGATGGTTTATGCGGACGAGTATAATTCTCTTCTTAAAT 
V V N S R W F M R T S I I L F L N 
1151 AAGGTCGACCTCTTCCGGCAAAAACTCGACCGGTCCCCATTGAATAAATA 
K V D L F R Q K L D R S P L N K 
1201 CTTTCCCGATTACTCTGGAGGAAACGACGTCAACCGTGCCGCCAAGTACT 
Y F P D Y S G G N D V N R A A K Y 
1251 TGCTCTGGAGATTTAACCAAGTTAACCGGGCGCATTTGAATCTTTATCCT 
L L W R F N Q V N R A H L N L Y P 
1301 CAgtatgtataggaaaagcacaccttaattacttcttcctttgttttcaa 
1351 aaagcccttgtcctgtacctaacctccccgctgcggcagCCTTACTCAAG 
H L T Q 
1401 CCACCGACACGTCGAATATTCGCCTCGTCTTCGCAGCCGTGAAGGAAACC 
A T D T S N I R L V F A A V K E T 
1451 ATTTTACAGAACGCCCTGAAAGATTCTGGTATTTTGTGAAAGGGAGAAAA 
I L Q N A L K D S G I L * 
1501 CGAAGAAAACAAAGCAAAAAGGAAAACAAATACACCACGAATTGTCGGAA 
1551 TTTTTTGTTCCACCTTGATATTTTTTTTTTGGAAGGCTGCGGGGGTCGTC 
1601 TTAGCCATCGAGAGCGAATATTCTATACCCCGCCGTTCCGNACCGCATTT 
1651 CCGTTTCCGCCGCAAATTATTACTTACTTGCAAATTCTTCACCGGTTTGA 
1701 CTTACGATGACGACACCATTACCCACTACCCACCACCGTCTACAAAAAAA 
1751 ACGCCATAATAATGTCTTTACCCCTCTACATGCTTTTCAAACTTGTGCTT 
1801 CATCAAGTGCCCGGTGCTTCTCTCTGTATACAGCCAGCNACGCTTTTAAA 
1851 CGCCAACTTTTGGATACCAGCCCGGGCCGGAA 
Notes: 
Nucleotide positions are written in red numerals, amino acids in blue. 
Introns are denoted by lowercase letters with red celom. 
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Figure 3.7-4 Comparative alignment ofPbGpal, 2 and 3. Protein sequences of 
PbGpal , 2 and 3 are aligned by using VectorNTI (Informax). Positions where 
introns are spliced are indicated with black vertical bars. PbGpal, 2 and 3 have 
intom-splicing sites at the same positions as indicated by the yellow triangle. 
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Figure 3.7-5. The phylogenetic relationship between fungal Ga-proteins. A 
neighbour-joining bootstrap tree is derived from the amino acid sequences of all the 
fungal Ga-proteins using the VectorNTI 6.0 align program. The GenBank accession 
numbers of the Ga-proteins are indicated following the abbreviated name of the 
protein. The abbreviations are as follows: Ph, P. brasiliensis; Af, Aspergillus 
fumigatus,· An, A. nidulans; Bf, Botryotinia fuckeliana; Ca, Candida albicans; Cc, 
Coprinellus congregatus; Ch, Cochliobolus heterostrophus; Cn, Cryptococcus 
neoformans; Cp, Cryphonectria parasitica; Ct. Colletotrichum trifolii; Fo, Fusarium 
oxysporum; Gz, Gilbberella zeae; Kl, Kluyveromyces lactis; Mg, Magnaporthe 
grisea; Nc, Neurospora crassa; Oy, Oculimacula yallundae; Pa, Podospora 
anserine; Pm, Penicillium marneffei; Rn, Rosellinia necatrix; Sc, S. cerevisiae; Sp, S. 
pombe; Ss, Sporothrix schenckii; Ta, Trichoderma atroviride; Uh, Ustilago hordei; 
and Urn, Ustilago maydis. 
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3.8 Cloning of a G Protein p Subunit Gene PbGPBJ from PbOJ 
A G protein ~ subunit gene PbGPBJ has been cloned using a degenerate PCR 
approach. Two degenerate primers, PbGPB-F 1 and PbGPB-R 1, corresponding to 
conserved amino acid residues AKIY AMHW and WVMTCA Y A, were used to 
amplify a 153 bp fragment from PbOJ genomic DNA. The fragment was sequenced 
and specific primers were designed. Fragments upstream and downstream of the 
gene were amplified from both our genomic walker library and pDNR-PbOlcDNA 
library. The cloning of PbGPBI was later finished by Dr G. Chen in our lab. 
Figure 3.8-1 illustrates the genomic DNA, eDNA and the deduced amino acid 
sequence of PbGPBI. The coding sequence of PbGPBJ is 1,059 bp long and is 
interrupted by 4 introns. The gene encodes a protein of 353 amino acid residues with 
a molecular weight of 39 kDa and predicted pi of 6.8. 
G protein ~ subunits are highly conserved from humans to fungi (Figure 3.8-2 and 
Figure 3.8-3). When analysed with EMBL's SMART, G protein~ subunits contain a 
conserved coiled-coil domain (SpGit5 is an exception that lacks this domain) and 7 
conserved WD40 domains as illustrated in Figure 3.8-2. Phylogenetic analysis 
indicates that PbGpb 1 is closely related to AnSfaD (Figure 3.8-3). Interestingly, the 
distance between PbGpb1 and the G ~subunits of S. cerevisiae (Ste4) and S. pombe 
(Git5) is further than the distance between PbGpb 1 and the G ~ subunits of humans 
(e.g. Gnb1, Bnb2, Gnb4 and Gnb3). The percentage of identity to PbGpb1 is as 
follows: 
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Protein: organism %identity to PbGpbl 
AnSfaD: A. nidulans 93% 
CpCpgb 1: Cryphonectria parasitica 83% 
MgMgb 1: Magnaporthe grisea 81% 
NcGnb 1: Neurospora crass a 81% 
UmBpp 1: Ustilago maydis 72% 
CnGpb 1: Cryptococcus neoformans 70% 
HumanGnb 1: Homo sapiens 66% 
HumanBnb 1: Homo sapiens 64% 
HumanGnb4: Homo sapiens 63% 
HumanGnb3: Homo sapiens 62% 
Ste4: S. cerevisiae 35% 
Git5: S. pombe 37% 
!50 
Figure 3.8-1. The nucleotide sequence and deduced amino acid sequence of 
PbGPBJ. Nucleotide positions are written in red numerals, amino acids in blue. 
Introns are denoted by lowercase letters with red colour. 
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GCACTTTGACGTTGCAGGATGTTCCAAAATAAAGAATTAACTATCCATAG 
GGAGGCAAGTTGGGTAGGTGCCTGCGTTGGAAAAGAAATCTCATGTCGAC 
TCATTGTATTTGCTTATTGACCCATATATCGATAACTATTGCACCTCCGA 
AAAAGCCGAGGAAATCGGTAACTTGTCAACATGTCAAAAACTATTTTGGT 
GGAGCATAGACACGGGATAGTTACTAATAGAAATGTTGTTTTATGAATAG 
GCAAGGCACTGATGCTTCGTCATTGAGAACTGACAATTTCCCGAAATCCC 
AGCAAACTCCAATGACCCAGCTCCATTGGTTTTTTTTTTTTTTTTTTTTT 
GGTGGCCCCTTCTGGAAACCGTCTCCAGAATGCTGGTGTCGAGGAAGTCC 
GTCCCCAAATGATTTGACAATTGCGTCTGGCTAGGTCCTGCCAAGGCGCC 
TGAAGAAGTCTTCCATGGAAGTTTTTTGCTTTCCACAAACACCCTGGCGA 
CTCTTAGGCAAGCTGGTGTTTCTGACGTGCCAATAGGACAGTAAGTAATA 
ATAAAGGGTGTTCCAATCATCTACAACCCTATGTTTGCTGACACCGAGCA 
CTGAGCACTGAGCAGTCGAAGGAACGGGAGGAAAGAAACTCAAAAATTGT 
AACAAAAAGGAGAATAGATAACCGTGTCAGTCCTCAAATAAGACGGGTGG 
TTGGAATATTTCCTGGTGTAGCCTTCTGTATCAATCGCTTTTCAGCCACA 
GCAGGGCAGATGCATGAACGCTGTTAATATTCAGACATAGGAAAAAAACT 
TTGTATTTAACTTATCGGTGTCATTCCCTTGGTTTGTCAGCAGCGGATAT 
TTGTGGAGTAGAATACCGGGGATTAAATACAGCAGATATACCGACAGATT 
ATGGGCACAATACAACCCAAGTACATCCACGGGATATAGTGTATGGATAG 
ATACAGTTCTGTAGGCAAACGCACTCTGTACCGTGAGTGTAATATTACTT 
ACCCTAGGTACCGCCCAAACCAGTTCCAAACCAGCACAACCACTGTCTTC 
ATCAGCCTCAACCCTTGAACCTCATCCTCATCTTCATCTGCTCCTCTCAC 
TCACTCACCCTAATTTACCCAAACGCCTCACACATCCCCAGACTGGAATT 
TCTCCTATCCCTCTCCTCTCTTCAATCTTAGTTGCCCCCTCGATTCTGCC 
TGCTGCTGGTCATCGTGGATTGCTTGCTCCCCAGTCCTCTCCTCTCACCC 
TGCTGCCAGCCATCCCTGAGCATATCCAGTGGTTGGTGTGGCCATTTGCC 
CTGTCTGTGCTGTGGTAGAGGGGACGACTCTTCTGTTTACTATATTCAAA 
GATCTGTCACCTTCGCATCTGGTGCTTCCACCACTGCAACTGCTGGAGTC 
CCAAGTTCTCCACTCTATCTCATTAACCATTATTCCAGCCAACCACCCTC 
TCTGCCTCCTGTCCCAGGGCCCCCAATAATAGTGCTATTGGTGCAATCCC 
AGCTAGGTCGCTTTCTAGTTCCCACATCATTTCTCCCAACCACAACCACA 
ACGGTTACCACAACCCTCCACTGCCTCCTCCCCCGATCGACCATTCGCCA 
AATTTTGCTCTCCGTTAAACTACCACCCTTCTTCCTATCCATCCTCTTCC 
CATCCAGTTGACCACCCTCTCTCTATTCTTTGTGGTCTCGTTAATCTACC 
ATGGCGGCCGATTTGAGCGGCGAGCAAATGCAGGCGAAGATCACCGCTGC 
M A A D L S G E Q M Q A K I T A 
CCGTCGTGAGGCAGAGGGTCTAAAGGATCGCATCAAGCGCAGGAAAGATG 
A R R E A E G L K D R I K R R K D 
AGCTTGCGGATACCTCTCgtaaggactgctgtctcttttactcttcaccc 
E L A D T S 
catctccacatatgttatcacccaccatggcatctatgaactcctctgaa 
tctctctttacacaactctcgtccattgaacccagccaagtcataagagt 
tttctcactcgttggggctttctcgcacatgtccaccagtcattggctct 
atccccatcccgaggttaaacccaggccattggttaattaatactgacat 
aacataccttcctcatagTTCGCCAAGTCGCACAGAACAATACGGACCCC 
L R Q V A Q N N T D P 
CTTCCACGAATTGGAATGAGACCGCGACGGAACTTAAAGGGCCACTTGGC 
L P R I G M R P R R N L K G H L 
CAAGATCTATGCGATGCACTGGTCGACAGACCGCCGCCATCTGGTTTCTG 
A K I Y A M H W S T D R R H L V S 
CCTCTCAAGACGGGAAACTAATCATCTGGGATGCATACACAACAAACAAA 
A S Q D G K L I I W D A Y T T N K 
GTGCACGCCATCCCCCTAAGATCGTCATGGGTGATGACTTGCGCCTATGC 
V H A I P L R S S W V M T C A Y 
151 
601 CCCGAGCGGTAACTATGTCGCCTGTGGTGGTCTAGACAACATCTGTTCCA 
117 A P S G N Y V A C G G L D N I C S 
651 TCTATAATCTTTCCTCTCGAGAAGGTCCAACCCGTGTCGCACGAGAATTG 
134 I Y N L S S R E G P T R V A R E L 
701 TCCGGCCACACCGGTTACCTGTCATGTTGTCGTTTCGTAAATGACCGTCG 
151 S G H T G Y L S C C R F V N D R 
751 AATCATCACTTCTTCCGGCGACATGACCTGTATGCTATGGGATATCGAAT 
167 R I I T S S G D M T C M L W D I E 
801 CGGGGTCGAAAGTCACTGAATTCGCCGATCATCTGGGTGATGTTATGAGC 
184 S G S K V T E F A D H L G D V M S 
851 ATCAGCATAAACCCGACAAACAACAACGTTTTCGTCTCCGGCGCATGCGA 
201 I S I N P T N N N V F V S G A C 
901 TGCCTTTGCTAAACTCTGGGATATCCGCGCTGGGAAGTCGGTACAAACAT 
217 D A F A K L W D I R A G K S V Q T 
951 TCTCCGGTCATGAATCGGATATCAATGCCATCCAGTTCTTCCCTGATGGC 
234 F S G H E S D I N A I Q F F P D G 
1001 AATGCTTTTGGTACCGGATCGGACGACACCACCTGCCGTCTATTCGATAT 
251 N A F G T G S D D T T C R L F D 
1051 CCGCGCGGATAGAGAACTTAATACATACCAGgtaatattattaattcaaa 
267 I R A D R E L N T Y Q 
1101 cgcctcatgacttaaattgtcaacataaaagttcgttggataactgacat 
1151 gatcttttatattatacgcagAGTGATCAAGTACTTTGCGGTATTACTTC 
278 S D Q V L C G I T 
1201 CGTTGCGTTCTCAGTCTCTGGTCGACTTTTGTTTGCTGGCTACGATGATT 
287 S V A F S V S G R L L F A G Y D D 
1251 ATGAGTGCAAGgtaagtcaacctatttatttgctatcccttttgtgcgaa 
304 Y E C K 
1301 ccaaactaattaatacgtaatcttttcaagGTCTGGGACGTTCTAAGAGG 
308 V W D V L R 
1351 AGAGAAGGTCGGTTCACTGAGTGGCCATGAAAATCGTGTCAGCTGCCTGG 
314 G E K V G S L S G H E N R V S C L 
1401 GCGTCAGCAACGATGGAATCAGCTTGTGCACAGGATCTTGGGATTCTCTG 
331 G V S N D G I S L C T G S W D S L 
1451 gtgagcgttcaatgattagttcaattctacagtgaagttccccttgctga 
1501 tatatggtttttttccaatcttcagCTCAAGGTCTGGGCATGGTAGACTT 
348 L K V W A W * 
1551 GGTTTTGGCCAAATTATCGATCGTTGATGGTGGAACTGAACGAACACCCC 
1601 ACACCACCCGCCTTCAATTTTGCAGTTCTCGTACCACACACCCTCCCTCC 
1651 CTCCCATCGACAAGGAAGTTTTTTCGCCTACAACATTCATATTCCGTATA 
1701 TCCGTTTCTCTCCCACACAAACACCATGATATCCTCGAGGAACTGTGCCA 
1751 TCTACAGGACAGGCATATATAATTGCAAGCATGCTTCTCAAAAATTTAAC 
1801 TACAGGGGGACGGACTCGAGCTTCTCGTCTCTTTCTCACAACAGCCTTCT 
1851 TACACTCGTAAGGCGACACAGAATAACATCAAACCTATGATGACATGAAG 
1901 GAAACAAACCTTGTTCCTTAATCCTCGCCATCCCTGCACACCTCTCTGAC 
1951 ACTATAACCCCCTTCTTTTGTCCCTTAAGTGTCTTAATTAGTGTCTTAAT 
2001 TTTCGGAACTAGAAGAAGATGAAAAGAGAGGAGTCAAGATCCTACCTTTT 
2051 ACTTTCTGCTCACAAAAAGCTCACGAAACGAAAAGAAAGACACTAGGAGG 
2101 AATAAAAAATTGAGACTCTTGAGCTGCGAGATATCATTTGGATAATAATC 
2151 TTTTTGATGGGATTTTCCTTCATTTTTTGTTCTTCACTTCAGTATATCCA 
2201 AGTACCTAATTTCTGGTTGCCACTTTTCCAGCTTTTGTTGATGTTTTCTG 
2251 TCTTTTTAAATGGCTCTCTGTTCTCCCCCTTACTGTTTACCTACACATAC 
2301 ACCGTTTTACTTTTCTTTATGGNGCTGGTTTCCTTATTTTCCTCCCGTTA 
2351 ATTTTTTATACCTCGGGCTTGGAAAGGATTGTGAGCCTTTATTATTTTCC 
2401 TTATAGTCTTTTGCTCCGTTGTTTTAAACCCCCATTATCAGGCTATAAGT 
2451 TTCTTCATTTTTCTTCCCTACTTTCTTTGCTGCCGGGTTTCTCTCTCTCT 
2501 TTCTCTCTCAAAAATTCTTTTTGGGGATTTCTTCGTCGTTTCTTCCTTGT 
2551 TTGATTCCTACATTCCGAATTGCCTAGGTGTGTATTACCTTTTTCCCCCT 
2601 TTTCTTTCTTTCTCTATAGCCATTGGTCCTCATGTACTCCTGATATTTCC 
2651 TCCTAGGTCCTGTTCTTAACCCCACGTTCTATTTTCCATTATGTTTTCCT 
2701 TATCTCC 
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Figure 3.8-2. Comparative alignment of PbGpbl with a G protein p subunit of 
human being and the Ste4 protein of S. cerevisiae. 
The alignment was done with the software Vector NTI 6.0 (informax). 
G protein ~ subunit is conserved among different organisms. Its characteristic is the 
7 WD40 repeats which form a circular beta-propeller structure with 7 blades. The 
repeating units serve as a rigid scaffold for protein interactions. The specificity of 
the proteins is determined by the residues outside the repeat structure. 
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Figure 3.8-3. Phylogenetic analysis of fungal and human G protein ll subunits. 
The tree was generated with the programme Vector NTI 6.0 (Informax). GenBank 
protein accession number was given after the protein name. The abbreviations are: 
Pb, P. brasiliensis; An, A. nidulans; Cn, Cryptococcus neoformans; Cp, 
Cryphonectria parasitica; Human, Homo sapiens; Mg, Magnaporthe grisea; Nc, 
Neurospora crassa; Sc, S. cerevisiae; Sp, S. pombe; and Urn, Ustilago maydis. 
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AnSfaD-AAC33436 
---[===~Um8pp1-AAN33051 
I CnGpb1-AAD03596 
HumanGnb1-NP _002065 
.----HumanBnb2-AAH 12348 
.__--HumanGnb4-NP _067642 
'-----HumanGnb3-AAM15920 
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3.9 Cloning a cAMP-Dependent Protein Kinase Catalytic Subunit Gene PbTPKl 
and a cAMP-Dependent Protein Kinase-Like Gene PbTPKLJ from PbOJ 
The strategy for cloning of PbTPKI was PCR amplifications walking on both 
genomic DNA and eDNA (Figure 3.9-1). Primers were designed on the basis of the 
immediate sequencing results. Initially, 2 degenerate primers, PbTPK-Fl and 
PbTPK-Rl, were designed that corresponded to conserved amino acid residues 
HPF(IL)IRMWG and DFGFAK(YE)V, respectively. A single fragment, namely 
gPbTPK-FlRl, was obtained. The fragment was sequenced and 2 specific primers, 
PbTPK-F40 and PbTPK-R5, were designed. Using PbTPK-F40 and the anchor 
primer M13Rl, a downstream eDNA fragment, named cPbTPK-F40M13Rl, was 
amplified by SSP-PCR from our pDNR-PbOlcDNA library. The cPbTPK-
F40M13Rl eDNA fragment contains a poly(A) tail, indicative of the end of the 
eDNA. An upstream eDNA fragment, cPbTPK-R5M13Fl, was amplified in the 
same way, by using PbTPK-R5 and the anchor primer M13Fl. Further upstream 
amplification of eDNA, using SMART RACE RT-PCR, was unsuccessful. Based on 
the sequence of cPbTPK-R5M13Fl, primers PbTPK1-R8, PbTPKl-RlO, PbTPK1-
F7 and PbTPK1-F8 were designed and used to amplify 2 genomic DNA fragments, 
namely gPbTPK1-RlOAP3 and gPbTPK1-F7AP4, from our PbOI GenomeWalker 
library. A genomic fragment, gPbTPK-F6Rll connecting gPbTPK-RlOAP3 and 
gPbTPK-F7AP4, was amplified with primer PbTPK1-F6 and PbTPKl-Rll. Primers 
PbTPK-R13 and PbTPK-R14 were synthesized based on the sequence of gPbTPK-
RlOAP3 for further upstream genomic walking. A fragment, gPbTPK1-R14AP3, 
was amplified from our GenomeWalker library by SSP-PCR using the anchor 
primers AP3 and AP4. 
!55 
In order to search for additional iso-forms of PbTPK genes, another 4 degenerate 
primers were synthesize; namely TPK-DFl, TPK-DF2, TPK-DRl and TPK-DR2, 
corresponding to amino acid residues GTGSFGRVH, QVEHTNDE, YRDLKPEN 
and DVKSHPWF, respectively. Eight fragments were amplified from both genomic 
DNA and eDNA by different combinations of forward and reverse degenerate 
pnmers. Sequencing results indicated that all these fragments have the same 
sequence as PbTPKJ. 
In order to check if there is a TPK-like gene in P. brasiliensis, 5 degenerate primers 
were designed based on the sequences of TPK-like proteins from Aspergillus 
nidulans and Candida albicans. These were 3 forward primers TPKL-DFl, TPKL-
DF2 and TPKL-DF3, corresponding to amino acid sequence PYVVC(VS)FE, 
SE(IL)D(VI)SVYD, (ED)AFLGHVR respectively; and 2 reverse primers TPKL-
DRl and TPK-DRl, corresponding to amino acid sequence TKMVDFWS and 
YRDLKPEN. Single band amplifications were obtained from both genomic DNA 
and eDNA by degenerate PCR with different combinations of forward and reverse 
primers. Sequencing of these fragments indicated that they have the same DNA 
sequence. The deduced amino acid sequence is highly conserved with that of Tpk-
like proteins from Aspergillus nidulans (AnSchA, GenBank accession number 
AAK71879; Fillinger et al, 2002) and Candida albicans (CaSch9, GenBank 
accession number EAL02261). The gene was thus named PbTPKLJ, which is 
illustrated in Figure 3.9-2. 
The nucleotide and the deduced amino acid sequence of PbTPKJ are illustrated in 
Figure 3.9-3. The 5' end ofthe eDNA was not cloned (Figure 3.9-1). Its sequence 
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was deduced from the sequence of genomic DNA. The start codon A TG was 
determined by finding a read-through in the genomic DNA ahead of the cloned 
eDNA. Interestingly, the deduced start codon ATG does not meet the requirement of 
a Kozak sequence "ANNATGG" (Kozak, 1987; and Kozak, 1991). However, only 1 
Kozak sequence is found in the upstream genomic DNA sequence (-2306-2300 in 
Figure 3.9-3). If this ATG were used as the start of translation, the eDNA of 
PbTPKJ would be too long to be possible. PCR or a RT-PCR needs to be done to 
confirm the start of translation. The coding sequence of PbTPKJ, which is 
interrupted by 3 introns, is 1,749 bp in length and encodes a protein of 583 amino 
acids with a molecular weight of 65 kDa and predicted pi of 8.4. 
A phylogenetic analysis of fungal cAMP-dependent protein kinases and cAMP-
dependent protein kinase-like proteins indicated that PbTpk1 is closely related to 
AnPkaA, NcPkaA, and MgCpkA; while the 3 cAMP-dependent protein kinases from 
S. cerevisiea and 2 from C. albicans constitute another related group (Figure 3.9-4). 
Figure 3.9-4 also shows that cAMP-dependent protein kinase-like proteins from P. 
brasiliensis, A. nidulans, C. albicans, S. cerevisiae and S. pombe form another group 
distantly related to fungal cAMP-dependent protein kinases. Interestingly, the 
second PKA catalytic subunits of A. nidulans, N crassa and M. grisea form another 
group which locates between their first PKA catalytic subunit group and the kinase-
like protein group (Figure 3.9-4). Proteins related to PbTpk1 are displayed as 
follows: 
157 
Protein: organism % identity to PbTpkl 
AnPkaA: A. nidulans 54% 
NcPkaA: N crassa 54% 
MgCpkA: M. grisea 52% 
ScTpk2: S. cerevisiae 43% 
ScTpk3: S. cerevisiae 39% 
ScTpkl: S. cerevisiae 39% 
CaTpk3: C. albicans 40% 
CaTpk2: C. albicans 42% 
CnPka 1: C. neoformans 42% 
SpPka 1: S. pombe 38% 
UmUkal: U. maydis 28% 
AnPkaB: A. nidulans 29% 
NcPkaB: N crassa 26% 
MgPkaB: M grise a 27% 
ScSch9: S.cerevisiae (kinase-like protein) 19% 
CaSch9: C. albicans (kinase-like protein) 19% 
AnSchA: A. nidulans (kinase-like protein) 15% 
158 
(1 
0 
:::3 s· 
(JQ 
'""0 
a () 
(1) g. 
d 
s· 
(1 
::::r-
'"1 
0 
:::3 
-· () (D 
0 
'"1 
0.. 
(1) 
'"1 
·.! 
intron 1 intron 2 intron 3 
gPbTPK-FlRl 
cPhTPK-F40M13R 1 ~! 1\ :A 
: 1 : : PolyA 
' cPhTPK-R5M13F~ 1\l 
I 
gPbTPKl-RlOAP3 
gPbTPKl-Rl4AP3 gPbTPKl-F6Rll 
Figure 3.9-1. Cloning of PbTPKI 
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Figure 3.9-2. The nucleotide and deduced amino acid sequence of PbTPKLJ. 
Nucleotide positions are written in red numerals, amino acids in blue. Introns are 
denoted by lowercase letters with red colour. 
1 CTCAAACTGAGGAGCCAATCGAATTCGAACTCGAGAATGGAACAAATGAG 
1 Q T E E P I E F E L E N G T N E 
51 ACGCTATCATCTGTACCGATCCAACGATCCAACAGTGACTCAGGTCGCCC 
17 T L S S V P I Q R S N S D S G R 
101 CATGGCTATCCCAATGAAAAGTCGACAAAGTAGTAACAACAGCATGTTGG 
33 P M A I P M K S R Q S S N N S M L 
151 ATAGTCATGGCCATAAGGGGCTAAGTGAGGTTACAGATCCATTGTGGAAT 
50 D S H G H K G L S E V T D P L W N 
201 CATGAAGCCGTTTTgtgcgttttgcttcttttcttttctactcattatcc 
67 H E A V 
251 tttaattattggcaaagcctatgcgcgtccttatcttactgaccttatta 
301 cttctagTGATGTCCTTGGGGATGAATCTGAAATTGAAGTTTCGGTATAC 
71 F D V L G D E S E I E V S V Y 
351 GATCGATCGAACCACGAAGCGTTCTTGGGTCATGTAAAGTTGCGTGTCAG 
86 D R S N H E A F L G H V K L R V 
401 TTTTAAGGAAGATAATAAATCAATAGCAGGATGGTATCCTCTAGTGGTTC 
102 S F K E D N K S I A G W Y P L V V 
451 GTGATCGGGGTGATGGCTATGTGTCGGGAGAGATACATCTAGAAATGAGC 
119 R D R G D G Y V S G E I H L E M S 
501 TTTCAGAAAACAGACAAGAAGCAGTTTGGACCAAATGATTTCCAAATCCT 
136 F Q K T D K K Q F G P N D F Q I 
551 TAAGCTCATAGGGAAGGGAACGTTTGGGCAAGTCTATCAAGTGAGGAAAA 
152 L K L I G K G T F G Q V Y Q V R K 
601 AGGACACCCAGAGAATCTACGCGATGAAAGTCCTTTCCAAAAAGGTGATC 
169 K D T Q R I Y A M K V L S K K V I 
651 ATTCAGAAAAAAGAAGTTGCCCATACACTTGGCGAAAGGAACATCCTGGT 
176 I Q K K E V A H T L G E R N I L 
701 CCGGACTGCTATGACGAATTCTCCTTTCATAGTTGGTCTCAAATTTTCTT 
202 V R T A M T N S P F I V G L K F S 
751 TTCAAACACCCACAGATTTGTACCTTGTCACAGACTACATGTCTGGAGGG 
218 F Q T P T D L Y L V T D Y M S G G 
801 GAGCTGTTCTGGCATCTGCAAAAAGAAGGGAGATTTCAGGAAGCTAGAGC 
236 E L F W H L Q K E G R F Q E A R 
851 GAAGTTTTACATCGCTGAGTTGATACTAGCTTTGCAGCATCTACACGAAC 
252 A K F Y I A E L I L A L Q H L H E 
901 ATGACATCGTGTATCGGGACCTCAAGCCAGAAAACATCCTACTTGATGCA 
279 H D I V Y R D L K P E N I L L D A 
951 AATGGTCACATTGCGCTCTGCGATTTTGGTCTATCCAAGGCAAAC 
286 N G H I A L C D F G L S K A N 
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Figure 3.9-3. The nucleotide and deduced amino acid sequence of PbTPKJ. 
Nucleotide positions are written in red numerals, amino acids in blue. Introns are 
denoted by lowercase letters with red colour. Polyadenylation site are underlined. 
The start codon does not include the Kozak sequence. 
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CAATCCTGGCATACCAAATAGAGAGCAAAAGGCACTAGAAATTGGGGCTG 
TGGGACAAGCTGCAGGACCAGCAGCTTTCCAAAACTGGCTTCAGAAAGCT 
GTATCCCCCCTCAATCTCATCACATATACTGATGGCTCCAAAGACAGTCA 
AGGAGTTTCAGGCGGAGGCTACTGTCTATACTGAGGAACAAATCAATCTC 
TGGAGCTTGGTAAGCTGCCTCTGGGCCACACTGCTGAGGTCTTTGATGCT 
GAAGTGCTTGCAGCAGTTGCCAGTCTTGAGGCAGTGCTACGGAATCCCTT 
CTCTATGTTCACACAGCACATTATAGTGGCTCTAGACAATGAAGAGGCTG 
CAATAAGACTCCACACAGACATGCCCACACGAACATCTTTTCTCACCTTT 
GCTAAGTTCAATGAACTCCACAGGTCCTGGACAAAACAGGGCCCAGGTCC 
AGCCAGCCTGAGACGGGTCTATGTTCGATGGTGCCCCAGCCATGCTGGGA 
TTCCAGGCAATGATGCTGCAGATGCTGCGGCCAAGTCAGCCTGCACAATG 
GAATGCACTCACCGCACTCTGACCCTGGCACGGGCCAAATCCTATGCTAA 
AGAACACTTCAATGCCTCACTGCAACAATACTGGAGCTCCAATAGCACAT 
CACGATACAAGGACCTCAATATCCCAATGCCAAAAGGACCCTCCCCTGAG 
CTCACTCTCCCCTGAAGGAACCTAGGCCACTTGCTGGCAGCTAGAACAGG 
CCACAGTGACTTTGCAGCCTATCATCACAGATGGGCACATGACAATGCAC 
TCCTCACCTGCTCTTGCGGCCGAGATAAGACCCCCGAGCACTTCTTCTTT 
TGCTGGAAAGGCTGGAACATTGAATGAATTAAAACCCCTGAAGCATGCTG 
AGGACCAAAGGAAGCAATTGACTGGCTTCTCAGCACAGTAAGAGGAGCTA 
TGGCCTTCTCTACCTGGTGCACTAATACCCGCTTCTTCATCAACATCCAA 
CGCTGCTACTAGAACCTGTTCAACATCCGACTTCTCCCTCCCCCTCTCTC 
TTTCCTATGTTCCTTATATACATTTCTCATCACCCCTACACACCACCCTA 
GAAGCCCTTGGCTTCCTCAGTCCCGTAATCTTCGGCTACTACGCCATTCA 
GAACCTCCAGGACAGGGGCTACTCTGTACATAGACTCTCAAGAGGGCTTC 
GGCCGACTAGACATGTCAGGCAGCAGACTAGCTGCTGCGCTGGCACGCCT 
GATACCCTTAGGGAGGTGCTGTGGCCGCGACGGCAGACTATTCTTAGTCA 
GCTGATCACGTGCCTCCAGGCGTTAAATAAGTAATAATAATAATAATAAT 
AATAACTGGCTTATGCCCTAACTCGTCAGCCTGGTTAATGCCACTAAACA 
ATCGGACTATTCTTTTTCCACCTGATAACTAAAATACATCCATAATACTT 
CCACCGTTCATCTCTTCTTCCCTTAACTTCCCTAACTTCCCTCCCTTCTC 
TCTCTACTCTCTTTTCTCTATTTTCTCTAATAACGAATTCGGGCGTGTTA 
TGTAGGCAGTGCTAGAGCTGTATTCGGCAACGTGCCCATTCCAATAAGAA 
AGATCATTATCACTTTTTACTCCTTCAAGCATGAGTAGAAGACCAGGAGC 
TTATCGGTAAAAACGACCTTCGCGCTGAGTGTCTGCAGGTTCAATTCCAT 
TCTACAGATGCCATACAACCCCCCAAAGCATAGTTAAGTCCTGTACGCAG 
GTCGTCAAAAGCCAGATATCCGGAATTCTTCTTCATTAATCTCTGTCCAA 
CAGCTCCCTGCAGAGCTCCTGCTGCCAATCCACAAGTCTCTCATGGTGCA 
GGTGAATAAATTCAACCAACTACTGTCTTCTGAAATAACCATATATCTAT 
ATAATCTATTCTAGCTAGTTATATTTTTAATGGTTTAACACATAATACGA 
AAATATTATTGCGTTGCTGAGATGCCATTGAAAATATCCAGAGCTGGTAG 
ACGAATTCATTGCGTAATAGAGTTTGTTGGGCAGCTGGATTAACTAACGT 
TGCTATATATAGGTCAGAACAAAAAGCATAGTGATGCATATAACCCATCT 
CTCTATCAATGTCTTCCTCTCGGTTAAAGAGTGCTGATACTAGGGCGAGA 
TATTGTTCATAGGTTATGATGTAAGTTCGGGGTCCCTCTGTTCTGGGCGG 
GACCACATACTCCGAGCAGGCACCTCATCCATAGTTATCTAATTCCCTTG 
TTATAACTAACTATCTAGTGGCGTCGGGCCTCAGCATCATCGACGTCTGC 
TTACTACAACGTCCCATTACTACCTCAACTACGGCCGTCATCTATTCCGA 
ACGAGAGTACCAACAAACGTCAATCTTTGTCAAGTATTATAATTGCTCCC 
CAGGCACCAGAATCAACGAATCAACCCCTCTACCATCGCCAATTCCTTTA 
CCCTCCATTCCCCTGCCTCTCCGGTCCTGTCCATTCGTCCCGTCTACGCA 
AATGCCTGCACTCGTTTGAACCTCACAGGTATCTGCTCCACCCTCCACAT 
TAAGCACTCCCTCCGTACTTCGGATCCGTCTGTTTCCGACTATGTATTAA 
TTATTGCCACAGACGGCGAAGCCAATAGGTCCCCCCACAGATCCCTAACC 
CCATCGCCCCCAACCAAGAATTTACCCACCCCTGAACCCCAAGGCTGCTG 
161 
- 150 TTAGATATCGGGAGCGTACCAACGCAAAAGGCCGTCGATAGATCATTTGA 
- 100 AGAAAATCAAACCATACCTCGAAACAACGTCTCTCTCATTGTCCTTGTCG 
-50 ATCCGTCATCCACCCACAGGCCTTGCCGTAGTCCCTTGTCTTGGCGTTCC 
1 ATGCGGGGTCTAGGCAATTTGCTGAAGAAGAAGAAGAAGCGGACGAAGGA 
1 M R G L G N L L K K K K K R T K 
51 CTCGCGCATCTCGAGGGACCTGGATCTGTCCGCTTCGCCGGTAGCGGAGT 
17 D S R I S R D L D L S A S P V A E 
101 CAACCTCGTCGTCTCCTGGCGATAATAATAATAATATTATTAATAATAGT 
34 S T S S S P G D N N N N I I N N S 
151 AGCCCTCTCTTCCTGACGACAGCAGCTACAGCTACCGCACCAGCTACCGT 
51 S P L F L T T A A T A T A P A T 
201 AACAGCAGCACCAACAACGAACACCCTGCTCCAGCACCCTGCGTTTACCT 
67 V T A A P T T N T L L Q H P A F T 
251 CACCCGCCCGCGATTCCTCTTGCAAAGACCCCGCTTCCTCCCCCGGCACC 
84 S P A R D S S C K D P A S S P G T 
301 AATAAGATCAGTAGCAGTAGTAATCCTCCTGCCTCCGTTTTCCTTACAGC 
101 N K I S S S S N P P A S V F L T 
351 TATTCCTACCTCGACTAAACCAGAGGGAGTCGCCTCCTCTCCTCCCACTG 
117 A I P T S T K P E G V A S S P P T 
401 GCTCCACAACAGCTGGCGCAATCACGAAAATTGACAGCACACATTCTGCA 
134 G S T T A G A I T K I D S T H S A 
451 CCCATGAACCCCCTACATTCTCCCGGGCCCCCTTCCTCGGAATATAAGGC 
151 P M N P L H S P G P P S S E Y K 
501 GGGCGATCCCTCTCATTTCAAACAGCACCAGCAACAGCAACAGCAACCAC 
167 A G D P S H F K Q H Q Q Q Q Q Q P 
551 AGCAGCAATCCCACCACTCCCAAAATGTCGCCAGTATTAAGAACATTATA 
184 Q Q Q S H H S Q N V A S I K N I I 
601 AATCCACCCCTCAACGATGAAGTGGCGGCCTCCCCACAACCAGTTGGCGA 
201 N P P L N D E V A A S P Q P V G 
65 1 TGGCCTACATGCCGCACAACAACGAATGCATTCACAGCATCCACAGCAAC 
217 D G L H A A Q Q R M H S Q H P Q Q 
701 AACAACACCAACAGCAACAACAACAACAACAGCAACAACAACAACAACAA 
234 Q Q H Q Q Q Q Q Q Q Q Q Q Q Q Q Q 
751 CAAGTTCAACAATCTGTCCCGTCAGTTTCGCGGCAGACAAAGGGCAAATA 
251 Q V Q Q S V P S V S R Q T K G K 
801 CTCGCTAGATGACTTTACGTTGCAACGGACGTTGGGGACGGGCAGTTTCG 
267 Y S L D D F T L Q R T L G T G S F 
851 GGCGAGTACACCTGGTTCAATCGCGACATAACCAGCGCTTCTATGCCATC 
284 G R V H L V Q S R H N Q R F Y A I 
901 AAGGTGCTGAAGAAAGCGCAAGTGGTGAAGATGAAGCAGGTCGAGCATAC 
301 K V L K K A Q V V K M K Q V E H 
951 GAATGATGAAAGAAGAATGCTGCAGCGGGTTAAACATCCATTCCTAATTA 
317 T N D E R R M L Q R V K H P F L I 
1001 CGCTATGGGGCACGTTCCAGGATGTGAAGAATCTTTATATGGTTATGGAT 
334 T L W G T F Q D V K N L Y M V M D 
1051 TTTGTGGAGGGTGGAGAGCTGTTTAGTTTACTGAGGAAATCGCAGgtggg 
351 F V E G G E L F S L L R K S Q 
1101 gaaactccttttcctttccccttcggcttgttctatctaaagggattttt 
1151 ttttgaactaattgatatcggttcctcagCGCTTCCCAAATCCTGTTGCA 
366 R F P N P V A 
1201 AAGTTCTACGCTGCGGAGGTTACGTTGGCGTTGGAATATCTACATGACCA 
373 K F Y A A E V T L A L E Y L H D 
1251 TCACATTATATACCGAGACCTAAAGCCAGAGAATCTACTTTTAGATCGAT 
389 H H I I Y R D L K P E N L L L D R 
1301 ATGGACATTTGAAGATTACAGATTTTGGATTCGCGAAGGAAGTCAAGGAT 
406 Y G H L K I T D F G F A K E V K D 
1351 ATTACATGGACTTTATGCGGGACACCAGATTATCTGGCGCCGGAGGTAGT 
423 I T W T L C G T P D Y L A P E V 
1401 TTCGTCAAAGGGATACAACATGTCCGTTGACTGgtaagcggttctccgcc 
439 V S S K G Y N M S V D 
162 
1451 cccccccccccccccccctccttttatttttatttttattttttgtattg 
1501 ttccaccgcattacacaccactaaccactccactccataatcaaccgaaa 
1551 agGTGGTCCCTCGGCATCCTAATCTTCGAAATGCTTTGCGGCTTCACCCC 
450 W W S L G I L I F E M L C G F T 
1601 CTTCTGGGACGGCGGCAGCCCCATGAAAATCTACGAAAACATCATAAAAT 
466 P F W D G G S P M K I Y E N I I K 
1651 GCCGAGTCAAGTATCCGTCCTACATGCACCCGGACGCCCAAGATCTACTC 
483 C R V K Y P S Y M H P D A Q D L L 
1701 TCCCAACTCATTACTCCCGATCTCACAGTACGCCTGGGCAACTTGCACGG 
500 S Q L I T P D L T V R L G N L H 
1751 CGGCAGTAAGGATGTTAAGGATCATCCGTGGTTTGCGGAGGTGACGTGGG 
516 G G S K D V K D H P W F A E V T W 
1801 ATCGGCTAGCGCGGAAGGATATTGATGCGCCGTATATTCCTCCGGTGAAG 
533 D R L A R K D I D A P Y I P P V K 
1851 GGAGGGCAGGGGGATGCAAGCCAGTTTGATAGGTATCCCGAGGAGACGGA 
550 G G Q G D A S Q F D R Y P E E T 
1901 GCCGTATGGGGGTAGTGGGGATGATCCgtatgtttctccttgctttccct 
566 E P Y G G S G D D 
1951 ctcgtttgcttcaacgacgaagctttactaatgatgttatagATATGGCG 
575 P Y G 
2001 ATTATTTCGTGGACTTTTGAATGGGGATAATTTTGTGAAGACCCGTCGAC 
578 D Y F V D F * 
2051 TGCGCTCTCTAGGTATTTCTATATATCTACCGGCCTATGCCAATATCTAG 
2101 ACGGAGAATTTTTATATGACCAATCATCCGCCTTTACATATTTCTTTTTC 
2151 CATTCTAAAAAGGGTCGGGGAAAAAACGAACTGAAAAGGAAAAGAAGGGA 
2201 CGGGAAACGATGTTTTATTCAATTCTCTCTCTTGAAGATAAATGTATGCA 
2251 TTTCCATCCGTATTAACGGGTTCTCTTCTTCTACTCTGAGAAAATATACG 
2301 GCCTTGGCCTGTATCTTCTAGCTTTTTGGGCCTCCCATTTCCTTTGGGCC 
2351 CTCATTTTCATCATTTAACTCTATCTTGCTCCATGGGACGGTTATACCTG 
2401 AGACTAACAGCGGGGTCTGTGAAAGGATTTATTTATTTTGTCCTTGCTAC 
2451 TCCATACTTGTTTTTTGAGTTCTCTTAACTATCATATACGGATTTCTATT 
2501 TTCGTACTTAATCTTTCTTTTCTTCTTTTCTTTCTCGTTCATTGGGGGAG 
2551 TGTTTAATATTATTGGACTTTTGTTTGGGGATGACATGTTCTTCTCAGAG 
2601 TATCTTTTTGGTCAATGGAATGGGCTTGCTATGGCGATCCGTGACATAAA 
2651 ATCAGTGAGTTGATGTAATGGGAAATGAAAATGCTGTGAAAAGAGAAGAT 
2701 AAACGTTTTGTTTCCCTATGGTCATGTATTTCATATCTTCTACCGTTTTT 
2751 GTCTCTCTTTTCTCGTTCATCGTACGTCGCTTATTCCTGGATCCTACATA 
2801 GTCGTCGTGAATAGATTTTATAGCCCGACTTAATAGTCAGACTTAAAATA 
2851 AGAAAAGGGGTGTTCATATCTGTTCCTTAATTTCTCAATTCATACTTGGT 
2901 ATCCTAACTTTTGTCATGGATGATAGAAACCATTCCTTCGTGTGATTCAC 
2951 CGCTCCCATGTTTCAGAAAAGGGGCAGGATAGGAAAAATGGAAATAGGAC 
3001 TGGAAAAGCATAAACTATAAATACAGGGAGATAAAAACAAGACCACCCAG 
3051 TAGGAGGTTATAGGGAGCAGGTGCGTGCAAAAAGGGGGGGGAAAAGCGAG 
3101 GAGATATATAAA 
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Figure ~.9-4. Phylogenetic analysis of fungal cAMP-dependent protein kinase catalytic subunits and cAMP-dependent protein kinases-
like pr~Jeins. The tree was created with Vector NTI 6.0 (Informax). Protein GenBank accession numbers are given after the name of the protein. 
The abbreviations are: Pb, P. brasiliensis; An, A. nidulans; Ca, Candida albicans; Nc, Neurospora crassa; Mg, Magnaporthe grisea; Urn, 
Usti/agq maydis; Cn, Cryptococcus neoformans; Sc, S. cerevisiea; and Sp, S. pombe. 
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3.10 Cloning a Transcription Repressor Gene PbTUPA from PbOJ 
Cloning of PbTUPA was achieved by a degenerate PCR approach and amplifications 
with SSP-RCR from both our PbOJ genomic DNA and eDNA libraries. Two 
degenerate primers, PbTUPA-F1 and PbTUPA-R1, were used to clone a fragment of 
the gene with genomic DNA. Specific primers were then designed on the basis of 
the sequence of this fragment (see Table 2.6-1 ); and with these primers, fragments of 
the genomic DNA and eDNA were cloned and sequenced. By overlapping the 
sequences, the full-length gene was delineated, as illustrated in Figure 3.10-1. 
The coding sequence of PbTUPA, which is interrupted by 7 introns, is 1,776 bp in 
length and encodes a protein of 592 amino acids with a molecular weight of 65 kDa 
and predicted pi of 6.4. Like other fungal TupA proteins, the PbTupA protein 
contains a predicted N-terminal coiled-coil domain and seven WD40 domains 
(Figure 3.10-2). It is highly conserved with PmTupA (GenBank No. AAL99251; 
79% identity), AnTupA (GenBank No. AAG28504; 74% identity), NcRco1 
(GenBank No. P78706; 58% identity), SpTup1 (GenBank No. CAB52736; 40% 
identity) and ScTup1 (GenBank No. CAA42259; 35% identity), as illustrated in 
Figure 3.10-2. The predicted site of initiation of translation of PbTUPA appears 
correct because the position of the first methionine is conserved with that of P. 
marneffei TupA (Figure 3.10-2). However, the first ATG of PbTUPA eDNA does 
not meet the requirement of a Kozak sequence (ANNATGG). It is worth noting that 
A. nidulans TupA has an extra 26 amino acids beyond the N-terminal ends of both 
PbTupA and PmTupA (Figure 3.10-2), suggesting theN-terminal ends of PbTupA 
and PmTupA are incomplete. Another possibility is that Pb can use an alternative 
consensus sequence at the site of translation initiation. It requires further 
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Figure 3.10-1. The nucleotide and deduced amino acid sequence of PbTUPA. 
Nucleotide positions are written in red numerals, amino acids in blue. Introns are 
denoted by lowercase letters with red colour. 
- 100 ACCGCAGCTCTCTTCCTGTCTTCCTTTCAGACAGTGCAACTCAAATAATC 
- 50 AACATAACTTCTTACCTTAGGCCAGCCTCGCCCTCAAGGCTTGTGCCAAC 
1 ATGTATAACCCACACCGTGGTATGGTTACTGCTCCAAACTCACGATTGAC 
1 M Y N P H R G M V T A P N S R L 
51 AGAGCTGCTCGATCAGCTGCGCCAGGAGTATGAGAACCAGTCGCGGAATA 
17 T E L L D Q L R Q E Y E N Q S R N 
101 CCGGCGAGTTTGAACATCAACgtgtgttccccccctccccctctttcttt 
34 T G E F E H Q 
151 ctttcttccttccttcctttttcttcttcttataataccctcccaaccct 
201 tatctcggaaacaggtgtagccatctctctgtcatgtctgcaattacaat 
251 agacgcaacgtgcatatgaacgcatggttttgcgcccgatgttgtcatca 
301 aataccccctttttgcacactgttaaccgttcactgacaaacttttgcat 
351 ttgcattcacagTCACTGGCCAACTCCAGGAGATGGAGATGATCAGACAG 
41 L T G Q L Q E M E M I R Q 
401 AAAGTGTACCAGCTGGAGCAGGCGCAGATAAAAATGAAGCAAGAgtacgt 
54 K V Y Q L E Q A Q I K M K Q 
451 cttcggctcttatttataatcctcataaatgatctcgagtgagagtgttt 
501 gctaactgtctctgcacttgctttcaagATACGAGGCTGAAATCCGCACT 
68 E Y E A E I R T 
551 CTTCGAATGGAACTCGAATCTCGTGGCGTGCATCTCCCCCAGTCTCACAT 
75 L R M E L E S R G V H L P Q S H 
601 TGGTGGTCCCCCAACACATGCTGGGCCTTCTCAAGCTCCTCCTCCCGCGC 
92 I G G P P T H A G P S Q A P P P A 
651 TTGGACATGGCCCTGCCAATCTGTTTGGCGGCATCATGACCAACCCAGGA 
109 L G H G P A N L F G G I M T N P G 
701 GGTGGAGCTCCAGCCCTTGCGCCCCCTCCTCCTCCACAGGACCAGCAACA 
125 G G A P A L A P P P P P Q D Q Q 
751 ACCGCCCCAGCACGCTCTTCAGCAACCCGGTTCTGGCGCCCAAGGCCCTC 
142 Q P P Q H A L Q Q P G S G A Q G P 
801 CTCAACCACAGCAAGGTGCCTTTGGAGGGTATCAGCCTGCCTCTGCAGTT 
158 P Q P Q Q G A F G G Y Q P A S A V 
851 AACGgtatgtcccaacgtcacaaaatatgggaaaagcaaaattctgatca 
176 N 
901 aaactgttatagGTTATGGACCTCCACCTCCCGCTCCAACCTCGTCCCCA 
177 G Y G P P P P A P T S S P 
951 GGCCCTGGAAAAGGCAGAGCCAGTCGCGCACCTCCCGGTCCAGCCACCCC 
190 G P G K G R A S R A P P G P A T 
1001 CCAACAGAACCATCAAGTCGCCTATCCCGACACTCGTGCATCCCCTCAGA 
206 P Q Q N H Q V A Y P D T R A S P Q 
1051 TGCCCCGCCCCACTCCTCCCGGCCAGCAACTGAGCTATCGCGTAGGAAAC 
223 M P R P T P P G Q Q L S Y R V G N 
1101 ACACTCGCAGACCTGGATCCTGACAAGTTGCCCCCCAGCCAAAAGCGCGA 
240 T L A D L D P D K L P P S Q K R 
1151 AGGTTCTGATTGGTACGCCGTTTTCAACCCGGAGGTTCCTCGTTTGCTGG 
256 E G S D W Y A V F N P E V P R L L 
1201 ATGTCGACCTTGTCCACCATCTCGTTCATGACAGTGTAGTTTGTTGTGTT 
273 D V D L V H H L V H D S V V C C V 
1251 AGGTTCAGCAATGATGGGAAATTTGTTGCTACGGGCTGCAATCGCTCTGC 
290 R F S N D G K F V A T G C N R S 
1301 GCAGATCTTTGACGTTCAGAGTGGACAGCTTGTCACCTCTTTGCAAGATG 
306 A Q I F D V Q S G Q L V T S L Q D 
166 
1351 ATTCTGTTCTTGATAAGGAAGGGGACCTTTATATCCGTAGCGTCTGCTTT 
323 D S V L D K E G D L Y I R S V C F 
1401 AGTCCAGATGGGAGATACCTTGCTACTGGTGCAGAAGATAAACAGATTAG 
340 S P D G R Y L A T G A E D K Q I 
1451 Agtaaggacatgcccttgttctttttcttttctgctatttatatattgtt 
356 R 
1501 ccattccaccaactaacctccacctacagGTCTGGGATATCCAAAAACGC 
357 V W D I Q K R 
1551 ACCATAAAACACATCTTCTCCGGCCACGAACAAGATATCTACTCTCTCGA 
364 T I K H I F S G H E Q D I Y S L 
1601 CTTCGCCCGCAATGGCCGCTACATTGCCTCCGGCTCCGGCGACAAAACCG 
379 D F A R N G R Y I A S G S G D K T 
1651 TCCGCCTTTGGGACATCGTCGACGGCAAGCAGGAACTAATCCTCAACATC 
397 V R L W D I V D G K Q E L I L N I 
1701 GAAGATGGCGTTACTACCGTCGCCATATCTCCCGATGGCCGCTTCGTCGC 
414 E D G V T T V A I S P D G R F V 
1751 TGCCGGTTCCCTCGATAAGAGTGTTCGGGTCTGGGATACGACGACTGGAT 
430 A A G S L D K S V R V W D T T T G 
1801 ATCTTATTGAGCGTCTTGAGAATCCGGATGGGCATATGGATAGTGTGTAT 
447 Y L I E R L E N P D G H M D S V Y 
1851 TCTGTGGCGTTTGCGCCGAATGGGAGGGATCTTGTGTCGGGCAGTTTGGA 
464 S V A F A P N G R D L V S G S L 
1901 TAAGACTATTAAATTGTGGGAGTTGACGCCGCCTAGAGGGATGGTCCCTG 
479 D K T I K L W E L T P P R G M V P 
1951 GTTCTGGTCCTAAGGGTGGCAAGTGTGTTAGGACTTTTGAGGGGCATAAG 
497 G S G P K G G K C V R T F E G H K 
2001 gtgggtttcccctctttttgtgtcaattcaagttgatgaaggctgtaact 
2051 gacatatctatgtttcttcgcagGATTTTGTTCTTAGTGTCTGCTTGACA 
514 D F V L S V C L T 
2101 CCCGATGGACGCTGGGTTATGAGTGGATCTAAGGATCGTGGCGTACAGTT 
523 P D G R W V M S G S K D R G V Q 
2151 CTGGGATCCAGCGACTGGGAATGCGCAGATGATGCTTCAGGGCCATAAGA 
539 F W D P A T G N A Q M M L Q G H K 
2201 ATTCAGgttcgttattcgtttttattctttgtttctgcggcccccctcct 
556 N S 
2251 tttgtctctcaagctaaccatatcctccttcgttagTTATCTCCGTCGCA 
558 V I S V A 
2301 CCCAGCCCAGTCGGCAACCTGTTTGCGACCGGAAGCGGAGACATGCGTGC 
563 P S P V G N L F A T G S G D M R 
2351 TAGAATCTGGAGgttagtttcaaccctcaacgtttgatatcatatatttg 
579 A R I W 
2401 cgtttctgttcatcctcgttatcaccgccgtcatcatataattcgcgctc 
2451 ccttgccccttctaccatagtttgtctttgtatccactcttatttattct 
2501 ccttcatgtcccagtatactaacgtctacaaaacctaactctcgacatgg 
2551 gatttacagCTATTCCAATTGGGATCCCAGAAGGTCATAGGTTATGTTTA 
583 S Y S N W D P R R S * 
2601 ATTCACAAGCGGACGCAGGCACGCTCACGCATATGGCAGAACTTGCAAAA 
2651 CATGCAGTTGGGCATATATTTAAATATGCGCAACACGTAACTTTGCCAGA 
2701 GGAAGGAAATAAAGGAGGAAACGGGCCAAGGGAAAGGGGAAAGGCGTTCT 
2751 GTGGCTACTACATTTACCGGCTCTTGCGATTGATTGG 
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Figure 3.10-2. PbTupA is highly conserved with TupA from P. marneffei and A. 
nidulans. Alignment was done with Vector NTI 6.0. GenBank protein accession 
numbers are indicated after the name of protein. The predicted N-terminal coiled-
coil domain and seven WD40 repeats are shown with black lines. 
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amplification of upstream eDNA fragments to tum this hypothesis into a conclusion. 
3.11 Plasmid Constructions for Yeast-Two-Hybrid Analysis 
As illustrated in Figure 3.5-1 and Figure 3.5-2, a fidelity PbCYRI eDNA has been 
cloned into vectors to obtain the constructions pYES6-cPbAC-F26R34-1-14 (-21 bp 
eDNA version with a point mutation Q600R), pBSK-cPbAC-F26R34-1 (full-length 
eDNA version) and pGEMTE-cPbAC-F26R34-1 (full-length eDNA version) as 
templates for downstream sub-cloning. Fidelity full-length cDNAs of PbGPA I, 
PbGPA2, PbGPA3, GPRI of S. cerevisiae (ScGPRJ) and the actin gene of Pb 
(PbACTIN, GenBank accession No. AY383732) have also been cloned into pGEM T 
Easy vector as templates for sub-cloning (Table 3.11). These cDNAs were then sub-
cloned into Clontech's bait vector pGBKT7 and prey vector pGADT7 to make 
constructions for Yeast-2-Hybrid experiments. All the genes in the constructions are 
in frame with the vectors. Some constructions of PbRASJ (RAS gene of Pb, 
GenBank accession No. A Y547438; cloned by Dr M.I. Borges-Walmsley) and 
PbGPBI were made by Dr M.I. Borges-Walmsley and Dr G. Chen in our lab. Major 
constructions in this thesis are illustrated in the following Table 3 .11. 
Table 3.11 Major plasmid constructions used in this thesis. 
Plasmid Names Vectors Clonin2 and insert descriptions 
Constructions as templates 
p YES6-cPbAC-F26R34-1-14 pYES6/CT See Figure 3.5-1; The insert is the -21 bp 
(Invitrogen) PbCYRJ eDNA version with a point 
mutation Q600R m addition to the 
mutation A2S introduced by primer 
PbAC-F26. 
pBSK-cPbAC~F26R34~ 1 pBSK See-Figure 3.5-2~ The insert is the full-
(Stratagene) length PbCYRJ eDNA version without 
any point mutation at protein level 
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except for the mutation A2S introduced 
by primer PbAC-F26. 
pGEMTE-cPbAC-F26R34-I pGEM T Easy See Figure 3.5-2; The insert is the full-
(Promega) length PbCYRJ eDNA version without 
any point mutation at protein level 
except for the mutation A2S introduced 
by primer PbAC-F26. 
pGEMTE-cPbGPA 1- pGEM T Easy The insert IS the RT-PCR product 
ExGPAF 1 p YER3-9(T7>SP6) (Promega) amplified with PbGPA 1-ExGPAFI and 
PbGPA 1-p YER3 from PbOJ mRNA. 
The insert is the full-length PbGPAJ 
eDNA. 
pGEMTE-cPbGPA2-F6R6- pGEM T Easy The insert is the RT-PCR product 
2(SP6>T7) (Pro mega) amplified with PbGPA2-F6 and 
PbGPA2-R6 from PbOJ mRNA. The 
insert is the full-length PbGPA2 eDNA. 
pGEMTE-cPbGPA3-F5R5- pGEM T Easy The insert is the RT-PCR product 
2(T7>SP6) (Promega) amplified with PbGPA3-F5 and 
PbGPA3-R5 from pDNR-PbOJcDNA 
library. The insert is the full-length 
PbGPA3 eDNA. 
pGEM-TE-PbACTIN -GAD F 1 R 1- pGEM T Easy The insert is RT-PCR product amplified 
12(SP6>T7) (Pro mega) with PbActinGADF 1 and 
PbActinGADRI from PbOJ mRNA. 
The insert is the full-length PbA CTIN 
eDNA. 
pGEMTE-ScGPR1-F IR1-17 pGEM T Easy The insert is the full length ScGPRJ 
(Promega) which was cloned by recombination of 
fidelity PCR products. The sequence of 
ScGPRJ in this clone spans from the 
position of primer ScGPRl-Fl to that of 
ScGPRl-Rl. 
Constructions for Y2H 
pGAD- PbCYR1 1-678 pGADT7 PbCYR1 1-678 fragment from pGBK-
(Clontech) PbCYR1 1-678 was digested with 
Ndel/BamHI and cloned into pGADT7 
(N del!BamHI). This insert corresponds 
to the RA domain of PbCyr 1. 
pGAD- PbCYRJ600-1316 pGADT7 PbCYRJ600-1316 fragment from pGBK-
(Clontech) PbCYRJ6oo-t3t6 was digested with 
Ndei/BamHI and cloned into pGADT7 
(Ndei/BamHI). This insert corresponds 
to the LRR domains ofPbCyrl. 
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pGAD- PbCYRJ 1302-1876 pGADT7 PbCYRJ eDNA fragment (Ndei/Xhol 
(Clontech) digested) obtained by PCR with PbAC-
EFI and PbAC-ER2 was cloned into 
pGADT7 (Ndei/Xhol). This insert 
corresponds to the PP2Cc and CYCc 
domains of PbCyr I. 
pGAD- PbCYRJ'648-2Joo pGADT7 PbCYRJ eDNA fragment (Ndei/Xhol 
(Clontech) digested) obtained by PCR with PbAC-
EF2 and PbAC-ERl was cloned into 
pGADT7 (Ndei/Xhol). This insert 
corresponds to the CYCc domain of 
PbCyrl. 
pGAD-PbGPA 1 pGADT7 Full-length PbGPAJ insert from pGBK-
(Clontech) PbGPAJ was digested with Ndel and 
cloned into pGADT7 (Ndel). 
pGAD-PbGPA2 pGADT7 Full-length PbGPA2 insert from pGBK-
(Clontech) PbGPA2 was digested with Ndei/Sall 
and cloned into pGADT7 (Ndei/Xhol). 
pGAD-PbGPA3 pGADT7 Full-length PbGPA3 insert from pGBK-
(Clontech) PbGPA3 (Ndei/BamHI) was cloned into 
pGADT7 (Ndei/BamHI). 
pGAD-PbGPBJ pGADT7 Full-length PbGPBJ eDNA 
(Clontech) (Ndei/BarnHI) was cloned into the 
vector pGADT7 (Ndei/BamHI); This 
construction was made by Dr G. Chen in 
our lab. 
pGAD-PbRASJ pGADT7 Full-length PbRASJ insert from pGBK-
(Clontech) PbRASJ (Ndei/EcoRI) was cloned into 
pGADT7 (Ndei/EcoRI). 
pGAD-PbRASJ 1-83 pGADT7 PCR product amplified with S'BD 
(Clontech) Screening and PbRAS-Rl as primers, 
and pGBK-PbRASJ as template was 
digested with Ndei/EcoRI and cloned 
into pGADT7 (Ndei/EcoRI). 
pGAD-PbRASJ26-238 pGADT7 PCR product amplified with 3'BD 
(Clontech) Screening and PbRAS-FI as primers, 
and pGBK-PbRASJ as template was 
digested with Ndei/EcoRI and cloned 
into pGADT7 (Ndei/EcoRI). 
pGAD-PbA CTIN pGADT7 Full-length PbACTIN insert 
(Clontech) (Ndei/EcoRI) from pGEMTE-
. PbACTIN-GADF I RI-12 was cloned 
into pGADT7 (Ndei/EcoRI). 
pGAD-PbA CTJN1-314 pGADT7 PCR product amplified with PbACTIN-
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pGAD-ScGPR/679.961-FSRl 
pGAD-ScGPRJ274.621-F4R3 
pGAD-ScGPR/ 1.961 -F3Rl 
pGADT7-T 
pGAD-?5372-390 
pGAD-lam66.230 
pGBK-PbCYR/ 1"678 
pGBK-PbCYR16oo-1316 
(Clontech) 
pGADT7 
(Clontech) 
pGADT7 
(Clontech) 
pGADT7 
(Clontech) 
pGADT7 
(Clontech) 
pGADT7 
(Clontech) 
pGADT7 
(Clontech) 
pGBKT7 
(Clontech) 
pGBKT7 
(Clontech) 
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R3 and SP6 as primers and pGEMTE-
PbACTIN-GADFIRI-12 as template 
was digested with Ndei/EcoRI and 
cloned into pGADT7 (Ndei/EcoRI). 
PCR product amplified with ScGPRl-F5 
and ScGPRl-Rl as primers and 
pGEMTE-ScGPRI-FIRl-17 as template 
was digested with BamHI and cloned 
into pGADT7 (BamHI); This insert is 
the C-terminal cytoplasmic domain of 
ScGPRJ. 
PCR product amplified with ScGPRI-F4 
and ScGPRI-R3 as primers and 
pGEMTE-ScGPRl-FlRl-17 as 
template, was digested with BamHI and 
cloned into pGADT7 (BamHI); This 
insert is the third cytoplasmic loop of 
ScGPRJ. 
PCR product amplified with ScGPRl-F3 
and ScGPRl-Rl as primers, and 
pGEMTE-ScGPRl-FlRl-17 as 
template, was digested with BamHI and 
cloned into pGADT7 (BamHI); This 
insert is the full-length ScGPRJ. 
From Clontech 
P53 insert from pGBKT7-P53 
(Ndei/BamHI digested), was cloned into 
pGADT7 (Ndei/BamHI). 
Lam insert from pGBKT7-Lam 
(Ndei/BamHI digested) was cloned into 
pGADT7 (Ndei/BamHI). 
PbCYRJ eDNA fragment obtained by 
PCR with PbAC-GADFl and PbAC-
GADRl was digested with Ncoi/BamHI 
and cloned into pGBKT7 
(Ncoi/BamHI). This insert corresponds 
to the RA domain of PbCyr l. 
PbCYRJ eDNA fragment obtained by 
PCR with PbAC-GADF2 and PbAC-
GADR2 was digested with Ncoi/BamHI 
and cloned into pGBKT7 
(Ncoi/BamHI). This insert corresponds 
to the LRR domain ofPbCyrl. 
pGBK-PbCYR 1 I 302-1876 pGBKT7 PbCYRJ eDNA fragment obtained by 
(Clontech) PCR with PbAC-EFI and PbAC-ER2 
was digested with NdeVXhol and cloned 
into pGBKT7 (Ndei/Sall). This insert 
corresponds to the PP2Cc and CYCc 
domain of PbCyr I. 
pGBK-PbCYRJ 1648-2100 pGBKT7 PbCYRJ eDNA fragment obtained by 
(Clontech) PCR with PbAC-EF2 and PbAC-ERI 
was digested with Ndei!Xhol and cloned 
into pGBKT7 (Ndei/Sall). This insert 
corresponds to the CYCc domain of 
PbCyrl. 
pGBK-PbGPAJ pGBKT7 Full-length eDNA of PbGPAJ from 
(Clontech) pGEMTE-cPbGPAI-ExGPAFlpYER3-
9 was digested with Ndel and cloned 
into pGBKT7 (Ndel). 
pGBK-PbGPA2 pGBKT7 PCR product obtained by PCR with 
(Clontech) PbGPA2-F7 and T7 as primers and 
pGEMTE-cPbGPA2-F6R6-2 as template 
was digested with EcoRI and cloned into 
pGBKT7 (EcoRI). The insert is the full-
length eDNA. 
pGBK-PbGPA3 pGBKT7 PCR product obtained by PCR with 
(Clontech) PbGPA3-F8 and SP6 as primers and 
pGEMTE-cPbGPA3-F5R5-2 as template 
was digested with EcoRI and cloned into 
pGBKT7 (EcoRI digested). The insert is 
the full-length eDNA. 
pGBK-PbGPBJ pGBKT7 Full-length PbGPBJ eDNA (PCR 
(Clontech) product digested with Ndei/BamHI) was 
cloned into the vector pGBKT7 
(Ndei/BamHI); This construction was 
made by Dr G. Chen in our lab. 
pGBK-PbRASJ pGBKT7 Full-length PbRASJ eDNA (PCR 
(Clontech) product digested with Ndei/EcoRI) was 
cloned into the vector pGBKT7 
(Ndei/EcoRI); This clone was made by 
Dr M.I. Borges-Walmsley. 
pGBKT7-53 pGBKT7 From Clontech 
(Clontech) 
pGBKT7-Lam pGBKT7 . FromClontech 
(Clontech) 
pGBK-ScGPRJ 1-961 -F3Rl pGBKT7 Insert (BamHI digested) from pGAD-
173 
(Ciontech) ScGPR1 1-961 -F3R I was cloned into 
pGBKT7 (BamHI). This insert is the 
full-length ScGPRJ. 
pGBK-ScGPA2-FlRl pGBKT7 PCR product obtained with ScGPA2-Fl 
(Clontech) and ScGPA2-Rl as primers and S. 
cerevisiae DNA as template was 
digested with BamHI and cloned into 
pGBKT7 (BamHI); This insert is the 
full-length ScGPA2. 
3.12 Construction of Random Mutagenesis Libraries for Yeast-Two-Hybrid 
Screening 
Nine random mutagenesis libraries were made with Stratagene's GeneMorph II 
Random Mutagenesis kit and cloned into prey vector pGADT7 for yeast-2-hybrid 
screening. These libraries were so named as the following: pGAD-PbGPAJ-RM-
Lib, pGAD-PbGPA2-RM-Lib, pGAD-PbGPA3-RM-Lib, pGAD-PbGPBJ-RM-Lib, 
pGAD-PbRASJ-RM-Lib, pGAD-PbACTIN-RM-Lib, pGAD-ScGPRJ679-961-RM-Lib, 
pGAD-P53-RM-Lib, and pGAD-/am-RM-Lib. The procedures for the individual 
constructions are described below. 
For pGAD-PbGPAJ-RM-Lib, random mutagenesis PCR was undertaken using 5'BD 
Screening and 3'BD Screening as primers, and pGBKT7-PbGPAJ as template. The 
PCR product was cleaned with Qiagen's Gel Extraction column, digested with 
Ndei/San, and ligated into pGADT7 (Ndei!Xhol). The ligation product was 
transformed into XL-10 Gold Ultracompetent Cell (Stratagene ), generating 4 X 104 
transforrnants. Five clones were randomly selected and sequenced for quality control 
of the library. The plasmid library pGAD-PbGPAJ-RM-Lib was obtained with 
Qiagen's plamid Maxi kit.from pooled ttaJisforirtants. The final concentration of this 
library was 2.4 Jlg/Jll of plasmid DNA. 
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For pGAD-PbGPA2-RM-Lib, random mutagenesis PCR was undertaken using 
PbGPA2-FlO and 3'BD Screening as primers, and pGBKT7-PbGPA2 as template. 
The PCR product was cleaned, digested with Ndei!EcoRl, and ligated into pGADT7 
(Ndell EcoRl). The ligation product was transformed into XL-I 0 Gold 
Ultracompetent Cell, generating 4 X 104 trans formants. Five clones were randomly 
selected and sequenced for quality control of the library. The plasmid library pGAD-
PbGPA2-RM-Lib was obtained with Qiagen's plamid Maxi kit from pooled 
transformants. The final concentration of this library was 2.2 l-!g/l-!1 of plasmid DNA. 
For pGAD-PbGPA3-RM-Lib, random mutagenesis PCR was undertaken usmg 
PbGPA3-Fll and 3'BD Screening as primers, and pGBKT7-PbGPA3 as template. 
The PCR product was cleaned, digested with Ndei!EcoRl, and ligated into pGADT7 
(Ndei!EcoRl). The ligation was transformed into XL-10 Gold Ultracompetent Cell, 
generating 4 X 1 04transformants. Five clones were randomly selected and sequenced 
for quality control of the library. The plasmid library pGAD-PbGPA3-RM-Lib was 
obtained with Qiagen's plamid Maxi kit from pooled transformants. The final 
concentration ofthis library was 2.0 llgllll of plasmid DNA. 
For pGAD-PbGPBJ-RM-Lib, random mutagenesis PCR was undertaken using S'BD 
Screening and 3'BD Screening as primers, and pGBKT7-PbGPBJ as template. The 
PCR product was cleaned, digested with Ndei/BamHI, and ligated into pGADT7 
(Ndel/BamHI). The ligation was transformed into XL-10 Gold Ultracompetent Cell, 
generating 4 X 104transformants. The plasmid library pGAD-PbGPBJ-RM-Lib was 
obtained with Qiagen' s plamid Maxi kit from pooled transformants. The final 
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concentration ofthis library was 1.7 !lg/!ll ofplasmid DNA. 
For pGAD-PbRASJ-RM-Lib, random mutagenesis PCR was underatken using 5'BD 
Screening and 3'BD Screening as primers, and pGBKT7-PbRAS as template. The 
PCR products were pooled, cleaned, digested with NdeJ/EcoRl, and ligated into 
pGADT7 (Ndell EcoRl). The ligation was transformed into XL-I 0 Gold 
Ultracompetent Cell, generating 4 X 104transformants. The plasmid library pGAD-
PbRASJ-RM-Lib was obtained with Qiagen's plamid Maxi kit from pooled 
transformants. The final concentration of this library was 1. 7 !lgl!ll of plasmid DNA. 
For pGAD-PbACTIN-RM-Lib, random mutagenesis PCR was underatken usmg 
PbACTIN-GADF2 and T7 as primers, and pGEMTE-PbACTIN-GADF1R1-12 as 
template. The PCR product was cleaned, digested with Ndei/EcoRl, and ligated into 
pGADT7 (Ndei/EcoRl). The ligation was transformed into XL-1 0 Gold 
Ultracompetent Cell, generating 2 X 1 04transformants. The plasmid library pGAD-
PbACTIN-RM-Lib was obtained with Qiagen's plamid Maxi kit from pooled 
transformants. The final concentration ofthis library was 0.4 !lgl!ll of plasmid DNA. 
For pGAD-ScGPRJ679-961 -RM-Lib, random mutagenesis PCR was undertaken using 
5'AD Screening and 3'AD Screening as primers, and pGAD-ScGPRJ 679-961 -F5R1 
(C-terminal cytoplasmic domain) as template. PCR product was cleaned, digested 
with Ndel!Xhol, and ligated into pGADT7 (Ndel!Xhol). The ligation was 
transformed into XL-1 0 Gold Ultracompetent Cell, generating 2 X 1 04transformants. 
The plasmid library pGAD-ScGPRJ679-961 -RM-Lib was obtained with Qiagen's 
plamid Maxi kit from pooled transformants. The final concentration of this library 
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was 0.25 11g/j..tl of plasmid DNA. 
For pGAD-P53-RM-Lib, random mutagenesis PCR was undertaken usmg 5'BD 
Screening and 3 'BD Screening as primers, and pGBK-53 as template. The PCR 
products was cleaned, digested with NdeiJBamHI, and ligated into pGADT7 
(Ndel!BamHI). The ligation was transformed into XL-10 Gold Ultracompetent Cell, 
generating 4 X 104transformants. The plasmid library pGAD-P53-RM-Lib was 
obtained with Qiagen's plamid Maxi kit from pooled transformants. The final 
concentration ofthis library was 0.4 11g/11l of plasmid DNA. 
For pGAD-Lam-RM-Lib, random mutagenesis PCR was undertaken using 5'BD 
Screening and 3 'BD Screening as primers, and pGBK-Lam as template. The PCR 
product was cleaned, digested with Ndell Bam HI, and ligated into pGADT7 
(Ndel!BamHI). The ligation was transformed into XL-10 Gold Ultracompetent Cell, 
generating 4 X 104transformants. The plasmid library pGAD-lam-RM-Lib was 
obtained with Qiagen's plamid Maxi kit from pooled transformants. The final 
concentration of this library was 0.4 11g/11l of plasmid DNA. 
The Random mutagenesis libraries are summarized as below in Table 3.12. 
Table 3.12. Random Mutagenesis Libraries. 
RM libraries Original titer Concentration of library plasmids 
pGAD-PbGPAJ-RM-Lib 4Xl04 2.4 J.lg/j.!l 
pGAD-PbGPA2-RM-Lib 4Xl04 2.2 J.lg/J.ll 
pGAD-PbGPA3-RM-Lib 4Xl04 2.0 J.lg/j.!l 
pGAD-PbGPBJ-RM-Lib 4Xl04 1.7 J.lg/~1 
pGAD-PbRASJ-RM-Lib 4Xl04 
. }, : 1J±g/,J11 
'·' 
.. 
··-· ·--- ·-· 
pGAD-PbACTIN-RM-Lib 2Xl04 0.4 J.lg/J.ll 
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pGAD-ScGPRJ679-Y01 -RM-Lib 2Xl04 0.25 jlg/f.LI 
pGAD-P53-RM-Lib 4Xl04 0.4 jlg/jll 
pGAD-/am-RM-Lib 4Xl04 0.5 jlg/jll 
Quality control sequencing of the libraries indicated that the mutations introduced by 
the GeneMorphii Enzyme (Stratagene) are evenly distributed and there is no hot spot 
for clustering ofmutations (Figure 3.12). 
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Figure 3.12. Quality control of random mutagenesis libraries. Three random 
mutagenesis libraries were selected for quality test, with 5 clones from each library 
undergone for DNA sequencing. The upper panel gives a schematic demonstration 
of mutations created. DNA strands are indicated by green lines. Mutations are 
indicated by red blocks. The lower table gives the detail of mutations. Mutations are 
evenly distributed along the DNA without obvious hot spots of point mutations, 
frame shifts and terminations. 
PbGPA1RM 
PbGPA2RM • • 
PbGPA3RM 
Random Mutagenesis Libraries Mutations (5 clones tested for each library) 
pGAD-PbGP A 1-RM-Lib E238D; 
Q98K, G202D, R348G; 
S47P, E65G, L194H; 
No mutation at amino acid level; 
E291V 
pGAD-PbGP A2-RM-Lib Dl19V; 
Kl4E, H61Q, mis-sense mutations from 86-97, 
il98-359; 
No mutation; 
DlOE, Pl16S,El22K; 
LllOP 
pGAD-PbGPA3-RM-Lib R265N; 
P141L; 
No mutation; 
No mutation; 
One sequencing reaction failed 
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3.13 Full-Length PbGpal and PbGpbl Interact with PbCyr1"678 in the Yeast-
Two-Hybrid System. 
As indicated in Table 3.11, segments PbCYRI 1-678, PbCYRJ 600-1316, PbCYRJ 1302-1876 
and PbCYR1 1648-2100 were cloned into the bait vector pGBKT7, while full-length 
PbGPAI, PbGPA2, PbGPA3, PbGPBI and PbRASI were cloned into the prey vector 
pGADT7. Each bait construction was then combined with each prey construction to 
undergo simultaneous transformation in yeast-2-hybrid analyses. The results 
indicated that pGAD-PbGPAI and pGAD-PbGPBI directly interact with pGBK-
PbCYRJ1-678 because cotransformants with these 2 combinations of bait and prey 
construction grew well in SD/-Ade/-His/-Leu/-Try, while cotransfromants with other 
combinations could not grow on SD/-Ade/-His/-Leu/-Try (Figure 3.13). 
In order to exclude the possibility of false positives, 6 control constructions were 
used. As indicated in Table 3.11, full-length Pb actin gene, and S. cerecisiae GPRI 
C-terminal cytoplasmic domain were cloned into pGADT7 to make constructions 
pGAD-PbACTIN, and pGAD-ScGPRJ679-961-F5Rl. Fragments of the P53 and Lamin 
C genes were removed from pGBKT7-53 and pGBKT7-Lam (both from Clontech) to 
make constructions pGAD-P5372-390 and pGAD-lam66-230. Clontech's pGADT7 
(empty vector) and pGADT7-T (SV40 large T antigen) were directly used without 
modification in yeast-2-hybrid analyses. The results indicated that all 6 
aforementioned prey constructions could not interact with pGBK-PbCYRI 1-678 
(Figure 3.13). Therefore, the following conclusion was drawn: full-length PbGpa1 
and PbGpb1 interact with the first third of Pb adenylate cyclase PbCyr1 1-678 (the Ras 
association domain is included in this region) in the yeast-2-hybrid system, while 
full-length PbGpa2, PbGpa3, PbRas1 and PbActin do not interact with PbCyrl in the 
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Figure 3.13. Full-length PbGpal and PbGpbl directly interact with PbCyr1 1-678• 
Bait and prey vectors were simultaneously transformed into yeast strain AH109 and 
plated out on SD/-Leu/-Trp for 3 days. Yeast colonies grown on SD/-Leu/Trp were 
re-streaked on SD/-Ade/-His/-Leu/-Trp and incubated for 3 days. Results shown 
below indicate that pGAD-PbGPAJ and pGAD-PbGPBJ can directly interact with 
pGBK-PbCYRJ'-678, while full-length pGAD-PbGPA2, pGAD-PbGPA3, pGAD-
PbRASJ , and pGAD-PbACTIN can not directly interact with pGBK-PbCYRJ 1-678. 
pGBK-
PbCYR1 1-678 
pGBK-
PbCYR11-678 
pGAD-
PbGPA1 
pGAD-
PbACTIN 
pGBK-
pGAD-
PbGPA2 
pGAD-
PbGPA3 
pGAD- pGADT7-
ScGPR1679-961 T 
pGBK-
PbCYR1 1-678 PbCYRJ 6o0-1316 
pGAD-PbGPAJ + -
pGAD-PbGPA2 - -
pGAD-PbGPA3 - -
pGAD-PbGPBJ + -
pGAD-PbRASJ - -
pGAD-PbACTIN - Not tested 
pGAD-ScGPRJ 0 1Y-YOI 
- Not tested 
pGADT7-T - Not tested 
pGAD-P5372-390 
- Not tested 
pGAD-lam66-2Jo 
- Not tested 
pGADT7 - Not tested 
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pGAD-
PbGPB1 
pGAD-
p5372-J9o 
pGBK-
PbCYRJ'Jol-1876 
-
-
-
-
-
Not tested 
Not tested 
Not tested 
Not tested 
Not tested 
Not tested 
pGAD-
PbRAS1 
pGAD-
/am66-2Jo 
pGBK-
PbCYRJ'648-2Joo 
-
-
-
-
-
Not tested 
Not tested 
Not tested 
Not tested 
Not tested 
Not tested 
yeast-2-hybrid system. 
3.14 Screening Random Mutagenesis (RM) Libraries: Truncated Versions of 
PbGpa2, PbGpa3, PbRasl, and PbActin Interact with PbCyr1 1-678 
Given that full-length PbRas1 does not interact with adenylate cyclase PbCyrl 
(Figure 3.13); a hypothesis was made that either an additional iso-form of Ras exists 
in Pb with adenylate cyclase binding activity, or PbRas requires assistance of 
cognate partner( s) to interact with adenylate cyclase. Previous reports indicate that 
Ras directly acts on adeny1ate cyclase inS. cerevisiae (Shima et al, 1997; Kido et al, 
2002). Besides, there is an obvious Ras association domain in PbCyrl. However, 
only one RAS gene has been cloned form Pb even though extensive degenerate PCR 
primers have been used (personal communication with Dr M.l. Borges-Walmsley). 
A further question was raised for PbGPA2 and PbGPA3: if they do not interact with 
PbCYRI, what do they interact with? With bait constructions pGBK-PbGPA2 and 
pGBK-PbGPA3, a PbOJ eDNA library in prey vector pGADT7 was screened in a 
search for PbGpa2 and PbGpa3 interacting partners (this job was done by Dr G. 
Chen in our lab). Several candidate genes were obtained and their functions require 
further analysis (data not shown). However, these genes seem not to belong to the 
existing cAMP signalling and MAP kinase pathway. With the belief in mind that 
PbGpa2, PbGpa3 and PbRas1 still work on PbCyrl but they may switch between 
inactive and active binding states in vivo in Pb cells, which are unresolved in S. 
cerevisiae yeast two-hybrid experiments, random mutagenesis libraries (Table 3.12) 
of these genes were made and used in screening for mutants that were locked in an 
active dominant form to interact with PbCyr1. The library screening turned out to be 
successful. The four bait constructions pGBK-PbCYRJ 1-678; pGBK-PbCYRJ600-1316; 
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pGBK-PbCYRJ 1302-1876 and pGBK-PbCYRJ 1648-2100 were used in screening. Positive 
clones were obtained from each RM library of PbGPAJ, PbGPA2, PbGPA3, 
PbGPBJ, and PbRASJ as illustrated in Table 3.14-1. 
Table 3.14-1. Number of positive clones obtained after screening random 
mutagenesis (RM) libraries with truncated constructions of PbCyrl. 
Pre-transformed Bait Vector 
RM Libraries pGBK- pGBK- pGBK- pGBK-
PbCYRJ 1-678 PbCYR16o0-1316 PbCYRJ 1302-1876 PbCYRJ'648-2Joo 
pGAD-
:::::200 0 0 0 PbGPAJ-RM-Lib 
pGAD- 55 0 0 0 PbGPA2-RM-Lib 
pGAD- 8 0 0 0 PbGPA3-RM-Lib 
pGAD-
::::: 100 0 0 0 PbGPBJ-RM-Lib 
pGAD- 3 0 0 0 PbRASJ-RM-Lib 
It is interesting to observe that all positive clones arose from screening with pGBK-
PbCYRJ 1-678, indicating that the first third of adenylate cyclase is the region for 
protein interaction. In fact, pGAD-PbGPAJ-RM-Lib and pGAD-PbGPBJ-RM-Lib 
were used as positive controls because we had already proved that PbGPAJ and 
PbGPBJ interact with PbCYRJ 1-678 (Figure 3.13). About 200 and 100 positive 
clones were obtained respectively from screening the 2 positive control libraries. 
Given that the transformation efficiency was about 105-106 per library screening, 
100-200 positive clones were only a very small portion of all trans formants, 
indicating that most mutations had disrupted the structure of the protein with a 
consequent loss of interaction. Meanwhile, it was interesting to determine what kind 
of mutations arose in PbGPA2, PbGPA3 and PbRASJ to promote interaction with 
PbCyr1 1-678 . Prey plasmid constructions were retrieved and purified from positive 
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clones after screening and submitted for sequence analysis. Sequencing results 
disclosed that these mutations are truncations as demonstrated in Table 3.14-2. 
Table 3.14-2. Sequencing results of positive clones obtained from screening 
mutagenesis libraries with pGBK-PbCYR11-678• Note: clones were selected 
randomly before sequencing analysis. 
RM Libraries 
Sequences of positive clones 
after screening with pGBK-PbCYRJ1-678 
pGBK-PbGPAJ-RM-Lib L91P, F199T. 
~211-353, K54N. 
~209-353, E65D, I107T. 
~160-353, L38M. 
~157-353. 
~155-353. 
~145-353. 
~139-353. 
pGBK-PbGPBJ-RM-Lib K229E, S257T. 
K323L. 
~319-353, missense mutations 307-318. 
~314-353, F219L, A227G. 
~304-353, P205S, V292D. 
~257-353. 
~223-353, L90P. 
~221-353, R107T, A220C. 
~180-353, A12E, S108P. 
pGBK-PbGPA2-RM-Lib ~200-359, missense mutations 184-199. 
~184-359. 
~174-359. 
~ 171-359, missense mutations 153-170. 
~107-359, missense mutations 103-106. 
~103-359. 
~103-359, G63D. 
pGBK-PbGPA3-RM-Lib V76L. 
~214-356. 
~198-356. 
~192-356, S30T. 
~189-356, V127A. 
~175-356, S7Y. 
~164-356. 
~161-356. 
pGBK-PbRASJ-RM-Lib Q74R, G157W, V179D, R205I. 
~.~~.~.~' c!:-lp7I. 
~149-238, missense mutations 84-148. 
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The results of Table 3.14-2 are also schematically illustrated in Figure 3.14-1. As 
indicated in the table and the figure, it was surprising to find that most positive 
clones turned out to be truncated versions of the genes after screening. This was 
significant because no propensity for truncation has been found in any original RM 
libraries. As aforementioned, full-length PbGpa1 and PbGpb1 but not full-length 
PbGpa2, PbGpa3 and PbRas1 interact with PbCyr1 1-678• It was not surprising that 
some point mutations and C-terminal truncations still retain their ability to interact. 
In this experiment, the shortest version for PbGpa1 was PbGpa1 1-138, and PbGpb1 1-
179 for PbGpbl. For PbGpa2, all the mutants sequenced were C-terminal truncated 
(some with further point mutation or frame-shifts that caused stretches of missense 
mutations). It is worth noting that 3 mutants (~184-359, ~174-359, ~103-359) are 
only C-terminal truncations without any further mutations. For PbGpa3, only one 
mutant of those sequenced was the full-length gene form (with one point mutation 
V76L). Others were C-terminal truncated versions. It is worth noting that 4 clones 
were C-terminal truncations without any other forms of mutations (i.e. ~214-356; 
~198-356; ~164-356; and ~161-356). 
For PbRASJ, only 3 positive clones were obtained after screening, which were all 
sequenced. One clone was the full-length PbRASJ with 4 point mutations (Q74R, 
G 157W, V179D, and R2051). It is worth noting that the other 2 clones were 
truncations, one N-terminal truncation with an additional point mutation (~ 1-
25+L 1 071) and the other, a C-terminal truncation with a stretch of mutations caused 
by a frame-shift (~149-238+missense mutations 84-148). It is interesting that theN-
terminal deletion was obtained from screening of the RM library, although this 
phenomenon is not fully understood. To exclude the possibility that the interactions 
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were caused by the point mutations rather than truncations, 2 new prey constructions 
(pGAD-PbRASJ 1-83 and pGAD-PbRASJ26-238 as indicated in Table 3.11) were made, 
which retained the truncations but eliminated the point mutations. Yeast-2-hybrid 
results indicated that pGAD-PbRASJ 1-83 and pGAD-PbRASJ 26-238 can interact with 
PbCYR1 1-678, confirming that truncations without any additional mutation lead to 
interaction with PbCYRJ 1-678 . 
Apart from the aforementioned results, it was surprising to find that a C-terminal 
truncated version of Pb actin PbActin could also interact with PbCyr1 1-678 • Initially, 
the actin gene PbA CTIN was used as a negative control in RM library screening. An 
RM library (pGAD-PbACTIN-RM-Lib) was made (Table 3.12) and screened with 
pGBK-PbCYR1 1-678• About 200 positive clones were obtained on SD/-Ade/-His/-
Leu/-Trp media. Four randomly selected clones were used for sequencing. The 
results indicated that these clones fell into 3 types of C-terminal truncations as shown 
below. 
RM librariy Sequencing results of 4 positive clones 
after screening pGAD-PbACTIN-RM-Lib 
pGAD- ~325-375, D244V, and missense mutations 315-324. 
PbACTIN-RM-Lib ~327-375, liON, Q59H, V76A, R206H, and K326R. 
~336-375, R116P, L189F, missense mutations 316-335. 
In order to exclude the possibility that the interaction was caused by the point 
mutations rather than the C-terminal truncations, a new construction pGAD-
PbACTIN1-314 was made as described in Table 3.11. Sequencing confirmed that the 
construction pGAD-PbACTIN1-314 had no other mutations except for the truncation 
~315-375. Yeast-2-hybrid analysis indicated that this truncated version of Pb actin 
interacts with PbCyr1 1-678 • 
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To exclude the possibility of false positives, 3 negative control RM libraries were 
made by recruiting 3 genes, i.e. ScGPR1 679-961 (C-terminal cytoplasmic domain, 
functional as indicated by interacting with ScGPA2), P53 and Lamin C, because they 
do not interact with PbCYR1 1-678 (Table 3.12 and Figure 3.13). No positive clones 
were obtained after screening RM library pGAD- ScGPR1 679-961-RM-Lib. However, 
about 1,000 and 300 positive clones were obtained respectively after screening 
pGAD-P53-RM-Lib and pGAD-lam-RM-Lib. Sequencing results indicated that none 
of these clones contained any forms of truncations. However, point mutations are 
essential for their interaction with PbCYRJ 1-678 (Figure 3.14-2). It is worth noting 
that for Lamin C, a mutation from E or D to V at the end of the gene seems essential 
for its interaction with PbCyr1 1-678 . It still requires further investigation that point 
mutation(s) of an unrelated gene such as P53 or Lamin C can lead to the interaction 
with PbCyr1 1-678 . In this thesis, my understanding of this issue is that interactions 
caused by point mutation(s) but not by truncations without point mutation are 
considered false positives, especially for genes that are not closely related to the 
cAMP signaling pathway. 
In general, truncated versions of PbGpa2, PbGpa3, PbRas 1 and PbActin can interact 
with PbCyr1 1-678 as shown in Figure 3.14-3. 
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Figure 3.14-1. Sequencing results of positive clones obtained from screening 
mutagenesis libraries with pGBK-PbCYR11-678• This is the schematic diagram of 
the table 3.14-2. Clones were randomly selected before sequencing analysis. Genes 
were denoted by green lines. Mutations are indicated by red blocks . 
pGBK-
PbGPA J-
RM-Lib 
pGBK-
PbGPBJ-
RM-Lib 
pGBK-
PbGPA2-
RM-Lib 
pGBK-
PbGPA3-
RM-Lib 
pGBK-
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
~157-353 
~155-353 
~145-353 
~139-353 
• • 
• • 
• 
• 
~184-359 
~174-359 
• ~257-353 
~103-359 
• 
~164-356 
~161 -356 
~214-356 
~198-356 
• •• 
PbRASJ- L'll-25+Ll07I-------t--------------
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L\149-238, missense 
mutations 84-148 
Figure 3.14-2. Sequencing results of positive clones obtained from screening 
negative control mutagenesis libraries with pGBK-PbCYR1 1-678• Clones were 
randomly selected before sequencing analysis. Genes were denoted by green lines. 
Mutations are indicated by red blocks. Mutated P53 and Lam genes were obtained 
after screening. No positive clones were obtained after screening random 
mutagenesis library pGAD-ScGPRJ679-961-RM-Lib. 
pGBK-
P53-RM-Lib 
pGBK-
lam-RM-Lib 
• 
• 
• 
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Figure 3.14-3. Truncated versions of PbGpa2, PbGpa3, PbRasl and PbActin 
interact with PbCyr1 1-678• Bait and prey vectors were simultaneously transformed 
into yeast strain AH109 and plated out on SD/-Leu/-Trp for 3 days. Yeast colonies 
grown on SD/-Leu/Trp were re-streaked on SD/-A de/-His/-Leu/-Trp and incubated 
for 3 days. Results shown below indicate that pGAD-PbGPA21-102, pGAD-
PbGPA31-160, pGAD-PbRASI 1-83, GAD-PbRASJ26-238 and pGAD-PbACTIN1-314 can 
interact with pGBK-PbCYRJ 1_J?8, while controls pGAD-PbACTIN, pGAD-
ScGPRJ 679-961, pGADT7-T, P-GAD-?5372-390, and pGAD-lam66-230 can not directly 
interact with pGBK-PbCYRI -678. 
pGBK-
PbCYRJ 1-678 
pGBK-
PbCYR11-678 
pGAD-
PbGPA21-102 
pGAD-
PbACT/N 
pGAD- pGAD-
PbGPA31-160 PbRAS1 1-83 
pGAD- pGADT7-
ScGPR1679-961 T 
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3.15 Yeast-Two-Hybrid: Some Negative Results 
In S. cerevisiae, S. pombe and C. albicans GPRs are membrane proteins, for which 
their cytoplasmic sides interact with a G protein a subunit and their cell surface side 
senses signalling molecules (Xue et al, 1998; Lamaire et al, 2004; Hoffman, 2005b; 
Miwa et al, 2004; Maidan et al, 2005b). We supposed that GPR exists in Pb and this 
gene could be conserved with other fungal GPRs, with a capacity to interact with our 
cloned Pb G protein a subunits. However, no GPR homologue was obtained when 
screening a PbOJ eDNA library with pGBK-PbGPAI, 2, and 3. Another pilot 
experiment was done by screening RM library pGAD-ScGPRJ 679-961 -RM-Lib with 
pGBK-PbGPAI, 2, and 3. Yeast-2-hybrid results indicated that Pb G protein a 
subunits do not interact with the ScGprl C-terminal cytoplasmic domain (Table 
3.15-1). 
Table 3.15-1. Number of positive clones after screening pGAD- ScGPRJ679-961-
RM-Lib. 
pGBK- pGBK- pGBK- pGBK-
PbGPAI PbGPA2 PbGPA3 ScGPA2 
pGAD-
ScGPR1679-96I_ 0 0 0 50 
RM-Lib 
A positive control was made by screening pGAD-ScGPRJ679-961-RM-Lib with 
pGBK-ScGPA2 (for construction see Table 3.11). As expected, a number of positive 
clones were obtained, indicating that most mutations of ScGPRI disrupt its protein 
structure, preventing its interaction with ScGpa2. Although Pb G protein a subunits 
can not interact with ScGprl, we still can not exclude the possibility that Pb has a 
GPR gene(s) that interacts with G proteins. Recently, we have cloned a putative G 
protein-coupled-receptor which is 47% identical to the G protein-coupled receptor 
GprF from A. nidulans (data not shown; Han et al, 2004). It needs further 
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examination to determine its relationship with G proteins in Pb. 
As we have 4 segments of PbCYRI cloned into both bait and prey vector, a yeast-2-
hybrid analysis was made to test intra-protein interactions of adenylate cyclase or 
interactions generated from its homo-polymers. Most members of Class III 
adenylate cyclases, with a single copy catalytic domain in their genes, exist as 
homodimers formed by interactions of identical catalytic domains (Linder and 
Schultz, 2003). However, there is no evidence to prove the case for fungal adenylate 
cyclases. Our pilot yeast-2-hybrid analysis with Pb adenylate cyclase could not find 
any interactions between the existing functional domains (Table 3.15-2). 
Table 3.15-2. Yeast-2-hybrid analysis for interactions between PbCyrl domains. 
pGBK- pGBK- pGBK- pGBK-
PbCYR1 1-678 PbCYRJ 600-1316 PbCYRJI302-1876 PbCYRJI648-2!oo 
pGAD-
PbCYR1 1-678 
-
-
- -
pGAD-
PbCYRJ6oo-J316 Not tested - - -
pGAD-
PbCYRJI30I-1876 Not tested Not tested - -
pGAD-
PbCYRJJ347-2!oo Not tested Not tested Not tested -
However, we could not exclude the possibility of some false negatives because some 
protein interactions may not show in the artificial yeast-2-hybrid system. For 
example, PbCYRI 1-678 in prey vector pGADT7 was not functional in yeast-2-hybrid 
system (data not shown). The reason for this is not clear. It is noteworthy that the 
catalytic domain PbCYR1 1648-2100, when cloned into both bait and prey vectors, did 
not yield positives in the yeast-2-hybrid system, suggesting that homodimers of Pb 
adenylat~ cycl~se do not form. flpyvev,er, it is still too early to make a firm 
conclusion. 
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3.16 Ph G Protein y Subunit PbGpg1 Interacts with Truncated Adenylate 
Cyclase PbCyr1 1"678 and Truncated p Subunit PbGpb1 but not Full-Length p 
Subunit PbGpb1 and Full-Length a Subunits PbGpa1-3 
A G protein y subunit gene PbGPG 1 was cloned by using degenerate PCR and SSP-
PCR with pDNR-PbOlcDNA Library plasmids (Dr. G. Chen, unpublished data). 
The gene encodes a protein with 91 amino acids and a molecular weight of 10 kDa 
(data not shown). PbGpg 1 is highly conserved, with 62% identity to the G protein y 
subunit Gngl of N. crassa and 22% identity to Ste18 of S. cerevisiae. When 
analyzed by SMART (EMBL), PbGpg1 contains a GGL (G protein gamma subunit-
like) motif, i.e. an extended a-helical polypeptide that is supposed to form a stable 
dimer with the G protein ~ subunit but not to contact with the a subunits. 
The full-length PbGPGJ was cloned into bait vector pGBKT7 and prey vector 
pGADT7 respectively (a gift from Dr G. Chen). Yeast-2-hybrid analysis was done 
(by Dr G. Chen) and the results are shown in Table 3.16-1 as below. 
Table 3.16-1. Yeast-2-hybrid: PbGpg1 interacts with PbCyr1 1"678 but not full-
length PbGpb1 and full-length PbGpa1-3. 
Constructions for PbCyrl, PbGpbl and pbGpal-3 (see Table 3.11) 
Constructions pGBK- pGBK- pGBK- pGAD- pGAD-
for PbGpgl PbCYR1 1-678 PbGPBJ PbGPAJ-3 PbGPBJ PbGPAJ-3 
pGAD- + Not Not PbGPGJ - - applicable applicable 
pGBK- Not Not Not 
PbGPGJ applicable applicable applicable - -
The results indicated that PbGpgl interacts with PbCyr1 1-678 but not full-length 
PbGpbl and full-length PbGpal-3. In order to further test the interaction between 
PbGpgl and PbGpbl, tnmcated PbQPBJ constructions were made by deleting one or 
more WD40 domain(s) and cloning into prey vector pGADT7 (the positions of 
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WD40 domains are illustrated in Figure 3.8-2). This job was finished by Dr G. Chen 
and illustrated in Table 3.16-2 as below. 
Table 3.16-2. Constructions with truncated PbGPBJ cloned into pGAI>T7. 
Constructions Descriptions 
pGAD-PbGPBJWD1 WD40 domains 2-7 were deleted. 
pGAD-PbGPBJWD1-2 WD40 domains 3-7 were deleted. 
pGAD-PbGPB JWD 1-3 WD40 domains 4-7 were deleted. 
pGAD-PbGPBJWD1-4 WD40 domains 5-7 were deleted. 
pGAD-PbGPBJWD1-5 WD40 domains 6-7 were deleted. 
pGAD-PbGPBJWD1-6 WD40 domain 7 was deleted. 
pGAD-PbGPBJWD2-7 WD40 domain 1 and coiled-coil domain 
were deleted. 
pGAD-PbGPBJWD6-7 Coiled-coil domain and WD40 domains 
1-5 were deleted. 
These truncated PbGPBJ constructions were then used to test their interactions with 
pGBK-PbGPGJ in the yeast-2-hybrid system (this job was done by Dr G. Chen). 
The results are displayed in Table 3.16-3 as below. 
Table 3.16-3. PbGpg1 interacts with truncated PbGpbl. 
pGAD- pGAD- pGAD- pGAD- pGAD- pGAD- pGAD- pGAD-
PbGPBJ PbGPBJ PbGPBJ PbGPBJ PbGPBJ PbGPBJ PbGPBJ PbGPBJ 
WDI WDI-2 WDI-3 WDI-4 WDI-5 WDI-6 WD2-7 WD6-7 
pGBK-
+ + + + - - -PbGPGJ -
The results indicated that PbGPGJ can interact with pGAD-PbGPBJWD1-2, pGAD-
PbGPBJWD1-3, pGAD-PbGPBJWD1-4 and pGAD-PbGPBJWDI-5 but not with 
pGAD-PbGPBJWDI, pGAD-PbGPBJWDI-6, pGAD-PbGPBJWD2-7 and pGAD-
PbGP B JWD6-7, indicating that the Pb G protein y subunit PbGpg 1 interacts with the 
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truncated ~ subunit PbGpb 1. The shortest truncated form of PbGpb 1 that interacted 
with PbGpg1 was the coiled-coil domain plus the first and the second WD40 domain. 
3.17 Truncated PbGpb1 Interacts with Full-Length PbGpa1 but not Full-
Length PbGpa2 and PbGpa3. 
Full-length PbGpb1 can not interact with full-length PbGpa1-3 as indicated in the 
following Table 3.17-1. 
Table 3.17-1. Yeast-2-hybrid: full-length PbGpb1 do not interact with full-
length PbGpa1-3 (see Table 3.11 for the constructions). 
pGBK-PbGPAJ pGBK-PbGPA2 pGBK-PbGPA3 pGBK-PbGPBJ 
pGAD-PbGPAJ Not tested Not tested Not tested -
pGAD-PbGPA2 Not tested Not tested Not tested -
pGAD-PbGPA3 Not tested Not tested Not tested -
pGAD-PbGPBJ - - - Not tested 
Random mutagenesis libraries were used in screening to search for such potential 
interactions. However, no positive clones were found. The results are illustrated as 
below in Table 3.17-2. 
Table 3.17-2. Yeast-2-hybrid: RM libraries screening for potential interaction 
between PbGpb1 and PbGpa1-3. 
pGBK- pGBK- pGBK- pGBK-
RM Library PbGPAI PbGPA2 PbGPA3 PbGPBI 
pGAD- Not tested Not tested Not tested 0 PbGPAJ-RM-Lib 
pGAD- Not tested Not tested Not tested 0 PbGPA2-RM-Lib 
pGAD- Not tested Not tested Not tested 0 PbGPA3-RM-Lib 
pGAD- 0 0 0 Not tested PbGPBJ-RM-Lib 
To further test the interaction between PbGpb1 and PbGpa1-3, the truncated 
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PbGPBJ constructions listed in Table 3.16-2 were used to co-transform with pGBK-
PbGPAJ-3 (see Table 3.11) in yeast-2-hybrid system. The results are shown below 
in Table 3.17-3 (finished by Dr G. Chen). 
Table 3.17-3. Yeast-2-hybrid: Truncated PbGpbl interacts with full-length 
PbGpal but not full-length PbGpa2 and 3. 
pGAD- pGAD- pGAD- pGAD- pGAD- pGAD- pGAD- pGAD-
PbGPBJ PbGPBJ PbGPBJ PbGPBJ PbGPBJ PbGPBJ PbGPBJ PbGPBJ 
WDI WDI-2 WDI-3 WDI-4 WDI-5 WDI-6 WD2-7 WD6-7 
pGBK-
+ + + - - - -PbGPAI -
pGBK-
- - - - - - - -PbGPA2 
pGBK-
- - - - - - - -PbGPA3 
The results indicate that truncated G protein ~ subunit PbGpb 1 interacts with full-
length a subunit PbGpal but not full-length PbGpa2 and 3. The shortest form of 
PbGpb 1 for interaction with PbGpa 1 is the coiled-coil domain plus the first and the 
second WD40 domains. This is the same as for PbGpg 1. 
196 
Chapter VI 
Discussion 
4.1 An Effective Way of Cloning Genes from Ph 
Before the genome era, most yeast genes were cloned by cross hybridization on the 
basis of homologous gene sequences from other organisms. For example, ScGPAJ 
and ScGPA2 were cloned by using a rat Ga gene (Nakafuku et al, 1987 and 1988); 
fission yeast gpa2 gene was cloned by using the Ga genes from rat and Dictyostelium 
discoideum (Obara et al, 1991; Isshiki et al, 1992). The adenylate cyclase gene from 
fission yeast was cloned using low-stringency hybridization with the budding yeast 
adenylate cyclase gene (Young et al, 1989); Candida's adenylate cyclase gene 
CaCYRJ was cloned by degenerate PCR (Mallet et al, 2000). In our experience, 
degenerate PCR is an effective way to clone Pb genes but attention should be paid to 
avoid primers spanning introns. In fact, intorns are probably prevalent in Pb genes 
as all the genes we have cloned indicate the existence of introns, for example, 
PbGPA2 even contains 9 introns. However, introns are not a major problem in S. 
cerevisiae, as 70% of yeast genes are intron free including those in the cAMP 
signaling pathway. Therefore, cloning genes from Pb is more difficult than from S. 
cerevisiae. This may explain why by 2000, relatively few genes had been cloned 
from Pb. To date, we still need to clone genes one by one for an organism if its 
genome information is not complete. In order to overcome the trouble caused by 
introns, a eDNA library of good quality is needed. Amplification of genes with 
degenerate primers from a Pb eDNA library is much more direct and convenient than 
from genomic DNA. However, for some genes with low abundance of transcription 
or no expression in a specific biological state or a stage of development, there could 
be a problem when a eDNA library is used. In this case, genomic DNA or its library 
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ts necessary. 
Our cloning was done by degenerate PCR usmg a combination of eDNA and 
genomic DNA libraries. This proved to be effective as all three isoforms of G 
protein a subunits have been cloned. In addition, only one TPK gene was amplified 
from Ph when different combinations of very degenerated PCR primers were used. 
However, when PbTpkl was used in searching homologous sequences in a Ph EST 
database, additional TPK polypeptide sequences could be found. Further 
investigation is needed to ensure if they are true isoforms or simply strain variation. 
Interestingly, A. nidulans, N. crassa and M grisiea, which are phylogenetically 
related to Ph, each have 2 PKA catalytic subunits, falling into 2 groups during 
evolution (Figure 3.9-4). PbTpkl belongs to one group but another potential PKA 
catalytic subunit from Ph seems missing in the other group. We are confident to 
obtain this missing gene with further degenerate PCR if it does exist in Ph. With 
RACE PCR or single specific PCR, full length genes of major components of the 
cAMP signaling pathway have been cloned. In fact, our eDNA library is of quite 
good quality because it is markedly representative of expressed genes in Ph. We 
cloned most components of cAMP signaling pathway from it, even for the Gy protein 
which is quite small with a length of only 0.3 kb. 
Recently, several EST (expressed sequence tag) projects have been finished by 
scientists in Brazil (Goldman et al, 2003; Felipe et al, 2003 and 2005). However, all 
these sequence tags only represent about 25-80% of the whole transcriptome. In fact, 
most of our genes are not included in their findings, indicating the limitation of their 
eDNA libraries. Therefore, a project for whole genome sequencing is also necessary. 
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Given the existence of intron sequences in most of the genes and differential splicing 
in some of the genes, there will be difficulties in analyzing the genomic data. We 
strongly suggest that both genomic and eDNA libraries be used in combination or in 
complementation with each other in cloning genes from Pb. 
4.2 Clues from the Primary Structure of the Major Components of the cAMP 
Signaling Pathway 
Including the work presented in this thesis, we have cloned the central components 
of the cAMP-signalling pathway of Paracoccidioides brasiliensis using the genomic 
and eDNA libraries. Phylogentic analyses of PbCyrl, PbGpa1,2,3, PbGpbl, 
PbGpgl, PbRasl, PbTpkl and PbTpkll indicate that Pb is evolutionally related to 
Aspergillus nidulans and Penicillium marneffei. However, the biological behaviors 
of these fungi are diverse including geographical distributions. A. nidulans is only a 
weak opportunistic fungal pathogen. P. marneffei is an opportunistic fungal 
pathogen in Southeast Asia, while Pb is restricted to South America. This will bring 
difficulty in judging the exact function of a protein just by analyzing the homology 
of its primary structure with a protein having a known function. A detailed 
description of a Pb protein's function will depend on analysis in a tractable genetic 
system of Pb which at present does not exist. However, that does not mean we can 
not do anything without this system. We can still obtain some basic information 
from cloning genes and analyzing primary structures. Gene expression and 
biochemical analyses will also be useful in analyzing a protein's function(s). 
The Pb adenylate cyclase PbCyrl is not a membrane protein but it could be a 
membrane-associated protein similar to ScCyr 1. Like other fungal adenylate 
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cyclases, PbCyrl has 4 domains: an RA domain, LRR domains, a PP2Cc domain and 
a CYCc domain. It has little homology with mammalian adenylate cyclase except in 
the catalytic CYCc domain (Fig. 3.3-5). These domains can be effectively expressed 
in the yeastS. cerevisiae and E. coli (data not shown). TheN-terminal region (1-
678; with RA domain included) of PbCyrl can interact with G proteins, Ras 1 and 
actin in yeast two-hybrid systems, while constructs with other domains do not 
interact with any proteins tested. There are 3 possibilities for this. First, these 
proteins are non-interactive. Secondly, the yeast two-hybrid system is an artificial 
system and sometimes false negatives occur without known reasons. Thirdly, the 
segmented gene construction might be unstable and degraded in the yeast cells. 
However, this seems unlikely because the PP2Cc domain and CYCc domain were 
easily expressed in E. coli (data not shown). 
There are 3 different transcripts for Pb adenylate cyclase that differ in their splicing 
at the first intron to produce 2 types of truncations, PbCyr lli58 and PbCyr 1li58-64 • This 
is not a surprise because differential splicings can also be found in an adenylate 
cyclase of the malaria parasite Plasmodium falciparum (Muhia et al, 2003). 
However, this region of truncation does not overlap with the conserved residues 
responsible for interaction with Gpa2 in S. pombe (Ivy and Hoffman, 2005). The 
behavior of N-terminal PbCyr1li58-64 is the same as that of N-terminal full-length 
PbCyr1 in terms of interacting with G proteins, Rasl and actin (data not shown). 
The function of this truncation still needs further examination. 
The conserved motif aXX:a:XXX (a represents a hydrophobic ammo acid and X 
represent any amino acid) or L:XX:XXXX at the C-terminal end (1916-1930) of the 
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yeastS. cerevisiae adenylate cyclase is also conserved in PbCyrl (1953-1967). This 
motif repeat is responsible for the coiled-coil domain that interacts with the cyclase-
associated protein CAP in yeast (Nishida et al, 1998), suggesting the existence of a 
CAP homologue in Pb. 
Adenylate cyclases can be classified into 3 groups (Linder and Schultz, 2003). Class 
I cyclases are present in many gram-negative bacteria such as E. coli. Class II 
cyclases serves as extracellular toxins in certain pathogens such as Bacillus anthracis 
or Bordetella pertussis. Class III adenylate cyclases are phylogenetically related 
multi-domain proteins. They are found in prokaryotes and in eukaryotes, including 
bacteria, metazoans, protazoans, mammals and fungi. There are 6 conserved amino 
acids in the catalytic domains of the Class III adenylate cyclases, serving 3 principle 
functions in catalysis: two aspartate residues for metal-cofactors (Mg2+ or Mn2+) 
binding; a lysine and aspartate pair for selecting A TP as substrate, and an arginine 
and asparagine pair for transition-state stabilization (Linda and Schultz, 2003). The 
current understanding of catalytic domains of mammalian adenylate cyclase indicates 
that they form homo- or heterodimers for function. The catalytic activity of 
mammalian adenylate cyclases is activated or inhibited by the binding of Gas or Gai 
proteins to the C2 and Cl cytoplasmic domains, respectively, to increase or decrease 
the interactions of these domains (Dessauer et al, 2002). Yeast S. cerevisiae 
adenylate cyclase is always purified as a complex with molecular weight from 670 to 
890 kDa (Wang et al, 1992), indicating that it is a dimer. Adenylate cyclases from 
both Pb and S. cerevisiae contain all the 6 conserved amino acids for catalytic 
functions. Given that the primary structure of Pb adenylate cyclase is similar to that 
of S. cerevisiae, PbCyr 1 should also exist as a dimer complex. It is interesting that 
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the catalytic domain alone of S. cerevisiae adenylate cyclase is active (Kataoka et al, 
1985), indicating that dimer formation is independent of other domains within 
adenylate cyclase itself. In contrast to mammalian cells, G proteins do not act on the 
catalytic domain of adenylate cyclase in Pb. Nor is there evidence that there is an 
interaction between the two catalytic domains themselves (Table 3 .15-2). The 
question is how the dimer is formed. Interestingly, CAP forms a dimer using its last 
27 amino acid residues (Freeman et al, 1996). Its N-terminus interacts with the C-
terminal end of adenylate cyclase (Nishida et al, 1988). In addition, CAP was co-
purified with adenylate cyclase (Wang et al, 1992). Therefore, dimer formation of 
adenylate cyclase could be brought by the cyclase associated protein CAP. 
Gene duplication is an important mechanism for acquiring new biological functions 
during evolution. Many genes are present in multiple isoforms in fungi. For 
example, in the cAMP signaling pathway of the yeast S. cerevisiae there are 2 G 
protein a subunits, 2 Ras proteins and 3 cAMP-dependent protein kinases. These 
proteins, although homologous in their primary sequences, have divergent functions. 
In Pb, 3 isoforms of G protein a subunits have been cloned (this thesis). We believe 
that they have evolved from duplication of a single copy gene as the introns are 
localized in the same positions in the genes (Figure 3.7-4). YeastS. cerevisiae G 
protein a subunits function divergently, one controls cAMP levels for pseudohyphal 
growth and one controls mating through the MAPK pathway (Borges-Walmsley and 
Walmsley, 2000; Hoffman, 2005a). Therefore, the 3 Ga proteins in Pb may have 
different functions. The data in this thesis indicate that they all act on adenylate 
cyclase but supposedly have different roles in regulating adenylate cyclase. They 
might also work on additional pathways such as the MAPK pathway, components of 
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which have been identified in an EST analysis (Felipe et al, 2005). 
In S. cerevisiae, there are two artificial dominant active alleles GPA2G132v and 
GPA2QJOoL, and a dominant negative allele GPA2G299A (Harashima and Heitman, 
2005). These amino acids are conserved in Pb Ga subunits for potential point 
mutations to yield dominant active or negative alleles. The corresponding mutations 
for PbGpal are G42V, Q204L and G203A; for PbGpa2 are G46V, Q210L and 
G209A; for Gpa3 are G45V, Q208L and G207A. In addition, the GXG 16:XXG motif 
is also conserved in PbRasl. Therefore, PbRASIG16v should be a dominant active 
allele. It is worth testing the biological behaviors of these dominant active or 
negative alleles once the transformation system for Pb has been established. 
All Ga proteins have N-terminal lipid modifications, i.e. myristoylation and 
palmitoylation, for membrane targeting (Cabrera-Vera et al, 2003). The site of 
myristoylation is the glycine at the second position in the consensus sequence 
MGXXXS. Palmitoylation occurs on cysteine(s) near theN-terminus. All the Pb 
Ga proteins isolated here retain these consensus sequences. They are MGCGMS for 
PbGpa1, MGCASS for PbGpa2 and MGGCCS for PbGpa3. Myristoylation of Ga 
proteins is responsible for membrane localization and coupling to the membrane 
receptor but does not affect the interaction with Gpy (Song et al, 1996). Therefore, 
the 3 Ga proteins from Pb are likely to be myristoylated, palmitoylated and 
membrane targeted. In addition, PbRas1 and PbGpg1 both have the conserved 
CAAX (A for aliphatic amino acids) motif(Kuroda et al, 1993), suggesting that they 
are both palmitoylated, farnesylated and targeted to the membrane. These findings 
suggest that all the G proteins of Pb are membrane anchored and probably coupled to 
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membrane receptors. When using S. cerevisiae Gprl to search a Pb EST database, 
however, no homologous sequence can be found. Recently, we have cloned a 
putative G protein-coupled receptor from Pb (data not shown). It is 47% identical to 
the G protein-coupled receptor GprF from A. nidulans (Han et al, 2004). Its 
relationship with G proteins need to be tested. 
In S. cerevisiae, there are 3 catalytic subunits of cAMP-dependent protein kinases, 
which have probably acquired different functions during evolution by development 
of specific domains for different protein interactions. Tpk2 is responsible for both 
pseudohyphal and invasive growth, while Tpk1 and Tpk3 play negative roles 
(Robertson and Fink, 1998; Pan and Heitman, 1999). The 3 Tpk proteins are highly 
conserved at their C-terminal but are highly divergent at their N-terminal ends. The 
distinct N-terminal extension of Tpk2 is glutamine-rich (29%) compared with Tpk1 
(9% glutamine) and Tpk3 (3% glutamine). One ofthe two catalytic subunits ofPKA 
in C. albicans is also glutamine-rich (19% for CaTpk2) in its distinct N-terminus, 
while the other is not (5% for CaTpk1). Both Tpk proteins of C. albicans are 
involved in regulation of dimorphism (Bockmuhl et al, 2001). We have cloned one 
copy of a TPK gene in Pb, namely PbTPKJ. The PbTpkl is also glutamine-rich 
(15%) in its N-terminus. Although the function of the poly-glutamine stretch is still 
unknown, it is possible that PbTpk1 belongs to a class of fungal PKA catalytic 
subunits that evolved to specifically regulate dimorphism. 
InS. cerevisiae, Tpkl and Tpk3 are specialized to inhibit filamentous differentiation. 
Epistasis analyses suggest that Tpk 1 and Tpk3 exert their negative effects through 
element(s) upstream of PKA itself (Pan and Heitman, 1999). In fact, there is a 
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cAMP accumulation in cells growing on glucose-containing media when the Tpk 
proteins are disrupted (Nikawa, et al, 1987). This indicates that Tpkl and Tpk3 
function in a negative feedback loop that represses cAMP production. The target of 
this feedback has not been found but it may include adenylate cyclase. In Pb, 
although we have cloned only one catalytic subunit (PbTPKJ) of PKA, we cloned 
another Tpk-like gene PbTPKLJ. A similar situation also prevails in S. cerevisiae 
and C. albicans. InS. cerevisiae, the Tpk-like protein, Sch9, functions in parallel to 
both the Gprl-Gpa2-cAMP pathway and the MAPK pathway. The Sch9 kinase is 
required for normal vegetative growth and heat shock sensitivity when Gpa2 is 
activated (Lorenz et al, 2000; Xue et al, 1998). However, further experiments are 
required to test if the PbTpk-like protein is in the cAMP pathway or not. 
Interestingly, the PbTpk-like gene transcript level correlated well with peaks for 
PbCyrl, suggesting that it plays an important role in controlling the morphological 
switch (Chen et al, 2006a, manuscript for publication). In this thesis, the 
relationships between adenylate cyclase and the heterotrimeric G proteins, a Ras 
protein and actin have been delineated by yeast two-hybrid assays. Further 
experiments indicated that PbTpkl also interacts with the N-terminus of adenylate 
cyclase (data not shown). The relationships between adenylate cyclase and PbTpkll 
have not been tested. It will be interesting to see if a negative feedback loop could 
exist via either Tpkl or Tpk-like protein in the cAMP pathway of Pb. 
We have cloned a PbTUPA gene which is homologous to the S. cerevisiae TUPJ 
gene. The TUP 1 gene plays a major role in glucose repression in yeast (Williams 
and Trumbly, 1990). In addition, it can regulate other phenotypes such as yeast 
floculence, sporulation and mating (Williams and Trumbly, 1990). When yeast cells 
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are grown on glucose, enzymes that are needed for utilizing alternate carbon sources 
are turned off, i.e. repressed. When glucose is exhausted, these enzymes are 
derepressed. The TUP 1 gene is probably at the end of a signaling pathway that is 
responsive to glucose. Glucose is one of the stimulants that are involved in 
triggering the cAMP signaling pathway in yeast. Therefore, we suspect that TUP 1 is 
an element in the cAMP pathway or an element that interacts with the pathway, but 
currently there is no genetic evidence to support this. Interestingly, PbTupA contains 
seven WD40 repeats which are homologous to the Pb G protein ~ subunit PbGpb 1 
(13% identity), suggesting a similar function to the G~ subunit. Indeed the structure 
of the S. cerevisiae Tup 1 contains a seven-bladed ~ propeller which can be super-
imposed over the similar structure of G~ proteins (Sprague et al, 2000). It could be 
involved in protein-protein interactions such as binding to transcriptional factors or 
binding to an element in a signaling pathway. Alternatively, it could bind to DNA 
directly to exert its repressive function. The function of PbTupA needs further 
examination. 
4.3 Yeast Two-Hybrid Assay 
Genetic analysis is an essential way to delineate a signaling transduction pathway but 
a detailed map depends on the solid evidence of protein-protein interactions, which 
are usually demonstrated by yeast two-hybrid assays and co-immunoprecipitation. 
However, in most cases for cell signaling pathways, protein interactions are not 
constitutive but exhibited only in a transient state. In the yeast S. cerevisiae, for 
example, Rgs2 physically interacts with Gpa2 but this interaction is very weak in 
yeast two-hybrid analyses and in immunoprecipitation assays; a strong interaction is 
only observed when Gpa2 is in the GTP-binding state (Versele et al, 1999). The 
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reason for this is probably that a specific and tight binding of proteins depends on the 
existence of a signal which triggers a change in protein conformation(s). Proteins 
can change between 'switched-on' and 'switched-off states corresponding to its 
conformation with the ability to bind or not to its partner. This makes it very 
difficult to find a protein-protein interaction simply by a routine yeast two-hybrid 
screening. To overcome this difficulty, we devised an effective way of finding an 
interaction by screening a random mutagenesis library when the interaction can not 
be observed with the full-length wild type gene. We supposed that random 
mutagenesis could bring the protein, which otherwise is incompetent for binding, 
into a conformational state competent for binding or to remove a part of the protein 
that may have a negative regulatory role for binding. In this thesis, the interactions 
of Pb adenylate cyclase with PbGpa2, PbGpa3, PbRasl and PbActin were all found 
in this way. This is consistent with some observations of other researchers. For 
example, in the yeast S. cerevisiae, Gpa2 is also involved in sporulation regulation 
through direct inhibition of a meiosis-specific protein kinase Ime2 (Donzeau and 
Bandlow, 1999), which was cloned by yeast two-hybrid screening with Gpa2. It is 
noteworthy that most of the isolated clones are a C-terminal fragment of the 
regulatory domain. Further analysis indicates that although Gpa2 interacts with the 
full-length Ime2, the strength of interaction is only 1140 of that of the interaction with 
the C-terminal fragment of Ime2. It is interesting to note that this interaction is also 
dependent on the GTP-binding state of Gpa2. We could imagine that because Gpa2 
is a yeast gene that it can easily transform into a transient GTP-binding state in yeast 
cells under the cognate regulator(s). In yeast two-hybrid analysis, a dominant active 
Gpa2° 132v can interact with full-length Ime2 but an inactive Gpa20299A can not 
interact with the full-length Ime2. However, both the active and inactive forms of 
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Gpa2 can interact well with the C-terminal fragment of Ime2 (Donzeau and 
Bandlow, 1999). These results indicate that the conformational change of Gpa2 
triggered by GTP is responsible for its interaction with Ime2, possibly by changing 
the conformation of both Gpa2 and Ime2 and exposing the C-terminal interacting 
domain of Ime2. Once theN-terminus is deleted from Ime2, the interacting domain 
is readily exposed so that it interacts with both the active and inactive Gpa2 in a 
constitutive and strong manner. This example is highly consistent with our 
expenence. In some cases, yeast two-hybrid analyses, especially for a transient 
protein interaction in a cell signaling pathway, the interactions may be too weak to 
detect. This is especially the case when the two proteins are not from the yeast S. 
cerevisiae; since then their conformations might not be adjustable by yeast regulators 
and then they may not be competent for interaction. Point mutations or deletion of a 
part of one or both proteins may help to expose the interacting domains and facilitate 
their interaction. 
4.4 All the Three Ga prteins and a GJ3 Protein Interact with Adenyalte Cyclase 
in Paracoccidioides brasiliensis 
The cAMP signaling pathway of Paracoccidioides brasiliensis is very important as 
demonstrated by the fact that all 3 G protein a subunits, the G protein ~ subunit and 
~y dimer can interact with adenylate cyclase PbCyrl at its N-terminus. During the 
course of our study, it was reported that Gpa2 binds to theN-terminus of adenylate 
cyclase to cause its activation in S. pombe (Ogihara et al, 2004; lvey and Hoffman, 
2005). Our result is still unique in fungal biology because it is the first evidence that 
all the Ga proteins can directly interact with adenylate cyclase in an organism. Our 
study is also the first to demonstrate that G~ and the G~y dimer can directly interact 
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with adenylate cycalse in fungi. On the other hand, we have established that PbGpa1 
interacts with PbGpb 1, which also interact with PbGpg 1, indicative of the formation 
of a canonical Gpa 1-Gpb 1-Gpg 1 heterotrimer. In contrast, Gpa2 and Gpa3 seem to 
work alone or with other yet unidentified partners. Analysis of gene transcripts by 
real-time PCR indicated that PbCYRJ, PbTPKJ, PbGPAJ, 2, 3 and PbGPGJ are all 
expressed at higher levels in the yeast form than mycelial form (Chen et al, 2006a, 
manuscript for publication). This suggests that an elevated level of cAMP supports 
the yeast form of Pb. However, the addition of cAMP into the media retarded the 
mycelium to yeast transition, but did not prevent the yeast to mycelium transition, 
nor did it induce the transition of yeast at 37°C (Chen et al, 2006b, manuscript for 
publication). This result is in contrast to previous observation that exogenous cAMP 
blocked the yeast to mycelium transition (Paris and Duran, 1985). 
G proteins are a family of guanine nucleotide-binding proteins that are involved in a 
variety of receptor-mediated signal transduction systems, including sensory, 
neurotransmitter and hormone signalling (Lambright et al, 1996). For example, Gs, 
and Gi are involved in hormonal stimulation and inhibition. The best-understood 
pathways of G protein action are in mammalian cell systems. These G proteins, 
consisting of a, p, and y subunits, exist as inactive heterotrimers with GDP bound to 
the a subunit and are coupled to a cell surface receptor (Hoffman, 2005a). Receptor 
stimulation leads to a conformational change in Ga and exchange of GDP for GTP 
on the G protein a subunit, activating Ga. The activated Ga then dissociates from the 
py subunits, which do not undergo a conformational change. Both a and py subunits 
are then able to modulate diverse intracellular effectors, including adenylate cyclase, 
cyclic GMP phosphodiesterase, and phospholipase A2. Hydrolysis of GTP to GDP 
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turns off the Ga, which then reassociates with free ~y to return to the inactive Ga~y 
state. The duration of G protein signalling depends on the intrinsic GTPase rate of 
the Ga subunit but is also modulated by extrinsic factors such as the G~y dimer and 
RGS proteins (regulators ofG protein signalling; Hoffman, 2005a). 
In mammalian cells, an excess of the G~y dimer promotes reassociation with Ga, 
inhibiting Ga stimulated adenylate cyclase activity. In addition, G~y alone can 
activate or inhibit adenylate cyclase by direct interaction (Diel et al, 2006). The 
working mechanism of the canonical heterotrimeric G proteins in S. cerevisiae is 
probably similar to that of the mammalian ones but with differences. In the yeast 
pheromone pathway, it is the G~y dimer that activates the pathway. The Ga subunit 
turns off the signal by association with the G~y dimer. The G protein ~ subunit Ste4 
is probably the limiting component of the active G~y dimer because the activated 
pheromone response generated by overexpression of Ste4 (~) was abolished by 
deletion of Ste18 (y) but overexpression of Ste18 alone does not induce the 
pheromone response (Cole et al, 1990). In addition, overexpression of Gpal(a) 
neutralizes the biological effect of overexpression of the ~ subunit Ste4 (Cole et al, 
1990). Deletion of GPAJleads to the same phenotype as the overexpression of the~ 
subunit Ste4, i.e. haploid-specific cell cycle arrest, indicating that G~y is 
constitutively active without damping by the Ga subunit (Cole et al, 1990; Whiteway 
et al, 1990). These findings suggest that a proper stoichiometry in the levels of the 
G-protein subunits exists in a normal mating pheromone response. The ratio of G 
protein a, ~. and y subunits probably determine the state of the cells in response to 
pheromone. In fact, various phenotypes exist in response to different concentrations 
of pheromone. It was supposed that the pheromone pathway is capable of existing in 
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a state not fully active or inactive (Cole et al, 1990). Within the cells, the 
concentration ofSte4 (~)is probably lower than that ofSte18 (y). Overexpression of 
Ste4 further potentiates the pheromone response, while overexpression of Gpa 1 
sequesters the G~y dimer into an inactive Ga~y trimer, attenuating the pheromone 
response. In addition, activated Gpa1 is capable of producing an adaptive response 
by interacting with its own regulator or effector. For example, Gpa1 can directly 
interact with an upstream RGS (regulators of G-protein signalling) Sst2 that probably 
stimulates conversion of Gpa1 to the GDP-bound state and promotes recovery after 
pheromone-induced growth arrest (Dohlman et al, 1995; Dohlman et al, 1996). 
Furthermore, the GTP-charged Gpa1 directly interacts with activated Fus3, a 
downstream element of the MAPK pathway, performing an adaptive-negative 
control by inhibiting localization of Fus3 in nuclei (Metodiev et al, 2002; Blackwell 
et al, 2003). Recently, it has also been found that the GTPase-deficient GPAJQ323L 
allele can also activate the pheromone pathway by directly interacting with an RNA 
binding protein Scp160 (Guo et al, 2003). The possible position of Scp160 in the 
pathway is downstream of the receptor and upstream of G~y. Therefore, either Ga or 
G~y alone can activate the pheromone MAPK pathway and the traditional model 
should be modified. 
A similar situation has been noted in S. pombe, where the G~ Git5 is transcribed at 
much lower levels than Gpa2 and Gitll (Hoffman, 2005a). It has been hypothesized 
that the uncomplexed Gpa2 could be associated with adenylate cyclase to form an 
inactive complex: glucose activation of the signaling pathway would lead to the 
Gpa2-GTP complex, released from the Git5-Git11 dimer, being swapped for Gpa2-
GDP bound to adenylate cyclase that would then become activated (Hoffman, 
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2005a). 
In P. brasiliensis, there is one canonical heterotrimeric G proteins, consisting of 
PbGpal(a), PbGpbl(~) and PbGpgl(y). The latter two subunits form a tight G~y 
dimer supposedly but there is also an opportunity that PbGpb 1 works alone when 
transcript levels of PbGpbl and PbGpg1 are imbalanced (Chen et al, unpublished 
data). Both the PbGpal and the G~ (or G~y dimer) modulate the same effector, i.e. 
adenylate cyclase. The working mechanism is probably analogous to that in the 
pheromone pathway of S. cerevisiae. For example, PbGpb1-PbGpgl could activate 
the adenylate cyclase while PbGpa1 could negatively regulate adenylate cyclase, and 
meanwhile sequester the G~y dimer and inactivate it. Alternatively, PbGpa1 may 
play the active role while the Pb G~y dimer may play the negative role by interacting 
with both adenylate cyclase and Gpa 1. This situation is similar to that of Gpa2-
Gpbl/2 interaction inS. cerevisiae if both Gpa2 and Gpb1/2 directly act on the same 
target, adenylate cyclase. Therefore, either PbGpal or PbGpb1 activates the pathway, 
while the opposite component plays a negative role by directly damping its partner 
and exerting an adaptive negative effect via adenylate cyclase. It is also possible that 
both Gpal and the PbGpb1-PbGpgl dimer activate adenylate cyclise, while one 
sequesters another by direct interaction. 
The ratio of PbGpa 1 and the G~y dimer (or simply PbGpb 1) could also be crucial 
in determining the phenotype of the Pb cells. It is possible that overexpression of 
one component may cause the inability of the other to be fully sequestered, 
leading to a phenotype dominated by the overexpressed component. In fact, 
similar to the graded phenotype in yeast mating, the temperature induced 
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morphological transition in Pb is a long progress, taking 3 weeks for complete 
transition ( da Silva et al, 1999). This indicates that the transition is a complex set 
of events, including multiple genes that could be turned on or off, up-regulated or 
down-regulated, at the transcription level. One possible event is a change in the 
balance of the G protein subunits. According to our results, the a subunit PbGpa 1 
and the ~ subunit PbGpb 1 probably require conformational changes for interaction. 
Similarly, full-length PbGpb1 may not be in the required conformation to interact 
with PbGpg1, possibly due to the C-terminus blocking the interaction. The 
formation of the PbGpb1-PbGpg1 dimer may require Hsp30 as a chaperone since 
we found a high propensity to clone this gene from a yeast two-hybrid library 
screened with full-length PbGpb1 (Chen et al, unpublished results). This is not 
surprising as recent studies have revealed a role for phosducins as chaperones for 
the G~y complex (Lukov et al, 2005). PbGpa1 and PbGpb1 may be loosely 
associated and either of them alone may be capable of modulating the adenylate 
cyclase. Indeed, our gene transcriptional analysis with real-time PCR indicated 
that there was an increasing imbalance in the PbGPAJ and PbGPBJ transcript 
levels during the process of morphological transition (Chen et al, unpublished 
data). In mycelium the transcript levels for PbGPAl, PbGPBJ and PbGPGJ are 
nearly equivalent, suggesting that the signal is dependent upon GTP-induced 
dissociation of the Ga~y complex. However, during the mycelium to yeast 
transition, the PbGPBJ transcript levels were 11 fold higher than PbGPAJ after 24 
hours, but towards the end of the transition, after 240 hours, the PbGPAJ 
transcript levels were 3 times higher than those for PbGPBJ. In contrast, the 
PbGPG 1 transcript levels were either equivalent to, or less than, those for 
PbGPA 1. These results lead us to suggest that during the transition, PbGpb 1 
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would be in excess and freely available to modulate the activity of adenylate 
cyclase and govern the morphological switch. Indeed, the addition of exogenous 
cAMP, which retards the morphological switch, suppresses the PbGPAJ/PbGPBI 
imbalance but stimulates PbCYRI transcription, albeit with a maximum after 72 
hours instead of24 hours (Chen et al, unpublished data). 
It is interesting that all the interacting proteins including G proteins, PbRas 1 and 
PbActin work on adenylate cyclase through its N-terminal one third which is over 
800 amino acids residues away from the catalytic domain. This is in contrast to the 
situation in mammalian cells, in which G proteins modulate the activity of adenylate 
cyclase by binding to the catalytic domain (Tesmer et al, 1997). In Pb, the signals 
from regulators such as G proteins, PbRas 1 and PbActin have to be relayed to the 
catalytic domains. In our study, we did not detect any interaction between RA, LRR, 
PP2Cc and CYCc domains of adenylate cyclase, but these might be only be induced 
by the binding of effectors, such as Gpa1 to theN-terminal domain. 
Yeast Ras2 is a direct activator of adenylate cyclase and mediates the glucose 
signalling. Ras2 associates with adenylate cyclase via an interaction with the RA 
domain (Kido et al, 2002). Ras2 has a second binding site at the C-terminal end of 
adenylate cyclise in the presence of CAP (Shima et al, 2000), indicating that the RA 
domain and the C-terminus are in proximity in the 3-D structure. Interestingly, a 
mutant adnenylate cyclase Cyrl K 1876M allele abolishes glucose- and acidification-
induced increase in cAMP but still maintains the basal level of cAMP (Vanhalewyn 
et al, 1999). This mutation probably leads to a conformation change of the catalytic 
domain which in turn fails to communicate with the activated N-terminal domains. 
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The K1876 is conserved in Pb; consequently, it will be interesting to see how it 
affects Pb adenylate cyclase activity and further more how it affects the 
communication between the catalytic domain and theN-terminal domains. 
In S. cerevisiae, there is one canonical heterotrimeric G protein, consisting of 
Gpal(a), Ste4(p) and Stel8(y). The Ga can directly interact with Gpy as indicated 
by a yeast two-hybrid analysis (Ongay-Larios et al, 2000). A mutation of Ste4 with 
Leu-132 in the second WD40 domain replaced by phenylalanine leads to a defective 
interaction between Ga and Gpy, indicating that the second WD40 domain (but it is 
the first blade) is essential for the interaction. Crystal structures of mammalian 
heterotrimeric G proteins revealed that Ga changes its conformation when 
dissociated from the Gpy but that Gp does not change its conformation following 
dissociation (Lambright et al, 1996). The Gp folds into a symmetric propeller 
structure containing seven blades of p sheets. For each blade, there are 4 anti parallel 
p sheets radiating outwards from a central axis. The first 3 p sheets of an individual 
blade come from the C-terminus of a WD40 sequence but the fourth p sheet comes 
from theN-terminus of the next WD40. Therefore, theN-terminus of the first WD40 
and the C-terminus of the last WD40 form the ih blade. TheN-terminal region of 
Gp is involved in the coiled-coil interaction with theN-terminus of Gy. The Gpy use 
its N-terminal coiled-coil domain to interact with its downstream effector (Ongay-
Larios et al, 2000). 
In contrast to the situation in S. cerevisiae, PbGpal can not directly interact with 
PbGpb 1 in the yeast two-hybrid system. There are 3 possible explanations for this. 
Firstly, it might be that PbGpal can directly interact with PbGpbl but this is not 
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apparent in the yeast two-hybrid system. This situation is similar to the Gpa2-Krh1 
interaction inS. cerevisiae, where Gpa2 can not interact with full-length Krh1 (kelch 
repeat homologue; was named Gpb2 by Harashima and Heitman, 2002) but interacts 
with the C-terminus of Krh1 (Batlle et al, 2003). Secondly, in mammalian cells, the 
G protein ~ and y subunit are treated as a single unit because they are tightly 
associated throughout purification (Neer and Clapham, 1988). However, PbGpa1 
could not interact with a PbGpbl-linker-PbGpg1 fusion protein (Chen et al, 
unpublished data); it is notable that neither PbGpa1 nor PbGpg1 interacted with the 
full-length PbGpb1, which needed to be truncated at the C-terminus to enable the 
interaction (Table 3.16-1 and 3; Table 3.17-1 and 3). Thirdly, full-length PbGpb1 
can interact with Hsp30 which is an integral membrane protein that might serve as a 
chaperone, like phosducins, for assistance in G~y dimer assembly (Lucov et al, 2005; 
Chen et al, unpublished dara). It is interesting that the Gy PbGpgl and the Ga 
PbGpa 1 bind to the same first two WD domains on PbGpb 1. It is not clear if they 
compete for binding to PbGpbl. InS. cerevisiae, a HSP70 chaperone Ssal directly 
interacts with Cdc25 and positively controls the production of cAMP (Geymonet et 
al, 1998). Deletion of Ssa 1, for example, leads to a decrease in Cdc25 content in the 
cells but not at the transcript level. In Pb, Hsp70, which has been proposed to be a 
cellular thermometer, is highly correlated with the dimorphic switch ( da Silva et al, 
1999). It usually binds to and stabilizes unfolded proteins after heat shock. Hsp30 
may be another important chaperone in Pb. Its function may be different form 
Hsp70 because its expression is down-regulated during the mycelium to yeast 
transition, whilst the expression of Hsp70 is up-regulated (data not shown; da Silva 
et al, 1999). Given the suggestion that Hsp30 regulates the assembly of the G~y 
dimer, the down-regulation of Hsp30 may make Hsp30 unavailable for Ga and G~. 
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Without the assistance of Hsp30, Ga and G~ would be in a conformation not suitable 
for direct interaction, and would thus work independently. This would give even 
finer control of adenylate cyclase activation. In fact, the morphological 
transformation is quite a slow process, taking more than 2 or 3 weeks to go from 
mycelia to yeast. In this case, it is not a surprise that the organism responds to 
temperature change so slowly because the regulation is so complicated and indirect. 
Our data indicate that PbGpa2 and PbGpa3 do not interact with PbGpb 1. They must 
either act alone or with yet unidentified proteins, possibly with kelch repeat proteins. 
Similar situations have been observed in budding yeast and fission yeast. In budding 
yeast, Gpa2 can not form a typical heterotrimeric protein with Ste4 and Ste 18 but 
forms an atypical heterotrimeric protein with kelch repeat proteins Gpb1/Krh2 and 
Gpb2/Krh1 (Harashima and Heitman, 2002; BatHe et al, 2003). Similarly in fission 
yeast, Gpa 1 in the pheromone pathway fails to form a heterotrimeric protein with the 
known G~y subunits Git5/11 (Hoffman, 2005a). The Gpa1 of fission yeast possibly 
associates with the kelch repeat protein Ral2 as indicated by genetic studies 
(Hoffman, 2005a). In S. cerevisiae, the kelch repeat protein Gpb2/Krhl (or 
Gpb1/Krh2) works downstream of Gpa2 (BatHe et al, 2003). In addition, Both 
Gpb2/Krh 1 and Gpa2 could directly interacts with adenylate cyclase (Harashima and 
Heitman, 2002; Hoffman, 2005a). However, there is no direct evidence that Gpa2 
and Gpb2/Krh1 can directly interact with adenylate cyclase to date. 
4.5 Pb RAS Protein Acts on Adenylate Cyclase 
Mammalian RAS proteins can activate adenylate cyclase in the yeast S. cerevisiae 
but neither the mammalian RAS nor the yeast RAS proteins can regulate mammalian 
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adenylate cyclase (Kataoka et al, 1985). Even in the fission yeast S. pombe, there is 
no indication that adenylate cyclase is regulated by RAS proteins although there is an 
obvious RA domain (Hoffman 2005a). It seems that additional information in the 
primary structure of adenylate cyclase determines RAS interaction. Our data 
indicates that Pb is the second fungus whose adenylate cyclase is regulated by RAS 
protein. In yeast S. cerevisiae, Ras can bind directly to adenylate cyclase and the 
binding is dependent on GTP but not dependent on famesylation and CAP (Kido et 
al, 2000). However, activation of adenylate cyclase depends on famesylation of Ras 
and the N-terminus of CAP. Interestingly, full-length PbRasl did not interact with 
adenylate cyclise but interacted with its N-terminus or C-terminus truncated forms 
(Fig. 3.14-3). The possibility is that PbRas 1 is not in the GTP-binding state in the 
yeast cell in which there is no cognate regulators such as GEF. InS. cerevisiae, the 
adenylate cyclase complexes extracted from the membrane do not include Ras 
proteins because the molecular sizes of the complexes were not affected by the 
presence or absence ofthe RAS2 protein (Wang et al, 1992). Therefore, Ras proteins 
are not tightly associated with adenylate cyclise, suggesting a transient interaction. 
In S. cerevisiae, the conserved N-terminal half of Ras appeared to be involved in 
adenylate cyclase activation while the variable C-terminal half is not crucial as the C-
terminal half deletion mutation ras Ill or ras21l behaved the same as the wild type in 
terms of the cAMP level produced (Hurwitz et al, 1995). In addition, deletion of the 
C-terminal half of Ras2 generated a constitutively active Ras2/l protein which could 
activate adenylate cyclase independent ofGTP, and which bypassed a GEF mutation 
cdc2515 (Marshall et al, 1987). Therefore, the C-terminal half of Ras appears to play 
a negative regulatory role in adenylate cyclase activation. The adenylate cyclase 
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binding domain of Ras has been mapped to theN-terminus and a peptide spanning 
residues 17-44 can completely inhibit the binding of Ras to adenylate cyclase 
(Ohnishi et al, 1998). This is consistent with our results because full-length PbRas1 
does not interact with adenylate cyclase but the truncated version of PbRasl (1-83) 
interacts with adenylate cyclase. 
In S. cerevisiae, the RAS interaction site does not fall within the leucine-rich repeats. 
However, the leucine-rich repeats are indispensable for activation (Suzuki et al, 
1990). The leucine-rich repeats form a special stereo structure that is essential for 
protein-protein interactions (Kajava, 1998). There is probably an intramolecular 
interaction within adenylate cyclase so that the signals caused by interaction with G 
proteins and Ras, in the N-terminal third of adenylate cyclase, can be relayed to the 
catalytic domain. Currently, we have no evidence of interdomain interactions in 
adenylate cyclase. Given that Pb adenylate cyclase could be a dimer, regulation of 
its activity could be much more complicated than anticipated. 
4.6 Ph Actin Acts on Adenylate Cyclase 
PbActin can interact directly with the N-terminal domain of Ph adenylate cyclase. 
This is not without precedence because recent studies have established a direct 
interaction of adenylate cyclase with actin in mammalian cells (Bajo et al, 2004). 
Previous studies have also established a connection between nutritional response 
signalling and cytoskeleton remodelling in yeast. InS. cerevisiae, adenylate cyclase 
is tightly associated with CAP; a bifunctional protein, with its N-terminal 168 
residues being responsible for mediating farnesylated Ras activation of adenylate 
cyclase and its C-terminal 158 residues being responsible for mediating normal cell 
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morphology and reaction to nutrient deprivation and excess (Nishida et al, 1998; 
Vojtek et al, 1991 ). The latter function can be suppressed by overexpression of the 
profilin, an actin- and polyphosphoinositide-binding protein, indicating a possible 
role for CAP in cytoskeletal association. In fact, cap- cells bud randomly and are 
defective in actin distribution (Vojteck et al, 1991 ). The function of CAP is probably 
for cellular localization of adenylate cyclase to actin filaments other than the Ras-
adenylate cyclase interaction. Indeed, the C-terminal half of CAP can directly bind 
to actin (Freeman et al, 1995). In addition, its proline-rich region binds to a SH3 
containing protein Abp 1, another actin-binding protein which can localize CAP and 
adenylate cyclase to cortical actin (Freeman et al, 1996). It is possible that the two 
functions of the N- and C-terminus of CAP are correlated. CAP might be 
responsible for a subcellular localization of adenylate cyclase. However, in our 
study, we established that adenylate cyclase can interact directly with actin alone. 
This means that CAP might be redundant for the subcellular localization of adenylate 
cyclase in Pb. There is still no evidence as to whether adenylate cyclase of the yeast 
S. cerevisiae can bind actin or not. If not, it might be CAP that acts as a scaffold to 
hold actin and adenylate cyclase together, while in Pb, adenylate cyclase can localize 
itself to actin without the assistance of CAP. PbCyrl can interact with the C-
terminus truncated actin but not fulllengh actin (Fig. 3.13 and Fig. 3.14-3). This can 
be explained by 3 possibilities. Firstly, adenylate cyclase interacts with the actin 
polymer rather than the monomer. Secondly, adenylate cyclase interacts with actin 
with the aid of a third partner that is probably CAP in Pb. In this case, CAP might be 
responsible for the spatial distribution of adenylate cyclase to make it accessible for 
G proteins or Ras; or to concentrate it at specific developmental structures, where it 
could locally increase the cAMP level. Thirdly, actin could regulate a specific 
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conformation of adenylate cyclase, transiently activating it in response to a specific 
signal. 
4.7 Future Work 
Although the current model for the activation of heterotrimeric G protein dictates 
that Ga dissociates from G~y and reassociates with it thereafter, this is not 
necessarily the case in reality. It has been demonstrated in the yeast S. cerevisiae 
that a nondissociable Ste4-Gpal fusion protein with only one amino acid as a linker 
is fully active in transducing the pheromone signal (Klein et al, 2000). In another 
study, dissociation was not required for Ga to activate adenylate cyclase (Bar-Sinai 
et al, 1992). Therefore, we propose that most of the molecules involved in G protein 
signalling pathway likely form a large complex that could include the receptor, G 
proteins and effectors. Upon signalling, instead of dissociating and reassociating, 
these components could change their conformations to relay the signal downwards. 
This hypothesis is possible as all these upstream components are membrane-
associated. However, it is hard to prove this because in most situations the down 
stream effectors of Ga and G~y are different. Our data indicates that in Pb, both the 
Ga and G~y directly work on theN-terminal end of adenylate cyclase. It would be 
interesting to crystallize the Ga(GDP)-adenylate cyclase dimer, Ga(GppNHp )-
adenylate cyclase dimer and 0~-adenylate cyclase dimer, respectively. Comparing 
these structures will tell us the relationships between these three components in both 
the situation when the pathway is activated and when it is inactivated. 
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